1	The	DT	O	the	det	3	SENT_1	[p1l1105t88r1148b110],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_1	[p1l1157t87r1387b117],
3	Ioumal	NNP	O	Ioumal	nsubj	5	SENT_1	[p1l1395t88r1479b115],
4	(	CD	NUMBER	(	num	5	SENT_1	[p1l1489t88r1565b116],
5	2009	CD	DATE	2009	_	0	SENT_1	[p1l1489t88r1565b116],
6	)	CD	NUMBER	)	num	7	SENT_1	[p1l1489t88r1565b116],
7	9	CD	NUMBER	9	nsubj	17	SENT_1	[p1l1575t88r1594b114],
8	,	,	O	,	_	0	SENT_1	[p1l1575t88r1594b114],
9	161-167	CD	NUMBER	161-167	num	16	SENT_1	[p1l1606t88r1699b110],
10	©	CD	NUMBER	©	number	11	SENT_1	[p1l1105t120r1121b139],
11	2009	CD	DATE	2009	num	16	SENT_1	[p1l1129t120r1175b139],
12	Nature	NNP	O	Nature	nn	16	SENT_1	[p1l1185t120r1247b139],
13	Publishing	NNP	O	Publishing	nn	16	SENT_1	[p1l1256t119r1350b145],
14	Group	NNP	O	Group	nn	16	SENT_1	[p1l1359t120r1417b145],
15	All	NNP	O	All	nn	16	SENT_1	[p1l1425t119r1447b139],
16	rights	NNS	O	rights	appos	7	SENT_1	[p1l1456t119r1507b145],
17	reserved	VBD	O	reserve	rcmod	5	SENT_1	[p1l1516t119r1591b139],
18	1470-269X	NN	O	1470-269x	dobj	17	SENT_1	[p1l1601t119r1736b141],
19	/	:	O	/	punct	23	SENT_1	[p1l1601t119r1736b141],
20	09	CD	NUMBER	09	dep	23	SENT_1	[p1l1601t119r1736b141],
21	$	$	MONEY	$	dep	20	SENT_1	[p1l1745t119r1810b140],
22	32.00	CD	MONEY	32.00	num	21	SENT_1	[p1l1745t119r1810b140],
23	www.nature.com/tpj	NN	MONEY	www.nature.com/tpj	parataxis	5	SENT_1	[p1l1105t165r1300b190],

1	ORIGINAL	JJ	O	original	amod	2	SENT_2	[p1l1665t229r1919b268],
2	ARTICLE	NN	O	article	_	0	SENT_2	[p1l1939t229r2149b268],

1	TNF-oc	JJ	O	tnf-oc	amod	2	SENT_3	[p1l9t365r276b437],
2	-308	CD	NUMBER	-308	_	0	SENT_3	[p1l319t364r553b437],
3	G/A	NN	O	g/a	nn	4	SENT_3	[p1l596t362r765b447],
4	polymorphism	NN	O	polymorphism	dep	2	SENT_3	[p1l805t362r1429b461],
5	and	CC	O	and	_	0	SENT_3	[p1l1474t362r1630b437],
6	responsiveness	NN	O	responsiveness	dep	2	SENT_3	[p1l16t489r651b586],
7	to	TO	O	to	_	0	SENT_3	[p1l689t496r774b562],
8	TNF-oc	NN	O	tnf-oc	nn	10	SENT_3	[p1l812t490r1079b562],
9	blockade	NN	O	blockade	nn	10	SENT_3	[p1l1120t487r1505b562],
10	therapy	NN	O	therapy	prep_to	4	SENT_3	[p1l1544t487r1877b586],
11	in	IN	O	in	_	0	SENT_3	[p1l1917t489r1986b561],
12	moderate	JJ	O	moderate	amod	14	SENT_3	[p1l16t612r430b687],
13	to	TO	O	to	dep	14	SENT_3	[p1l469t621r555b687],
14	severe	JJ	O	severe	amod	16	SENT_3	[p1l594t634r862b687],
15	rheumatoid	JJ	O	rheumatoid	amod	16	SENT_3	[p1l906t612r1405b687],
16	arthritis	NN	O	arthritis	prep_in	2	SENT_3	[p1l1449t612r1797b687],
17	:	:	O	:	_	0	SENT_3	[p1l1449t612r1797b687],

1	a	DT	O	a	det	3	SENT_4	[p1l13t759r54b812],
2	systematic	JJ	O	systematic	amod	3	SENT_4	[p1l94t739r546b836],
3	review	NN	O	review	_	0	SENT_4	[p1l588t739r867b812],
4	and	CC	O	and	_	0	SENT_4	[p1l905t737r1061b812],
5	meta	NN	O	meta	nn	7	SENT_4	[p1l1108t737r1687b836],
6	—	NN	O	—	nn	7	SENT_4	[p1l1108t737r1687b836],
7	analysis	NN	O	analysis	conj_and	3	SENT_4	[p1l1108t737r1687b836],

1	DD	NN	O	dd	nn	2	SENT_5	[p1l13t924r77b958],
2	O’Rie	NN	O	o’rie	_	0	SENT_5	[p1l97t918r286b970],
3	|	CD	NUMBER	|	num	5	SENT_5	[p1l97t918r286b970],
4	|	NN	O	|	nn	5	SENT_5	[p1l97t918r286b970],
5	y	NN	O	y	dep	2	SENT_5	[p1l97t918r286b970],
6	‘	CD	NUMBER	‘	dep	5	SENT_5	[p1l97t918r286b970],
7	,	,	O	,	_	0	SENT_5	[p1l97t918r286b970],
8	NM	NNP	PERSON	NM	nn	12	SENT_5	[p1l310t924r384b958],
9	Roslinz	NNP	PERSON	Roslinz	nn	12	SENT_5	[p1l407t918r556b966],
10	,	,	O	,	_	0	SENT_5	[p1l407t918r556b966],
11	J	NNP	O	J	appos	12	SENT_5	[p1l9t982r18b1025],
12	Beyene2	NN	O	beyene2	appos	6	SENT_5	[p1l41t976r251b1028],
13	'	''	O	'	_	0	SENT_5	[p1l41t976r251b1028],
14	-3	CD	NUMBER	-3	dep	12	SENT_5	[p1l41t976r251b1028],
15	,	,	O	,	_	0	SENT_5	[p1l41t976r251b1028],
16	A	DT	O	a	det	18	SENT_5	[p1l271t982r300b1016],
17	Pope	NNP	O	Pope	nn	18	SENT_5	[p1l320t976r441b1028],
18	“	NN	O	“	dep	2	SENT_5	[p1l320t976r441b1028],
19	and	CC	O	and	_	0	SENT_5	[p1l460t980r535b1017],
20	P	NN	O	p	nn	22	SENT_5	[p1l13t1040r33b1075],
21	Rahman	NN	PERSON	rahman	nn	22	SENT_5	[p1l54t1034r236b1075],
22	‘	NN	O	‘	conj_and	18	SENT_5	[p1l54t1034r236b1075],

1	‘	NNP	O	‘	nn	2	SENT_6	[p1l11t1130r192b1166],
2	Department	NNP	O	Department	_	0	SENT_6	[p1l11t1130r192b1166],
3	of	IN	O	of	_	0	SENT_6	[p1l204t1133r233b1158],
4	Rheumatology	NNP	O	Rheumatology	prep_of	2	SENT_6	[p1l242t1133r447b1166],
5	,	,	O	,	_	0	SENT_6	[p1l242t1133r447b1166],
6	Memorial	NNP	ORGANIZATION	Memorial	nn	7	SENT_6	[p1l463t1133r596b1158],
7	University	NNP	ORGANIZATION	University	appos	4	SENT_6	[p1l12t1171r147b1203],
8	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l158t1170r186b1195],
9	Newfoundland	NNP	ORGANIZATION	Newfoundland	prep_of	7	SENT_6	[p1l195t1170r406b1201],
10	,	,	O	,	_	0	SENT_6	[p1l195t1170r406b1201],
11	Newfoundland	NNP	LOCATION	Newfoundland	dep	2	SENT_6	[p1l422t1170r632b1201],
12	,	,	O	,	_	0	SENT_6	[p1l422t1170r632b1201],
13	Canada	NNP	LOCATION	Canada	appos	11	SENT_6	[p1l12t1207r128b1238],
14	;	:	O	;	_	0	SENT_6	[p1l12t1207r128b1238],
15	2The	NNP	O	2The	nn	16	SENT_6	[p1l139t1204r205b1233],
16	Hospital	NNP	ORGANIZATION	Hospital	dep	11	SENT_6	[p1l215t1207r329b1241],
17	for	IN	ORGANIZATION	for	_	0	SENT_6	[p1l338t1208r376b1233],
18	Sick	NNP	ORGANIZATION	Sick	nn	21	SENT_6	[p1l385t1207r437b1233],
19	Children	NNP	ORGANIZATION	Children	nn	21	SENT_6	[p1l449t1207r562b1233],
20	Research	NNP	ORGANIZATION	Research	nn	21	SENT_6	[p1l574t1207r694b1233],
21	Institute	NNP	ORGANIZATION	Institute	prep_for	16	SENT_6	[p1l11t1245r129b1275],
22	,	,	O	,	_	0	SENT_6	[p1l11t1245r129b1275],
23	Ontario	NNP	LOCATION	Ontario	nn	25	SENT_6	[p1l146t1245r257b1275],
24	,	,	O	,	_	0	SENT_6	[p1l146t1245r257b1275],
25	Canada	NNP	LOCATION	Canada	appos	21	SENT_6	[p1l274t1245r391b1275],
26	;	:	O	;	_	0	SENT_6	[p1l274t1245r391b1275],
27	3Department	NN	O	3department	dep	11	SENT_6	[p1l404t1241r585b1278],
28	of	IN	O	of	prep	27	SENT_6	[p1l597t1245r626b1270],

1	Statistics	NNPS	O	Statistics	_	0	SENT_7	[p1l11t1358r138b1388],
2	,	,	O	,	_	0	SENT_7	[p1l11t1358r138b1388],
3	Dalla	NNP	ORGANIZATION	Dalla	nn	5	SENT_7	[p1l154t1357r226b1382],
4	Lana	NNP	ORGANIZATION	Lana	nn	5	SENT_7	[p1l239t1358r306b1382],
5	School	NNP	ORGANIZATION	School	appos	1	SENT_7	[p1l319t1357r410b1382],
6	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l421t1357r450b1382],
7	Public	NNP	ORGANIZATION	Public	nn	8	SENT_7	[p1l459t1357r541b1382],
8	Health	NNP	ORGANIZATION	Health	prep_of	5	SENT_7	[p1l553t1357r649b1388],
9	,	,	ORGANIZATION	,	_	0	SENT_7	[p1l553t1357r649b1388],
10	University	NNP	ORGANIZATION	University	appos	8	SENT_7	[p1l12t1395r147b1427],
11	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l158t1395r186b1420],
12	Toronto	NNP	ORGANIZATION	Toronto	prep_of	10	SENT_7	[p1l198t1396r310b1425],
13	,	,	O	,	_	0	SENT_7	[p1l198t1396r310b1425],
14	Toronto	NNP	LOCATION	Toronto	prep_of	10	SENT_7	[p1l328t1396r440b1425],
15	,	,	O	,	_	0	SENT_7	[p1l328t1396r440b1425],
16	Ontario	NNP	LOCATION	Ontario	prep_of	10	SENT_7	[p1l457t1395r568b1425],
17	,	,	O	,	_	0	SENT_7	[p1l457t1395r568b1425],
18	Canada	NNP	LOCATION	Canada	conj_and	12	SENT_7	[p1l585t1394r693b1420],
19	and	CC	O	and	_	0	SENT_7	[p1l11t1432r65b1457],
20	“	NNP	O	“	conj_and	12	SENT_7	[p1l74t1429r234b1457],
21	Newfound	NNP	ORGANIZATION	Newfound	nn	22	SENT_7	[p1l74t1429r234b1457],
22	Genomics	NNP	ORGANIZATION	Genomics	dep	1	SENT_7	[p1l246t1433r386b1463],
23	,	,	O	,	_	0	SENT_7	[p1l246t1433r386b1463],
24	St	NNP	O	St	appos	22	SENT_7	[p1l402t1433r429b1457],
25	/	:	O	/	punct	26	SENT_7	[p1l438t1432r530b1463],
26	ohn	NN	O	ohn	dep	24	SENT_7	[p1l438t1432r530b1463],
27	’s	POS	O	’s	possessive	26	SENT_7	[p1l438t1432r530b1463],
28	,	,	O	,	_	0	SENT_7	[p1l438t1432r530b1463],
29	Newfoundland	NNP	LOCATION	Newfoundland	appos	26	SENT_7	[p1l11t1469r221b1500],
30	,	,	O	,	_	0	SENT_7	[p1l11t1469r221b1500],
31	Canada	NNP	LOCATION	Canada	appos	26	SENT_7	[p1l238t1469r346b1495],

1	Correspondence	NN	O	correspondence	_	0	SENT_8	[p1l10t1627r272b1660],
2	:	:	O	:	_	0	SENT_8	[p1l10t1627r272b1660],
3	Dr	NNP	O	Dr	nn	5	SENT_8	[p1l11t1666r45b1689],
4	Proton	NNP	PERSON	Proton	nn	5	SENT_8	[p1l58t1666r152b1690],
5	Rahman	NNP	PERSON	Rahman	dep	1	SENT_8	[p1l167t1665r292b1695],
6	,	,	O	,	_	0	SENT_8	[p1l167t1665r292b1695],
7	Professor	NNP	O	Professor	appos	1	SENT_8	[p1l308t1665r436b1690],
8	of	IN	O	of	_	0	SENT_8	[p1l448t1665r476b1690],
9	Medicine	NNP	MISC	Medicine	nn	12	SENT_8	[p1l489t1665r621b1690],
10	(	NNP	O	(	nn	12	SENT_8	[p1l10t1702r252b1735],
11	Rheumatology	NNP	O	Rheumatology	nn	12	SENT_8	[p1l10t1702r252b1735],
12	)	NN	O	)	prep_of	7	SENT_8	[p1l10t1702r252b1735],
13	,	,	O	,	_	0	SENT_8	[p1l10t1702r252b1735],
14	Memorial	NNP	O	Memorial	nn	15	SENT_8	[p1l269t1702r404b1727],
15	University	NNP	O	University	appos	1	SENT_8	[p1l419t1702r567b1735],
16	,	,	O	,	_	0	SENT_8	[p1l419t1702r567b1735],
17	St	NNP	O	St	nn	19	SENT_8	[p1l583t1703r610b1727],
18	C	NNP	O	C	nn	19	SENT_8	[p1l10t1739r105b1765],
19	|	NN	O	|	nsubj	20	SENT_8	[p1l10t1739r105b1765],
20	are	VBP	O	be	dep	1	SENT_8	[p1l10t1739r105b1765],
21	’s	POS	O	’s	dep	23	SENT_8	[p1l10t1739r105b1765],
22	Mercy	NNP	O	Mercy	nn	23	SENT_8	[p1l119t1741r208b1773],
23	Hospital	NNP	O	Hospital	dep	20	SENT_8	[p1l222t1739r344b1773],
24	,	,	O	,	_	0	SENT_8	[p1l222t1739r344b1773],
25	154	CD	NUMBER	154	num	27	SENT_8	[p1l361t1740r414b1765],
26	LeMarchant	JJ	O	lemarchant	amod	27	SENT_8	[p1l429t1739r601b1765],
27	Rd	NN	O	rd	dep	33	SENT_8	[p1l614t1739r656b1770],
28	,	,	O	,	_	0	SENT_8	[p1l614t1739r656b1770],
29	St	NNP	PERSON	St	appos	27	SENT_8	[p1l11t1778r38b1802],
30	John	NNP	PERSON	John	poss	29	SENT_8	[p1l49t1776r143b1808],
31	's	POS	O	's	_	0	SENT_8	[p1l49t1776r143b1808],
32	,	,	O	,	_	0	SENT_8	[p1l49t1776r143b1808],
33	Newfoundland	NNP	LOCATION	Newfoundland	dep	23	SENT_8	[p1l159t1777r383b1802],
34	.	.	O	.	_	0	SENT_8	[p1l159t1777r383b1802],

1	Canada	NNP	LOCATION	Canada	nn	2	SENT_9	[p1l398t1777r506b1802],
2	A1C	NNP	O	A1C	_	0	SENT_9	[p1l519t1778r580b1802],
3	SB8	NN	O	sb8	dep	2	SENT_9	[p1l593t1778r647b1802],

1	Received	VBN	O	receive	_	0	SENT_10	[p1l11t2745r145b2771],
2	2	CD	DATE	2	dobj	1	SENT_10	[p1l159t2746r176b2770],
3	September	NNP	DATE	September	tmod	1	SENT_10	[p1l190t2745r359b2779],
4	2008	CD	DATE	2008	num	3	SENT_10	[p1l371t2746r453b2776],
5	;	:	O	;	_	0	SENT_10	[p1l371t2746r453b2776],
6	revised	VBN	O	revise	parataxis	1	SENT_10	[p1l468t2745r575b2771],
7	19	CD	DATE	19	dobj	6	SENT_10	[p1l591t2746r625b2770],
8	February	NNP	DATE	February	tmod	6	SENT_10	[p1l11t2783r146b2816],
9	2009	CD	DATE	2009	num	8	SENT_10	[p1l168t2783r251b2813],
10	;	:	O	;	_	0	SENT_10	[p1l168t2783r251b2813],
11	accepted	VBN	O	accept	parataxis	1	SENT_10	[p1l276t2783r413b2816],
12	16	CD	DATE	16	dobj	11	SENT_10	[p1l439t2783r474b2808],
13	March	NNP	DATE	March	tmod	11	SENT_10	[p1l498t2783r593b2808],
14	2009	CD	DATE	2009	num	13	SENT_10	[p1l618t2783r700b2813],
15	;	:	O	;	_	0	SENT_10	[p1l618t2783r700b2813],
16	published	VBN	O	publish	parataxis	1	SENT_10	[p1l11t2820r159b2853],
17	online	NN	O	online	prep	16	SENT_10	[p1l173t2820r268b2845],
18	14	CD	DATE	14	dep	17	SENT_10	[p1l283t2821r318b2845],
19	April	NNP	DATE	April	tmod	16	SENT_10	[p1l329t2820r401b2853],
20	2009	CD	DATE	2009	num	19	SENT_10	[p1l415t2821r490b2845],

1	Although	IN	O	although	mark	17	SENT_11	[p1l748t913r916b954],
2	tumor	NN	O	tumor	nn	7	SENT_11	[p1l930t916r1043b944],
3	necrosis	NN	O	necrosis	nn	7	SENT_11	[p1l1056t913r1198b944],
4	factor	NN	O	factor	nn	7	SENT_11	[p1l1210t913r1351b944],
5	—	CD	NUMBER	—	num	7	SENT_11	[p1l1210t913r1351b944],
6	oc	NN	O	oc	nn	7	SENT_11	[p1l1210t913r1351b944],
7	(	NN	O	(	nsubj	17	SENT_11	[p1l1365t913r1502b952],
8	TNF	NN	O	tnf	nn	12	SENT_11	[p1l1365t913r1502b952],
9	—	NN	O	—	nn	12	SENT_11	[p1l1365t913r1502b952],
10	oc	NN	O	oc	nn	12	SENT_11	[p1l1365t913r1502b952],
11	)	NN	O	)	nn	12	SENT_11	[p1l1365t913r1502b952],
12	blockade	NN	O	blockade	dep	7	SENT_11	[p1l1518t913r1679b944],
13	is	VBZ	O	be	cop	17	SENT_11	[p1l1694t913r1716b944],
14	a	DT	O	a	det	17	SENT_11	[p1l1729t922r1747b944],
15	very	RB	O	very	advmod	16	SENT_11	[p1l1760t922r1836b954],
16	effective	JJ	O	effective	amod	17	SENT_11	[p1l1849t913r1998b944],
17	therapy	NN	O	therapy	advcl	28	SENT_11	[p1l2011t913r2150b954],
18	for	IN	O	for	_	0	SENT_11	[p1l747t960r798b991],
19	rheumatoid	JJ	O	rheumatoid	amod	21	SENT_11	[p1l816t960r1026b991],
20	arthritis	NN	O	arthritis	nn	21	SENT_11	[p1l1045t960r1181b991],
21	(	NN	O	(	prep_for	17	SENT_11	[p1l1200t960r1285b999],
22	RA	NN	O	ra	prep	21	SENT_11	[p1l1200t960r1285b999],
23	)	CD	NUMBER	)	dep	22	SENT_11	[p1l1200t960r1285b999],
24	,	,	O	,	_	0	SENT_11	[p1l1200t960r1285b999],
25	not	RB	O	not	neg	27	SENT_11	[p1l1307t963r1366b991],
26	all	DT	O	all	det	27	SENT_11	[p1l1384t960r1420b991],
27	patients	NNS	O	patient	nsubj	28	SENT_11	[p1l1442t960r1583b1001],
28	achieve	VBP	O	achieve	_	0	SENT_11	[p1l1602t960r1736b991],
29	a	DT	O	a	det	31	SENT_11	[p1l1755t969r1772b991],
30	favorable	JJ	O	favorable	amod	31	SENT_11	[p1l1790t960r1957b991],
31	outcome	NN	O	outcome	dobj	28	SENT_11	[p1l1976t963r2147b991],
32	.	.	O	.	_	0	SENT_11	[p1l1976t963r2147b991],

1	The	DT	O	the	det	2	SENT_12	[p1l748t1006r815b1038],
2	objective	NN	O	objective	nsubj	6	SENT_12	[p1l833t1006r995b1048],
3	of	IN	O	of	_	0	SENT_12	[p1l1014t1006r1049b1038],
4	this	DT	O	this	det	5	SENT_12	[p1l1065t1006r1128b1038],
5	study	NN	O	study	prep_of	2	SENT_12	[p1l1146t1006r1244b1048],
6	was	VBD	O	be	_	0	SENT_12	[p1l1260t1016r1328b1038],
7	to	TO	O	to	aux	8	SENT_12	[p1l1346t1010r1381b1038],
8	determine	VB	O	determine	xcomp	6	SENT_12	[p1l1400t1006r1586b1038],
9	if	IN	O	if	mark	19	SENT_12	[p1l1605t1006r1625b1038],
10	the	DT	O	the	det	12	SENT_12	[p1l1641t1006r1699b1038],
11	common	JJ	O	common	amod	12	SENT_12	[p1l1717t1016r1879b1038],
12	TNF-or	NN	O	tnf-or	nsubj	19	SENT_12	[p1l1898t1008r2010b1038],
13	variant	JJ	O	variant	amod	14	SENT_12	[p1l2026t1007r2151b1038],
14	—	NN	O	—	dep	12	SENT_12	[p1l751t1053r904b1093],
15	308	CD	NUMBER	308	num	16	SENT_12	[p1l751t1053r904b1093],
16	(	NN	O	(	dep	12	SENT_12	[p1l751t1053r904b1093],
17	A	DT	O	a	det	18	SENT_12	[p1l751t1053r904b1093],
18	)	NN	O	)	dep	16	SENT_12	[p1l751t1053r904b1093],
19	predicts	VBZ	O	predict	advcl	8	SENT_12	[p1l929t1053r1070b1095],
20	poor	JJ	O	poor	amod	21	SENT_12	[p1l1095t1062r1179b1095],
21	response	NN	O	response	dobj	19	SENT_12	[p1l1202t1062r1359b1095],
22	to	TO	O	to	_	0	SENT_12	[p1l1381t1057r1417b1085],
23	TNF-oc	NN	O	tnf-oc	nn	24	SENT_12	[p1l1439t1055r1550b1085],
24	inhibitors	NNS	O	inhibitor	prep_to	19	SENT_12	[p1l1574t1053r1741b1085],
25	in	IN	O	in	_	0	SENT_12	[p1l1765t1054r1794b1084],
26	RA	NN	O	ra	nn	27	SENT_12	[p1l1821t1055r1866b1084],
27	patients	NNS	O	patient	prep_in	24	SENT_12	[p1l1889t1054r2030b1095],
28	using	VBG	O	use	partmod	27	SENT_12	[p1l2055t1054r2148b1095],
29	meta-analysis	NN	O	meta-analysis	dobj	28	SENT_12	[p1l751t1100r1002b1141],
30	.	.	O	.	_	0	SENT_12	[p1l751t1100r1002b1141],

1	Studies	NNS	O	study	nsubjpass	3	SENT_13	[p1l1028t1100r1156b1131],
2	were	VBD	O	be	auxpass	3	SENT_13	[p1l1177t1109r1265b1131],
3	identified	VBN	O	identify	_	0	SENT_13	[p1l1289t1100r1456b1131],
4	using	VBG	O	use	xcomp	3	SENT_13	[p1l1481t1101r1574b1141],
5	MEDLINE	NN	O	medline	dobj	4	SENT_13	[p1l1600t1101r1770b1131],
6	and	CC	O	and	_	0	SENT_13	[p1l1793t1100r1858b1131],
7	EMBASE	NN	O	embase	conj_and	5	SENT_13	[p1l1884t1101r2041b1131],
8	.	.	O	.	_	0	SENT_13	[p1l1884t1101r2041b1131],

1	Data	NNS	O	datum	nsubjpass	8	SENT_14	[p1l2067t1101r2149b1131],
2	were	VBD	O	be	auxpass	3	SENT_14	[p1l748t1156r835b1178],
3	extracted	VBN	O	extract	_	0	SENT_14	[p1l855t1147r1023b1178],
4	based	VBN	O	base	_	0	SENT_14	[p1l1045t1147r1147b1178],
5	on	IN	O	on	prepc_based_on	3	SENT_14	[p1l1168t1156r1211b1178],
6	DAS28	NN	O	das28	pobj	3	SENT_14	[p1l1234t1148r1354b1178],
7	or	CC	O	or	_	0	SENT_14	[p1l1374t1156r1411b1178],
8	achieving	VBG	O	achieve	conj_or	3	SENT_14	[p1l1429t1147r1599b1188],
9	at	IN	O	at	advmod	11	SENT_14	[p1l1620t1151r1654b1178],
10	least	JJS	O	least	pobj	9	SENT_14	[p1l1673t1147r1753b1178],
11	American	JJ	ORGANIZATION	american	amod	12	SENT_14	[p1l1769t1148r1940b1178],
12	College	NNP	ORGANIZATION	College	dobj	8	SENT_14	[p1l1961t1147r2097b1188],
13	of	IN	ORGANIZATION	of	_	0	SENT_14	[p1l2116t1147r2151b1178],
14	Rheumatology	NNP	ORGANIZATION	Rheumatology	nn	16	SENT_14	[p1l751t1193r1015b1235],
15	20	CD	NUMBER	20	num	16	SENT_14	[p1l1030t1194r1074b1225],
16	response	NN	O	response	prep_of	12	SENT_14	[p1l1092t1203r1260b1235],
17	.	.	O	.	_	0	SENT_14	[p1l1092t1203r1260b1235],

1	A	DT	O	a	det	2	SENT_15	[p1l1276t1195r1302b1224],
2	total	NN	O	total	nsubj	6	SENT_15	[p1l1315t1193r1395b1225],
3	of	IN	O	of	_	0	SENT_15	[p1l1412t1193r1448b1225],
4	nine	CD	NUMBER	nine	num	5	SENT_15	[p1l1463t1194r1538b1225],
5	studies	NNS	O	study	prep_of	2	SENT_15	[p1l1554t1193r1678b1225],
6	met	VBD	O	meet	_	0	SENT_15	[p1l1695t1197r1765b1225],
7	the	DT	O	the	det	9	SENT_15	[p1l1779t1193r1836b1225],
8	inclusion	NN	O	inclusion	nn	9	SENT_15	[p1l1853t1193r2010b1225],
9	criteria	NNS	O	criterion	dobj	6	SENT_15	[p1l2027t1194r2149b1225],
10	representing	VBG	O	represent	xcomp	6	SENT_15	[p1l751t1241r975b1281],
11	a	DT	O	a	det	12	SENT_15	[p1l1014t1249r1032b1271],
12	total	NN	O	total	dobj	10	SENT_15	[p1l1069t1240r1148b1271],
13	of	IN	O	of	_	0	SENT_15	[p1l1188t1240r1223b1271],
14	692	CD	NUMBER	692	num	16	SENT_15	[p1l1259t1241r1326b1271],
15	RA	NN	O	ra	nn	16	SENT_15	[p1l1366t1242r1412b1271],
16	patients	NNS	O	patient	prep_of	12	SENT_15	[p1l1449t1241r1601b1281],
17	.	.	O	.	_	0	SENT_15	[p1l1449t1241r1601b1281],

1	There	EX	O	there	expl	2	SENT_16	[p1l1639t1240r1741b1271],
2	was	VBD	O	be	dep	10	SENT_16	[p1l1778t1249r1846b1271],
3	no	DT	O	no	det	5	SENT_16	[p1l1884t1249r1928b1271],
4	significant	JJ	O	significant	amod	5	SENT_16	[p1l1965t1240r2151b1281],
5	heterogeneity	NN	O	heterogeneity	nsubj	2	SENT_16	[p1l751t1362r1003b1403],
6	among	IN	O	among	_	0	SENT_16	[p1l1022t1371r1148b1403],
7	study	NN	O	study	nn	9	SENT_16	[p1l1169t1362r1267b1403],
8	effect	NN	O	effect	nn	9	SENT_16	[p1l1286t1362r1385b1393],
9	sizes	NNS	O	size	prep_among	5	SENT_16	[p1l1403t1363r1483b1393],
10	(	VBP	O	(	_	0	SENT_16	[p1l1503t1362r1690b1401],
11	P	NN	O	p	nsubj	12	SENT_16	[p1l1503t1362r1690b1401],
12	=	JJ	O	=	xcomp	10	SENT_16	[p1l1503t1362r1690b1401],
13	0.36	CD	NUMBER	0.36	num	14	SENT_16	[p1l1503t1362r1690b1401],
14	)	NN	O	)	nsubj	10	SENT_16	[p1l1503t1362r1690b1401],
15	.	.	O	.	_	0	SENT_16	[p1l1503t1362r1690b1401],

1	The	DT	O	the	det	2	SENT_17	[p1l1711t1362r1778b1393],
2	frequency	NN	O	frequency	nsubj	9	SENT_17	[p1l1796t1362r1978b1403],
3	of	IN	O	of	_	0	SENT_17	[p1l1997t1362r2032b1393],
4	the	DT	O	the	det	6	SENT_17	[p1l2049t1362r2107b1393],
5	A	NN	O	a	nn	6	SENT_17	[p1l2125t1363r2151b1393],
6	allele	NN	O	allele	prep_of	2	SENT_17	[p1l749t1408r839b1440],
7	was	VBD	O	be	cop	9	SENT_17	[p1l870t1418r938b1440],
8	22	CD	PERCENT	22	num	9	SENT_17	[p1l970t1409r1053b1440],
9	%	NN	PERCENT	%	_	0	SENT_17	[p1l970t1409r1053b1440],
10	(	CD	NUMBER	(	number	11	SENT_17	[p1l1085t1408r1269b1448],
11	119/531	CD	NUMBER	119/531	num	12	SENT_17	[p1l1085t1408r1269b1448],
12	)	NN	O	)	attr	9	SENT_17	[p1l1085t1408r1269b1448],
13	in	IN	O	in	_	0	SENT_17	[p1l1303t1409r1332b1440],
14	responders	NNS	O	responder	prep_in	12	SENT_17	[p1l1367t1408r1563b1450],
15	and	CC	O	and	_	0	SENT_17	[p1l1595t1408r1661b1440],
16	37	CD	PERCENT	37	num	17	SENT_17	[p1l1696t1409r1777b1440],
17	%	NN	PERCENT	%	conj_and	14	SENT_17	[p1l1696t1409r1777b1440],
18	(	CD	NUMBER	(	number	19	SENT_17	[p1l1810t1408r1970b1448],
19	60/161	CD	NUMBER	60/161	num	20	SENT_17	[p1l1810t1408r1970b1448],
20	)	NN	O	)	dep	17	SENT_17	[p1l1810t1408r1970b1448],
21	in	IN	O	in	_	0	SENT_17	[p1l2004t1409r2033b1440],
22	nonresponders	NNS	O	nonresponder	prep_in	12	SENT_17	[p1l2067t1418r2149b1440, p1l751t1455r957b1497],
23	.	.	O	.	_	0	SENT_17	[p1l2067t1418r2149b1440, p1l751t1455r957b1497],

1	The	DT	O	the	det	2	SENT_18	[p1l975t1455r1042b1487],
2	odds	NNS	O	odds	nsubj	19	SENT_18	[p1l1060t1455r1146b1487],
3	of	IN	O	of	_	0	SENT_18	[p1l1164t1455r1198b1487],
4	having	VBG	O	have	prepc_of	2	SENT_18	[p1l1216t1455r1334b1497],
5	the	DT	O	the	det	7	SENT_18	[p1l1353t1455r1410b1487],
6	A	NN	O	a	nn	7	SENT_18	[p1l1426t1457r1452b1487],
7	allele	NN	O	allele	dobj	4	SENT_18	[p1l1468t1455r1558b1487],
8	was	VBD	O	be	cop	19	SENT_18	[p1l1574t1465r1642b1487],
9	lower	JJR	O	lower	advmod	19	SENT_18	[p1l1661t1455r1760b1487],
10	in	IN	O	in	_	0	SENT_18	[p1l1777t1456r1806b1487],
11	responders	NNS	O	responder	prep_in	9	SENT_18	[p1l1827t1455r2023b1497],
12	versus	CC	O	versus	prep	11	SENT_18	[p1l2039t1465r2150b1487],
13	non-responders	JJ	O	non-responders	amod	15	SENT_18	[p1l751t1502r1033b1544],
14	(	NN	O	(	nn	15	SENT_18	[p1l1062t1502r1163b1542],
15	odds	NNS	O	odds	dep	12	SENT_18	[p1l1062t1502r1163b1542],
16	ratio	NN	O	ratio	nn	19	SENT_18	[p1l1193t1503r1272b1534],
17	(	CD	NUMBER	(	num	19	SENT_18	[p1l1302t1502r1523b1542],
18	OR	NN	O	or	nn	19	SENT_18	[p1l1302t1502r1523b1542],
19	)	NN	O	)	ccomp	27	SENT_18	[p1l1302t1502r1523b1542],
20	=	JJ	O	=	amod	19	SENT_18	[p1l1302t1502r1523b1542],
21	0.43	CD	NUMBER	0.43	tmod	20	SENT_18	[p1l1302t1502r1523b1542],
22	,	,	O	,	_	0	SENT_18	[p1l1302t1502r1523b1542],
23	95	CD	PERCENT	95	number	24	SENT_18	[p1l1555t1503r1637b1534],
24	%	NN	PERCENT	%	amod	26	SENT_18	[p1l1555t1503r1637b1534],
25	confidence	NN	O	confidence	nn	26	SENT_18	[p1l1666t1502r1865b1534],
26	intervals	NNS	O	interval	nsubj	27	SENT_18	[p1l1895t1502r2042b1534],
27	(	VBP	O	(	_	0	SENT_18	[p1l2071t1502r2147b1542],
28	CI	NN	O	ci	nn	29	SENT_18	[p1l2071t1502r2147b1542],
29	)	NN	O	)	dobj	27	SENT_18	[p1l2071t1502r2147b1542],
30	:	:	O	:	_	0	SENT_18	[p1l2071t1502r2147b1542],

1	0.28-0	CD	NUMBER	0.28-0	num	2	SENT_19	[p1l749t1625r955b1662],
2	.68	CD	NUMBER	.68	_	0	SENT_19	[p1l749t1625r955b1662],
3	,	,	O	,	_	0	SENT_19	[p1l749t1625r955b1662],
4	P	NN	O	p	appos	2	SENT_19	[p1l983t1624r1249b1663],
5	=	JJ	O	=	amod	2	SENT_19	[p1l983t1624r1249b1663],
6	0.000245	CD	NUMBER	0.000245	number	7	SENT_19	[p1l983t1624r1249b1663],
7	)	CD	NUMBER	)	dep	5	SENT_19	[p1l983t1624r1249b1663],
8	,	,	O	,	_	0	SENT_19	[p1l983t1624r1249b1663],
9	irrespective	RB	O	irrespective	_	0	SENT_19	[p1l1276t1625r1479b1665],
10	of	IN	O	of	_	0	SENT_19	[p1l1503t1624r1538b1655],
11	the	DT	O	the	det	13	SENT_19	[p1l1559t1624r1616b1655],
12	TNF-or	NN	O	tnf-or	nn	13	SENT_19	[p1l1638t1625r1750b1655],
13	inhibitor	NN	O	inhibitor	prep_irrespective_of	14	SENT_19	[p1l1774t1624r1927b1655],
14	prescribed	VBN	O	prescribe	partmod	2	SENT_19	[p1l1950t1624r2147b1665],
15	,	,	O	,	_	0	SENT_19	[p1l1950t1624r2147b1665],
16	indicating	VBG	O	indicate	partmod	2	SENT_19	[p1l750t1671r927b1712],
17	that	IN	O	that	complm	25	SENT_19	[p1l960t1671r1033b1702],
18	the	DT	O	the	det	21	SENT_19	[p1l1063t1671r1120b1702],
19	—	NN	O	—	nn	21	SENT_19	[p1l1154t1671r1307b1710],
20	308	CD	NUMBER	308	num	21	SENT_19	[p1l1154t1671r1307b1710],
21	(	NN	O	(	nsubj	25	SENT_19	[p1l1154t1671r1307b1710],
22	A	DT	O	a	det	23	SENT_19	[p1l1154t1671r1307b1710],
23	)	NN	O	)	npadvmod	24	SENT_19	[p1l1154t1671r1307b1710],
24	variant	JJ	O	variant	amod	21	SENT_19	[p1l1338t1672r1463b1702],
25	predicts	VBZ	O	predict	ccomp	16	SENT_19	[p1l1494t1671r1635b1712],
26	poor	JJ	O	poor	amod	27	SENT_19	[p1l1668t1680r1753b1712],
27	response	NN	O	response	dobj	25	SENT_19	[p1l1784t1680r1941b1712],
28	to	TO	O	to	_	0	SENT_19	[p1l1972t1675r2008b1702],
29	TNF-or	NN	O	tnf-or	nn	30	SENT_19	[p1l2038t1672r2150b1702],
30	inhibitors	NNS	O	inhibitor	prep_to	2	SENT_19	[p1l750t1717r928b1749],
31	.	.	O	.	_	0	SENT_19	[p1l750t1717r928b1749],

1	The	DT	O	the	det	3	SENT_20	[p1l953t1717r1020b1749],
2	clinical	JJ	O	clinical	amod	3	SENT_20	[p1l1044t1717r1165b1749],
3	utility	NN	O	utility	nsubjpass	20	SENT_20	[p1l1192t1717r1292b1759],
4	of	IN	O	of	_	0	SENT_20	[p1l1315t1717r1350b1749],
5	prospectively	RB	O	prospectively	advmod	6	SENT_20	[p1l1374t1717r1612b1759],
6	genotyping	VBG	O	genotype	prepc_of	3	SENT_20	[p1l1635t1718r1844b1759],
7	for	IN	O	for	_	0	SENT_20	[p1l1868t1717r1919b1749],
8	this	DT	O	this	det	9	SENT_20	[p1l1941t1717r2003b1749],
9	variant	NN	O	variant	prep_for	6	SENT_20	[p1l2026t1718r2151b1749],
10	when	WRB	O	when	advmod	11	SENT_20	[p1l748t1764r847b1796],
11	initiating	VBG	O	initiate	advcl	6	SENT_20	[p1l866t1765r1023b1806],
12	anti-TNF-or	JJ	O	anti-tnf-or	amod	13	SENT_20	[p1l1041t1765r1235b1796],
13	therapy	NN	O	therapy	dobj	11	SENT_20	[p1l1250t1764r1389b1806],
14	for	IN	O	for	_	0	SENT_20	[p1l1403t1764r1454b1796],
15	RA	NN	O	ra	prep_for	11	SENT_20	[p1l1471t1766r1516b1796],
16	should	MD	O	should	aux	20	SENT_20	[p1l1531t1764r1650b1796],
17	now	RB	DATE	now	advmod	20	SENT_20	[p1l1669t1774r1746b1796],
18	be	VB	O	be	auxpass	20	SENT_20	[p1l1764t1764r1805b1796],
19	formally	RB	O	formally	advmod	20	SENT_20	[p1l1820t1764r1969b1806],
20	assessed	VBN	O	assess	_	0	SENT_20	[p1l1985t1764r2144b1796],
21	.	.	O	.	_	0	SENT_20	[p1l1985t1764r2144b1796],

1	The	DT	O	the	det	3	SENT_21	[p1l753t1811r812b1842],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	3	SENT_21	[p1l834t1811r1165b1852],
3	journal	NN	O	journal	_	0	SENT_21	[p1l1183t1811r1309b1849],
4	(	CD	NUMBER	(	num	5	SENT_21	[p1l1327t1811r1446b1850],
5	2009	CD	DATE	2009	dep	3	SENT_21	[p1l1327t1811r1446b1850],
6	)	CD	NUMBER	)	number	7	SENT_21	[p1l1327t1811r1446b1850],
7	9	CD	NUMBER	9	dep	5	SENT_21	[p1l1468t1812r1500b1849],
8	,	,	O	,	_	0	SENT_21	[p1l1468t1812r1500b1849],
9	161	CD	NUMBER	161	number	10	SENT_21	[p1l1526t1812r1584b1842],
10	-167	CD	NUMBER	-167	appos	3	SENT_21	[p1l1593t1812r1692b1849],
11	;	:	O	;	_	0	SENT_21	[p1l1593t1812r1692b1849],
12	doi	FW	O	doi	dep	10	SENT_21	[p1l1716t1811r2148b1852],
13	:10.1038	CD	NUMBER	:10.1038	dep	12	SENT_21	[p1l1716t1811r2148b1852],
14	/	:	O	/	punct	15	SENT_21	[p1l1716t1811r2148b1852],
15	tpj	NN	O	tpj	dep	13	SENT_21	[p1l1716t1811r2148b1852],
16	.2009.7	CD	NUMBER	.2009.7	num	15	SENT_21	[p1l1716t1811r2148b1852],
17	;	:	O	;	_	0	SENT_21	[p1l1716t1811r2148b1852],
18	published	VBN	O	publish	partmod	10	SENT_21	[p1l751t1858r921b1899],
19	online	NN	O	online	prep	18	SENT_21	[p1l938t1858r1047b1889],
20	14	CD	DATE	14	dep	19	SENT_21	[p1l1065t1859r1107b1889],
21	April	NNP	DATE	April	tmod	18	SENT_21	[p1l1122t1858r1202b1899],
22	2009	CD	DATE	2009	num	21	SENT_21	[p1l1220t1859r1310b1889],

1	Keywords	NNPS	O	Keywords	_	0	SENT_22	[p1l749t1955r920b1988],
2	:	:	O	:	_	0	SENT_22	[p1l749t1955r920b1988],
3	TNF-or	NN	O	tnf-or	dep	1	SENT_22	[p1l938t1956r1035b1985],
4	;	:	O	;	_	0	SENT_22	[p1l938t1956r1035b1985],
5	rheumatoid	JJ	O	rheumatoid	amod	6	SENT_22	[p1l1051t1955r1217b1980],
6	arthritis	NN	O	arthritis	dep	3	SENT_22	[p1l1231t1955r1348b1985],
7	;	:	O	;	_	0	SENT_22	[p1l1231t1955r1348b1985],
8	pharmacogenetics	NNS	O	pharmacogenetic	dep	6	SENT_22	[p1l1363t1955r1629b1988],

1	Introduction	NN	O	introduction	_	0	SENT_23	[p1l751t2139r965b2167],

1	Rheumatoid	JJ	O	rheumatoid	amod	2	SENT_24	[p1l749t2231r962b2260],
2	arthritis	NN	O	arthritis	nsubj	20	SENT_24	[p1l974t2232r1111b2260],
3	(	CD	NUMBER	(	num	5	SENT_24	[p1l1125t2232r1196b2267],
4	RA	NN	O	ra	nn	5	SENT_24	[p1l1125t2232r1196b2267],
5	)	NN	O	)	nsubj	11	SENT_24	[p1l1125t2232r1196b2267],
6	is	VBZ	O	be	cop	11	SENT_24	[p1l1210t2233r1235b2260],
7	a	DT	O	a	det	11	SENT_24	[p1l1248t2240r1265b2260],
8	chronic	JJ	O	chronic	amod	11	SENT_24	[p1l1278t2232r1410b2260],
9	systemic	JJ	O	systemic	amod	11	SENT_24	[p1l1423t2233r1570b2269],
10	autoimmune	JJ	O	autoimmune	amod	11	SENT_24	[p1l1582t2233r1806b2260],
11	disease	NN	O	disease	rcmod	2	SENT_24	[p1l1820t2232r1938b2260],
12	resulting	VBG	O	result	partmod	11	SENT_24	[p1l1951t2232r2104b2269],
13	in	IN	O	in	_	0	SENT_24	[p1l2115t2233r2150b2260],
14	inﬂammation	NN	O	inﬂammation	prep_in	12	SENT_24	[p1l749t2278r989b2306],
15	in	IN	O	in	_	0	SENT_24	[p1l1004t2280r1038b2306],
16	articular	JJ	O	articular	amod	19	SENT_24	[p1l1054t2278r1198b2306],
17	and	CC	O	and	_	0	SENT_24	[p1l1213t2278r1277b2306],
18	extra-articular	JJ	O	extra-articular	conj_and	16	SENT_24	[p1l1292t2278r1536b2306],
19	structures	NNS	O	structure	prep_in	14	SENT_24	[p1l1551t2275r1744b2306],
20	}	VBP	O	}	_	0	SENT_24	[p1l1551t2275r1744b2306],
21	Although	IN	O	although	mark	27	SENT_24	[p1l1760t2278r1925b2315],
22	the	DT	O	the	det	23	SENT_24	[p1l1940t2278r1995b2306],
23	etiology	NN	O	etiology	nsubj	27	SENT_24	[p1l2011t2278r2151b2315],
24	of	IN	O	of	_	0	SENT_24	[p1l749t2325r784b2353],
25	RA	NN	O	ra	prep_of	23	SENT_24	[p1l796t2326r843b2353],
26	remains	VBZ	O	remain	cop	27	SENT_24	[p1l856t2327r993b2353],
27	elusive	JJ	O	elusive	advcl	30	SENT_24	[p1l1007t2325r1132b2359],
28	,	,	O	,	_	0	SENT_24	[p1l1007t2325r1132b2359],
29	there	EX	O	there	expl	30	SENT_24	[p1l1148t2325r1236b2353],
30	is	VBZ	O	be	ccomp	20	SENT_24	[p1l1250t2326r1275b2353],
31	substantive	JJ	O	substantive	amod	32	SENT_24	[p1l1289t2325r1484b2353],
32	evidence	NN	O	evidence	nsubj	30	SENT_24	[p1l1498t2325r1649b2353],
33	that	IN	O	that	complm	45	SENT_24	[p1l1663t2325r1733b2353],
34	tumor	NN	O	tumor	nn	39	SENT_24	[p1l1746t2329r1853b2353],
35	necrosis	NN	O	necrosis	nn	39	SENT_24	[p1l1866t2326r2004b2353],
36	factor	NN	O	factor	nn	39	SENT_24	[p1l2018t2325r2150b2353],
37	—	CD	NUMBER	—	num	39	SENT_24	[p1l2018t2325r2150b2353],
38	oc	NN	O	oc	nn	39	SENT_24	[p1l2018t2325r2150b2353],
39	(	NN	O	(	nsubj	45	SENT_24	[p1l750t2372r876b2408],
40	TNF-or	NN	O	tnf-or	nn	41	SENT_24	[p1l750t2372r876b2408],
41	)	NN	O	)	dep	39	SENT_24	[p1l750t2372r876b2408],
42	is	VBZ	O	be	cop	45	SENT_24	[p1l895t2373r920b2400],
43	a	DT	O	a	det	45	SENT_24	[p1l938t2380r954b2400],
44	key	JJ	O	key	amod	45	SENT_24	[p1l971t2372r1031b2409],
45	cytokine	NN	O	cytokine	ccomp	30	SENT_24	[p1l1047t2372r1195b2409],
46	in	IN	O	in	_	0	SENT_24	[p1l1212t2373r1247b2400],
47	the	DT	O	the	det	48	SENT_24	[p1l1263t2372r1318b2400],
48	pathogenesis	NN	O	pathogenesis	prep_in	45	SENT_24	[p1l1336t2372r1560b2409],
49	of	IN	O	of	_	0	SENT_24	[p1l1578t2372r1613b2400],
50	RA	NN	O	ra	prep_of	48	SENT_24	[p1l1628t2373r1684b2400],
51	.	.	O	.	_	0	SENT_24	[p1l1628t2373r1684b2400],

1	The	DT	O	the	det	2	SENT_25	[p1l1702t2372r1767b2400],
2	latter	JJ	O	latter	nsubj	3	SENT_25	[p1l1784t2372r1875b2400],
3	plays	VBZ	O	play	_	0	SENT_25	[p1l1891t2372r1978b2409],
4	a	DT	O	a	det	6	SENT_25	[p1l1996t2380r2013b2400],
5	pivotal	JJ	O	pivotal	amod	6	SENT_25	[p1l2030t2372r2150b2409],
6	role	NN	O	role	dobj	3	SENT_25	[p1l749t2427r813b2455],
7	in	IN	O	in	_	0	SENT_25	[p1l825t2428r859b2455],
8	stimulating	VBG	O	stimulate	prepc_in	3	SENT_25	[p1l871t2427r1069b2464],
9	cytokines	NNS	O	cytokine	nsubj	10	SENT_25	[p1l1080t2427r1244b2464],
10	critical	JJ	O	critical	xcomp	8	SENT_25	[p1l1255t2427r1372b2455],
11	in	IN	O	in	_	0	SENT_25	[p1l1384t2429r1418b2455],
12	initiating	VBG	O	initiate	prepc_in	10	SENT_25	[p1l1429t2428r1591b2464],
13	and	CC	O	and	_	0	SENT_25	[p1l1602t2427r1666b2455],
14	perpetuating	VBG	O	perpetuate	prepc_in	10	SENT_25	[p1l1677t2428r1899b2464],
15	inﬂammation	NN	O	inﬂammation	dobj	12	SENT_25	[p1l1910t2427r2150b2455],
16	in	IN	O	in	_	0	SENT_25	[p1l749t2482r783b2508],
17	RA	NN	O	ra	prep_in	12	SENT_25	[p1l799t2477r873b2509],
18	.	.	O	.	_	0	SENT_25	[p1l799t2477r873b2509],

1	”	RB	O	”	advmod	4	SENT_26	[p1l799t2477r873b2509],
2	It	PRP	O	it	nsubj	4	SENT_26	[p1l889t2482r914b2509],
3	also	RB	O	also	advmod	4	SENT_26	[p1l930t2481r995b2509],
4	activates	VBZ	O	activate	ccomp	8	SENT_26	[p1l1012t2482r1160b2509],
5	the	DT	O	the	det	6	SENT_26	[p1l1176t2481r1231b2509],
6	endothelium	NN	O	endothelium	dobj	4	SENT_26	[p1l1247t2481r1480b2515],
7	,	,	O	,	_	0	SENT_26	[p1l1247t2481r1480b2515],
8	enhances	VBZ	O	enhance	_	0	SENT_26	[p1l1498t2481r1659b2509],
9	the	DT	O	the	det	10	SENT_26	[p1l1675t2481r1730b2509],
10	expression	NN	O	expression	nsubj	17	SENT_26	[p1l1747t2482r1929b2518],
11	of	IN	O	of	_	0	SENT_26	[p1l1945t2480r1980b2509],
12	adhesion	NN	O	adhesion	nn	13	SENT_26	[p1l1994t2481r2150b2509],
13	molecules	NNS	O	molecule	prep_of	10	SENT_26	[p1l749t2535r921b2564],
14	and	CC	O	and	_	0	SENT_26	[p1l949t2535r1013b2564],
15	co	NN	O	co	nn	16	SENT_26	[p1l1040t2536r1269b2564],
16	—	NN	O	—	prep_of	10	SENT_26	[p1l1040t2536r1269b2564],
17	stimulates	VBZ	O	stimulate	ccomp	8	SENT_26	[p1l1040t2536r1269b2564],
18	T	NN	O	t	dobj	17	SENT_26	[p1l1295t2536r1388b2564],
19	—	JJ	O	—	amod	21	SENT_26	[p1l1295t2536r1388b2564],
20	cell	NN	O	cell	nn	21	SENT_26	[p1l1295t2536r1388b2564],
21	activation	NN	O	activation	nsubj	8	SENT_26	[p1l1415t2537r1588b2564],
22	and	CC	O	and	_	0	SENT_26	[p1l1616t2535r1680b2564],
23	antibody	NN	O	antibody	nn	24	SENT_26	[p1l1707t2535r1862b2573],
24	production	NN	O	production	conj_and	21	SENT_26	[p1l1888t2536r2082b2573],
25	by	IN	O	by	_	0	SENT_26	[p1l2108t2536r2151b2573],
26	B	NN	O	b	nn	27	SENT_26	[p1l749t2584r769b2611],
27	cells	NNS	O	cell	prep_by	21	SENT_26	[p1l784t2579r884b2611],
28	.3	NN	NUMBER	.3	dep	21	SENT_26	[p1l784t2579r884b2611],
29	Without	IN	O	without	_	0	SENT_26	[p1l785t2630r932b2658],
30	any	DT	O	any	det	31	SENT_26	[p1l949t2638r1013b2667],
31	hyperbole	NN	O	hyperbole	prep_without	35	SENT_26	[p1l1028t2630r1210b2667],
32	,	,	O	,	_	0	SENT_26	[p1l1028t2630r1210b2667],
33	TNF-or	NN	O	tnf-or	nn	34	SENT_26	[p1l1228t2631r1333b2658],
34	blockade	NN	O	blockade	nsubj	35	SENT_26	[p1l1349t2630r1502b2658],
35	represents	VBZ	O	represent	rcmod	28	SENT_26	[p1l1519t2633r1694b2667],
36	a	DT	O	a	det	38	SENT_26	[p1l1711t2638r1728b2658],
37	major	JJ	O	major	amod	38	SENT_26	[p1l1745t2631r1846b2667],
38	breakthrough	NN	O	breakthrough	dobj	35	SENT_26	[p1l1862t2630r2098b2667],
39	in	IN	O	in	_	0	SENT_26	[p1l2115t2631r2150b2658],
40	the	DT	O	the	det	41	SENT_26	[p1l748t2677r804b2705],
41	treatment	NN	O	treatment	prep_in	38	SENT_26	[p1l815t2680r986b2705],
42	of	IN	O	of	_	0	SENT_26	[p1l997t2677r1032b2705],
43	RA	NN	O	ra	prep_of	41	SENT_26	[p1l1041t2678r1097b2705],
44	.	.	O	.	_	0	SENT_26	[p1l1041t2678r1097b2705],

1	Controlled	VBN	O	control	_	0	SENT_27	[p1l1110t2677r1297b2705],
2	trials	NNS	O	trial	nsubj	6	SENT_27	[p1l1308t2677r1392b2705],
3	with	IN	O	with	_	0	SENT_27	[p1l1402t2677r1481b2705],
4	all	DT	O	all	det	5	SENT_27	[p1l1492t2677r1532b2705],
5	three	CD	NUMBER	three	prep_with	2	SENT_27	[p1l1543t2677r1631b2705],
6	anti	JJ	O	anti	xcomp	1	SENT_27	[p1l1642t2678r1827b2705],
7	.	.	O	.	_	0	SENT_27	[p1l1642t2678r1827b2705],

1	—	NN	O	—	_	0	SENT_28	[p1l1642t2678r1827b2705],
2	.	.	O	.	_	0	SENT_28	[p1l1642t2678r1827b2705],

1	TNF	NN	O	tnf	_	0	SENT_29	[p1l1642t2678r1827b2705],
2	.	.	O	.	_	0	SENT_29	[p1l1642t2678r1827b2705],

1	—	NN	O	—	_	0	SENT_30	[p1l1642t2678r1827b2705],
2	.	.	O	.	_	0	SENT_30	[p1l1642t2678r1827b2705],

1	oc	NN	O	oc	nn	2	SENT_31	[p1l1642t2678r1827b2705],
2	agents	NNS	O	agent	nsubj	28	SENT_31	[p1l1838t2681r1956b2714],
3	,	,	O	,	_	0	SENT_31	[p1l1838t2681r1956b2714],
4	etanercept	FW	O	etanercept	nn	7	SENT_31	[p1l1970t2680r2150b2714],
5	(	FW	O	(	nn	7	SENT_31	[p1l750t2724r894b2759],
6	Enbrel	NN	O	enbrel	nn	7	SENT_31	[p1l750t2724r894b2759],
7	)	NN	O	)	conj_and	2	SENT_31	[p1l750t2724r894b2759],
8	,	,	O	,	_	0	SENT_31	[p1l750t2724r894b2759],
9	inﬂiximab	NN	O	inﬂiximab	conj_and	2	SENT_31	[p1l912t2724r1092b2752],
10	(	CD	NUMBER	(	num	12	SENT_31	[p1l1110t2724r1299b2759],
11	Remicade	NNP	O	Remicade	nn	12	SENT_31	[p1l1110t2724r1299b2759],
12	)	NN	O	)	dep	9	SENT_31	[p1l1110t2724r1299b2759],
13	and	CC	O	and	_	0	SENT_31	[p1l1317t2724r1381b2752],
14	adalimumab	JJ	O	adalimumab	amod	17	SENT_31	[p1l1397t2724r1614b2752],
15	(	NN	O	(	nn	17	SENT_31	[p1l1631t2724r1796b2759],
16	Humira	NNP	LOCATION	Humira	nn	17	SENT_31	[p1l1631t2724r1796b2759],
17	)	NNP	O	)	conj_and	2	SENT_31	[p1l1631t2724r1796b2759],
18	,	,	O	,	_	0	SENT_31	[p1l1631t2724r1796b2759],
19	presently	RB	O	presently	advmod	20	SENT_31	[p1l1814t2724r1974b2761],
20	approved	VBN	O	approve	partmod	2	SENT_31	[p1l1989t2724r2150b2761],
21	for	IN	O	for	_	0	SENT_31	[p1l749t2770r797b2798],
22	the	DT	O	the	det	23	SENT_31	[p1l810t2770r865b2798],
23	treatment	NN	O	treatment	prep_for	20	SENT_31	[p1l879t2774r1050b2798],
24	of	IN	O	of	_	0	SENT_31	[p1l1065t2770r1100b2798],
25	RA	NN	O	ra	prep_of	23	SENT_31	[p1l1112t2771r1167b2804],
26	,	,	O	,	_	0	SENT_31	[p1l1112t2771r1167b2804],
27	have	VBP	O	have	aux	28	SENT_31	[p1l1184t2770r1264b2798],
28	shown	VBN	O	show	_	0	SENT_31	[p1l1279t2770r1393b2798],
29	impressive	JJ	O	impressive	amod	30	SENT_31	[p1l1407t2772r1588b2807],
30	improvement	NN	O	improvement	dobj	28	SENT_31	[p1l1603t2772r1839b2807],
31	in	IN	O	in	_	0	SENT_31	[p1l1853t2772r1888b2798],
32	most	JJS	O	most	amod	34	SENT_31	[p1l1901t2774r1987b2798],
33	response	NN	O	response	nn	34	SENT_31	[p1l2000t2778r2149b2807],
34	measures	NNS	O	measure	prep_in	28	SENT_31	[p1l748t2825r915b2851],
35	,	,	O	,	_	0	SENT_31	[p1l748t2825r915b2851],
36	including	VBG	O	include	_	0	SENT_31	[p1l963t2817r1130b2854],
37	clinical	JJ	O	clinical	prep_including	28	SENT_31	[p1l1176t2817r1309b2851],
38	,	,	O	,	_	0	SENT_31	[p1l1176t2817r1309b2851],
39	laboratory	NN	O	laboratory	prep_including	28	SENT_31	[p1l1357t2817r1536b2854],
40	and	CC	O	and	_	0	SENT_31	[p1l1581t2817r1645b2845],
41	radiographic	JJ	O	radiographic	amod	43	SENT_31	[p1l1691t2817r1910b2854],
42	outcomesf	NN	O	outcomesf	nn	43	SENT_31	[p1l1956t2814r2150b2845],
43	‘	NN	O	‘	prep_including	28	SENT_31	[p1l1956t2814r2150b2845],

1	TNF-oz	JJ	O	tnf-oz	amod	4	SENT_32	[p1l1021t3022r1154b3065],
2	-308	CD	NUMBER	-308	tmod	1	SENT_32	[p1l1174t3021r1296b3065],
3	G/A	NN	O	g/a	nn	4	SENT_32	[p1l1314t3020r1411b3071],
4	variant	NN	O	variant	dep	16	SENT_32	[p1l1427t3020r1600b3065],
5	and	CC	O	and	_	0	SENT_32	[p1l1617t3020r1705b3065],
6	anti-TNF	JJ	O	anti-tnf	amod	11	SENT_32	[p1l1725t3020r1971b3065],
7	-	:	O	-	_	0	SENT_32	[p1l1725t3020r1971b3065],
8	<	JJR	O	<	dep	6	SENT_32	[p1l1725t3020r1971b3065],
9	1	CD	NUMBER	1	num	10	SENT_32	[p1l1725t3020r1971b3065],
10	agents	NNS	O	agent	dep	8	SENT_32	[p1l1989t3025r2149b3079],
11	D	NN	O	d	dep	16	SENT_32	[p1l1791t3093r1820b3132],
12	D	NN	O	d	nn	13	SENT_32	[p1l1841t3093r1870b3132],
13	O’Rie	NN	O	o’rie	dep	16	SENT_32	[p1l1890t3091r2045b3146],
14	|	CD	NUMBER	|	num	16	SENT_32	[p1l1890t3091r2045b3146],
15	|	NN	O	|	nn	16	SENT_32	[p1l1890t3091r2045b3146],
16	y	NN	O	y	_	0	SENT_32	[p1l1890t3091r2045b3146],
17	et	FW	O	et	nn	18	SENT_32	[p1l2065t3096r2101b3133],
18	al	FW	O	al	dep	16	SENT_32	[p1l2117t3091r2153b3133],

1	These	DT	O	these	det	2	SENT_33	[p2l7t84r209b142],
2	biologics	NNS	O	biologic	nsubj	3	SENT_33	[p2l272t84r586b160],
3	are	VBP	O	be	conj_or	3	SENT_33	[p2l653t101r754b142],
4	of	IN	O	of	_	0	SENT_33	[p2l820t84r892b142],
5	benefit	NN	O	benefit	prep_of	3	SENT_33	[p2l950t84r1199b142],
6	as	IN	O	as	_	0	SENT_33	[p2l1264t101r1328b142],
7	monotherapy	NN	O	monotherapy	prep_as	5	SENT_33	[p2l1394t84r1880b160],
8	or	CC	O	or	_	0	SENT_33	[p2l1944t101r2015b142],
9	in	IN	O	in	_	0	SENT_33	[p2l2078t87r2149b141],
10	combination	NN	O	combination	nsubj	14	SENT_33	[p2l9t179r466b237],
11	with	IN	O	with	_	0	SENT_33	[p2l494t179r655b237],
12	disease	NN	O	disease	prep_with	10	SENT_33	[p2l685t179r1328b255],
13	—	CD	NUMBER	—	num	12	SENT_33	[p2l685t179r1328b255],
14	modifying	VBG	O	modify	prepc_in	3	SENT_33	[p2l685t179r1328b255],
15	drugs	NNS	O	drug	dobj	14	SENT_33	[p2l1357t179r1565b255],
16	.	.	O	.	_	0	SENT_33	[p2l1357t179r1565b255],

1	Despite	IN	O	despite	dep	131	SENT_34	[p2l86t276r346b349],
2	the	DT	O	the	dep	131	SENT_34	[p2l410t273r522b331],
3	marked	JJ	O	marked	dep	131	SENT_34	[p2l585t273r850b331],
4	improvement	NN	O	improvement	dep	131	SENT_34	[p2l912t276r1396b349],
5	of	IN	O	of	dep	131	SENT_34	[p2l1459t273r1530b331],
6	symptoms	NNS	O	symptom	dep	131	SENT_34	[p2l1590t281r1954b349],
7	and	CC	O	and	dep	131	SENT_34	[p2l2018t273r2149b331],
8	radiographic	JJ	O	radiographic	dep	131	SENT_34	[p2l9t368r457b444],
9	retardation	NN	O	retardation	dep	131	SENT_34	[p2l495t368r889b426],
10	of	IN	O	of	dep	131	SENT_34	[p2l928t368r999b426],
11	RA	NN	O	ra	dep	131	SENT_34	[p2l1033t370r1131b425],
12	with	IN	O	with	dep	131	SENT_34	[p2l1164t368r1325b426],
13	the	DT	O	the	dep	131	SENT_34	[p2l1363t368r1475b426],
14	use	NN	O	use	dep	131	SENT_34	[p2l1512t385r1625b426],
15	of	IN	O	of	dep	131	SENT_34	[p2l1665t368r1736b426],
16	anti-TNF-or	JJ	O	anti-tnf-or	dep	131	SENT_34	[p2l1771t371r2150b426],
17	agents	NNS	O	agent	dep	131	SENT_34	[p2l9t471r251b540],
18	,	,	O	,	_	0	SENT_34	[p2l9t471r251b540],
19	randomized	VBN	O	randomize	dep	131	SENT_34	[p2l281t464r705b522],
20	controlled	JJ	O	controlled	dep	131	SENT_34	[p2l731t464r1096b522],
21	trials	NNS	O	trial	dep	131	SENT_34	[p2l1121t464r1292b522],
22	reveal	VBP	O	reveal	dep	131	SENT_34	[p2l1318t464r1525b522],
23	that	IN	O	that	dep	131	SENT_34	[p2l1550t464r1694b522],
24	only	RB	O	only	dep	131	SENT_34	[p2l1720t464r1880b540],
25	70	CD	PERCENT	70	dep	131	SENT_34	[p2l1908t466r2055b522],
26	%	NN	PERCENT	%	dep	131	SENT_34	[p2l1908t466r2055b522],
27	of	IN	O	of	dep	131	SENT_34	[p2l2081t464r2153b522],
28	patients	NNS	O	patient	dep	131	SENT_34	[p2l8t562r290b634],
29	with	IN	O	with	dep	131	SENT_34	[p2l326t559r488b616],
30	moderate	JJ	O	moderate	dep	131	SENT_34	[p2l525t559r1201b616],
31	—	CD	NUMBER	—	dep	131	SENT_34	[p2l525t559r1201b616],
32	to	TO	O	to	dep	131	SENT_34	[p2l525t559r1201b616],
33	—	CD	NUMBER	—	dep	131	SENT_34	[p2l525t559r1201b616],
34	severe	JJ	O	severe	dep	131	SENT_34	[p2l525t559r1201b616],
35	RA	NN	O	ra	dep	131	SENT_34	[p2l1240t560r1337b616],
36	achieve	VB	O	achieve	dep	131	SENT_34	[p2l1375t559r1639b616],
37	a	DT	O	a	dep	131	SENT_34	[p2l1677t575r1712b616],
38	satisfactory	JJ	O	satisfactory	dep	131	SENT_34	[p2l1751t558r2151b634],
39	response	NN	O	response	dep	131	SENT_34	[p2l9t671r332b730],
40	,	,	O	,	_	0	SENT_34	[p2l9t671r332b730],
41	as	IN	O	as	dep	131	SENT_34	[p2l366t671r430b712],
42	defined	VBN	O	define	dep	131	SENT_34	[p2l460t654r725b712],
43	by	IN	O	by	dep	131	SENT_34	[p2l751t654r838b730],
44	an	DT	O	a	dep	131	SENT_34	[p2l865t671r950b712],
45	American	NNP	ORGANIZATION	American	dep	131	SENT_34	[p2l976t656r1317b712],
46	College	NNP	ORGANIZATION	College	dep	131	SENT_34	[p2l1347t654r1608b730],
47	of	IN	ORGANIZATION	of	dep	131	SENT_34	[p2l1638t654r1709b712],
48	Rheumatology	NNP	ORGANIZATION	Rheumatology	dep	131	SENT_34	[p2l1734t654r2148b712, p2l9t765r136b824],
49	20	CD	NUMBER	20	dep	131	SENT_34	[p2l165t750r247b806],
50	response	NN	O	response	dep	131	SENT_34	[p2l277t765r582b824],
51	(	CD	NUMBER	(	dep	131	SENT_34	[p2l616t742r963b820],
52	ACR20	NN	O	acr20	dep	131	SENT_34	[p2l616t742r963b820],
53	)	CD	NUMBER	)	dep	131	SENT_34	[p2l616t742r963b820],
54	.4	CD	NUMBER	.4	dep	131	SENT_34	[p2l616t742r963b820],
55	The	DT	O	the	dep	131	SENT_34	[p2l992t748r1124b806],
56	response	NN	O	response	dep	131	SENT_34	[p2l1155t765r1460b824],
57	rate	NN	O	rate	dep	131	SENT_34	[p2l1491t755r1622b806],
58	for	IN	O	for	dep	131	SENT_34	[p2l1653t748r1751b806],
59	inﬂammatory	JJ	O	inﬂammatory	dep	131	SENT_34	[p2l1779t748r2147b806, p2l8t850r153b918],
60	arthritis	NN	O	arthritis	dep	131	SENT_34	[p2l179t843r458b900],
61	seems	VBZ	O	seem	dep	131	SENT_34	[p2l487t859r692b900],
62	to	TO	O	to	dep	131	SENT_34	[p2l719t850r789b900],
63	be	VB	O	be	dep	131	SENT_34	[p2l814t843r894b900],
64	similar	JJ	O	similar	dep	131	SENT_34	[p2l923t843r1163b900],
65	for	IN	O	for	dep	131	SENT_34	[p2l1189t842r1287b900],
66	all	PDT	O	all	dep	131	SENT_34	[p2l1313t843r1395b900],
67	the	DT	O	the	dep	131	SENT_34	[p2l1422t843r1534b900],
68	three	CD	NUMBER	three	dep	131	SENT_34	[p2l1562t843r1742b900],
69	anti-TNF-oc	JJ	O	anti-tnf-oc	dep	131	SENT_34	[p2l1770t845r2150b900],
70	agents	NNS	O	agent	dep	131	SENT_34	[p2l9t944r233b1012],
71	presently	RB	O	presently	dep	131	SENT_34	[p2l296t936r623b1012],
72	marketed	VBN	O	market	dep	131	SENT_34	[p2l683t936r1015b994],
73	for	IN	O	for	dep	131	SENT_34	[p2l1077t936r1175b994],
74	RA	NN	O	ra	dep	131	SENT_34	[p2l1238t938r1336b993],
75	in	IN	O	in	dep	131	SENT_34	[p2l1398t939r1468b993],
76	North	NNP	LOCATION	North	dep	131	SENT_34	[p2l1529t936r1741b994],
77	America	NNP	LOCATION	America	dep	131	SENT_34	[p2l1802t929r2148b994],
78	.4	CD	NUMBER	.4	dep	131	SENT_34	[p2l1802t929r2148b994],
79	Furthermore	RB	O	furthermore	dep	131	SENT_34	[p2l9t1031r471b1102],
80	,	,	O	,	_	0	SENT_34	[p2l9t1031r471b1102],
81	the	DT	O	the	dep	131	SENT_34	[p2l517t1031r629b1089],
82	use	NN	O	use	dep	131	SENT_34	[p2l671t1048r783b1089],
83	of	IN	O	of	dep	131	SENT_34	[p2l827t1031r898b1089],
84	these	DT	O	these	dep	131	SENT_34	[p2l934t1032r1117b1089],
85	agents	NNS	O	agent	dep	131	SENT_34	[p2l1160t1039r1383b1107],
86	has	VBZ	O	have	dep	131	SENT_34	[p2l1425t1031r1541b1089],
87	been	VBN	O	be	dep	131	SENT_34	[p2l1581t1031r1750b1089],
88	associated	VBN	O	associate	dep	131	SENT_34	[p2l1793t1031r2149b1089],
89	with	IN	O	with	dep	131	SENT_34	[p2l7t1127r168b1185],
90	side	JJ	O	side	dep	131	SENT_34	[p2l216t1127r349b1185],
91	effects	NNS	O	effect	dep	131	SENT_34	[p2l397t1127r636b1197],
92	,	,	O	,	_	0	SENT_34	[p2l397t1127r636b1197],
93	some	DT	O	some	dep	131	SENT_34	[p2l689t1144r870b1185],
94	of	IN	O	of	dep	131	SENT_34	[p2l918t1127r990b1185],
95	which	WDT	O	which	dep	131	SENT_34	[p2l1030t1127r1250b1185],
96	may	MD	O	may	dep	131	SENT_34	[p2l1297t1144r1449b1203],
97	have	VB	O	have	dep	131	SENT_34	[p2l1493t1127r1657b1185],
98	serious	JJ	O	serious	dep	131	SENT_34	[p2l1707t1130r1947b1185],
99	consequences	NNS	O	consequence	dep	131	SENT_34	[p2l1994t1144r2147b1185, p2l10t1213r415b1295],
100	.5	CD	NUMBER	.5	dep	131	SENT_34	[p2l1994t1144r2147b1185, p2l10t1213r415b1295],
101	Given	VBN	O	give	dep	131	SENT_34	[p2l446t1221r656b1277],
102	that	IN	O	that	dep	131	SENT_34	[p2l683t1220r827b1277],
103	anti-TNF-oz	JJ	O	anti-tnf-oz	dep	131	SENT_34	[p2l854t1222r1233b1277],
104	agents	NNS	O	agent	dep	131	SENT_34	[p2l1260t1227r1484b1295],
105	are	VBP	O	be	dep	131	SENT_34	[p2l1512t1236r1613b1277],
106	expensive	JJ	O	expensive	dep	131	SENT_34	[p2l1642t1222r1989b1295],
107	and	CC	O	and	dep	131	SENT_34	[p2l2018t1219r2149b1277],
108	are	VBP	O	be	dep	131	SENT_34	[p2l9t1332r111b1373],
109	potentially	RB	O	potentially	dep	131	SENT_34	[p2l175t1315r565b1391],
110	associated	VBN	O	associate	dep	131	SENT_34	[p2l627t1316r983b1373],
111	with	IN	O	with	dep	131	SENT_34	[p2l1045t1315r1206b1373],
112	serious	JJ	O	serious	dep	131	SENT_34	[p2l1272t1318r1512b1373],
113	adverse	JJ	O	adverse	dep	131	SENT_34	[p2l1577t1315r1836b1373],
114	events	NNS	O	event	dep	131	SENT_34	[p2l1902t1323r2144b1386],
115	,	,	O	,	_	0	SENT_34	[p2l1902t1323r2144b1386],
116	minimizing	VBG	O	minimize	dep	131	SENT_34	[p2l9t1414r424b1487],
117	exposure	NN	O	exposure	dep	131	SENT_34	[p2l461t1428r775b1487],
118	of	IN	O	of	dep	131	SENT_34	[p2l813t1411r885b1469],
119	these	DT	O	these	dep	131	SENT_34	[p2l918t1411r1100b1469],
120	biologics	NNS	O	biologic	dep	131	SENT_34	[p2l1135t1411r1450b1487],
121	to	TO	O	to	dep	131	SENT_34	[p2l1488t1418r1557b1469],
122	non-responders	NNS	O	non-responder	dep	131	SENT_34	[p2l1595t1411r2148b1487],
123	will	MD	O	will	dep	131	SENT_34	[p2l7t1506r137b1563],
124	improve	VB	O	improve	dep	131	SENT_34	[p2l170t1509r463b1581],
125	their	PRP$	O	they	dep	131	SENT_34	[p2l498t1506r666b1563],
126	safety	NN	O	safety	dep	131	SENT_34	[p2l700t1505r912b1581],
127	,	,	O	,	_	0	SENT_34	[p2l700t1505r912b1581],
128	efficacy	NN	O	efficacy	dep	131	SENT_34	[p2l952t1505r1221b1581],
129	and	CC	O	and	dep	131	SENT_34	[p2l1252t1506r1384b1563],
130	pharmaco-economic	JJ	O	pharmaco-economic	dep	131	SENT_34	[p2l1416t1506r2149b1581],
131	profile	NN	O	profile	_	0	SENT_34	[p2l8t1601r256b1677],
132	.	.	O	.	_	0	SENT_34	[p2l8t1601r256b1677],

1	At	IN	O	at	_	0	SENT_35	[p2l293t1603r372b1659],
2	present	JJ	DATE	present	prep_at	5	SENT_35	[p2l405t1608r682b1677],
3	,	,	O	,	_	0	SENT_35	[p2l405t1608r682b1677],
4	there	EX	O	there	expl	5	SENT_35	[p2l720t1601r900b1659],
5	are	VBP	O	be	_	0	SENT_35	[p2l935t1618r1037b1659],
6	limited	JJ	O	limited	amod	7	SENT_35	[p2l1072t1601r1326b1659],
7	clinical	JJ	O	clinical	nsubj	5	SENT_35	[p2l1360t1601r1615b1659],
8	and	CC	O	and	_	0	SENT_35	[p2l1650t1601r1781b1659],
9	biochemical	JJ	O	biochemical	amod	10	SENT_35	[p2l1812t1601r2148b1659, p2l9t1696r129b1754],
10	predictors	NNS	O	predictor	nsubj	5	SENT_35	[p2l157t1696r510b1772],
11	of	IN	O	of	_	0	SENT_35	[p2l541t1696r612b1754],
12	response	NN	O	response	prep_of	7	SENT_35	[p2l638t1713r943b1772],
13	to	TO	O	to	_	0	SENT_35	[p2l973t1703r1043b1754],
14	TNF-or	NN	O	tnf-or	nn	15	SENT_35	[p2l1072t1699r1285b1754],
15	blockade	NN	O	blockade	prep_to	5	SENT_35	[p2l1312t1696r1626b1754],
16	in	IN	O	in	_	0	SENT_35	[p2l1657t1699r1727b1753],
17	RA	NN	O	ra	prep_in	15	SENT_35	[p2l1757t1698r1872b1754],
18	.	.	O	.	_	0	SENT_35	[p2l1757t1698r1872b1754],

1	Pharmacogenetics	NNS	O	pharmacogenetic	nsubj	3	SENT_36	[p2l86t1791r727b1866],
2	has	VBZ	O	have	aux	3	SENT_36	[p2l757t1791r873b1848],
3	drawn	VBN	O	draw	_	0	SENT_36	[p2l904t1791r1125b1848],
4	a	DT	O	a	det	6	SENT_36	[p2l1156t1807r1190b1848],
5	great	JJ	O	great	amod	6	SENT_36	[p2l1219t1798r1393b1866],
6	deal	NN	O	deal	dobj	3	SENT_36	[p2l1422t1791r1565b1848],
7	of	IN	O	of	_	0	SENT_36	[p2l1596t1790r1667b1848],
8	attention	NN	O	attention	prep_of	6	SENT_36	[p2l1694t1794r2022b1848],
9	for	IN	O	for	_	0	SENT_36	[p2l2051t1790r2150b1848],
10	its	PRP$	O	its	poss	11	SENT_36	[p2l9t1889r88b1944],
11	potential	JJ	O	potential	prep_for	8	SENT_36	[p2l121t1886r442b1962],
12	to	TO	O	to	aux	13	SENT_36	[p2l476t1893r545b1944],
13	individualize	VB	O	individualize	xcomp	3	SENT_36	[p2l580t1886r1039b1944],
14	drug	NN	O	drug	nn	15	SENT_36	[p2l1075t1886r1236b1962],
15	therapy	NN	O	therapy	dobj	13	SENT_36	[p2l1267t1886r1550b1962],
16	.	.	O	.	_	0	SENT_36	[p2l1267t1886r1550b1962],

1	With	IN	O	with	_	0	SENT_37	[p2l1587t1886r1766b1944],
2	respect	NN	O	respect	_	0	SENT_37	[p2l1799t1893r2045b1962],
3	to	TO	O	to	_	0	SENT_37	[p2l2078t1893r2148b1944],
4	anti-TNF-oc	JJ	O	anti-tnf-oc	amod	5	SENT_37	[p2l9t1983r388b2038],
5	agents	NNS	O	agent	prep_with_respect_to	10	SENT_37	[p2l412t1988r635b2056],
6	in	IN	O	in	_	0	SENT_37	[p2l660t1983r730b2037],
7	RA	NN	O	ra	prep_in	5	SENT_37	[p2l755t1982r869b2051],
8	,	,	O	,	_	0	SENT_37	[p2l755t1982r869b2051],
9	there	EX	O	there	expl	10	SENT_37	[p2l897t1981r1077b2038],
10	is	VBZ	O	be	_	0	SENT_37	[p2l1102t1983r1152b2038],
11	a	DT	O	a	det	13	SENT_37	[p2l1177t1997r1212b2038],
12	growing	VBG	O	grow	amod	13	SENT_37	[p2l1235t1983r1525b2056],
13	body	NN	O	body	nsubj	10	SENT_37	[p2l1546t1980r1725b2056],
14	of	IN	O	of	_	0	SENT_37	[p2l1747t1980r1818b2038],
15	evidence	NN	O	evidence	prep_of	13	SENT_37	[p2l1838t1980r2147b2038],
16	directed	VBN	O	direct	partmod	15	SENT_37	[p2l9t2076r294b2134],
17	at	IN	O	at	_	0	SENT_37	[p2l328t2083r391b2134],
18	a	DT	O	a	det	24	SENT_37	[p2l426t2093r461b2134],
19	single	JJ	O	single	amod	24	SENT_37	[p2l497t2076r699b2152],
20	nucleotide	NN	O	nucleotide	nn	24	SENT_37	[p2l734t2076r1108b2134],
21	polymorphism	NN	O	polymorphism	nn	24	SENT_37	[p2l1143t2076r1669b2152],
22	(	CD	NUMBER	(	num	24	SENT_37	[p2l1707t2076r1893b2148],
23	SNP	NN	O	snp	nn	24	SENT_37	[p2l1707t2076r1893b2148],
24	)	NN	O	)	prep_at	16	SENT_37	[p2l1707t2076r1893b2148],
25	in	IN	O	in	_	0	SENT_37	[p2l1931t2079r2001b2133],
26	the	DT	O	the	det	30	SENT_37	[p2l2035t2076r2148b2134],
27	human	JJ	O	human	amod	30	SENT_37	[p2l9t2170r264b2228],
28	TNF-or	NN	MISC	tnf-or	nn	30	SENT_37	[p2l300t2173r514b2228],
29	gene	NN	O	gene	nn	30	SENT_37	[p2l551t2187r714b2246],
30	promoter	NN	O	promoter	prep_in	24	SENT_37	[p2l752t2178r1098b2246],
31	,	,	O	,	_	0	SENT_37	[p2l752t2178r1098b2246],
32	the	DT	O	the	det	35	SENT_37	[p2l1141t2171r1253b2228],
33	-308	CD	NUMBER	-308	num	35	SENT_37	[p2l1296t2172r1477b2228],
34	G/A	NN	O	g/a	nn	35	SENT_37	[p2l1518t2170r1656b2236],
35	variant	NN	O	variant	appos	30	SENT_37	[p2l1689t2173r1958b2228],
36	.	.	O	.	_	0	SENT_37	[p2l1689t2173r1958b2228],

1	This	DT	O	this	det	2	SENT_38	[p2l1998t2170r2148b2228],
2	variant	NN	O	variant	nsubjpass	9	SENT_38	[p2l6t2268r258b2323],
3	of	IN	O	of	_	0	SENT_38	[p2l280t2265r352b2323],
4	the	DT	O	the	det	6	SENT_38	[p2l370t2266r483b2323],
5	TNF-or	NN	O	tnf-or	nn	6	SENT_38	[p2l505t2268r719b2323],
6	gene	NN	O	gene	prep_of	2	SENT_38	[p2l740t2282r904b2341],
7	has	VBZ	O	have	aux	9	SENT_38	[p2l927t2265r1043b2323],
8	been	VBN	O	be	auxpass	9	SENT_38	[p2l1064t2265r1234b2323],
9	selected	VBN	O	select	_	0	SENT_38	[p2l1258t2265r1536b2323],
10	partly	RB	O	partly	advmod	39	SENT_38	[p2l1557t2265r1766b2341],
11	because	IN	O	because	_	0	SENT_38	[p2l1784t2265r2057b2323],
12	of	IN	O	of	_	0	SENT_38	[p2l2081t2265r2153b2323],
13	its	PRP$	O	its	poss	14	SENT_38	[p2l9t2364r88b2419],
14	functionality	NN	O	functionality	prep_because_of	39	SENT_38	[p2l110t2361r586b2437],
15	,	,	O	,	_	0	SENT_38	[p2l110t2361r586b2437],
16	as	IN	O	as	mark	20	SENT_38	[p2l613t2378r678b2419],
17	this	DT	O	this	det	18	SENT_38	[p2l701t2361r830b2419],
18	SNP	NN	O	snp	nsubj	20	SENT_38	[p2l854t2363r992b2419],
19	may	MD	O	may	aux	20	SENT_38	[p2l1014t2378r1166b2437],
20	inﬂuence	VB	O	inﬂuence	advcl	39	SENT_38	[p2l1185t2361r1516b2419],
21	the	DT	O	the	det	22	SENT_38	[p2l1539t2361r1652b2419],
22	magnitude	NN	O	magnitude	dep	20	SENT_38	[p2l1675t2361r2058b2437],
23	of	IN	O	of	_	0	SENT_38	[p2l2081t2361r2153b2419],
24	the	DT	O	the	det	26	SENT_38	[p2l8t2454r121b2511],
25	secretory	JJ	O	secretory	amod	26	SENT_38	[p2l147t2461r465b2529],
26	response	NN	O	response	prep_of	22	SENT_38	[p2l487t2471r792b2529],
27	of	IN	O	of	_	0	SENT_38	[p2l817t2453r888b2511],
28	TNF-oc	NN	O	tnf-oc	prep_of	26	SENT_38	[p2l906t2446r1174b2511],
29	.6	CD	NUMBER	.6	num	28	SENT_38	[p2l906t2446r1174b2511],
30	In	IN	O	in	dep	22	SENT_38	[p2l1199t2456r1271b2511],
31	addition	NN	O	addition	pobj	30	SENT_38	[p2l1295t2454r1612b2524],
32	,	,	O	,	_	0	SENT_38	[p2l1295t2454r1612b2524],
33	variants	NNS	O	variant	nsubjpass	39	SENT_38	[p2l1638t2457r1920b2511],
34	of	IN	O	of	_	0	SENT_38	[p2l1945t2453r2016b2511],
35	the	DT	O	the	det	37	SENT_38	[p2l2035t2454r2148b2511],
36	-308	CD	NUMBER	-308	num	37	SENT_38	[p2l13t2551r194b2607],
37	SNP	NN	ORGANIZATION	snp	prep_of	33	SENT_38	[p2l220t2551r359b2607],
38	are	VBP	O	be	auxpass	39	SENT_38	[p2l384t2566r485b2607],
39	associated	VBN	O	associate	dep	9	SENT_38	[p2l511t2550r867b2607],
40	with	IN	O	with	_	0	SENT_38	[p2l889t2550r1051b2607],
41	increased	VBN	O	increase	amod	42	SENT_38	[p2l1076t2550r1406b2607],
42	susceptibility	NN	O	susceptibility	prep_with	39	SENT_38	[p2l1432t2550r1900b2625],
43	to	TO	O	to	prep	39	SENT_38	[p2l1922t2557r1991b2607],
44	and	CC	O	and	_	0	SENT_38	[p2l2018t2550r2149b2607],
45	severity	NN	O	severity	conj_and	39	SENT_38	[p2l10t2647r282b2720],
46	of	IN	O	of	_	0	SENT_38	[p2l324t2644r395b2702],
47	RA	NN	O	ra	prep_of	45	SENT_38	[p2l435t2638r586b2702],
48	.7	CD	NUMBER	.7	num	47	SENT_38	[p2l435t2638r586b2702],
49	At	IN	O	at	dep	45	SENT_38	[p2l630t2646r708b2702],
50	present	JJ	DATE	present	pobj	49	SENT_38	[p2l751t2651r1028b2720],
51	,	,	O	,	_	0	SENT_38	[p2l751t2651r1028b2720],
52	there	EX	O	there	expl	53	SENT_38	[p2l1077t2644r1257b2702],
53	are	VBP	O	be	dep	9	SENT_38	[p2l1302t2661r1403b2702],
54	a	DT	O	a	det	55	SENT_38	[p2l1449t2661r1484b2702],
55	handful	NN	O	handful	nsubj	53	SENT_38	[p2l1528t2644r1806b2702],
56	of	IN	O	of	_	0	SENT_38	[p2l1851t2644r1923b2702],
57	small	JJ	O	small	amod	58	SENT_38	[p2l1963t2644r2148b2702],
58	studies	NNS	O	study	prep_of	55	SENT_38	[p2l10t2738r250b2795],
59	that	WDT	O	that	nsubj	61	SENT_38	[p2l289t2738r433b2795],
60	have	VBP	O	have	aux	61	SENT_38	[p2l471t2738r636b2795],
61	set	VBN	O	set	rcmod	55	SENT_38	[p2l677t2745r770b2795],
62	out	RP	O	out	prt	61	SENT_38	[p2l808t2745r925b2795],
63	to	TO	O	to	aux	64	SENT_38	[p2l964t2745r1033b2795],
64	examine	VB	O	examine	xcomp	61	SENT_38	[p2l1074t2741r1374b2795],
65	whether	IN	O	whether	_	0	SENT_38	[p2l1412t2738r1707b2795],
66	the	DT	O	the	det	67	SENT_38	[p2l1744t2738r1856b2795],
67	G	NN	O	g	prep_whether	64	SENT_38	[p2l1897t2739r1953b2795],
68	to	TO	O	to	prep	67	SENT_38	[p2l1991t2745r2061b2795],
69	A	DT	O	a	dep	67	SENT_38	[p2l2098t2739r2149b2794],

1	polymorphism	NN	O	polymorphism	dep	14	SENT_39	[p2l8t2833r534b2909],
2	at	IN	O	at	_	0	SENT_39	[p2l558t2840r621b2891],
3	position	NN	O	position	prep_at	1	SENT_39	[p2l643t2836r935b2909],
4	-308	CD	NUMBER	-308	num	3	SENT_39	[p2l962t2835r1143b2891],
5	in	IN	O	in	_	0	SENT_39	[p2l1168t2836r1238b2890],
6	the	DT	O	the	det	7	SENT_39	[p2l1261t2833r1373b2891],
7	promoter	NN	O	promoter	prep_in	3	SENT_39	[p2l1396t2840r1730b2909],
8	of	IN	O	of	_	0	SENT_39	[p2l1753t2833r1824b2891],
9	the	DT	O	the	det	11	SENT_39	[p2l1843t2833r1955b2891],
10	TNFoc	NN	O	tnfoc	nn	11	SENT_39	[p2l1978t2836r2148b2890, p2l10t2947r48b2985],
11	gene	NN	O	gene	prep_of	7	SENT_39	[p2l99t2944r262b3003],
12	inﬂuences	NNS	O	inﬂuences	dep	14	SENT_39	[p2l314t2927r676b2985],
13	clinical	JJ	O	clinical	amod	14	SENT_39	[p2l730t2927r985b2985],
14	response	NN	O	response	dep	29	SENT_39	[p2l1038t2944r1343b3003],
15	to	TO	O	to	_	0	SENT_39	[p2l1396t2935r1465b2985],
16	TNF	NN	MISC	tnf	nn	17	SENT_39	[p2l1516t2930r1661b2984],
17	blockade	NN	O	blockade	prep_to	14	SENT_39	[p2l1711t2927r2025b2985],
18	in	IN	O	in	_	0	SENT_39	[p2l2078t2930r2149b2984],
19	patients	NNS	O	patient	prep_in	17	SENT_39	[p2l8t3024r290b3097],
20	with	IN	O	with	_	0	SENT_39	[p2l319t3021r480b3079],
21	moderate	JJ	O	moderate	amod	26	SENT_39	[p2l509t3021r1185b3079],
22	—	CD	NUMBER	—	number	24	SENT_39	[p2l509t3021r1185b3079],
23	to	TO	O	to	dep	24	SENT_39	[p2l509t3021r1185b3079],
24	—	CD	NUMBER	—	dep	21	SENT_39	[p2l509t3021r1185b3079],
25	severe	JJ	O	severe	amod	26	SENT_39	[p2l509t3021r1185b3079],
26	RA	NN	O	ra	prep_with	19	SENT_39	[p2l1216t3014r1463b3079],
27	.8	CD	NUMBER	.8	number	28	SENT_39	[p2l1216t3014r1463b3079],
28	‘	CD	NUMBER	‘	num	26	SENT_39	[p2l1216t3014r1463b3079],
29	16	CD	NUMBER	16	_	0	SENT_39	[p2l1216t3014r1463b3079],

1	Owing	VBG	O	owe	partmod	27	SENT_40	[p2l87t3118r321b3192],
2	to	TO	O	to	_	0	SENT_40	[p2l347t3124r417b3174],
3	the	DT	O	the	det	6	SENT_40	[p2l444t3117r557b3174],
4	relatively	RB	O	relatively	advmod	5	SENT_40	[p2l585t3116r913b3192],
5	small	JJ	O	small	amod	6	SENT_40	[p2l940t3116r1125b3174],
6	number	NN	O	number	prep_to	1	SENT_40	[p2l1153t3116r1432b3174],
7	of	IN	O	of	_	0	SENT_40	[p2l1459t3116r1530b3174],
8	patients	NNS	O	patient	prep_of	6	SENT_40	[p2l1553t3119r1835b3192],
9	exposed	VBN	O	expose	partmod	8	SENT_40	[p2l1864t3116r2149b3192],
10	to	TO	O	to	_	0	SENT_40	[p2l8t3219r78b3269],
11	anti-TNF-oc	JJ	O	anti-tnf-oc	amod	12	SENT_40	[p2l102t3214r481b3269],
12	agents	NNS	O	agent	prep_to	9	SENT_40	[p2l504t3219r727b3287],
13	in	IN	O	in	_	0	SENT_40	[p2l751t3214r821b3268],
14	all	DT	O	all	prep_in	12	SENT_40	[p2l845t3211r926b3269],
15	of	IN	O	of	_	0	SENT_40	[p2l950t3211r1022b3269],
16	the	DT	O	the	det	18	SENT_40	[p2l1040t3211r1153b3269],
17	pharmacogenetic	JJ	O	pharmacogenetic	amod	18	SENT_40	[p2l1176t3211r1790b3287],
18	studies	NNS	O	study	prep_of	14	SENT_40	[p2l1815t3212r2055b3269],
19	in	IN	O	in	_	0	SENT_40	[p2l2078t3214r2149b3268],
20	RA	NN	O	ra	prep_in	18	SENT_40	[p2l9t3309r107b3364],
21	to	TO	O	to	_	0	SENT_40	[p2l135t3314r204b3365],
22	date	NN	O	date	prep_to	9	SENT_40	[p2l235t3307r401b3377],
23	,	,	O	,	_	0	SENT_40	[p2l235t3307r401b3377],
24	each	DT	O	each	det	26	SENT_40	[p2l436t3307r596b3365],
25	individual	JJ	O	individual	amod	26	SENT_40	[p2l626t3307r988b3365],
26	study	NN	O	study	nsubj	27	SENT_40	[p2l1020t3307r1212b3383],
27	had	VBD	O	have	_	0	SENT_40	[p2l1239t3307r1371b3365],
28	insufficient	JJ	O	insufficient	amod	29	SENT_40	[p2l1400t3307r1803b3365],
29	power	NN	O	power	dobj	27	SENT_40	[p2l1832t3324r2050b3383],
30	to	TO	O	to	aux	32	SENT_40	[p2l2078t3314r2148b3365],
31	conclusively	RB	O	conclusively	advmod	32	SENT_40	[p2l9t3402r450b3477],
32	determine	VB	O	determine	infmod	29	SENT_40	[p2l493t3402r853b3459],
33	if	IN	O	if	mark	43	SENT_40	[p2l898t3401r948b3459],
34	the	DT	O	the	det	36	SENT_40	[p2l988t3402r1101b3459],
35	-308	CD	NUMBER	-308	num	36	SENT_40	[p2l1149t3403r1330b3459],
36	variant	NN	O	variant	nsubj	43	SENT_40	[p2l1373t3405r1625b3459],
37	of	IN	O	of	_	0	SENT_40	[p2l1669t3401r1741b3459],
38	the	DT	O	the	det	40	SENT_40	[p2l1780t3402r1893b3459],
39	TNF-oc	NN	MISC	tnf-oc	nn	40	SENT_40	[p2l1935t3404r2150b3459],
40	gene	NN	O	gene	prep_of	36	SENT_40	[p2l9t3513r172b3572],
41	would	MD	O	would	aux	43	SENT_40	[p2l207t3497r428b3554],
42	be	VB	O	be	cop	43	SENT_40	[p2l461t3497r541b3554],
43	helpful	JJ	O	helpful	advcl	32	SENT_40	[p2l578t3496r830b3572],
44	in	IN	O	in	_	0	SENT_40	[p2l866t3500r936b3554],
45	predicting	VBG	O	predict	prepc_in	43	SENT_40	[p2l971t3497r1335b3572],
46	patients	NNS	O	patient	dobj	45	SENT_40	[p2l1369t3500r1651b3572],
47	that	IN	O	that	nsubj	48	SENT_40	[p2l1687t3497r1830b3554],
48	respond	VBP	O	respond	rcmod	46	SENT_40	[p2l1865t3497r2149b3572],
49	poorly	RB	O	poorly	advmod	48	SENT_40	[p2l8t3590r240b3666],
50	to	TO	O	to	_	0	SENT_40	[p2l275t3598r345b3648],
51	T	NN	O	t	nn	53	SENT_40	[p2l382t3593r429b3647],
52	NF-or	NN	O	nf-or	nn	53	SENT_40	[p2l430t3593r596b3648],
53	blockade	NN	O	blockade	prep_to	48	SENT_40	[p2l632t3590r965b3648],
54	.	.	O	.	_	0	SENT_40	[p2l632t3590r965b3648],

1	Lee	NNP	PERSON	Lee	nsubj	5	SENT_41	[p2l1009t3593r1123b3648],
2	et	FW	O	et	dep	1	SENT_41	[p2l1163t3596r1223b3648],
3	al.	FW	O	al.	nn	4	SENT_41	[p2l1255t3583r1402b3648],
4	”	FW	O	”	dep	1	SENT_41	[p2l1255t3583r1402b3648],
5	carried	VBD	O	carry	_	0	SENT_41	[p2l1442t3590r1682b3648],
6	out	RP	O	out	prt	5	SENT_41	[p2l1720t3597r1837b3648],
7	a	DT	O	a	det	8	SENT_41	[p2l1876t3607r1911b3648],
8	metaanalysis	NN	O	metaanalysis	dobj	5	SENT_41	[p2l1948t3597r2148b3648, p2l9t3686r285b3762],
9	investigating	VBG	O	investigate	partmod	8	SENT_41	[p2l327t3689r788b3762],
10	the	DT	O	the	det	11	SENT_41	[p2l829t3686r941b3744],
11	association	NN	O	association	dobj	9	SENT_41	[p2l985t3689r1375b3744],
12	of	IN	O	of	_	0	SENT_41	[p2l1418t3686r1490b3744],
13	TNF-oc	JJ	O	tnf-oc	amod	15	SENT_41	[p2l1525t3688r1740b3743],
14	-308	CD	NUMBER	-308	tmod	13	SENT_41	[p2l1785t3687r1967b3744],
15	G/A	NN	O	g/a	prep_of	11	SENT_41	[p2l2011t3686r2149b3751],

1	polymorphism	NN	O	polymorphism	_	0	SENT_42	[p3l8t16r534b92],
2	with	IN	O	with	_	0	SENT_42	[p3l556t16r717b74],
3	responsiveness	NN	O	responsiveness	prep_with	1	SENT_42	[p3l741t19r1264b92],
4	to	TO	O	to	_	0	SENT_42	[p3l1288t23r1357b74],
5	TNF-or-blockers	NNS	O	tnf-or-blocker	prep_to	1	SENT_42	[p3l1380t16r1911b74],
6	in	IN	O	in	_	0	SENT_42	[p3l1935t19r2006b73],
7	RA	NN	O	ra	prep_in	5	SENT_42	[p3l2030t18r2145b74],
8	.	.	O	.	_	0	SENT_42	[p3l2030t18r2145b74],

1	A	DT	O	a	det	2	SENT_43	[p3l7t112r58b167],
2	total	NN	O	total	nsubjpass	7	SENT_43	[p3l117t110r279b168],
3	of	IN	O	of	_	0	SENT_43	[p3l339t110r411b168],
4	six	CD	NUMBER	six	num	5	SENT_43	[p3l468t113r563b168],
5	studies	NNS	O	study	prep_of	2	SENT_43	[p3l623t110r863b168],
6	were	VBD	O	be	auxpass	7	SENT_43	[p3l922t127r1086b168],
7	included	VBN	O	include	_	0	SENT_43	[p3l1147t110r1456b168],
8	in	IN	O	in	_	0	SENT_43	[p3l1516t113r1587b167],
9	that	DT	O	that	det	10	SENT_43	[p3l1646t110r1790b168],
10	analysis	NN	O	analysis	nsubj	19	SENT_43	[p3l1850t110r2144b186],
11	,	,	O	,	_	0	SENT_43	[p3l1850t110r2144b186],
12	including	VBG	O	include	_	0	SENT_43	[p3l9t206r350b282],
13	240	CD	NUMBER	240	num	14	SENT_43	[p3l375t207r501b264],
14	responders	NNS	O	responder	prep_including	19	SENT_43	[p3l526t206r907b282],
15	and	CC	O	and	_	0	SENT_43	[p3l933t206r1064b264],
16	70	CD	NUMBER	70	num	17	SENT_43	[p3l1094t207r1172b264],
17	non-responders	NNS	O	non-responder	prep_including	19	SENT_43	[p3l1197t206r1768b282],
18	,	,	O	,	_	0	SENT_43	[p3l1197t206r1768b282],
19	representing	VBG	O	represent	prepc_in	7	SENT_43	[p3l1797t213r2147b282, p3l9t301r122b374],
20	a	DT	O	a	quantmod	21	SENT_43	[p3l161t315r196b356],
21	total	NN	O	total	num	25	SENT_43	[p3l234t298r397b356],
22	of	IN	O	of	quantmod	21	SENT_43	[p3l437t298r509b356],
23	310	CD	NUMBER	310	number	21	SENT_43	[p3l546t300r672b356],
24	RA	NN	O	ra	nn	25	SENT_43	[p3l712t300r810b355],
25	patients	NNS	O	patient	dobj	19	SENT_43	[p3l848t291r1218b374],
26	.	.	O	.	_	0	SENT_43	[p3l848t291r1218b374],

1	”	NN	O	”	nsubj	18	SENT_44	[p3l848t291r1218b374],
2	However	RB	O	however	advmod	1	SENT_44	[p3l1259t301r1585b369],
3	,	,	O	,	_	0	SENT_44	[p3l1259t301r1585b369],
4	in	IN	O	in	_	0	SENT_44	[p3l1630t301r1700b355],
5	the	DT	DURATION	the	det	7	SENT_44	[p3l1739t299r1852b356],
6	3	CD	DURATION	3	num	7	SENT_44	[p3l1894t300r1930b356],
7	years	NNS	NUMBER	year	prep_in	18	SENT_44	[p3l1970t315r2148b374],
8	since	IN	O	since	_	0	SENT_44	[p3l10t398r185b452],
9	that	DT	O	that	det	10	SENT_44	[p3l211t395r355b452],
10	report	NN	O	report	prep_since	7	SENT_44	[p3l380t402r612b470],
11	,	,	O	,	_	0	SENT_44	[p3l380t402r612b470],
12	there	EX	O	there	expl	18	SENT_44	[p3l642t395r823b452],
13	have	VBP	O	have	aux	18	SENT_44	[p3l849t395r1015b452],
14	been	VBN	O	be	cop	18	SENT_44	[p3l1040t395r1209b452],
15	an	DT	O	a	det	18	SENT_44	[p3l1236t411r1321b452],
16	additional	JJ	O	additional	amod	18	SENT_44	[p3l1347t395r1709b452],
17	four	CD	NUMBER	four	num	18	SENT_44	[p3l1736t394r1881b452],
18	studies	NNS	O	study	_	0	SENT_44	[p3l1908t395r2148b452],
19	investigating	VBG	O	investigate	partmod	18	SENT_44	[p3l9t493r469b566],
20	the	DT	O	the	det	21	SENT_44	[p3l524t490r636b548],
21	association	NN	O	association	dobj	19	SENT_44	[p3l694t493r1085b548],
22	of	IN	O	of	_	0	SENT_44	[p3l1141t490r1213b548],
23	T	NN	O	t	nn	24	SENT_44	[p3l1262t492r1310b547],
24	NF-oc	NN	O	nf-oc	prep_of	21	SENT_44	[p3l1310t492r1477b548],
25	-308	CD	NUMBER	-308	num	27	SENT_44	[p3l1536t492r1717b548],
26	G/A	NN	O	g/a	nn	27	SENT_44	[p3l1776t490r1914b555],
27	polymorphism	NN	O	polymorphism	advmod	19	SENT_44	[p3l1968t490r2148b566, p3l9t585r376b660],
28	with	IN	O	with	_	0	SENT_44	[p3l458t585r619b642],
29	responsiveness	NN	O	responsiveness	prep_with	27	SENT_44	[p3l704t588r1226b660],
30	to	TO	O	to	_	0	SENT_44	[p3l1310t592r1380b642],
31	TNF-oc-blockers	NNS	O	tnf-oc-blocker	prep_to	27	SENT_44	[p3l1463t585r1993b642],
32	in	IN	O	in	_	0	SENT_44	[p3l2079t588r2149b642],
33	RA	NN	O	ra	prep_in	31	SENT_44	[p3l9t672r288b737],
34	.13	CD	NUMBER	.13	number	33	SENT_44	[p3l9t672r288b737],
35	‘	CD	NUMBER	‘	number	33	SENT_44	[p3l9t672r288b737],
36	16	CD	NUMBER	16	number	33	SENT_44	[p3l9t672r288b737],
37	These	DT	O	these	det	39	SENT_44	[p3l316t679r519b737],
38	recent	JJ	O	recent	amod	39	SENT_44	[p3l550t686r769b737],
39	studies	NNS	O	study	nsubj	40	SENT_44	[p3l801t679r1041b737],
40	account	VBP	O	account	rcmod	33	SENT_44	[p3l1073t686r1354b737],
41	for	IN	O	for	_	0	SENT_44	[p3l1384t678r1483b737],
42	an	DT	O	a	det	46	SENT_44	[p3l1513t696r1598b737],
43	additional	JJ	O	additional	amod	46	SENT_44	[p3l1628t679r1990b737],
44	408	CD	NUMBER	408	num	46	SENT_44	[p3l2022t680r2147b737],
45	RA	NN	O	ra	nn	46	SENT_44	[p3l9t777r107b832],
46	patients	NNS	O	patient	prep_for	40	SENT_44	[p3l149t778r432b851],
47	exposed	VBN	O	expose	partmod	46	SENT_44	[p3l477t775r763b851],
48	to	TO	O	to	_	0	SENT_44	[p3l806t782r876b833],
49	anti-TNF-oc	JJ	O	anti-tnf-oc	amod	50	SENT_44	[p3l922t778r1301b833],
50	agents	NNS	O	agent	prep_to	47	SENT_44	[p3l1345t782r1587b851],
51	,	,	O	,	_	0	SENT_44	[p3l1345t782r1587b851],
52	including	VBG	O	include	_	0	SENT_44	[p3l1636t775r1978b851],
53	306	CD	NUMBER	306	num	54	SENT_44	[p3l2022t777r2148b833],
54	responders	NNS	O	responder	prep_including	46	SENT_44	[p3l9t870r390b946],
55	and	CC	O	and	_	0	SENT_44	[p3l423t870r554b928],
56	102	CD	NUMBER	102	num	59	SENT_44	[p3l591t871r713b928],
57	non	JJ	O	non	amod	59	SENT_44	[p3l745t870r1316b946],
58	—	NN	O	—	nn	59	SENT_44	[p3l745t870r1316b946],
59	responders	NNS	O	responder	prep_including	46	SENT_44	[p3l745t870r1316b946],
60	.	.	O	.	_	0	SENT_44	[p3l745t870r1316b946],

1	As	IN	O	as	_	0	SENT_45	[p3l1351t871r1431b928],
2	a	DT	O	a	det	3	SENT_45	[p3l1464t887r1499b928],
3	result	NN	O	result	prep_as	6	SENT_45	[p3l1531t870r1742b940],
4	,	,	O	,	_	0	SENT_45	[p3l1531t870r1742b940],
5	we	PRP	O	we	nsubj	6	SENT_45	[p3l1777t887r1873b928],
6	set	VBD	O	set	_	0	SENT_45	[p3l1907t877r2000b928],
7	out	RP	O	out	prt	6	SENT_45	[p3l2032t877r2149b928],
8	to	TO	O	to	aux	9	SENT_45	[p3l8t972r78b1023],
9	carry	VB	O	carry	xcomp	6	SENT_45	[p3l102t982r279b1041],
10	out	RP	O	out	prt	9	SENT_45	[p3l300t972r417b1023],
11	a	DT	O	a	det	18	SENT_45	[p3l440t982r475b1023],
12	more	RBR	O	more	advmod	13	SENT_45	[p3l498t982r678b1023],
13	current	JJ	DATE	current	amod	18	SENT_45	[p3l703t972r959b1023],
14	and	CC	O	and	_	0	SENT_45	[p3l983t965r1114b1023],
15	detailed	JJ	O	detailed	amod	18	SENT_45	[p3l1137t965r1418b1023],
16	meta	NN	O	meta	nn	18	SENT_45	[p3l1441t965r1921b1041],
17	—	NN	O	—	nn	18	SENT_45	[p3l1441t965r1921b1041],
18	analysis	NN	O	analysis	dobj	9	SENT_45	[p3l1441t965r1921b1041],
19	of	IN	O	of	_	0	SENT_45	[p3l1945t965r2017b1023],
20	the	DT	O	the	det	21	SENT_45	[p3l2035t965r2148b1023],
21	effect	NN	O	effect	prep_of	18	SENT_45	[p3l9t1059r200b1117],
22	of	IN	O	of	_	0	SENT_45	[p3l224t1059r295b1117],
23	TNF-oc	JJ	O	tnf-oc	prep_of	21	SENT_45	[p3l312t1062r526b1117],
24	-308	CD	NUMBER	-308	tmod	23	SENT_45	[p3l553t1061r734b1117],
25	A	DT	O	a	dep	23	SENT_45	[p3l757t1059r836b1125],
26	/	:	O	/	punct	28	SENT_45	[p3l757t1059r836b1125],
27	G	NN	O	g	nn	28	SENT_45	[p3l842t1061r897b1117],
28	variant	NN	O	variant	dep	23	SENT_45	[p3l918t1062r1169b1117],
29	and	CC	O	and	_	0	SENT_45	[p3l1193t1060r1324b1117],
30	response	NN	O	response	conj_and	28	SENT_45	[p3l1347t1076r1652b1135],
31	to	TO	O	to	_	0	SENT_45	[p3l1676t1067r1746b1117],
32	anti-TNF-or	JJ	O	anti-tnf-or	amod	33	SENT_45	[p3l1771t1062r2150b1117],
33	therapy	NN	O	therapy	prep_to	9	SENT_45	[p3l8t1155r282b1231],
34	in	IN	O	in	_	0	SENT_45	[p3l308t1158r379b1212],
35	patients	NNS	O	patient	prep_in	33	SENT_45	[p3l407t1158r690b1231],
36	with	IN	O	with	_	0	SENT_45	[p3l718t1155r879b1213],
37	RA	NN	O	ra	prep_with	35	SENT_45	[p3l910t1157r1024b1213],
38	.	.	O	.	_	0	SENT_45	[p3l910t1157r1024b1213],

1	Results	NNS	O	result	_	0	SENT_46	[p3l11t1385r279b1442],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_47	[p3l9t1574r620b1649],
2	studies	NNS	O	study	_	0	SENT_47	[p3l655t1574r895b1631],
3	investigating	VBG	O	investigate	dep	2	SENT_47	[p3l929t1577r1390b1649],
4	the	DT	O	the	det	5	SENT_47	[p3l1422t1574r1535b1631],
5	inﬂuence	NN	O	inﬂuence	dobj	3	SENT_47	[p3l1569t1573r1900b1631],
6	of	IN	O	of	_	0	SENT_47	[p3l1935t1573r2007b1631],
7	the	DT	O	the	det	12	SENT_47	[p3l2035t1574r2148b1631],
8	TNF-or	NN	O	tnf-or	nn	12	SENT_47	[p3l7t1672r221b1727],
9	promoter	NN	O	promoter	nn	12	SENT_47	[p3l259t1676r592b1745],
10	-308	CD	NUMBER	-308	num	12	SENT_47	[p3l635t1671r816b1727],
11	A/G	NN	O	a/g	nn	12	SENT_47	[p3l856t1669r996b1734],
12	polymorphism	NN	O	polymorphism	prep_of	5	SENT_47	[p3l1035t1669r1561b1745],
13	on	IN	O	on	_	0	SENT_47	[p3l1602t1686r1693b1727],
14	response	NN	O	response	prep_on	12	SENT_47	[p3l1732t1686r2037b1745],
15	to	TO	O	to	prep	3	SENT_47	[p3l2078t1676r2148b1727],

1	TNF	NN	O	tnf	nn	4	SENT_48	[p3l9t2152r222b2207],
2	—	NN	O	—	nn	4	SENT_48	[p3l9t2152r222b2207],
3	oc	NN	O	oc	nn	4	SENT_48	[p3l9t2152r222b2207],
4	inhibitors	NNS	O	inhibitor	nsubjpass	9	SENT_48	[p3l255t2149r601b2207],
5	in	IN	O	in	_	0	SENT_48	[p3l636t2152r706b2206],
6	RA	NN	O	ra	nn	7	SENT_48	[p3l740t2151r837b2206],
7	patients	NNS	O	patient	prep_in	4	SENT_48	[p3l870t2152r1152b2225],
8	were	VBD	O	be	auxpass	9	SENT_48	[p3l1184t2166r1347b2207],
9	evaluated	VBN	O	evaluate	_	0	SENT_48	[p3l1382t2149r1739b2207],
10	.	.	O	.	_	0	SENT_48	[p3l1382t2149r1739b2207],

1	Whereas	IN	O	whereas	mark	8	SENT_49	[p3l1775t2149r2078b2207],
2	a	DT	O	a	det	3	SENT_49	[p3l2113t2166r2148b2207],
3	total	NN	O	total	nsubjpass	8	SENT_49	[p3l10t2244r172b2302],
4	of	IN	O	of	_	0	SENT_49	[p3l208t2244r280b2302],
5	11	CD	NUMBER	11	num	6	SENT_49	[p3l317t2246r389b2301],
6	hits	NNS	O	hit	prep_of	3	SENT_49	[p3l429t2244r559b2302],
7	were	VBD	O	be	auxpass	8	SENT_49	[p3l593t2261r756b2302],
8	obtained	VBN	O	obtain	advcl	17	SENT_49	[p3l793t2244r1105b2302],
9	using	VBG	O	use	xcomp	8	SENT_49	[p3l1139t2247r1331b2320],
10	our	PRP$	O	we	poss	12	SENT_49	[p3l1366t2261r1485b2302],
11	search	NN	O	search	nn	12	SENT_49	[p3l1520t2244r1740b2302],
12	algorithm	NN	O	algorithm	dobj	9	SENT_49	[p3l1775t2244r2142b2320],
13	,	,	O	,	_	0	SENT_49	[p3l1775t2244r2142b2320],
14	two	CD	NUMBER	two	num	15	SENT_49	[p3l10t2346r140b2396],
15	papers	NNS	O	papers	nsubjpass	17	SENT_49	[p3l167t2355r393b2414],
16	were	VBD	O	be	auxpass	17	SENT_49	[p3l418t2355r582b2396],
17	excluded	VBN	O	exclude	_	0	SENT_49	[p3l610t2338r944b2396],
18	.	.	O	.	_	0	SENT_49	[p3l610t2338r944b2396],

1	One	CD	NUMBER	one	nsubj	6	SENT_50	[p3l977t2340r1121b2396],
2	was	VBD	O	be	cop	6	SENT_50	[p3l1147t2355r1274b2396],
3	a	DT	O	a	det	6	SENT_50	[p3l1302t2355r1337b2396],
4	meta	NN	O	meta	nn	6	SENT_50	[p3l1363t2338r1842b2414],
5	—	NN	O	—	nn	6	SENT_50	[p3l1363t2338r1842b2414],
6	analysis	NN	O	analysis	_	0	SENT_50	[p3l1363t2338r1842b2414],
7	with	IN	O	with	_	0	SENT_50	[p3l1868t2338r2029b2396],
8	no	DT	O	no	det	12	SENT_50	[p3l2056t2355r2147b2396],
9	new	JJ	O	new	amod	12	SENT_50	[p3l10t2448r158b2489],
10	original	JJ	O	original	amod	12	SENT_50	[p3l188t2432r460b2507],
11	data	NNS	O	datum	nn	12	SENT_50	[p3l493t2425r706b2489],
12	”	NN	O	”	prep_with	6	SENT_50	[p3l493t2425r706b2489],
13	and	CC	O	and	_	0	SENT_50	[p3l740t2432r871b2489],
14	the	DT	O	the	det	16	SENT_50	[p3l903t2432r1015b2489],
15	second	JJ	ORDINAL	second	amod	16	SENT_50	[p3l1050t2431r1293b2489],
16	study	NN	O	study	nsubj	17	SENT_50	[p3l1327t2432r1519b2507],
17	pooled	VBD	O	pool	conj_and	6	SENT_50	[p3l1548t2432r1790b2507],
18	results	NNS	O	result	dobj	17	SENT_50	[p3l1822t2431r2047b2489],
19	of	IN	O	of	_	0	SENT_50	[p3l2080t2431r2152b2489],
20	two	CD	NUMBER	two	num	21	SENT_50	[p3l10t2534r140b2585],
21	diseases	NNS	O	disease	prep_of	18	SENT_50	[p3l181t2527r472b2597],
22	,	,	O	,	_	0	SENT_50	[p3l181t2527r472b2597],
23	Crohn	NN	PERSON	crohn	poss	25	SENT_50	[p3l518t2527r792b2585],
24	’s	POS	O	’s	_	0	SENT_50	[p3l518t2527r792b2585],
25	disease	NN	O	disease	appos	21	SENT_50	[p3l833t2527r1075b2585],
26	and	CC	O	and	_	0	SENT_50	[p3l1115t2527r1246b2585],
27	RA	NN	O	ra	conj_and	25	SENT_50	[p3l1286t2529r1400b2597],
28	,	,	O	,	_	0	SENT_50	[p3l1286t2529r1400b2597],
29	which	WDT	O	which	nsubjpass	31	SENT_50	[p3l1442t2527r1662b2585],
30	were	VBD	O	be	auxpass	31	SENT_50	[p3l1699t2544r1863b2585],
31	treated	VBN	O	treat	rcmod	21	SENT_50	[p3l1902t2527r2147b2585],
32	with	IN	O	with	_	0	SENT_50	[p3l9t2621r170b2678],
33	anti	JJ	O	anti	prep_with	31	SENT_50	[p3l205t2623r515b2678],
34	.	.	O	.	_	0	SENT_50	[p3l205t2623r515b2678],

1	—	NN	O	—	_	0	SENT_51	[p3l205t2623r515b2678],
2	.	.	O	.	_	0	SENT_51	[p3l205t2623r515b2678],

1	TNF	NN	O	tnf	_	0	SENT_52	[p3l205t2623r515b2678],
2	therapy	NN	O	therapy	dep	1	SENT_52	[p3l550t2613r902b2696],
3	.	.	O	.	_	0	SENT_52	[p3l550t2613r902b2696],

1	”	RB	O	”	advmod	5	SENT_53	[p3l550t2613r902b2696],
2	As	IN	O	as	dep	5	SENT_53	[p3l936t2622r1016b2678],
3	we	PRP	O	we	nsubj	5	SENT_53	[p3l1050t2638r1145b2678],
4	were	VBD	O	be	cop	5	SENT_53	[p3l1180t2638r1343b2678],
5	unable	JJ	O	unable	advcl	18	SENT_53	[p3l1378t2621r1617b2678],
6	to	TO	O	to	aux	7	SENT_53	[p3l1652t2628r1722b2678],
7	extract	VB	O	extract	xcomp	5	SENT_53	[p3l1759t2628r2000b2678],
8	the	DT	O	the	det	9	SENT_53	[p3l2034t2621r2146b2678],
9	data	NNS	O	datum	dobj	7	SENT_53	[p3l11t2717r160b2775],
10	solely	RB	O	solely	advmod	7	SENT_53	[p3l190t2717r392b2793],
11	for	IN	O	for	_	0	SENT_53	[p3l419t2717r517b2775],
12	RA	NN	O	ra	nn	13	SENT_53	[p3l546t2719r644b2774],
13	patients	NNS	O	patient	prep_for	7	SENT_53	[p3l671t2720r971b2793],
14	,	,	O	,	_	0	SENT_53	[p3l671t2720r971b2793],
15	this	DT	O	this	det	16	SENT_53	[p3l1006t2717r1135b2775],
16	study	NN	O	study	nsubjpass	18	SENT_53	[p3l1166t2717r1358b2793],
17	was	VBD	O	be	auxpass	18	SENT_53	[p3l1384t2734r1512b2775],
18	excluded	VBN	O	exclude	_	0	SENT_53	[p3l1542t2717r1876b2775],
19	.	.	O	.	_	0	SENT_53	[p3l1542t2717r1876b2775],

1	Characteristics	NNS	O	characteristic	nsubjpass	35	SENT_54	[p3l88t2812r606b2870],
2	pertinent	JJ	O	pertinent	amod	1	SENT_54	[p3l643t2815r974b2888],
3	to	TO	O	to	_	0	SENT_54	[p3l1011t2819r1080b2870],
4	the	DT	O	the	det	7	SENT_54	[p3l1117t2812r1230b2870],
5	meta	NN	O	meta	nn	7	SENT_54	[p3l1268t2812r1765b2888],
6	—	NN	O	—	nn	7	SENT_54	[p3l1268t2812r1765b2888],
7	analysis	NN	O	analysis	prep_to	2	SENT_54	[p3l1268t2812r1765b2888],
8	,	,	O	,	_	0	SENT_54	[p3l1268t2812r1765b2888],
9	including	VBG	O	include	_	0	SENT_54	[p3l1807t2812r2149b2888],
10	genotype	NN	O	genotype	nn	11	SENT_54	[p3l10t2914r336b2982],
11	frequency	NN	O	frequency	prep_including	7	SENT_54	[p3l396t2906r749b2982],
12	of	IN	O	of	_	0	SENT_54	[p3l806t2906r878b2964],
13	the	DT	O	the	det	18	SENT_54	[p3l932t2907r1044b2964],
14	TNF-oc	NN	O	tnf-oc	nn	18	SENT_54	[p3l1102t2909r1316b2964],
15	promoter	NN	O	promoter	nn	18	SENT_54	[p3l1373t2914r1706b2982],
16	-308	CD	NUMBER	-308	num	18	SENT_54	[p3l1768t2908r1948b2964],
17	A/G	NN	O	a/g	nn	18	SENT_54	[p3l2008t2906r2147b2972],
18	polymorphism	NN	O	polymorphism	prep_of	11	SENT_54	[p3l10t3003r535b3079],
19	between	IN	O	between	_	0	SENT_54	[p3l570t3003r867b3061],
20	responders	NNS	O	responder	prep_between	18	SENT_54	[p3l902t3003r1283b3079],
21	and	CC	O	and	_	0	SENT_54	[p3l1321t3003r1452b3061],
22	non-responders	NNS	O	non-responder	prep_between	18	SENT_54	[p3l1488t3003r2040b3079],
23	in	IN	O	in	_	0	SENT_54	[p3l2077t3006r2147b3060],
24	RA	NN	LOCATION	ra	nn	25	SENT_54	[p3l11t3121r108b3176],
25	patients	NNS	O	patient	prep_in	20	SENT_54	[p3l140t3122r440b3195],
26	,	,	O	,	_	0	SENT_54	[p3l140t3122r440b3195],
27	as	RB	O	as	_	0	SENT_54	[p3l480t3136r544b3177],
28	well	RB	O	well	_	0	SENT_54	[p3l577t3119r721b3177],
29	as	IN	O	as	_	0	SENT_54	[p3l755t3136r820b3177],
30	the	DT	O	the	det	33	SENT_54	[p3l854t3119r966b3177],
31	corresponding	JJ	O	corresponding	amod	33	SENT_54	[p3l1001t3119r1512b3195],
32	percent	NN	O	percent	nn	33	SENT_54	[p3l1544t3126r1808b3195],
33	response	NN	O	response	conj_and	20	SENT_54	[p3l1842t3136r2147b3195],
34	are	VBP	O	be	auxpass	35	SENT_54	[p3l11t3229r112b3270],
35	summarized	VBN	O	summarize	_	0	SENT_54	[p3l147t3213r577b3270],
36	in	IN	O	in	_	0	SENT_54	[p3l609t3216r680b3269],
37	Table	NNP	O	Table	prep_in	35	SENT_54	[p3l709t3213r894b3270],
38	1	CD	NUMBER	1	num	37	SENT_54	[p3l933t3215r985b3270],
39	.	.	O	.	_	0	SENT_54	[p3l933t3215r985b3270],

1	The	DT	O	the	det	2	SENT_55	[p3l1020t3213r1152b3270],
2	size	NN	O	size	nsubj	9	SENT_55	[p3l1187t3216r1310b3270],
3	of	IN	O	of	_	0	SENT_55	[p3l1343t3213r1415b3270],
4	the	DT	O	the	det	5	SENT_55	[p3l1443t3213r1555b3270],
5	cohorts	NNS	O	cohort	prep_of	2	SENT_55	[p3l1589t3213r1851b3270],
6	in	IN	O	in	_	0	SENT_55	[p3l1884t3216r1955b3269],
7	each	DT	O	each	det	8	SENT_55	[p3l1987t3213r2147b3270],
8	study	NN	O	study	prep_in	5	SENT_55	[p4l12t29r204b104],
9	ranged	VBD	O	range	_	0	SENT_55	[p4l233t29r474b104],
10	from	IN	O	from	_	0	SENT_55	[p4l505t28r675b86],
11	a	DT	O	a	det	15	SENT_55	[p4l708t45r742b86],
12	low	JJ	O	low	amod	15	SENT_55	[p4l774t28r902b86],
13	of	IN	O	of	_	0	SENT_55	[p4l933t28r1004b86],
14	161	CD	NUMBER	161	prep_of	12	SENT_55	[p4l1037t21r1181b86],
15	°	NN	O	°	prep_from	9	SENT_55	[p4l1037t21r1181b86],
16	to	TO	O	to	_	0	SENT_55	[p4l1212t36r1281b86],
17	a	DT	O	a	det	18	SENT_55	[p4l1315t45r1350b86],
18	high	JJ	O	high	prep_to	15	SENT_55	[p4l1381t29r1543b104],
19	of	IN	O	of	_	0	SENT_55	[p4l1575t28r1647b86],
20	198,16	CD	NUMBER	198,16	prep_of	18	SENT_55	[p4l1680t21r1889b99],
21	with	IN	O	with	_	0	SENT_55	[p4l1919t29r2080b86],
22	a	DT	O	a	det	23	SENT_55	[p4l2113t45r2148b86],
23	total	NN	O	total	prep_with	9	SENT_55	[p4l10t125r172b182],
24	of	IN	O	of	_	0	SENT_55	[p4l230t124r301b182],
25	692	CD	NUMBER	692	num	27	SENT_55	[p4l357t126r482b182],
26	RA	NN	O	ra	nn	27	SENT_55	[p4l540t126r637b181],
27	patients	NNS	O	patient	prep_of	23	SENT_55	[p4l693t127r994b200],
28	.	.	O	.	_	0	SENT_55	[p4l693t127r994b200],

1	Three	CD	NUMBER	three	num	3	SENT_56	[p4l1053t124r1253b182],
2	TNF-oc	NN	O	tnf-oc	nn	3	SENT_56	[p4l1310t127r1524b182],
3	inhibitors	NNS	O	inhibitor	nsubjpass	5	SENT_56	[p4l1580t124r1927b182],
4	were	VBD	O	be	auxpass	5	SENT_56	[p4l1983t141r2146b182],
5	included	VBN	O	include	_	0	SENT_56	[p4l10t220r319b278],
6	in	IN	O	in	_	0	SENT_56	[p4l380t223r451b277],
7	the	DT	O	the	det	8	SENT_56	[p4l512t220r624b278],
8	meta-analysis	NN	O	meta-analysis	prep_in	5	SENT_56	[p4l686t220r1185b296],
9	:	:	O	:	_	0	SENT_56	[p4l686t220r1185b296],
10	adalimumab	NN	O	adalimumab	dobj	5	SENT_56	[p4l1251t220r1711b290],
11	,	,	O	,	_	0	SENT_56	[p4l1251t220r1711b290],
12	etanercept	NN	O	etanercept	dobj	5	SENT_56	[p4l1778t227r2147b296],
13	and	CC	O	and	_	0	SENT_56	[p4l11t315r142b372],
14	inﬂiximab	NN	O	inﬂiximab	dobj	5	SENT_56	[p4l171t314r557b372],
15	.	.	O	.	_	0	SENT_56	[p4l171t314r557b372],

1	Although	IN	O	although	mark	7	SENT_57	[p4l590t315r926b390],
2	the	DT	O	the	det	4	SENT_57	[p4l956t315r1068b372],
3	raw	JJ	O	raw	amod	4	SENT_57	[p4l1099t331r1226b372],
4	data	NN	O	datum	nsubj	7	SENT_57	[p4l1254t315r1403b372],
5	was	VBD	O	be	cop	7	SENT_57	[p4l1430t331r1558b372],
6	not	RB	O	not	neg	7	SENT_57	[p4l1588t322r1709b372],
7	available	JJ	O	available	advcl	15	SENT_57	[p4l1739t315r2047b372],
8	in	IN	O	in	_	0	SENT_57	[p4l2077t318r2147b372],
9	one	CD	NUMBER	one	num	10	SENT_57	[p4l11t425r139b466],
10	study	NN	O	study	prep_in	7	SENT_57	[p4l169t401r437b484],
11	,	,	O	,	_	0	SENT_57	[p4l169t401r437b484],
12	“	CD	NUMBER	“	num	13	SENT_57	[p4l169t401r437b484],
13	counts	NNS	O	count	nsubjpass	15	SENT_57	[p4l468t415r702b466],
14	were	VBD	O	be	auxpass	15	SENT_57	[p4l728t425r892b466],
15	derived	VBN	O	derive	dep	22	SENT_57	[p4l920t408r1180b466],
16	from	IN	O	from	_	0	SENT_57	[p4l1207t408r1376b466],
17	Figure	NNP	O	Figure	prep_from	15	SENT_57	[p4l1404t411r1618b484],
18	1	CD	NUMBER	1	num	17	SENT_57	[p4l1652t410r1680b465],
19	of	IN	O	of	_	0	SENT_57	[p4l1713t408r1785b466],
20	the	DT	O	the	det	21	SENT_57	[p4l1807t408r1920b466],
21	metaanalysis	NN	O	metaanalysis	prep_of	17	SENT_57	[p4l1947t415r2147b466, p4l11t502r286b578],
22	carried	VBD	O	carry	_	0	SENT_57	[p4l316t502r556b560],
23	out	RP	O	out	prt	22	SENT_57	[p4l586t509r703b560],
24	by	IN	O	by	_	0	SENT_57	[p4l729t502r817b578],
25	Lee	NNP	PERSON	Lee	prep_by	22	SENT_57	[p4l845t505r960b560],
26	et	FW	O	et	nn	27	SENT_57	[p4l990t508r1051b560],
27	al.	FW	O	al.	nsubj	22	SENT_57	[p4l1074t495r1239b560],
28	17	CD	NUMBER	17	dep	27	SENT_57	[p4l1074t495r1239b560],
29	.	.	O	.	_	0	SENT_57	[p4l1074t495r1239b560],

1	The	DT	O	the	nsubj	2	SENT_58	[p4l85t598r217b656],
2	follow	VBP	O	follow	_	0	SENT_58	[p4l242t598r581b674],
3	—	CD	NUMBER	—	nsubj	6	SENT_58	[p4l242t598r581b674],
4	up	IN	O	up	_	0	SENT_58	[p4l242t598r581b674],
5	period	NN	O	period	prep_up	3	SENT_58	[p4l605t598r831b674],
6	ranged	VBD	O	range	ccomp	2	SENT_58	[p4l855t598r1096b674],
7	from	IN	O	from	_	0	SENT_58	[p4l1119t598r1288b656],
8	12	CD	DURATION	12	num	9	SENT_58	[p4l1318t599r1396b655],
9	weeks	NNS	NUMBER	week	prep_from	6	SENT_58	[p4l1418t598r1625b656],
10	to	TO	O	to	_	0	SENT_58	[p4l1650t605r1719b656],
11	25	CD	DURATION	25	num	12	SENT_58	[p4l1745t599r1824b656],
12	months	NNS	NUMBER	month	prep_to	6	SENT_58	[p4l1851t598r2143b656],
13	.	.	O	.	_	0	SENT_58	[p4l1851t598r2143b656],

1	A	DT	O	a	det	3	SENT_59	[p4l9t695r60b750],
2	successful	JJ	O	successful	amod	3	SENT_59	[p4l96t693r440b751],
3	response	NN	O	response	nsubjpass	11	SENT_59	[p4l475t710r780b769],
4	to	TO	O	to	_	0	SENT_59	[p4l816t700r885b751],
5	anti-TNF-oc	JJ	O	anti-tnf-oc	amod	6	SENT_59	[p4l923t696r1301b751],
6	blockade	NN	O	blockade	prep_to	3	SENT_59	[p4l1333t693r1647b751],
7	in	IN	O	in	_	0	SENT_59	[p4l1683t696r1753b750],
8	moderateto-severe	JJ	O	moderateto-severe	amod	9	SENT_59	[p4l1788t693r2146b751, p4l10t793r322b842],
9	RA	NN	O	ra	prep_in	6	SENT_59	[p4l384t787r482b842],
10	was	VBD	O	be	auxpass	11	SENT_59	[p4l538t802r665b842],
11	defined	VBN	O	define	_	0	SENT_59	[p4l727t785r993b842],
12	as	IN	O	as	_	0	SENT_59	[p4l1054t802r1118b842],
13	a	DT	O	a	det	14	SENT_59	[p4l1180t802r1214b842],
14	decrease	NN	O	decrease	prep_as	11	SENT_59	[p4l1275t786r1568b842],
15	in	IN	O	in	_	0	SENT_59	[p4l1629t788r1699b842],
16	DAS	NNP	O	DAS	prep_in	14	SENT_59	[p4l1760t787r1905b842],
17	2	CD	NUMBER	2	number	18	SENT_59	[p4l1978t795r2026b850],
18	1.2	CD	NUMBER	1.2	num	16	SENT_59	[p4l2047t787r2147b842],

1	(	NN	O	(	nsubj	2	SENT_60	[p4l14t881r355b957],
2	preferred	VBD	O	prefer	_	0	SENT_60	[p4l14t881r355b957],
3	outcome	NN	O	outcome	dobj	2	SENT_60	[p4l397t881r731b953],
4	)	CD	NUMBER	)	num	3	SENT_60	[p4l397t881r731b953],
5	or	CC	O	or	_	0	SENT_60	[p4l776t898r848b939],
6	achieving	VBG	O	achieve	dobj	2	SENT_60	[p4l889t881r1231b957],
7	at	IN	O	at	advmod	6	SENT_60	[p4l1273t888r1336b939],
8	least	JJS	O	least	pobj	7	SENT_60	[p4l1377t881r1534b939],
9	an	DT	O	a	det	10	SENT_60	[p4l1576t898r1661b939],
10	ACR20	NN	O	acr20	dobj	6	SENT_60	[p4l1701t882r1961b939],
11	.	.	O	.	_	0	SENT_60	[p4l1701t882r1961b939],

1	Five	CD	NUMBER	five	nsubj	6	SENT_61	[p4l2008t883r2146b939],
2	of	IN	O	of	_	0	SENT_61	[p4l11t974r82b1032],
3	the	DT	O	the	det	5	SENT_61	[p4l130t974r242b1032],
4	nine	CD	NUMBER	nine	num	5	SENT_61	[p4l295t977r452b1032],
5	studies	NNS	O	study	prep_of	1	SENT_61	[p4l506t974r746b1032],
6	used	VBD	O	use	_	0	SENT_61	[p4l798t974r958b1032],
7	DAS	NN	O	da	nsubj	13	SENT_61	[p4l1010t976r1155b1032],
8	2	CD	NUMBER	2	number	9	SENT_61	[p4l1219t984r1267b1039],
9	1.2	CD	NUMBER	1.2	dep	7	SENT_61	[p4l1288t976r1406b1045],
10	,	,	O	,	_	0	SENT_61	[p4l1288t976r1406b1045],
11	three	CD	NUMBER	three	num	12	SENT_61	[p4l1462t974r1642b1032],
12	studies	NNS	O	study	appos	7	SENT_61	[p4l1696t974r1936b1032],
13	used	VBD	O	use	ccomp	6	SENT_61	[p4l1987t974r2148b1032],
14	ACR20	NN	O	acr20	dobj	13	SENT_61	[p4l9t1072r269b1141],
15	,	,	O	,	_	0	SENT_61	[p4l9t1072r269b1141],
16	whereas	IN	O	whereas	mark	19	SENT_61	[p4l323t1070r607b1128],
17	one	CD	NUMBER	one	num	18	SENT_61	[p4l659t1087r788b1128],
18	study	NN	O	study	nsubj	19	SENT_61	[p4l841t1070r1033b1146],
19	considered	VBN	O	consider	advcl	13	SENT_61	[p4l1082t1070r1464b1128],
20	responders	NNS	O	responder	nsubj	23	SENT_61	[p4l1515t1070r1895b1146],
21	to	TO	O	to	aux	23	SENT_61	[p4l1947t1078r2017b1128],
22	be	VB	O	be	cop	23	SENT_61	[p4l2066t1070r2146b1128],
23	those	DT	O	those	xcomp	19	SENT_61	[p4l10t1164r199b1221],
24	who	WP	O	who	nsubj	25	SENT_61	[p4l228t1164r381b1221],
25	fulfilled	VBD	O	fulfil	rcmod	23	SENT_61	[p4l410t1164r686b1221],
26	either	CC	O	either	prep	29	SENT_61	[p4l716t1164r921b1221],
27	DAS	NN	O	da	dep	26	SENT_61	[p4l951t1166r1096b1221],
28	2	CD	NUMBER	2	number	29	SENT_61	[p4l1138t1173r1186b1228],
29	1.2	CD	NUMBER	1.2	dobj	25	SENT_61	[p4l1206t1166r1307b1221],
30	or	CC	O	or	_	0	SENT_61	[p4l1337t1181r1408b1221],
31	ACR20	NN	O	acr20	dobj	25	SENT_61	[p4l1435t1166r1696b1221],
32	.	.	O	.	_	0	SENT_61	[p4l1435t1166r1696b1221],

1	Meta-analysis	NN	O	meta-analysis	nsubj	6	SENT_62	[p4l86t1259r567b1334],
2	of	IN	O	of	_	0	SENT_62	[p4l599t1258r670b1316],
3	the	DT	O	the	det	5	SENT_62	[p4l697t1259r809b1316],
4	nine	CD	NUMBER	nine	num	5	SENT_62	[p4l840t1262r998b1316],
5	studies	NNS	O	study	prep_of	1	SENT_62	[p4l1031t1259r1271b1316],
6	showed	VBD	O	show	dep	14	SENT_62	[p4l1304t1259r1570b1316],
7	the	DT	O	the	det	8	SENT_62	[p4l1600t1259r1713b1316],
8	presence	NN	O	presence	dobj	6	SENT_62	[p4l1743t1275r2048b1334],
9	of	IN	O	of	_	0	SENT_62	[p4l2080t1258r2152b1316],
10	an	DT	O	a	det	12	SENT_62	[p4l11t1370r95b1411],
11	A	NN	O	a	nn	12	SENT_62	[p4l159t1355r210b1411],
12	allele	NN	O	allele	prep_of	8	SENT_62	[p4l275t1354r456b1411],
13	significantly	RB	O	significantly	advmod	14	SENT_62	[p4l524t1353r963b1429],
14	decreased	VBD	O	decrease	_	0	SENT_62	[p4l1026t1354r1366b1411],
15	response	NN	O	response	dobj	14	SENT_62	[p4l1430t1370r1735b1429],
16	to	TO	O	to	_	0	SENT_62	[p4l1801t1361r1871b1411],
17	TNF-oc	NN	O	tnf-oc	nn	18	SENT_62	[p4l1934t1356r2148b1411],
18	inhibitors	NNS	O	inhibitor	prep_to	14	SENT_62	[p4l10t1449r357b1507],
19	in	IN	O	in	_	0	SENT_62	[p4l387t1452r457b1506],
20	RA	NN	O	ra	nn	21	SENT_62	[p4l488t1451r585b1506],
21	patients	NNS	O	patient	prep_in	18	SENT_62	[p4l613t1452r895b1525],
22	(	CD	NUMBER	(	num	25	SENT_62	[p4l929t1449r1167b1525],
23	Figure	NN	O	figure	nn	25	SENT_62	[p4l929t1449r1167b1525],
24	1	CD	NUMBER	1	num	25	SENT_62	[p4l1203t1449r1282b1521],
25	)	NN	O	)	nsubj	14	SENT_62	[p4l1203t1449r1282b1521],
26	.	.	O	.	_	0	SENT_62	[p4l1203t1449r1282b1521],

1	The	DT	O	the	det	2	SENT_63	[p4l1315t1449r1447b1507],
2	frequency	NN	O	frequency	nsubj	11	SENT_63	[p4l1478t1449r1831b1525],
3	of	IN	O	of	_	0	SENT_63	[p4l1859t1449r1931b1507],
4	the	DT	O	the	det	8	SENT_63	[p4l1956t1449r2068b1507],
5	A	NN	O	a	nn	8	SENT_63	[p4l2098t1451r2148b1506],
6	allele	NN	O	allele	nn	8	SENT_63	[p4l11t1544r192b1602],
7	carrier	NN	O	carrier	nn	8	SENT_63	[p4l222t1547r446b1602],
8	state	NN	O	state	prep_of	2	SENT_63	[p4l474t1551r633b1602],
9	was	VBD	O	be	cop	11	SENT_63	[p4l660t1561r788b1602],
10	119/531	CD	PERCENT	119/531	number	11	SENT_63	[p4l822t1544r1099b1609],
11	(	CD	PERCENT	(	_	0	SENT_63	[p4l1136t1544r1336b1616],
12	22	CD	PERCENT	22	num	13	SENT_63	[p4l1136t1544r1336b1616],
13	%	NN	PERCENT	%	dep	11	SENT_63	[p4l1136t1544r1336b1616],
14	)	CD	NUMBER	)	npadvmod	11	SENT_63	[p4l1136t1544r1336b1616],
15	in	IN	O	in	_	0	SENT_63	[p4l1367t1547r1438b1601],
16	responders	NNS	O	responder	prep_in	11	SENT_63	[p4l1466t1544r1846b1620],
17	and	CC	O	and	_	0	SENT_63	[p4l1876t1544r2007b1602],
18	60	CD	NUMBER	60	conj_and	16	SENT_63	[p4l2036t1544r2147b1609],
19	/	:	O	/	punct	25	SENT_63	[p4l2036t1544r2147b1609],
20	161	CD	NUMBER	161	num	21	SENT_63	[p4l16t1641r132b1697],
21	(	NN	O	(	dep	25	SENT_63	[p4l168t1639r228b1711],
22	3	CD	PERCENT	3	number	24	SENT_63	[p4l168t1639r228b1711],
23	7	CD	PERCENT	7	number	24	SENT_63	[p4l241t1639r368b1711],
24	%	NN	PERCENT	%	amod	21	SENT_63	[p4l241t1639r368b1711],
25	)	CD	NUMBER	)	dep	11	SENT_63	[p4l241t1639r368b1711],
26	in	IN	O	in	_	0	SENT_63	[p4l398t1642r469b1696],
27	non-responders	JJ	O	non-responders	amod	31	SENT_63	[p4l495t1639r1047b1715],
28	(	CD	NUMBER	(	tmod	27	SENT_63	[p4l1078t1639r1316b1715],
29	Figure	NN	O	figure	nn	31	SENT_63	[p4l1078t1639r1316b1715],
30	1	CD	NUMBER	1	num	31	SENT_63	[p4l1349t1640r1429b1711],
31	)	NN	O	)	prep_in	11	SENT_63	[p4l1349t1640r1429b1711],
32	.	.	O	.	_	0	SENT_63	[p4l1349t1640r1429b1711],

1	We	PRP	O	we	nsubj	4	SENT_64	[p4l1458t1642r1568b1697],
2	did	VBD	O	do	aux	4	SENT_64	[p4l1596t1639r1708b1697],
3	not	RB	O	not	neg	4	SENT_64	[p4l1734t1646r1855b1697],
4	observe	VB	O	observe	dep	9	SENT_64	[p4l1882t1639r2146b1697],
5	significant	JJ	O	significant	amod	6	SENT_64	[p4l12t1733r383b1809],
6	heterogeneity	NN	O	heterogeneity	dobj	4	SENT_64	[p4l413t1733r905b1809],
7	between	IN	O	between	_	0	SENT_64	[p4l932t1733r1229b1791],
8	studies	NNS	O	study	prep_between	6	SENT_64	[p4l1262t1733r1502b1791],
9	(	VBP	O	(	_	0	SENT_64	[p4l1538t1733r1902b1805],
10	Cochrane	NNP	PERSON	Cochrane	nn	13	SENT_64	[p4l1538t1733r1902b1805],
11	Q	NNP	O	Q	nn	13	SENT_64	[p4l1936t1735r2000b1803],
12	test	NN	O	test	nn	13	SENT_64	[p4l2024t1741r2148b1791],
13	P	NN	O	p	dobj	9	SENT_64	[p4l7t1829r120b1884],
14	:	:	O	:	_	0	SENT_64	[p4l7t1829r120b1884],
15	0.37	CD	NUMBER	0.37	dep	13	SENT_64	[p4l139t1828r306b1896],
16	;	:	O	;	_	0	SENT_64	[p4l139t1828r306b1896],
17	I2	NN	O	i2	dep	13	SENT_64	[p4l334t1820r393b1884],
18	=	JJ	O	=	amod	17	SENT_64	[p4l411t1855r462b1873],
19	8.17	CD	PERCENT	8.17	num	20	SENT_64	[p4l482t1827r744b1899],
20	%	NN	PERCENT	%	dep	18	SENT_64	[p4l482t1827r744b1899],
21	)	CD	NUMBER	)	nsubj	9	SENT_64	[p4l482t1827r744b1899],
22	,	,	O	,	_	0	SENT_64	[p4l482t1827r744b1899],
23	indicating	VBG	O	indicate	partmod	9	SENT_64	[p4l776t1827r1138b1903],
24	that	IN	O	that	complm	33	SENT_64	[p4l1164t1827r1307b1885],
25	the	DT	O	the	det	26	SENT_64	[p4l1334t1827r1446b1885],
26	results	NNS	O	result	nsubj	33	SENT_64	[p4l1474t1827r1699b1885],
27	from	IN	O	from	_	0	SENT_64	[p4l1727t1827r1896b1885],
28	all	PDT	O	all	predet	30	SENT_64	[p4l1925t1827r2007b1885],
29	the	DT	O	the	det	30	SENT_64	[p4l2034t1827r2146b1885],
30	studies	NNS	O	study	prep_from	26	SENT_64	[p4l12t1923r252b1980],
31	were	VBD	O	be	cop	33	SENT_64	[p4l290t1939r454b1980],
32	reasonably	RB	O	reasonably	advmod	33	SENT_64	[p4l494t1922r876b1998],
33	consistent	JJ	O	consistent	ccomp	23	SENT_64	[p4l914t1925r1274b1980],
34	with	IN	O	with	_	0	SENT_64	[p4l1312t1922r1473b1980],
35	one	CD	NUMBER	one	prep_with	33	SENT_64	[p4l1513t1939r1642b1980],
36	another	DT	O	another	dep	35	SENT_64	[p4l1683t1923r1972b1980],
37	.	.	O	.	_	0	SENT_64	[p4l1683t1923r1972b1980],

1	The	DT	O	the	det	2	SENT_65	[p4l2014t1922r2146b1980],
2	odds	NNS	O	odds	nsubjpass	11	SENT_65	[p4l11t2017r174b2075],
3	for	IN	O	for	_	0	SENT_65	[p4l202t2017r300b2075],
4	the	DT	O	the	det	8	SENT_65	[p4l326t2017r438b2075],
5	A	NN	O	a	nn	8	SENT_65	[p4l465t2019r515b2074],
6	allele	NN	O	allele	nn	8	SENT_65	[p4l542t2017r723b2075],
7	carrier	NN	O	carrier	nn	8	SENT_65	[p4l752t2020r975b2075],
8	state	NN	O	state	prep_for	2	SENT_65	[p4l1002t2025r1161b2075],
9	was	VBD	O	be	auxpass	11	SENT_65	[p4l1187t2034r1315b2075],
10	significantly	RB	O	significantly	advmod	11	SENT_65	[p4l1344t2017r1783b2093],
11	decreased	VBN	O	decrease	_	0	SENT_65	[p4l1808t2017r2148b2075],
12	in	IN	O	in	_	0	SENT_65	[p4l10t2116r81b2170],
13	responders	NNS	O	responder	prep_in	11	SENT_65	[p4l104t2113r485b2189],
14	versus	CC	O	versus	_	0	SENT_65	[p4l507t2130r724b2171],
15	non-responders	JJ	O	non-responders	amod	17	SENT_65	[p4l748t2113r1300b2189],
16	(	NN	O	(	nn	17	SENT_65	[p4l1328t2113r1516b2185],
17	odds	NNS	O	odds	conj_versus	13	SENT_65	[p4l1328t2113r1516b2185],
18	ratio	NN	O	ratio	nn	21	SENT_65	[p4l1540t2116r1702b2171],
19	(	CD	NUMBER	(	num	21	SENT_65	[p4l1730t2113r1957b2185],
20	OR	NN	O	or	nn	21	SENT_65	[p4l1730t2113r1957b2185],
21	)	NN	O	)	dep	17	SENT_65	[p4l1730t2113r1957b2185],
22	:	:	O	:	_	0	SENT_65	[p4l1730t2113r1957b2185],
23	0.43	CD	NUMBER	0.43	dep	17	SENT_65	[p4l1975t2115r2142b2183],
24	,	,	O	,	_	0	SENT_65	[p4l1975t2115r2142b2183],
25	95	CD	PERCENT	95	number	26	SENT_65	[p4l11t2208r163b2264],
26	%	NN	PERCENT	%	amod	27	SENT_65	[p4l11t2208r163b2264],
27	confidence	NN	O	confidence	appos	23	SENT_65	[p4l229t2206r617b2264],
28	interval	NN	O	interval	nn	31	SENT_65	[p4l683t2207r956b2264],
29	(	CD	NUMBER	(	num	31	SENT_65	[p4l1025t2207r1173b2279],
30	CI	NN	O	ci	nn	31	SENT_65	[p4l1025t2207r1173b2279],
31	)	NN	O	)	dep	27	SENT_65	[p4l1025t2207r1173b2279],
32	:	:	O	:	_	0	SENT_65	[p4l1025t2207r1173b2279],
33	0.28-0	CD	NUMBER	0.28-0	num	34	SENT_65	[p4l1243t2208r1601b2277],
34	.68	CD	NUMBER	.68	dep	17	SENT_65	[p4l1243t2208r1601b2277],
35	,	,	O	,	_	0	SENT_65	[p4l1243t2208r1601b2277],
36	P	NN	O	p	appos	34	SENT_65	[p4l1669t2208r2143b2276],
37	=	JJ	O	=	amod	36	SENT_65	[p4l1669t2208r2143b2276],
38	0.000245	CD	NUMBER	0.000245	tmod	37	SENT_65	[p4l1669t2208r2143b2276],
39	;	:	O	;	_	0	SENT_65	[p4l1669t2208r2143b2276],
40	Figure	NNP	O	Figure	dep	17	SENT_65	[p4l11t2305r225b2378],
41	1	CD	NUMBER	1	number	42	SENT_65	[p4l271t2303r350b2375],
42	)	CD	NUMBER	)	dep	40	SENT_65	[p4l271t2303r350b2375],
43	.	.	O	.	_	0	SENT_65	[p4l271t2303r350b2375],

1	Therefore	RB	O	therefore	advmod	12	SENT_66	[p4l391t2302r748b2373],
2	,	,	O	,	_	0	SENT_66	[p4l391t2302r748b2373],
3	carriage	NN	O	carriage	nsubj	12	SENT_66	[p4l793t2306r1065b2378],
4	of	IN	O	of	_	0	SENT_66	[p4l1106t2302r1178b2360],
5	the	DT	O	the	det	7	SENT_66	[p4l1212t2303r1324b2360],
6	A	NN	O	a	nn	7	SENT_66	[p4l1362t2304r1413b2360],
7	allele	NN	O	allele	prep_of	3	SENT_66	[p4l1452t2303r1633b2360],
8	for	IN	O	for	_	0	SENT_66	[p4l1673t2302r1771b2360],
9	the	DT	O	the	det	11	SENT_66	[p4l1809t2303r1921b2360],
10	-308	CD	NUMBER	-308	num	11	SENT_66	[p4l1965t2304r2146b2360],
11	SNP	NN	ORGANIZATION	snp	prep_for	7	SENT_66	[p4l11t2400r149b2456],
12	predicted	VBD	O	predict	_	0	SENT_66	[p4l177t2398r509b2474],
13	poor	JJ	O	poor	amod	14	SENT_66	[p4l538t2415r702b2474],
14	response	NN	O	response	dobj	12	SENT_66	[p4l730t2415r1035b2474],
15	to	TO	O	to	_	0	SENT_66	[p4l1065t2405r1135b2456],
16	anti-TNF-or	JJ	O	anti-tnf-or	amod	17	SENT_66	[p4l1165t2401r1544b2456],
17	therapy	NN	O	therapy	prep_to	12	SENT_66	[p4l1573t2398r1855b2474],
18	.	.	O	.	_	0	SENT_66	[p4l1573t2398r1855b2474],

1	To	TO	O	to	aux	2	SENT_67	[p4l85t2495r169b2551],
2	determine	VB	O	determine	purpcl	29	SENT_67	[p4l200t2493r560b2551],
3	the	DT	O	the	det	4	SENT_67	[p4l590t2493r703b2551],
4	effect	NN	O	effect	dobj	2	SENT_67	[p4l733t2493r924b2551],
5	of	IN	O	of	_	0	SENT_67	[p4l954t2493r1025b2551],
6	the	DT	O	the	det	12	SENT_67	[p4l1050t2493r1163b2551],
7	T	NN	O	t	nn	12	SENT_67	[p4l1190t2495r1237b2550],
8	NF-oc	NN	MISC	nf-oc	nn	12	SENT_67	[p4l1238t2495r1404b2550],
9	promoter	NN	O	promoter	nn	12	SENT_67	[p4l1432t2500r1765b2569],
10	-308	CD	NUMBER	-308	num	12	SENT_67	[p4l1798t2494r1978b2551],
11	A/G	NN	O	a/g	nn	12	SENT_67	[p4l2008t2493r2148b2558],
12	polymorphism	NN	O	polymorphism	prep_of	4	SENT_67	[p4l10t2588r535b2664],
13	on	IN	O	on	_	0	SENT_67	[p4l595t2605r687b2646],
14	response	NN	O	response	prep_on	12	SENT_67	[p4l747t2605r1051b2664],
15	to	TO	O	to	_	0	SENT_67	[p4l1112t2595r1182b2646],
16	TNF-or	NN	O	tnf-or	nn	17	SENT_67	[p4l1240t2591r1454b2646],
17	inhibitors	NNS	O	inhibitor	prep_to	2	SENT_67	[p4l1513t2588r1859b2646],
18	in	IN	O	in	_	0	SENT_67	[p4l1920t2591r1990b2645],
19	RA	NN	O	ra	nn	20	SENT_67	[p4l2051t2590r2148b2645],
20	patients	NNS	O	patient	prep_in	2	SENT_67	[p4l10t2685r292b2758],
21	solely	RB	O	solely	advmod	20	SENT_67	[p4l325t2682r527b2758],
22	of	IN	O	of	_	0	SENT_67	[p4l556t2682r628b2740],
23	Caucasian	JJ	LOCATION	caucasian	amod	24	SENT_67	[p4l656t2684r1014b2740],
24	descent	NN	O	descent	prep_of	20	SENT_67	[p4l1046t2682r1328b2753],
25	,	,	O	,	_	0	SENT_67	[p4l1046t2682r1328b2753],
26	the	DT	O	the	det	27	SENT_67	[p4l1364t2682r1477b2740],
27	meta-analysis	NN	O	meta-analysis	nsubjpass	29	SENT_67	[p4l1509t2682r1988b2758],
28	was	VBD	O	be	auxpass	29	SENT_67	[p4l2019t2699r2146b2740],
29	repeated	VBN	O	repeat	_	0	SENT_67	[p4l10t2776r311b2852],
30	excluding	VBG	O	exclude	_	0	SENT_67	[p4l335t2776r684b2852],
31	the	DT	O	the	det	33	SENT_67	[p4l705t2776r818b2834],
32	Korean	JJ	MISC	korean	amod	33	SENT_67	[p4l843t2778r1092b2834],
33	cohort	NN	O	cohort	prep_excluding	29	SENT_67	[p4l1116t2768r1436b2834],
34	.	.	O	.	_	0	SENT_67	[p4l1116t2768r1436b2834],

1	”	NN	O	”	nsubj	31	SENT_68	[p4l1116t2768r1436b2834],
2	Although	IN	O	although	mark	3	SENT_68	[p4l1458t2776r1794b2852],
3	increased	VBN	O	increase	advcl	10	SENT_68	[p4l1817t2776r2147b2834],
4	compared	VBN	O	compare	_	0	SENT_68	[p4l11t2871r361b2947],
5	with	IN	O	with	prepc_compared_with	3	SENT_68	[p4l400t2871r561b2929],
6	Figure	NN	O	figure	pobj	3	SENT_68	[p4l602t2874r816b2947],
7	1	CD	NUMBER	1	num	6	SENT_68	[p4l864t2873r916b2942],
8	,	,	O	,	_	0	SENT_68	[p4l864t2873r916b2942],
9	there	EX	O	there	expl	10	SENT_68	[p4l961t2872r1141b2929],
10	was	VBD	O	be	rcmod	1	SENT_68	[p4l1181t2888r1309b2929],
11	no	DT	O	no	det	18	SENT_68	[p4l1351t2888r1442b2929],
12	significant	JJ	O	significant	amod	18	SENT_68	[p4l1485t2871r1855b2947],
13	heterogeneity	NN	O	heterogeneity	nn	18	SENT_68	[p4l1896t2871r2147b2929, p4l10t2968r272b3040],
14	(	CD	NUMBER	(	num	18	SENT_68	[p4l313t2965r677b3037],
15	Cochrane	NNP	PERSON	Cochrane	nn	18	SENT_68	[p4l313t2965r677b3037],
16	Q	NNP	O	Q	nn	18	SENT_68	[p4l720t2966r784b3034],
17	test	NN	O	test	nn	18	SENT_68	[p4l817t2972r940b3022],
18	P	NN	O	p	nsubj	10	SENT_68	[p4l977t2966r1276b3034],
19	=	JJ	O	=	amod	18	SENT_68	[p4l977t2966r1276b3034],
20	0.27	CD	NUMBER	0.27	tmod	19	SENT_68	[p4l977t2966r1276b3034],
21	;	:	O	;	_	0	SENT_68	[p4l977t2966r1276b3034],
22	I2	NN	O	i2	dep	18	SENT_68	[p4l1317t2958r1445b3022],
23	:	:	O	:	_	0	SENT_68	[p4l1317t2958r1445b3022],
24	19.6	CD	PERCENT	19.6	num	25	SENT_68	[p4l1469t2965r1705b3037],
25	%	NN	PERCENT	%	dep	22	SENT_68	[p4l1469t2965r1705b3037],
26	)	CD	NUMBER	)	dep	25	SENT_68	[p4l1469t2965r1705b3037],
27	among	IN	O	among	_	0	SENT_68	[p4l1750t2982r1995b3040],
28	the	DT	O	the	det	30	SENT_68	[p4l2034t2965r2146b3022],
29	Caucasian	JJ	MISC	caucasian	amod	30	SENT_68	[p4l12t3063r370b3119],
30	studies	NNS	O	study	prep_among	10	SENT_68	[p4l413t3061r653b3119],
31	(	VBP	O	(	_	0	SENT_68	[p4l700t3061r938b3137],
32	Figure	NN	O	figure	nn	34	SENT_68	[p4l700t3061r938b3137],
33	2	CD	NUMBER	2	num	34	SENT_68	[p4l982t3061r1066b3133],
34	)	NN	O	)	dobj	31	SENT_68	[p4l982t3061r1066b3133],
35	.	.	O	.	_	0	SENT_68	[p4l982t3061r1066b3133],

1	Again	RB	O	again	advmod	10	SENT_69	[p4l1112t3063r1316b3137],
2	the	DT	O	the	det	3	SENT_69	[p4l1358t3061r1470b3119],
3	presence	NN	O	presence	pobj	1	SENT_69	[p4l1513t3078r1818b3137],
4	of	IN	O	of	_	0	SENT_69	[p4l1862t3061r1933b3119],
5	an	DT	O	a	det	7	SENT_69	[p4l1972t3078r2057b3119],
6	A	NN	O	a	nn	7	SENT_69	[p4l2098t3063r2148b3118],
7	allele	NN	O	allele	prep_of	1	SENT_69	[p4l11t3156r192b3213],
8	was	VBD	O	be	auxpass	10	SENT_69	[p4l219t3172r347b3213],
9	significantly	RB	O	significantly	advmod	10	SENT_69	[p4l377t3155r816b3231],
10	associated	VBN	O	associate	_	0	SENT_69	[p4l842t3156r1197b3213],
11	with	IN	O	with	_	0	SENT_69	[p4l1223t3156r1384b3213],
12	a	DT	O	a	det	14	SENT_69	[p4l1412t3172r1447b3213],
13	decreased	VBN	O	decrease	amod	14	SENT_69	[p4l1474t3156r1814b3213],
14	response	NN	O	response	prep_with	10	SENT_69	[p4l1842t3172r2147b3231],
15	to	TO	O	to	_	0	SENT_69	[p4l10t3258r80b3308],
16	TNF-oc	NN	O	tnf-oc	nn	17	SENT_69	[p4l125t3253r338b3308],
17	inhibitors	NNS	O	inhibitor	prep_to	14	SENT_69	[p4l383t3251r730b3308],
18	in	IN	O	in	_	0	SENT_69	[p4l776t3254r846b3308],
19	RA	NN	O	ra	nn	20	SENT_69	[p4l893t3252r990b3308],
20	patients	NNS	O	patient	prep_in	17	SENT_69	[p4l1034t3254r1316b3326],
21	of	IN	O	of	_	0	SENT_69	[p4l1363t3250r1435b3308],
22	Caucasian	JJ	MISC	caucasian	amod	23	SENT_69	[p4l1478t3252r1835b3308],
23	descent	NN	O	descent	prep_of	20	SENT_69	[p4l1882t3251r2148b3308],
24	(	CD	NUMBER	(	num	27	SENT_69	[p4l14t3346r252b3422],
25	Figure	NN	O	figure	nn	27	SENT_69	[p4l14t3346r252b3422],
26	2	CD	NUMBER	2	num	27	SENT_69	[p4l276t3346r360b3418],
27	)	NN	O	)	nsubjpass	10	SENT_69	[p4l276t3346r360b3418],
28	.	.	O	.	_	0	SENT_69	[p4l276t3346r360b3418],

1	The	DT	O	the	det	2	SENT_70	[p4l384t3346r517b3404],
2	frequency	NN	O	frequency	nsubj	11	SENT_70	[p4l540t3346r893b3422],
3	of	IN	O	of	_	0	SENT_70	[p4l914t3346r985b3404],
4	the	DT	O	the	det	8	SENT_70	[p4l1002t3346r1114b3404],
5	A	NN	O	a	nn	8	SENT_70	[p4l1137t3348r1187b3403],
6	allele	NN	O	allele	nn	8	SENT_70	[p4l1209t3346r1391b3404],
7	carrier	NN	O	carrier	nn	8	SENT_70	[p4l1414t3349r1637b3404],
8	state	NN	O	state	prep_of	2	SENT_70	[p4l1660t3353r1819b3404],
9	was	VBD	O	be	cop	11	SENT_70	[p4l1840t3363r1968b3404],
10	1	CD	NUMBER	1	number	11	SENT_70	[p4l1996t3348r2025b3403],
11	18	CD	NUMBER	18	_	0	SENT_70	[p4l2040t3346r2147b3411],
12	/	:	O	/	punct	31	SENT_70	[p4l2040t3346r2147b3411],
13	471	CD	PERCENT	471	dep	17	SENT_70	[p4l11t3443r132b3498],
14	(	CD	PERCENT	(	dep	13	SENT_70	[p4l208t3441r407b3513],
15	25	CD	PERCENT	25	num	16	SENT_70	[p4l208t3441r407b3513],
16	%	NN	PERCENT	%	dep	17	SENT_70	[p4l208t3441r407b3513],
17	)	CD	NUMBER	)	dep	25	SENT_70	[p4l208t3441r407b3513],
18	in	IN	O	in	_	0	SENT_70	[p4l477t3444r548b3498],
19	responders	NNS	O	responder	prep_in	17	SENT_70	[p4l614t3441r994b3517],
20	and	CC	O	and	_	0	SENT_70	[p4l1063t3441r1194b3499],
21	60/151	CD	PERCENT	60/151	number	22	SENT_70	[p4l1262t3441r1498b3506],
22	(	CD	PERCENT	(	dep	25	SENT_70	[p4l1574t3441r1773b3513],
23	40	CD	PERCENT	40	num	24	SENT_70	[p4l1574t3441r1773b3513],
24	%	NN	PERCENT	%	dep	22	SENT_70	[p4l1574t3441r1773b3513],
25	)	CD	NUMBER	)	dep	29	SENT_70	[p4l1574t3441r1773b3513],
26	in	IN	O	in	_	0	SENT_70	[p4l1844t3444r1914b3498],
27	nonresponders	NNS	O	nonresponder	prep_in	25	SENT_70	[p4l1980t3458r2146b3499, p4l10t3536r391b3612],
28	(	CD	NUMBER	(	num	29	SENT_70	[p4l428t3536r666b3612],
29	Figure	NN	O	figure	dep	31	SENT_70	[p4l428t3536r666b3612],
30	2	CD	NUMBER	2	num	31	SENT_70	[p4l702t3536r786b3608],
31	)	NN	O	)	dep	11	SENT_70	[p4l702t3536r786b3608],
32	.	.	O	.	_	0	SENT_70	[p4l702t3536r786b3608],

1	The	DT	O	the	det	2	SENT_71	[p4l821t3536r954b3594],
2	odds	NNS	O	odds	nsubjpass	11	SENT_71	[p4l988t3536r1151b3594],
3	of	IN	O	of	_	0	SENT_71	[p4l1186t3536r1257b3594],
4	the	DT	O	the	det	8	SENT_71	[p4l1286t3536r1398b3594],
5	A	NN	O	a	nn	8	SENT_71	[p4l1430t3537r1481b3593],
6	allele	NN	O	allele	nn	8	SENT_71	[p4l1514t3536r1696b3594],
7	carrier	NN	O	carrier	nn	8	SENT_71	[p4l1730t3539r1954b3594],
8	state	NN	O	state	prep_of	2	SENT_71	[p4l1987t3543r2147b3594],
9	was	VBD	O	be	auxpass	11	SENT_71	[p4l9t3647r136b3688],
10	significantly	RB	O	significantly	advmod	11	SENT_71	[p4l205t3630r644b3706],
11	decreased	VBN	O	decrease	_	0	SENT_71	[p4l709t3630r1048b3688],
12	in	IN	O	in	_	0	SENT_71	[p4l1114t3633r1184b3687],
13	responders	NNS	O	responder	prep_in	11	SENT_71	[p4l1251t3630r1632b3706],
14	versus	CC	O	versus	prep	13	SENT_71	[p4l1696t3647r1913b3688],
15	nonresponders	NNS	O	nonresponder	dep	14	SENT_71	[p4l1980t3647r2146b3688, p4l10t3726r391b3802],
16	(	CD	NUMBER	(	num	17	SENT_71	[p4l458t3726r843b3798],
17	OR	NN	O	or	dep	15	SENT_71	[p4l458t3726r843b3798],
18	=	JJ	O	=	amod	17	SENT_71	[p4l458t3726r843b3798],
19	0.41	CD	NUMBER	0.41	tmod	18	SENT_71	[p4l458t3726r843b3798],
20	,	,	O	,	_	0	SENT_71	[p4l458t3726r843b3798],
21	95	CD	PERCENT	95	number	22	SENT_71	[p4l911t3727r1063b3784],
22	%	NN	PERCENT	%	amod	23	SENT_71	[p4l911t3727r1063b3784],
23	CI	NN	O	ci	appos	15	SENT_71	[p4l1127t3727r1223b3784],
24	:	:	O	:	_	0	SENT_71	[p4l1127t3727r1223b3784],
25	0.25-0	CD	NUMBER	0.25-0	number	26	SENT_71	[p4l1290t3727r1648b3796],
26	.68	CD	NUMBER	.68	dep	23	SENT_71	[p4l1290t3727r1648b3796],
27	,	,	O	,	_	0	SENT_71	[p4l1290t3727r1648b3796],
28	P	NN	O	p	appos	15	SENT_71	[p4l1712t3727r2143b3795],
29	=	JJ	O	=	amod	28	SENT_71	[p4l1712t3727r2143b3795],
30	0.00045	CD	NUMBER	0.00045	tmod	29	SENT_71	[p4l1712t3727r2143b3795],
31	;	:	O	;	_	0	SENT_71	[p4l1712t3727r2143b3795],

1	Figure	NN	O	figure	_	0	SENT_72	[p5l11t21r225b94],
2	2	CD	NUMBER	2	num	3	SENT_72	[p5l265t19r348b90],
3	)	NN	O	)	dep	1	SENT_72	[p5l265t19r348b90],
4	.	.	O	.	_	0	SENT_72	[p5l265t19r348b90],

1	Exclusion	NN	O	exclusion	nsubj	10	SENT_73	[p5l391t19r733b76],
2	of	IN	O	of	_	0	SENT_73	[p5l771t18r842b76],
3	the	DT	O	the	det	7	SENT_73	[p5l876t18r988b76],
4	Korean	JJ	MISC	korean	amod	7	SENT_73	[p5l1027t21r1275b76],
5	cohort	NN	O	cohort	nn	7	SENT_73	[p5l1314t18r1545b76],
6	study	NN	O	study	nn	7	SENT_73	[p5l1585t11r1840b94],
7	”	NN	O	”	prep_of	1	SENT_73	[p5l1585t11r1840b94],
8	did	VBD	O	do	aux	10	SENT_73	[p5l1878t18r1990b76],
9	not	RB	O	not	neg	10	SENT_73	[p5l2027t26r2148b76],
10	impact	VB	O	impact	_	0	SENT_73	[p5l10t118r254b190],
11	the	DT	O	the	det	12	SENT_73	[p5l297t115r410b172],
12	meta-analysis	NN	O	meta-analysis	dobj	10	SENT_73	[p5l455t115r952b190],
13	,	,	O	,	_	0	SENT_73	[p5l455t115r952b190],
14	as	IN	O	as	mark	21	SENT_73	[p5l1002t131r1066b172],
15	the	DT	O	the	det	16	SENT_73	[p5l1111t115r1223b172],
16	OR	NN	O	or	nsubj	26	SENT_73	[p5l1269t116r1376b172],
17	estimated	VBN	O	estimate	partmod	16	SENT_73	[p5l1419t115r1761b172],
18	from	IN	O	from	_	0	SENT_73	[p5l1804t114r1973b172],
19	this	DT	O	this	det	20	SENT_73	[p5l2018t115r2147b172],
20	study	NN	O	study	prep_from	17	SENT_73	[p5l12t210r204b286],
21	had	VBD	O	have	advcl	10	SENT_73	[p5l227t210r359b268],
22	high	JJ	O	high	amod	23	SENT_73	[p5l385t210r547b286],
23	Variance	NN	O	variance	dobj	21	SENT_73	[p5l571t213r867b268],
24	and	CC	O	and	_	0	SENT_73	[p5l895t210r1026b268],
25	only	RB	O	only	advmod	26	SENT_73	[p5l1053t210r1212b286],
26	received	VBD	O	receive	advcl	10	SENT_73	[p5l1235t210r1526b268],
27	1.6	CD	PERCENT	1.6	num	28	SENT_73	[p5l1557t212r1727b268],
28	%	NN	PERCENT	%	dobj	26	SENT_73	[p5l1557t212r1727b268],
29	of	IN	O	of	_	0	SENT_73	[p5l1754t210r1825b268],
30	the	DT	O	the	det	32	SENT_73	[p5l1846t210r1959b268],
31	total	JJ	O	total	amod	32	SENT_73	[p5l1986t210r2147b268],
32	Weight	NNP	O	Weight	prep_of	28	SENT_73	[p5l9t305r250b380],
33	in	IN	O	in	_	0	SENT_73	[p5l289t308r359b362],
34	the	DT	O	the	det	38	SENT_73	[p5l399t305r512b362],
35	full	JJ	O	full	amod	38	SENT_73	[p5l552t304r669b362],
36	meta	NN	O	meta	nn	38	SENT_73	[p5l709t305r1208b380],
37	—	NN	O	—	nn	38	SENT_73	[p5l709t305r1208b380],
38	ana1ysis	NN	O	ana1ysis	prep_in	26	SENT_73	[p5l709t305r1208b380],
39	.	.	O	.	_	0	SENT_73	[p5l709t305r1208b380],

1	Funnel	VB	O	funnel	csubjpass	16	SENT_74	[p5l1253t305r1497b362],
2	plots	NNS	O	plot	dobj	1	SENT_74	[p5l1537t305r1708b380],
3	of	IN	O	of	_	0	SENT_74	[p5l1750t304r1821b362],
4	the	DT	O	the	det	5	SENT_74	[p5l1856t305r1968b362],
5	ORs	NNS	O	or	prep_of	2	SENT_74	[p5l2011t306r2147b362],
6	from	IN	O	from	_	0	SENT_74	[p5l10t399r180b457],
7	each	DT	O	each	det	8	SENT_74	[p5l212t400r372b457],
8	study	NN	O	study	prep_from	1	SENT_74	[p5l405t400r597b475],
9	against	IN	O	against	_	0	SENT_74	[p5l626t403r875b475],
10	the	DT	O	the	det	11	SENT_74	[p5l905t400r1018b457],
11	inverse	NN	O	inverse	prep_against	8	SENT_74	[p5l1050t403r1298b457],
12	of	IN	O	of	_	0	SENT_74	[p5l1331t399r1402b457],
13	their	PRP$	O	they	poss	14	SENT_74	[p5l1429t400r1596b457],
14	Variances	NNS	MISC	variance	prep_of	11	SENT_74	[p5l1625t403r1953b457],
15	were	VBD	O	be	auxpass	16	SENT_74	[p5l1983t416r2146b457],
16	examined	VBN	O	examine	conj_and	16	SENT_74	[p5l11t493r359b551],
17	with	IN	O	with	_	0	SENT_74	[p5l406t493r568b551],
18	and	CC	O	and	_	0	SENT_74	[p5l618t493r749b551],
19	without	IN	O	without	_	0	SENT_74	[p5l797t493r1080b551],
20	the	DT	O	the	det	23	SENT_74	[p5l1129t493r1241b551],
21	Korean	JJ	MISC	korean	amod	23	SENT_74	[p5l1293t496r1541b551],
22	cohort	NN	O	cohort	nn	23	SENT_74	[p5l1592t493r1824b551],
23	study	NN	O	study	prep_without	16	SENT_74	[p5l1876t486r2148b568],
24	.	.	O	.	_	0	SENT_74	[p5l1876t486r2148b568],

1	”	NN	O	”	poss	7	SENT_75	[p5l1876t486r2148b568],
2	'	POS	O	'	_	0	SENT_75	[p5l1105t649r1295b711],
3	|	NN	O	|	nn	7	SENT_75	[p5l1105t649r1295b711],
4	gN	NN	O	gn	nn	7	SENT_75	[p5l1105t649r1295b711],
5	[	CD	NUMBER	[	number	6	SENT_75	[p5l1105t649r1295b711],
6	)	CD	NUMBER	)	num	7	SENT_75	[p5l1105t649r1295b711],
7	F	NN	O	f	_	0	SENT_75	[p5l1105t649r1295b711],
8	-	:	O	-	_	0	SENT_75	[p5l1105t649r1295b711],
9	(	CD	NUMBER	(	num	10	SENT_75	[p5l1105t649r1295b711],
10	o3I	NN	O	o3us	dep	7	SENT_75	[p5l1105t649r1295b711],
11	&	CC	O	&	_	0	SENT_75	[p5l1105t649r1295b711],
12	(	NN	O	(	dep	7	SENT_75	[p5l1105t649r1295b711],
13	?	.	O	?	_	0	SENT_75	[p5l1105t649r1295b711],

1	;	:	O	;	_	0	SENT_76	[p5l1105t649r1295b711],
2	|	NN	O	|	nn	6	SENT_76	[p5l1105t649r1295b711],
3	t	NN	O	t	nn	6	SENT_76	[p5l1105t649r1295b711],
4	|	NN	O	|	nn	6	SENT_76	[p5l1105t649r1295b711],
5	'	''	O	'	_	0	SENT_76	[p5l1105t649r1295b711],
6	J	NN	O	j	_	0	SENT_76	[p5l1105t649r1295b711],
7	)	CD	NUMBER	)	dep	6	SENT_76	[p5l1105t649r1295b711],
8	/	:	O	/	punct	9	SENT_76	[p5l1105t649r1295b711],
9	8	CD	NUMBER	8	dep	7	SENT_76	[p5l1105t649r1295b711],
10	;	:	O	;	_	0	SENT_76	[p5l1105t649r1295b711],
11	)	CD	NUMBER	)	num	12	SENT_76	[p5l1105t649r1295b711],
12	‘	CD	NUMBER	‘	dep	9	SENT_76	[p5l1105t649r1295b711],
13	/	:	O	/	punct	9	SENT_76	[p5l1105t649r1295b711],
14	1	CD	NUMBER	1	dep	7	SENT_76	[p5l1105t649r1295b711],
15	:	:	O	:	_	0	SENT_76	[p5l1105t649r1295b711],
16	-	:	O	-	_	0	SENT_76	[p5l1105t649r1295b711],
17	\	NN	O	\	nn	18	SENT_76	[p5l1105t649r1295b711],
18	variant	NN	O	variant	dep	7	SENT_76	[p5l1303t649r1387b671],
19	and	CC	O	and	_	0	SENT_76	[p5l1396t649r1439b671],
20	anti-TNF-or	JJ	O	anti-tnf-or	amod	21	SENT_76	[p5l1448t649r1568b671],
21	agents	NNS	O	agent	conj_and	18	SENT_76	[p5l1577t651r1655b678],
22	@	IN	O	@	prep	18	SENT_76	[p5l2089t643r2151b704],

1	Table	NNP	O	Table	nn	3	SENT_77	[p5l9t830r101b858],
2	1	CD	NUMBER	1	num	3	SENT_77	[p5l118t831r129b858],
3	Characteristics	NNS	O	characteristic	_	0	SENT_77	[p5l173t831r412b858],
4	of	IN	O	of	_	0	SENT_77	[p5l426t831r459b858],
5	pharmacogenetic	JJ	O	pharmacogenetic	amod	6	SENT_77	[p5l473t831r759b866],
6	studies	NNS	O	study	prep_of	3	SENT_77	[p5l773t831r886b858],
7	using	VBG	O	use	partmod	6	SENT_77	[p5l901t831r986b866],
8	the	DT	O	the	det	9	SENT_77	[p5l1001t831r1053b858],
9	TNF-or	NN	O	tnf-or	nsubj	12	SENT_77	[p5l1067t832r1164b858],
10	-308	CD	NUMBER	-308	npadvmod	11	SENT_77	[p5l1179t832r1264b858],
11	variant	JJ	O	variant	dep	12	SENT_77	[p5l1276t831r1391b858],
12	included	VBN	O	include	xcomp	7	SENT_77	[p5l1405t831r1543b858],
13	in	IN	O	in	_	0	SENT_77	[p5l1559t831r1586b858],
14	the	DT	O	the	det	15	SENT_77	[p5l1601t831r1653b858],
15	meta-analysis	NN	O	meta-analysis	prep_in	12	SENT_77	[p5l1669t831r1889b866],

1	Study	NNP	O	Study	nn	4	SENT_78	[p5l11t966r184b1037],
2	Year	NNP	DURATION	Year	nn	4	SENT_78	[p5l548t967r679b1020],
3	Drug	NNP	O	Drug	nn	4	SENT_78	[p5l832t968r981b1037],
4	Number	NNP	O	Number	_	0	SENT_78	[p5l1262t965r1513b1020],
5	of	IN	O	of	_	0	SENT_78	[p5l1536t966r1599b1020],
6	Follow-up	JJ	MISC	follow-up	amod	7	SENT_78	[p5l1717t966r2005b1037],
7	patients	NNS	O	patient	prep_of	4	SENT_78	[p5l1257t1054r1502b1124],
8	period	NN	O	period	dep	4	SENT_78	[p5l1711t1053r1905b1124],

1	Mugnier	JJR	O	mugnier	dep	12	SENT_79	[p5l12t1194r280b1265],
2	2003	CD	DATE	2003	num	3	SENT_79	[p5l542t1195r700b1248],
3	INF	NN	O	inf	dep	1	SENT_79	[p5l833t1196r934b1247],
4	53	CD	NUMBER	53	number	5	SENT_79	[p5l1405t1195r1481b1248],
5	22	CD	DURATION	22	num	6	SENT_79	[p5l1714t1195r1790b1247],
6	weeks	NNS	NUMBER	week	tmod	3	SENT_79	[p5l1819t1193r2009b1248],
7	Padyukov	NNP	O	Padyukov	dep	12	SENT_79	[p5l12t1300r314b1372],
8	2003	CD	DATE	2003	num	12	SENT_79	[p5l542t1302r700b1355],
9	ETA	NNP	O	ETA	nn	12	SENT_79	[p5l833t1303r948b1354],
10	123	CD	NUMBER	123	num	12	SENT_79	[p5l1367t1302r1481b1355],
11	3	CD	DURATION	3	num	12	SENT_79	[p5l1717t1302r1748b1355],
12	months	NNS	NUMBER	month	dep	19	SENT_79	[p5l1782t1300r2018b1355],
13	Cuchacovich	JJ	O	cuchacovich	amod	15	SENT_79	[p5l10t1405r412b1459],
14	2004	CD	DATE	2004	num	15	SENT_79	[p5l542t1407r701b1459],
15	INF	NN	O	inf	dep	12	SENT_79	[p5l833t1408r934b1459],
16	16	CD	NUMBER	16	number	17	SENT_79	[p5l1409t1407r1483b1459],
17	22	CD	DURATION	22	num	18	SENT_79	[p5l1714t1407r1790b1459],
18	weeks	NNS	NUMBER	week	tmod	15	SENT_79	[p5l1819t1405r2009b1459],
19	Fonseca	NNP	O	Fonseca	dep	25	SENT_79	[p5l12t1514r258b1566],
20	2005	CD	DATE	2005	num	19	SENT_79	[p5l542t1514r699b1566],
21	INF	NNP	O	INF	dep	19	SENT_79	[p5l833t1514r934b1565],
22	22	CD	NUMBER	22	number	23	SENT_79	[p5l1405t1514r1482b1565],
23	25	CD	DURATION	25	num	24	SENT_79	[p5l1714t1514r1789b1566],
24	months	NNS	NUMBER	month	tmod	21	SENT_79	[p5l1823t1512r2060b1566],
25	Kang	NNP	O	Kang	dep	31	SENT_79	[p5l12t1621r166b1691],
26	2005	CD	DATE	2005	num	25	SENT_79	[p5l542t1621r699b1674],
27	ETA	NNP	ORGANIZATION	ETA	dep	25	SENT_79	[p5l833t1621r948b1673],
28	70	CD	NUMBER	70	number	29	SENT_79	[p5l1409t1621r1483b1674],
29	12	CD	DURATION	12	num	30	SENT_79	[p5l1717t1621r1790b1673],
30	weeks	NNS	NUMBER	week	tmod	27	SENT_79	[p5l1819t1619r2010b1674],
31	Cuchacovich	JJ	O	cuchacovich	_	0	SENT_79	[p5l10t1725r412b1779],
32	2006	CD	DATE	2006	num	33	SENT_79	[p5l542t1726r702b1779],
33	ADA	NN	O	ada	dep	31	SENT_79	[p5l827t1727r970b1778],
34	70	CD	NUMBER	70	number	35	SENT_79	[p5l1409t1726r1483b1779],
35	24	CD	DURATION	24	num	36	SENT_79	[p5l1714t1726r1791b1778],
36	weeks	NNS	NUMBER	week	tmod	33	SENT_79	[p5l1819t1724r2010b1779],

1	Seitz	NNP	PERSON	Seitz	_	0	SENT_80	[p5l10t1934r155b1987],
2	2007	CD	DATE	2007	num	1	SENT_80	[p5l542t1934r701b1987],
3	INF	NNP	O	INF	dep	1	SENT_80	[p5l833t1935r952b1999],
4	;	:	O	;	_	0	SENT_80	[p5l833t1935r952b1999],
5	54	CD	NUMBER	54	number	6	SENT_80	[p5l1405t1935r1483b1987],
6	24	CD	DURATION	24	num	7	SENT_80	[p5l1714t1934r1791b1987],
7	weeks	NNS	NUMBER	week	dep	3	SENT_80	[p5l1819t1933r2010b1987],

1	ETA	NNP	O	ETA	_	0	SENT_81	[p5l833t2022r963b2086],
2	;	:	O	;	_	0	SENT_81	[p5l833t2022r963b2086],
3	ADA	NN	O	ada	dep	1	SENT_81	[p5l993t2022r1136b2074],

1	Guis	NNP	O	Guis	_	0	SENT_82	[p5l10t2113r145b2166],
2	2007	CD	DATE	2007	num	6	SENT_82	[p5l542t2114r701b2166],
3	ETA	NNP	O	ETA	nn	6	SENT_82	[p5l833t2114r948b2165],
4	86	CD	NUMBER	86	num	6	SENT_82	[p5l1406t2114r1483b2166],
5	6	CD	DURATION	6	num	6	SENT_82	[p5l1715t2114r1750b2166],
6	months	NNS	NUMBER	month	dep	14	SENT_82	[p5l1782t2112r2018b2166],
7	Marotte	NNP	PERSON	Marotte	dep	6	SENT_82	[p5l13t2220r261b2271],
8	2008	CD	DATE	2008	num	7	SENT_82	[p5l542t2219r701b2271],
9	INF	NNP	O	INF	dep	7	SENT_82	[p5l833t2220r934b2271],
10	198	CD	NUMBER	198	num	9	SENT_82	[p5l1367t2219r1482b2271],
11	30	CD	DURATION	30	num	12	SENT_82	[p5l1717t2219r1792b2271],
12	weeks	NNS	NUMBER	week	dep	14	SENT_82	[p5l1819t2217r2009b2271],
13	Response	NN	O	response	nn	14	SENT_82	[p5l41t2314r303b2379],
14	TNF-or	NN	O	tnf-or	dep	1	SENT_82	[p5l607t2314r772b2363],
15	-308	CD	NUMBER	-308	num	17	SENT_82	[p5l802t2313r968b2363],
16	Responder	NNP	O	Responder	nn	17	SENT_82	[p5l1089t2311r1389b2379],
17	Non	NNP	O	Non	dep	14	SENT_82	[p5l1504t2314r1647b2363],
18	-	:	O	-	_	0	SENT_82	[p5l1504t2314r1647b2363],
19	Percent	NN	O	percent	nn	20	SENT_82	[p5l1905t2314r2116b2363],
20	criteria	NNS	O	criterion	dep	1	SENT_82	[p5l40t2408r236b2458],
21	genotype	NN	O	genotype	nn	23	SENT_82	[p5l598t2413r867b2474],
22	responder	NN	O	responder	nn	23	SENT_82	[p5l1504t2406r1790b2474],
23	response	NN	O	response	dep	20	SENT_82	[p5l1904t2422r2153b2474],

1	IDAS28	NN	O	idas28	dep	7	SENT_83	[p5l48t2581r289b2646],
2	21.2	CD	NUMBER	21.2	num	3	SENT_83	[p5l327t2582r478b2639],
3	G/G	NN	O	g/g	dep	1	SENT_83	[p5l601t2580r722b2639],
4	33	CD	NUMBER	33	number	5	SENT_83	[p5l1201t2582r1269b2632],
5	8	CD	NUMBER	8	dep	3	SENT_83	[p5l1645t2582r1678b2632],
6	80	CD	NUMBER	80	dep	7	SENT_83	[p5l2010t2582r2083b2632],
7	CA	NNP	O	CA	dep	12	SENT_83	[p5l601t2665r692b2715],
8	or	CC	O	or	_	0	SENT_83	[p5l717t2679r779b2715],
9	A/A	NNP	O	A/A	conj_or	7	SENT_83	[p5l801t2663r913b2722],
10	5	CD	NUMBER	5	num	9	SENT_83	[p5l1236t2666r1268b2715],
11	7	CD	NUMBER	7	num	12	SENT_83	[p5l1648t2666r1679b2715],
12	42	CD	NUMBER	42	_	0	SENT_83	[p5l2007t2665r2082b2715],

1	IDAS28	NN	O	idas28	dep	6	SENT_84	[p5l48t2830r289b2895],
2	21.2	CD	NUMBER	21.2	dep	1	SENT_84	[p5l327t2831r478b2888],
3	G/G	NN	O	g/g	dep	6	SENT_84	[p5l601t2829r722b2888],
4	65	CD	NUMBER	65	num	3	SENT_84	[p5l1198t2831r1269b2881],
5	12	CD	NUMBER	12	num	6	SENT_84	[p5l1608t2831r1678b2881],
6	84	CD	NUMBER	84	dep	9	SENT_84	[p5l2010t2831r2082b2881],
7	or	CC	O	or	_	0	SENT_84	[p5l38t2928r100b2964],
8	ACR20	NN	O	acr20	dep	9	SENT_84	[p5l121t2914r326b2964],
9	CA	NNP	O	CA	dep	14	SENT_84	[p5l601t2914r692b2964],
10	or	CC	O	or	_	0	SENT_84	[p5l717t2928r779b2964],
11	A/A	NNP	O	A/A	conj_or	9	SENT_84	[p5l801t2912r913b2971],
12	34	CD	NUMBER	34	num	11	SENT_84	[p5l1201t2914r1271b2964],
13	12	CD	NUMBER	12	num	14	SENT_84	[p5l1608t2914r1678b2964],
14	74	CD	NUMBER	74	_	0	SENT_84	[p5l2012t2915r2082b2964],

1	AC	NN	O	ac	nn	3	SENT_85	[p5l35t3080r123b3130],
2	R20	NN	O	r20	nn	3	SENT_85	[p5l131t3080r240b3130],
3	G/G	NN	O	g/g	dep	7	SENT_85	[p5l601t3078r722b3137],
4	7	CD	NUMBER	7	num	5	SENT_85	[p5l1240t3081r1271b3130],
5	1	CD	NUMBER	1	dep	3	SENT_85	[p5l1648t3080r1666b3130],
6	88	CD	NUMBER	88	dep	7	SENT_85	[p5l2009t3080r2082b3130],
7	CA	NNP	O	CA	dep	12	SENT_85	[p5l601t3163r692b3214],
8	or	CC	O	or	_	0	SENT_85	[p5l717t3177r779b3214],
9	A/A	NNP	O	A/A	conj_or	7	SENT_85	[p5l801t3162r913b3221],
10	7	CD	NUMBER	7	num	9	SENT_85	[p5l1240t3164r1271b3214],
11	1	CD	NUMBER	1	num	12	SENT_85	[p5l1648t3163r1666b3213],
12	88	CD	NUMBER	88	_	0	SENT_85	[p5l2009t3163r2082b3214],

1	IDAS28	NN	O	idas28	dep	8	SENT_86	[p5l48t3329r289b3394],
2	21.2	CD	NUMBER	21.2	num	1	SENT_86	[p5l327t3330r478b3387],
3	(	CD	NUMBER	(	number	4	SENT_86	[p5l601t3328r722b3387],
4	3/6	CD	NUMBER	3/6	dep	1	SENT_86	[p5l601t3328r722b3387],
5	11	CD	NUMBER	11	num	6	SENT_86	[p5l1200t3330r1258b3379],
6	4	CD	NUMBER	4	dep	4	SENT_86	[p5l1643t3330r1678b3379],
7	73	CD	NUMBER	73	dep	8	SENT_86	[p5l2012t3330r2081b3380],
8	CA	NNP	O	CA	dep	13	SENT_86	[p5l601t3413r692b3463],
9	or	CC	O	or	_	0	SENT_86	[p5l717t3426r779b3463],
10	A/A	NNP	O	A/A	conj_or	8	SENT_86	[p5l801t3411r913b3470],
11	3	CD	NUMBER	3	num	10	SENT_86	[p5l1240t3413r1269b3463],
12	4	CD	NUMBER	4	num	13	SENT_86	[p5l1643t3413r1678b3462],
13	43	CD	NUMBER	43	_	0	SENT_86	[p5l2007t3413r2081b3463],

1	AC	NN	ORGANIZATION	ac	nn	3	SENT_87	[p5l35t3579r123b3629],
2	R20	NN	O	r20	nn	3	SENT_87	[p5l131t3579r240b3629],
3	G/G	NN	O	g/g	_	0	SENT_87	[p5l601t3577r722b3636],
4	59	CD	NUMBER	59	number	5	SENT_87	[p5l1197t3579r1270b3629],
5	1	CD	NUMBER	1	dep	3	SENT_87	[p5l1608t3579r1626b3628],
6	o	NN	O	o	nn	8	SENT_87	[p5l1644t3579r1679b3629],
7	86	CD	NUMBER	86	num	8	SENT_87	[p5l2010t3579r2082b3629],
8	CA	NNP	O	CA	dep	5	SENT_87	[p5l601t3662r692b3712],
9	or	CC	O	or	_	0	SENT_87	[p5l717t3676r779b3712],
10	A/A	NNP	O	A/A	dep	3	SENT_87	[p5l801t3660r913b3719],
11	1	CD	NUMBER	1	num	10	SENT_87	[p5l1240t3662r1258b3712],
12	O	NN	O	o	dep	10	SENT_87	[p5l1645t3662r1679b3712],
13	100	CD	NUMBER	100	num	12	SENT_87	[p5l1972t3662r2082b3712],

1	iDAS28	NN	O	idas28	_	0	SENT_88	[p6l48t62r289b126],
2	21.2	CD	NUMBER	21.2	num	3	SENT_88	[p6l327t62r478b119],
3	G/C	NN	O	g/c	dep	1	SENT_88	[p6l601t60r722b119],
4	.	.	O	.	_	0	SENT_88	[p6l601t60r722b119],

1	CA	NNP	O	CA	_	0	SENT_89	[p6l601t145r692b196],
2	or	CC	O	or	_	0	SENT_89	[p6l717t159r779b196],
3	A/A	NNP	O	A/A	conj_or	1	SENT_89	[p6l801t144r913b203],

1	G/G	NN	O	g/g	_	0	SENT_90	[p6l601t310r722b369],
2	CA	NNP	O	CA	dep	1	SENT_90	[p6l601t394r692b445],
3	or	CC	O	or	_	0	SENT_90	[p6l717t408r779b445],
4	A/A	NNP	O	A/A	dep	1	SENT_90	[p6l801t393r913b452],

1	LDASZ8	NN	O	ldasz8	_	0	SENT_91	[p6l48t311r289b376],
2	21.2	CD	NUMBER	21.2	num	1	SENT_91	[p6l327t311r478b369],

1	iDAS28	NN	O	idas28	_	0	SENT_92	[p6l48t560r289b625],
2	21.2	CD	NUMBER	21.2	num	3	SENT_92	[p6l327t560r478b618],
3	G/G	NN	O	g/g	dep	1	SENT_92	[p6l601t559r722b618],

1	CA	NNP	O	CA	_	0	SENT_93	[p6l601t644r692b694],
2	or	CC	O	or	_	0	SENT_93	[p6l717t657r779b694],
3	A/A	NNP	O	A/A	conj_or	1	SENT_93	[p6l801t642r913b701],

1	ACR2O	NN	O	acr2o	_	0	SENT_94	[p6l35t810r240b860],
2	G/C	NN	O	g/c	dep	1	SENT_94	[p6l601t808r722b867],
3	.	.	O	.	_	0	SENT_94	[p6l601t808r722b867],

1	CA	NNP	O	CA	_	0	SENT_95	[p6l601t893r692b944],
2	or	CC	O	or	_	0	SENT_95	[p6l717t907r779b944],
3	A/A	NNP	O	A/A	conj_or	1	SENT_95	[p6l801t891r913b950],

1	O	NN	O	o	_	0	SENT_96	[p6l1645t62r1679b196],
2	\	CD	NUMBER	\	num	3	SENT_96	[p6l1645t62r1679b196],
3	O	NN	O	o	dep	1	SENT_96	[p6l1645t62r1679b196],
4	\	IN	O	\	amod	3	SENT_96	[p6l1645t62r1679b196],

1	O	NN	O	o	_	0	SENT_97	[p6l1645t311r1679b362],
2	100	CD	NUMBER	100	num	3	SENT_97	[p6l1972t311r2082b362],
3	82	CD	NUMBER	82	dep	1	SENT_97	[p6l2010t394r2082b445],

1	Uo	NN	O	uo	_	0	SENT_98	[p6l1648t394r1677b445],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_99	[p6l8t992r189b1014],
2	:	:	O	:	_	0	SENT_99	[p6l8t992r189b1014],
3	ACRZO	NNP	LOCATION	ACRZO	nn	6	SENT_99	[p6l203t993r296b1019],
4	,	,	O	,	_	0	SENT_99	[p6l203t993r296b1019],
5	American	NNP	ORGANIZATION	American	appos	6	SENT_99	[p6l309t993r429b1014],
6	College	NNP	ORGANIZATION	College	dep	1	SENT_99	[p6l443t992r538b1021],
7	of	IN	ORGANIZATION	of	_	0	SENT_99	[p6l552t992r576b1014],
8	Rheumatology	NNP	ORGANIZATION	Rheumatology	prep_of	6	SENT_99	[p6l589t992r774b1021],
9	20	CD	PERCENT	20	number	10	SENT_99	[p6l786t993r844b1014],
10	%	NN	PERCENT	%	amod	12	SENT_99	[p6l786t993r844b1014],
11	improvement	NN	O	improvement	nn	12	SENT_99	[p6l858t993r1031b1021],
12	criteria	NNS	O	criterion	dep	8	SENT_99	[p6l1043t993r1135b1019],
13	;	:	O	;	_	0	SENT_99	[p6l1043t993r1135b1019],
14	ADA	NN	ORGANIZATION	ada	dep	8	SENT_99	[p6l1149t993r1212b1019],
15	,	,	O	,	_	0	SENT_99	[p6l1149t993r1212b1019],
16	adalimumab	NN	O	adalimumab	appos	14	SENT_99	[p6l1226t992r1393b1019],
17	;	:	O	;	_	0	SENT_99	[p6l1226t992r1393b1019],
18	DAS28	NN	O	das28	dep	8	SENT_99	[p6l1408t993r1500b1019],
19	,	,	O	,	_	0	SENT_99	[p6l1408t993r1500b1019],
20	disease	NN	O	disease	nn	22	SENT_99	[p6l1515t992r1603b1014],
21	activity	NN	O	activity	nn	22	SENT_99	[p6l1617t993r1706b1021],
22	score	NN	NUMBER	score	appos	18	SENT_99	[p6l1719t999r1784b1014],
23	using	VBG	O	use	partmod	8	SENT_99	[p6l1797t993r1863b1021],
24	28	CD	NUMBER	28	num	26	SENT_99	[p6l1877t993r1908b1014],
25	joint	JJ	O	joint	amod	26	SENT_99	[p6l1920t993r1978b1021],
26	counts	NNS	O	count	dobj	23	SENT_99	[p6l1990t995r2080b1019],
27	;	:	O	;	_	0	SENT_99	[p6l1990t995r2080b1019],
28	ETA	NNP	ORGANIZATION	ETA	dep	1	SENT_99	[p6l2096t993r2148b1019],
29	,	,	O	,	_	0	SENT_99	[p6l2096t993r2148b1019],
30	etanercept	NNP	O	etanercept	appos	28	SENT_99	[p6l9t1033r152b1060],
31	;	:	O	;	_	0	SENT_99	[p6l9t1033r152b1060],
32	INF	NNP	O	INF	dep	1	SENT_99	[p6l166t1032r214b1058],
33	,	,	O	,	_	0	SENT_99	[p6l166t1032r214b1058],
34	infliximab	NN	O	infliximab	appos	32	SENT_99	[p6l228t1031r359b1053],
35	.	.	O	.	_	0	SENT_99	[p6l228t1031r359b1053],

1	Study	NNP	O	Study	nn	3	SENT_100	[p6l376t1137r446b1163],
2	Respnndesr	NNP	O	Respnndesr	nn	3	SENT_100	[p6l686t1137r816b1163],
3	Nnnallesponder	NNP	O	Nnnallesponder	_	0	SENT_100	[p6l876t1137r1066b1163],

1	WN	NN	O	wn	_	0	SENT_101	[p6l730t1170r774b1190],
2	im	NN	O	im	dep	1	SENT_101	[p6l948t1170r994b1190],
3	'N	CC	O	'n	rcmod	2	SENT_101	[p6l948t1170r994b1190],

1	Nfugnjez	NNP	O	Nfugnjez	_	0	SENT_102	[p6l260t1234r358b1260],
2	at	IN	O	at	_	0	SENT_102	[p6l364t1236r384b1254],
3	111	CD	NUMBER	111	prep_at	1	SENT_102	[p6l392t1234r424b1258],
4	.	.	O	.	_	0	SENT_102	[p6l392t1234r424b1258],

1	.	.	O	.	_	0	SENT_103	[p6l392t1234r424b1258],

1	2003	CD	DATE	2003	num	2	SENT_104	[p6l432t1234r488b1254],
2	S138	NN	O	s138	_	0	SENT_104	[p6l730t1234r780b1254],
3	7115	CD	NUMBER	7115	num	5	SENT_104	[p6l950t1234r998b1254],
4	Padyulmv	NNP	O	Padyulmv	nn	5	SENT_104	[p6l260t1270r374b1296],
5	st	NN	O	st	dep	2	SENT_104	[p6l380t1272r400b1290],
6	EL	NNP	O	EL	dep	5	SENT_104	[p6l408t1270r440b1294],
7	2003	CD	DATE	2003	num	6	SENT_104	[p6l448t1270r504b1290],
8	34.199	CD	NUMBER	34.199	number	9	SENT_104	[p6l716t1270r780b1290],
9	12.124	CD	NUMBER	12.124	num	10	SENT_104	[p6l938t1270r1000b1290],
10	Oachawvich	NN	O	oachawvich	dep	2	SENT_104	[p6l264t1304r410b1326],
11	at	IN	O	at	_	0	SENT_104	[p6l416t1308r438b1326],
12	31	CD	NUMBER	31	prep_at	10	SENT_104	[p6l444t1304r478b1328],
13	.	.	O	.	_	0	SENT_104	[p6l444t1304r478b1328],

1	.	.	O	.	_	0	SENT_105	[p6l444t1304r478b1328],

1	2004	CD	DATE	2004	_	0	SENT_106	[p6l486t1304r542b1326],
2	‘	CD	NUMBER	‘	num	4	SENT_106	[p6l730t1304r780b1326],
3	N14	NN	O	n14	nn	4	SENT_106	[p6l730t1304r780b1326],
4	H2	NN	O	h2	dep	1	SENT_106	[p6l966t1304r999b1326],
5	Fonseca	NNP	PERSON	Fonseca	tmod	4	SENT_106	[p6l260t1338r352b1360],
6	91	CD	NUMBER	91	npadvmod	7	SENT_106	[p6l358t1340r380b1360],
7	at	IN	O	at	advmod	5	SENT_106	[p6l386t1338r420b1362],
8	.	.	O	.	_	0	SENT_106	[p6l386t1338r420b1362],

1	2005	CD	DATE	2005	num	4	SENT_107	[p6l428t1338r484b1360],
2	3314	CD	NUMBER	3314	num	4	SENT_107	[p6l730t1338r780b1360],
3	4JB	NNP	O	4JB	nn	4	SENT_107	[p6l960t1338r996b1360],
4	King	NNP	O	King	_	0	SENT_107	[p6l262t1374r324b1402],
5	at	IN	O	at	_	0	SENT_107	[p6l330t1376r352b1396],
6	al.	FW	O	al.	nn	7	SENT_107	[p6l358t1374r392b1398],
7	“	FW	O	“	prep_at	4	SENT_107	[p6l358t1374r392b1398],
8	.	.	O	.	_	0	SENT_107	[p6l358t1374r392b1398],

1	,	,	O	,	_	0	SENT_108	[p6l358t1374r392b1398],
2	2005	CD	DATE	2005	num	3	SENT_108	[p6l400t1374r454b1396],
3	[	CD	NUMBER	[	dep	8	SENT_108	[p6l734t1374r780b1396],
4	I60	NN	O	i60	nsubj	8	SENT_108	[p6l734t1374r780b1396],
5	0/10	CD	NUMBER	0/10	num	4	SENT_108	[p6l950t1374r1000b1396],
6	L	NN	O	l	prep	8	SENT_108	[p6l264t1408r410b1429],
7	*	CD	NUMBER	*	dep	6	SENT_108	[p6l264t1408r410b1429],
8	let	VBD	O	let	_	0	SENT_108	[p6l416t1410r438b1429],
9	111.	CD	NUMBER	111.	dobj	8	SENT_108	[p6l444t1408r478b1432],
10	,	,	O	,	_	0	SENT_108	[p6l444t1408r478b1432],
11	2006	CD	DATE	2006	num	12	SENT_108	[p6l486t1408r542b1429],
12	13158	CD	NUMBER	13158	dobj	8	SENT_108	[p6l718t1408r780b1429],
13	6112	CD	NUMBER	6112	num	14	SENT_108	[p6l950t1408r999b1429],
14	Seitz	NNP	PERSON	Seitz	rcmod	12	SENT_108	[p6l264t1445r320b1467],
15	el	FW	O	el	nn	16	SENT_108	[p6l326t1449r346b1467],
16	a.	FW	O	a.	dep	17	SENT_108	[p6l354t1445r388b1471],
17	L	NN	O	l	dep	14	SENT_108	[p6l354t1445r388b1471],
18	,	,	O	,	_	0	SENT_108	[p6l354t1445r388b1471],
19	200	CD	NUMBER	200	dep	14	SENT_108	[p6l396t1446r452b1467],
20	'	''	O	'	_	0	SENT_108	[p6l396t1446r452b1467],
21	?	.	O	?	_	0	SENT_108	[p6l396t1446r452b1467],

1	|	NN	O	|	_	0	SENT_109	[p6l720t1445r776b1467],
2	4	CD	NUMBER	4	dep	1	SENT_109	[p6l720t1445r776b1467],
3	.	.	O	.	_	0	SENT_109	[p6l720t1445r776b1467],

1	'S	POS	O	's	nsubj	3	SENT_110	[p6l720t1445r776b1467],
2	‘	CD	NUMBER	‘	dep	3	SENT_110	[p6l720t1445r776b1467],
3	l	NN	O	l	_	0	SENT_110	[p6l720t1445r776b1467],
4	3	CD	NUMBER	3	dobj	3	SENT_110	[p6l962t1445r996b1467],
5	!	.	O	!	_	0	SENT_110	[p6l962t1445r996b1467],

1	3	CD	NUMBER	3	num	2	SENT_111	[p6l962t1445r996b1467],
2	Gui	NNP	O	Gui	_	0	SENT_111	[p6l264t1481r316b1503],
3	:	:	O	:	_	0	SENT_111	[p6l264t1481r316b1503],
4	eiia1	NN	O	eiia1	dep	2	SENT_111	[p6l322t1481r384b1505],
5	.	.	O	.	_	0	SENT_111	[p6l322t1481r384b1505],

1	.	.	O	.	_	0	SENT_112	[p6l322t1481r384b1505],

1	200	CD	NUMBER	200	num	2	SENT_113	[p6l392t1482r448b1503],
2	‘	NN	O	‘	_	0	SENT_113	[p6l392t1482r448b1503],
3	!	.	O	!	_	0	SENT_113	[p6l392t1482r448b1503],

1	10166	CD	NUMBER	10166	num	3	SENT_114	[p6l718t1481r780b1503],
2	SE20	NN	O	se20	nn	3	SENT_114	[p6l948t1481r998b1503],
3	Mnmtte	NN	O	mnmtte	_	0	SENT_114	[p6l262t1517r352b1537],
4	at	IN	O	at	_	0	SENT_114	[p6l358t1519r380b1537],
5	111.	CD	NUMBER	111.	prep_at	3	SENT_114	[p6l386t1515r420b1541],
6	,	,	O	,	_	0	SENT_114	[p6l386t1515r420b1541],
7	2008	CD	DATE	2008	num	8	SENT_114	[p6l428t1517r484b1537],
8	32.113	CD	NUMBER	32.113	appos	5	SENT_114	[p6l708t1515r783b1537],
9	!	.	O	!	_	0	SENT_114	[p6l708t1515r783b1537],

1	19.167	CD	NUMBER	19.167	_	0	SENT_115	[p6l938t1515r1000b1537],

1	To1al	JJ	O	to1al	amod	2	SENT_116	[p6l262t1619r432b1647],
2	[	NN	O	[	dep	9	SENT_116	[p6l262t1619r432b1647],
3	95	CD	PERCENT	95	num	4	SENT_116	[p6l262t1619r432b1647],
4	%	NN	PERCENT	%	dep	2	SENT_116	[p6l262t1619r432b1647],
5	CI	NN	O	ci	dep	4	SENT_116	[p6l262t1619r432b1647],
6	'	''	O	'	_	0	SENT_116	[p6l262t1619r432b1647],
7	_	NN	O	_	dep	9	SENT_116	[p6l262t1619r432b1647],
8	i	FW	O	i	nn	9	SENT_116	[p6l262t1619r432b1647],
9	|	FW	O	|	dep	15	SENT_116	[p6l262t1619r432b1647],
10	1191531	CD	NUMBER	1191531	number	11	SENT_116	[p6l694t1619r780b1641],
11	601161	CD	NUMBER	601161	dep	9	SENT_116	[p6l922t1619r996b1641],
12	E.	NNP	O	E.	nn	14	SENT_116	[p6l354t1657r428b1679],
13	ll	NN	O	ll	nn	14	SENT_116	[p6l354t1657r428b1679],
14	‘	NN	O	‘	dep	11	SENT_116	[p6l354t1657r428b1679],
15	ect	NN	O	ect	_	0	SENT_116	[p6l354t1657r428b1679],
16	:	:	O	:	_	0	SENT_116	[p6l354t1657r428b1679],
17	z	SYM	O	z	dep	18	SENT_116	[p6l436t1657r522b1679],
18	‘	CD	NUMBER	‘	dep	15	SENT_116	[p6l436t1657r522b1679],
19	.	.	O	.	_	0	SENT_116	[p6l436t1657r522b1679],

1	—	NN	O	—	_	0	SENT_117	[p6l436t1657r522b1679],
2	.	.	O	.	_	0	SENT_117	[p6l436t1657r522b1679],
3	'	''	O	'	_	0	SENT_117	[p6l436t1657r522b1679],

1	-3.15	CD	NUMBER	-3.15	num	2	SENT_118	[p6l436t1657r522b1679],
2	’	CD	NUMBER	’	_	0	SENT_118	[p6l436t1657r522b1679],
3	?	.	O	?	_	0	SENT_118	[p6l436t1657r522b1679],

1	(	RB	O	(	dep	3	SENT_119	[p6l530t1657r684b1685],
2	_	CD	NUMBER	_	num	3	SENT_119	[p6l530t1657r684b1685],
3	pE0	NN	O	pe0	_	0	SENT_119	[p6l530t1657r684b1685],
4	.	.	O	.	_	0	SENT_119	[p6l530t1657r684b1685],

1	DD	NN	O	dd	_	0	SENT_120	[p6l530t1657r684b1685],
2	|	SYM	O	|	dep	3	SENT_120	[p6l530t1657r684b1685],
3	124.5	CD	NUMBER	124.5	rcmod	1	SENT_120	[p6l530t1657r684b1685],
4	)	CD	NUMBER	)	dep	1	SENT_120	[p6l530t1657r684b1685],

1	Figure	NNP	O	Figure	_	0	SENT_121	[p6l11t1820r105b1853],
2	1	CD	NUMBER	1	dep	1	SENT_121	[p6l118t1821r128b1845],

1	DR	NN	O	dr	_	0	SENT_122	[p6l1225t1137r1387b1163],
2	(	CD	NUMBER	(	num	1	SENT_122	[p6l1225t1137r1387b1163],
3	l'andnm	NN	O	l'andnm	nn	8	SENT_122	[p6l1225t1137r1387b1163],
4	)	NN	O	)	nn	8	SENT_122	[p6l1225t1137r1387b1163],
5	Vleiglt	NN	O	vleiglt	nn	8	SENT_122	[p6l1493t1137r1581b1163],
6	BR	NN	O	br	nn	8	SENT_122	[p6l1697t1135r1861b1161],
7	(	CD	NUMBER	(	num	8	SENT_122	[p6l1697t1135r1861b1161],
8	i1	NN	O	i1	dep	1	SENT_122	[p6l1697t1135r1861b1161],
9	'	''	O	'	_	0	SENT_122	[p6l1697t1135r1861b1161],
10	nidrm1	NN	O	nidrm1	dep	8	SENT_122	[p6l1697t1135r1861b1161],
11	)	CD	PERCENT	)	num	13	SENT_122	[p6l1697t1135r1861b1161],
12	95	CD	PERCENT	95	num	13	SENT_122	[p6l1259t1170r1355b1190],
13	%	NN	PERCENT	%	dep	1	SENT_122	[p6l1259t1170r1355b1190],
14	CI	NN	O	ci	rcmod	13	SENT_122	[p6l1259t1170r1355b1190],
15	$	$	MONEY	$	dep	14	SENT_122	[p6l1523t1170r1551b1190],
16	6	CD	MONEY	6	number	15	SENT_122	[p6l1523t1170r1551b1190],
17	95901	CD	MONEY	95901	number	15	SENT_122	[p6l1731t1168r1825b1190],
18	:	:	O	:	_	0	SENT_122	[p6l1731t1168r1825b1190],
19	!	.	O	!	_	0	SENT_122	[p6l1731t1168r1825b1190],

1	8.68	CD	NUMBER	8.68	num	3	SENT_123	[p6l1519t1234r1567b1254],
2	0.1	CD	NUMBER	0.1	num	3	SENT_123	[p6l1691t1234r1739b1254],
3	‘	NN	O	‘	_	0	SENT_123	[p6l1691t1234r1739b1254],
4	:	:	O	:	_	0	SENT_123	[p6l1691t1234r1739b1254],
5	-	:	O	-	_	0	SENT_123	[p6l1691t1234r1739b1254],
6	'	''	O	'	_	0	SENT_123	[p6l1691t1234r1739b1254],
7	[	CD	NUMBER	[	num	10	SENT_123	[p6l1757t1230r1885b1258],
8	D.	NNP	O	D.	nn	10	SENT_123	[p6l1757t1230r1885b1258],
9	04,0	CD	NUMBER	04,0	num	10	SENT_123	[p6l1757t1230r1885b1258],
10	L69	NN	O	l69	dep	3	SENT_123	[p6l1757t1230r1885b1258],
11	]	CD	NUMBER	]	number	12	SENT_123	[p6l1757t1230r1885b1258],
12	20.45	CD	NUMBER	20.45	num	10	SENT_123	[p6l1505t1270r1567b1290],
13	0.52	CD	NUMBER	0.52	num	14	SENT_123	[p6l1691t1270r1739b1290],
14	[	NN	O	[	dep	10	SENT_123	[p6l1757t1270r1821b1298],
15	0.2	CD	NUMBER	0.2	num	16	SENT_123	[p6l1757t1270r1821b1298],
16	l	NN	O	l	tmod	10	SENT_123	[p6l1757t1270r1821b1298],
17	,	,	O	,	_	0	SENT_123	[p6l1757t1270r1821b1298],
18	1.26	CD	NUMBER	1.26	number	19	SENT_123	[p6l1831t1270r1885b1298],
19	]	CD	NUMBER	]	num	21	SENT_123	[p6l1831t1270r1885b1298],
20	1.39	CD	NUMBER	1.39	number	21	SENT_123	[p6l1521t1304r1567b1326],
21	1.00	CD	NUMBER	1.00	appos	10	SENT_123	[p6l1693t1304r1741b1326],
22	[	CD	NUMBER	[	num	23	SENT_123	[p6l1757t1304r1821b1332],
23	(	NN	O	(	dep	21	SENT_123	[p6l1757t1304r1821b1332],
24	105	CD	NUMBER	105	dep	21	SENT_123	[p6l1757t1304r1821b1332],
25	,	,	O	,	_	0	SENT_123	[p6l1757t1304r1821b1332],
26	19.36	CD	NUMBER	19.36	number	27	SENT_123	[p6l1831t1304r1899b1332],
27	]	CD	NUMBER	]	appos	3	SENT_123	[p6l1831t1304r1899b1332],
28	4.68	CD	NUMBER	4.68	num	29	SENT_123	[p6l1519t1338r1567b1360],
29	0.27	CD	NUMBER	0.27	dep	27	SENT_123	[p6l1691t1338r1739b1360],
30	[	NN	O	[	dep	3	SENT_123	[p6l1757t1338r1821b1366],
31	0.04	CD	NUMBER	0.04	num	30	SENT_123	[p6l1757t1338r1821b1366],
32	,	,	O	,	_	0	SENT_123	[p6l1757t1338r1821b1366],
33	1.79	CD	NUMBER	1.79	number	34	SENT_123	[p6l1831t1338r1885b1366],
34	]	CD	NUMBER	]	appos	30	SENT_123	[p6l1831t1338r1885b1366],
35	1.56	CD	NUMBER	1.56	num	36	SENT_123	[p6l1521t1374r1569b1396],
36	0.53	CD	NUMBER	0.53	dep	3	SENT_123	[p6l1691t1374r1739b1396],
37	[	CD	NUMBER	[	num	39	SENT_123	[p6l1757t1374r1899b1402],
38	o.m.	NN	O	o.m.	nn	39	SENT_123	[p6l1757t1374r1899b1402],
39	1a	NN	O	1a	dep	36	SENT_123	[p6l1757t1374r1899b1402],
40	.	.	O	.	_	0	SENT_123	[p6l1757t1374r1899b1402],

1	s9	NN	O	s9	nsubj	6	SENT_124	[p6l1757t1374r1899b1402],
2	]	CD	NUMBER	]	num	1	SENT_124	[p6l1757t1374r1899b1402],
3	10.00	CD	NUMBER	10.00	num	5	SENT_124	[p6l1507t1408r1569b1429],
4	029	CD	NUMBER	029	num	5	SENT_124	[p6l1691t1408r1739b1429],
5	[	NN	O	[	dep	1	SENT_124	[p6l1757t1406r1885b1435],
6	o.	VBD	O	o.	_	0	SENT_124	[p6l1757t1406r1885b1435],
7	us	PRP	O	we	nsubj	8	SENT_124	[p6l1757t1406r1885b1435],
8	.1	NN	NUMBER	.1	xcomp	6	SENT_124	[p6l1757t1406r1885b1435],
9	.	.	O	.	_	0	SENT_124	[p6l1757t1406r1885b1435],

1	o5	NN	O	o5	_	0	SENT_125	[p6l1757t1406r1885b1435],
2	]	CD	NUMBER	]	number	3	SENT_125	[p6l1757t1406r1885b1435],
3	1.82	CD	NUMBER	1.82	dep	1	SENT_125	[p6l1521t1446r1567b1467],
4	0.06	CD	NUMBER	0.06	num	5	SENT_125	[p6l1691t1446r1741b1467],
5	[	NN	O	[	dep	3	SENT_125	[p6l1757t1445r1885b1473],
6	0.00	CD	NUMBER	0.00	dep	1	SENT_125	[p6l1757t1445r1885b1473],
7	,	,	O	,	_	0	SENT_125	[p6l1757t1445r1885b1473],
8	,1.14	CD	NUMBER	,1.14	appos	6	SENT_125	[p6l1757t1445r1885b1473],
9	]	CD	NUMBER	]	number	10	SENT_125	[p6l1757t1445r1885b1473],
10	1326	CD	DATE	1326	dep	1	SENT_125	[p6l1507t1482r1569b1503],
11	0.27	CD	NUMBER	0.27	num	12	SENT_125	[p6l1691t1482r1739b1503],
12	[	NN	O	[	dep	10	SENT_125	[p6l1757t1481r1885b1509],
13	0.09.0.82	CD	NUMBER	0.09.0.82	number	14	SENT_125	[p6l1757t1481r1885b1509],
14	]	CD	NUMBER	]	dep	1	SENT_125	[p6l1757t1481r1885b1509],
15	31.6	CD	NUMBER	31.6	num	16	SENT_125	[p6l1505t1517r1567b1537],
16	‘	NN	O	‘	dep	14	SENT_125	[p6l1505t1517r1567b1537],
17	?	.	O	?	_	0	SENT_125	[p6l1505t1517r1567b1537],

1	0.92	CD	NUMBER	0.92	num	3	SENT_126	[p6l1687t1517r1737b1537],
2	[	CD	NUMBER	[	num	3	SENT_126	[p6l1759t1515r1823b1543],
3	M2	NN	O	m2	_	0	SENT_126	[p6l1759t1515r1823b1543],
4	,	,	O	,	_	0	SENT_126	[p6l1759t1515r1823b1543],
5	1.59	CD	NUMBER	1.59	num	6	SENT_126	[p6l1833t1515r1889b1543],
6	]	NN	O	]	appos	3	SENT_126	[p6l1833t1515r1889b1543],

1	0111	CD	DATE	0111	num	3	SENT_127	[p6l1121t1725r1155b1743],
2	run	NN	O	run	nn	3	SENT_127	[p6l1221t1725r1259b1743],
3	*	NN	O	*	_	0	SENT_127	[p6l1273t1725r1311b1743],
4	1	CD	NUMBER	1	dep	3	SENT_127	[p6l1335t1725r1343b1741],
5	an	DT	O	a	det	6	SENT_127	[p6l1375t1725r1411b1743],
6	:13	NN	O	:13	dep	3	SENT_127	[p6l1471t1725r1519b1743],

1	Forest	NN	O	forest	nn	2	SENT_128	[p6l167t1821r252b1845],
2	plot	NN	O	plot	_	0	SENT_128	[p6l263t1820r319b1853],
3	of	IN	O	of	_	0	SENT_128	[p6l328t1820r356b1845],
4	a	DT	O	a	det	7	SENT_128	[p6l365t1827r379b1845],
5	fixed	JJ	O	fixed	amod	7	SENT_128	[p6l389t1820r458b1845],
6	effects	NNS	O	effect	nn	7	SENT_128	[p6l470t1820r561b1845],
7	meta-analysis	NN	O	meta-analysis	prep_of	2	SENT_128	[p6l573t1820r765b1853],
8	of	IN	O	of	_	0	SENT_128	[p6l776t1820r804b1845],
9	nine	CD	NUMBER	nine	num	10	SENT_128	[p6l814t1821r874b1845],
10	studies	NNS	O	study	prep_of	7	SENT_128	[p6l885t1820r983b1845],
11	evaluating	VBG	O	evaluate	partmod	2	SENT_128	[p6l994t1820r1142b1853],
12	the	DT	O	the	det	13	SENT_128	[p6l1153t1820r1199b1845],
13	responsiveness	NN	O	responsiveness	dobj	11	SENT_128	[p6l1211t1821r1422b1853],
14	of	IN	O	of	_	0	SENT_128	[p6l1432t1820r1461b1845],
15	patients	NNS	O	patient	prep_of	13	SENT_128	[p6l1471t1821r1584b1853],
16	to	TO	O	to	_	0	SENT_128	[p6l1593t1823r1622b1845],
17	TNF-or	NN	O	tnf-or	nn	18	SENT_128	[p6l1631t1821r1721b1845],
18	inhibitors	NNS	O	inhibitor	prep_to	15	SENT_128	[p6l1731t1820r1865b1845],
19	by	IN	O	by	_	0	SENT_128	[p6l1877t1820r1910b1853],
20	genotype	NN	O	genotype	prep_by	18	SENT_128	[p6l1920t1823r2057b1853],
21	at	IN	O	at	_	0	SENT_128	[p6l2068t1823r2095b1845],
22	the	DT	O	the	det	24	SENT_128	[p6l2104t1820r2150b1845],
23	TNF	NN	O	tnf	nn	24	SENT_128	[p6l8t1862r97b1886],
24	—	NN	O	—	prep_at	20	SENT_128	[p6l8t1862r97b1886],
25	:	:	O	:	_	0	SENT_128	[p6l8t1862r97b1886],
26	x	CC	O	x	_	0	SENT_128	[p6l8t1862r97b1886],
27	—	CD	NUMBER	—	number	28	SENT_128	[p6l110t1862r188b1886],
28	308	CD	NUMBER	308	conj_x	13	SENT_128	[p6l110t1862r188b1886],
29	variant	NN	O	variant	dep	28	SENT_128	[p6l199t1862r306b1886],
30	.	.	O	.	_	0	SENT_128	[p6l199t1862r306b1886],

1	A	DT	O	a	det	4	SENT_129	[p6l318t1862r338b1886],
2	random	JJ	O	random	amod	4	SENT_129	[p6l350t1861r461b1886],
3	effect	NN	O	effect	nn	4	SENT_129	[p6l474t1861r554b1886],
4	model	NN	O	model	nsubj	7	SENT_129	[p6l565t1861r654b1886],
5	was	VBD	O	be	cop	7	SENT_129	[p6l666t1869r720b1886],
6	initially	RB	O	initially	advmod	7	SENT_129	[p6l732t1861r834b1894],
7	fit	JJ	O	fit	_	0	SENT_129	[p6l843t1861r879b1892],
8	,	,	O	,	_	0	SENT_129	[p6l843t1861r879b1892],
9	which	WDT	O	which	nsubj	10	SENT_129	[p6l892t1861r978b1886],
10	collapsed	VBD	O	collapse	ccomp	7	SENT_129	[p6l991t1861r1124b1894],
11	to	TO	O	to	_	0	SENT_129	[p6l1136t1864r1165b1886],
12	the	DT	O	the	det	15	SENT_129	[p6l1176t1861r1222b1886],
13	fixed	JJ	O	fixed	amod	15	SENT_129	[p6l1232t1861r1302b1886],
14	effect	NN	O	effect	nn	15	SENT_129	[p6l1315t1861r1394b1886],
15	model	NN	O	model	prep_to	10	SENT_129	[p6l1406t1861r1495b1886],
16	in	IN	O	in	_	0	SENT_129	[p6l1508t1862r1532b1886],
17	the	DT	O	the	det	18	SENT_129	[p6l1544t1861r1590b1886],
18	absence	NN	O	absence	prep_in	10	SENT_129	[p6l1602t1861r1718b1886],
19	of	IN	O	of	_	0	SENT_129	[p6l1729t1861r1757b1886],
20	heterogeneity	NN	O	heterogeneity	prep_of	18	SENT_129	[p6l1768t1861r1970b1894],
21	(	CD	NUMBER	(	num	20	SENT_129	[p6l1981t1858r2014b1893],
22	/	:	O	/	punct	27	SENT_129	[p6l1981t1858r2014b1893],
23	2	CD	NUMBER	2	dep	27	SENT_129	[p6l1981t1858r2014b1893],
24	=	JJ	O	=	dep	26	SENT_129	[p6l2022t1873r2044b1882],
25	8.2	CD	PERCENT	8.2	number	26	SENT_129	[p6l2052t1861r2148b1893],
26	%	NN	PERCENT	%	amod	23	SENT_129	[p6l2052t1861r2148b1893],
27	)	CD	NUMBER	)	parataxis	10	SENT_129	[p6l2052t1861r2148b1893],
28	.	.	O	.	_	0	SENT_129	[p6l2052t1861r2148b1893],

1	The	DT	O	the	det	3	SENT_130	[p6l8t1902r62b1927],
2	vertical	JJ	O	vertical	amod	3	SENT_130	[p6l72t1902r174b1927],
3	line	NN	O	line	nsubj	8	SENT_130	[p6l188t1902r236b1927],
4	in	IN	O	in	_	0	SENT_130	[p6l249t1902r272b1927],
5	the	DT	O	the	det	7	SENT_130	[p6l284t1902r330b1927],
6	OR	NN	O	or	nn	7	SENT_130	[p6l341t1903r384b1927],
7	plot	NN	O	plot	prep_in	3	SENT_130	[p6l396t1902r452b1935],
8	is	VBZ	O	be	_	0	SENT_130	[p6l463t1902r481b1927],
9	at	IN	O	at	_	0	SENT_130	[p6l492t1905r519b1927],
10	1	CD	NUMBER	1	prep_at	8	SENT_130	[p6l531t1903r554b1932],
11	,	,	O	,	_	0	SENT_130	[p6l531t1903r554b1932],
12	corresponding	VBG	O	correspond	prep	8	SENT_130	[p6l567t1902r775b1935],
13	to	TO	O	to	pcomp	12	SENT_130	[p6l787t1905r816b1927],
14	the	DT	O	the	det	16	SENT_130	[p6l827t1902r873b1927],
15	null	JJ	O	null	amod	16	SENT_130	[p6l885t1902r935b1927],
16	hypothesis	NN	O	hypothesis	pobj	13	SENT_130	[p6l949t1902r1101b1935],
17	of	IN	O	of	_	0	SENT_130	[p6l1112t1902r1140b1927],
18	no	DT	O	no	det	20	SENT_130	[p6l1151t1909r1186b1927],
19	genotype	NN	O	genotype	nn	20	SENT_130	[p6l1198t1905r1335b1935],
20	effect	NN	O	effect	prep_of	16	SENT_130	[p6l1346t1902r1433b1927],
21	.	.	O	.	_	0	SENT_130	[p6l1346t1902r1433b1927],

1	CI	NN	O	ci	_	0	SENT_131	[p6l1446t1903r1483b1932],
2	,	,	O	,	_	0	SENT_131	[p6l1446t1903r1483b1932],
3	confidence	NN	O	confidence	nn	4	SENT_131	[p6l1496t1902r1654b1927],
4	interval	NN	O	interval	appos	1	SENT_131	[p6l1666t1902r1779b1932],
5	;	:	O	;	_	0	SENT_131	[p6l1666t1902r1779b1932],
6	n	NN	O	n	dep	1	SENT_131	[p6l1793t1909r1816b1932],
7	,	,	O	,	_	0	SENT_131	[p6l1793t1909r1816b1932],
8	number	NN	O	number	appos	6	SENT_131	[p6l1830t1902r1945b1927],
9	of	IN	O	of	_	0	SENT_131	[p6l1954t1902r1982b1927],
10	responders	NNS	O	responder	prep_of	8	SENT_131	[p6l1993t1902r2150b1935],
11	or	CC	O	or	_	0	SENT_131	[p6l9t1950r39b1967],
12	non-responders	JJ	O	non-responders	conj_or	10	SENT_131	[p6l52t1942r277b1975],
13	carrying	VBG	O	carry	partmod	12	SENT_131	[p6l290t1943r406b1975],
14	the	DT	O	the	det	16	SENT_131	[p6l420t1942r466b1967],
15	A	NN	O	a	nn	16	SENT_131	[p6l477t1943r498b1967],
16	allele	NN	O	allele	dobj	13	SENT_131	[p6l510t1942r590b1973],
17	;	:	O	;	_	0	SENT_131	[p6l510t1942r590b1973],
18	N	NN	O	n	dep	1	SENT_131	[p6l606t1943r635b1973],
19	,	,	O	,	_	0	SENT_131	[p6l606t1943r635b1973],
20	total	JJ	O	total	amod	21	SENT_131	[p6l650t1942r713b1967],
21	number	NN	O	number	appos	18	SENT_131	[p6l729t1942r843b1967],
22	of	IN	O	of	_	0	SENT_131	[p6l855t1942r883b1967],
23	responders	NNS	O	responder	prep_of	21	SENT_131	[p6l895t1942r1052b1975],
24	or	CC	O	or	_	0	SENT_131	[p6l1065t1950r1095b1967],
25	non-responders	NNS	O	non-responder	prep_of	21	SENT_131	[p6l1108t1942r1341b1975],
26	;	:	O	;	_	0	SENT_131	[p6l1108t1942r1341b1975],
27	OR	NN	O	or	dep	1	SENT_131	[p6l1356t1943r1406b1973],
28	,	,	O	,	_	0	SENT_131	[p6l1356t1943r1406b1973],
29	odds	NNS	O	odds	nn	30	SENT_131	[p6l1421t1942r1490b1967],
30	ratio	NN	O	ratio	appos	27	SENT_131	[p6l1504t1943r1575b1972],
31	;	:	O	;	_	0	SENT_131	[p6l1504t1943r1575b1972],
32	TNF-cx	NN	O	tnf-cx	dep	1	SENT_131	[p6l1589t1943r1685b1973],
33	,	,	O	,	_	0	SENT_131	[p6l1589t1943r1685b1973],
34	tumor	NN	O	tumor	nn	36	SENT_131	[p6l1699t1945r1790b1967],
35	necrosis	NN	O	necrosis	nn	36	SENT_131	[p6l1803t1943r1916b1967],
36	factor-or	NN	O	factor-or	appos	32	SENT_131	[p6l1927t1942r2048b1967],
37	.	.	O	.	_	0	SENT_131	[p6l1927t1942r2048b1967],

1	Although	IN	O	although	mark	3	SENT_132	[p6l9t2050r173b2087],
2	there	EX	O	there	expl	3	SENT_132	[p6l186t2050r274b2078],
3	were	VBD	O	be	advcl	16	SENT_132	[p6l287t2058r367b2078],
4	only	RB	O	only	advmod	3	SENT_132	[p6l381t2050r459b2087],
5	nine	CD	NUMBER	nine	num	6	SENT_132	[p6l470t2052r547b2078],
6	studies	NNS	O	study	pobj	4	SENT_132	[p6l561t2050r679b2078],
7	in	IN	O	in	_	0	SENT_132	[p6l692t2052r727b2078],
8	the	DT	O	the	det	9	SENT_132	[p6l739t2050r794b2078],
9	meta-analysis	NN	O	meta-analysis	prep_in	3	SENT_132	[p6l808t2050r1051b2087],
10	,	,	O	,	_	0	SENT_132	[p6l808t2050r1051b2087],
11	making	VBG	O	make	xcomp	3	SENT_132	[p6l9t2097r140b2134],
12	interpretation	NN	O	interpretation	nsubj	13	SENT_132	[p6l171t2098r414b2134],
13	difficult	JJ	O	difficult	xcomp	11	SENT_132	[p6l447t2097r591b2131],
14	,	,	O	,	_	0	SENT_132	[p6l447t2097r591b2131],
15	there	EX	O	there	expl	16	SENT_132	[p6l626t2097r714b2125],
16	was	VBD	O	be	_	0	SENT_132	[p6l746t2105r809b2125],
17	no	DT	O	no	det	19	SENT_132	[p6l841t2105r886b2125],
18	obvious	JJ	O	obvious	amod	19	SENT_132	[p6l919t2097r1053b2125],
19	evidence	NN	O	evidence	nsubj	16	SENT_132	[p6l10t2143r161b2171],
20	of	IN	O	of	_	0	SENT_132	[p6l176t2143r211b2171],
21	publication	NN	O	publication	nn	22	SENT_132	[p6l222t2143r421b2180],
22	bias	NN	O	bias	prep_of	19	SENT_132	[p6l435t2143r501b2171],
23	(	CD	NUMBER	(	num	24	SENT_132	[p6l517t2143r602b2178],
24	data	NNS	O	datum	npadvmod	25	SENT_132	[p6l517t2143r602b2178],
25	not	RB	O	not	neg	26	SENT_132	[p6l616t2147r675b2171],
26	shown	VBN	O	show	partmod	22	SENT_132	[p6l690t2143r826b2178],
27	)	NN	O	)	dobj	26	SENT_132	[p6l690t2143r826b2178],
28	.	.	O	.	_	0	SENT_132	[p6l690t2143r826b2178],

1	To	TO	O	to	aux	2	SENT_133	[p6l46t2190r87b2217],
2	investigate	VB	O	investigate	_	0	SENT_133	[p6l106t2190r292b2226],
3	if	IN	O	if	mark	17	SENT_133	[p6l311t2189r336b2217],
4	RA	NN	O	ra	nn	5	SENT_133	[p6l353t2190r401b2217],
5	patients	NNS	O	patient	nsubjpass	17	SENT_133	[p6l418t2190r556b2226],
6	carrying	VBG	O	carry	partmod	5	SENT_133	[p6l575t2190r718b2226],
7	an	DT	O	a	det	9	SENT_133	[p6l736t2197r777b2217],
8	A	NN	O	a	nn	9	SENT_133	[p6l795t2190r820b2217],
9	allele	NN	O	allele	dobj	6	SENT_133	[p6l839t2189r927b2217],
10	of	IN	O	of	_	0	SENT_133	[p6l947t2189r982b2217],
11	the	DT	O	the	det	12	SENT_133	[p6l998t2189r1053b2217],
12	TNF-or	NN	O	tnf-or	prep_of	9	SENT_133	[p6l8t2236r113b2263],
13	-308	CD	NUMBER	-308	num	15	SENT_133	[p6l128t2236r217b2263],
14	G/A	NN	O	g/a	nn	15	SENT_133	[p6l232t2235r299b2267],
15	polymorphism	NN	O	polymorphism	dep	12	SENT_133	[p6l312t2235r569b2272],
16	is	VBZ	O	be	auxpass	17	SENT_133	[p6l583t2237r608b2263],
17	associated	VBN	O	associate	advcl	2	SENT_133	[p6l623t2235r796b2263],
18	more	RBR	O	more	advmod	19	SENT_133	[p6l810t2243r898b2263],
19	strongly	RB	O	strongly	advmod	17	SENT_133	[p6l913t2235r1055b2272],

1	TNF-or	JJ	O	tnf-or	_	0	SENT_134	[p6l502t2483r566b2504],
2	-308	CD	NUMBER	-308	num	4	SENT_134	[p6l576t2482r636b2504],
3	G/A	NN	O	g/a	nn	4	SENT_134	[p6l645t2482r692b2507],
4	variant	NN	O	variant	dep	1	SENT_134	[p6l700t2482r784b2504],
5	and	CC	O	and	_	0	SENT_134	[p6l793t2482r836b2504],
6	anti-TNF-or	JJ	O	anti-tnf-or	amod	7	SENT_134	[p6l845t2482r965b2504],
7	agents	NNS	O	agent	conj_and	4	SENT_134	[p6l974t2484r1052b2511],

1	NEW	NNP	O	NEW	_	0	SENT_135	[p6l7t2476r70b2537],

1	D	NN	O	d	nn	3	SENT_136	[p6l877t2518r892b2537],
2	D	NN	O	d	nn	3	SENT_136	[p6l902t2518r916b2537],
3	O’Rie	NN	O	o’rie	_	0	SENT_136	[p6l926t2517r1001b2544],
4	|	CD	NUMBER	|	num	6	SENT_136	[p6l926t2517r1001b2544],
5	|	NN	O	|	nn	6	SENT_136	[p6l926t2517r1001b2544],
6	y	NN	O	y	dep	3	SENT_136	[p6l926t2517r1001b2544],
7	et	FW	O	et	nn	8	SENT_136	[p6l1011t2519r1028b2538],
8	al	FW	O	al	dep	3	SENT_136	[p6l1036t2517r1054b2538],

1	Study	NNP	O	Study	_	0	SENT_137	[p6l374t2663r445b2689],
2	Responder	NNP	O	Responder	dep	1	SENT_137	[p6l688t2663r821b2691],
3	Nn	NNP	O	Nn	dep	2	SENT_137	[p6l881t2663r1075b2691],
4	;	:	O	;	_	0	SENT_137	[p6l881t2663r1075b2691],
5	.	.	O	.	_	0	SENT_137	[p6l881t2663r1075b2691],

1	—	NN	O	—	_	0	SENT_138	[p6l881t2663r1075b2691],
2	.	.	O	.	_	0	SENT_138	[p6l881t2663r1075b2691],

1	R.e.	NNP	O	R.e.	nn	2	SENT_139	[p6l881t2663r1075b2691],
2	5pn	NNP	O	5pn	_	0	SENT_139	[p6l881t2663r1075b2691],
3	;	:	O	;	_	0	SENT_139	[p6l881t2663r1075b2691],
4	IIier	NN	O	iiier	dep	2	SENT_139	[p6l881t2663r1075b2691],

1	MN	NN	O	mn	nn	2	SENT_140	[p6l732t2698r777b2718],
2	QIN	NN	O	qin	_	0	SENT_140	[p6l955t2698r1000b2718],

1	Mugnier	JJR	O	mugnier	_	0	SENT_141	[p6l256t2762r355b2790],
2	e1al	NN	O	e1al	dep	1	SENT_141	[p6l362t2762r487b2786],
3	.	.	O	.	_	0	SENT_141	[p6l362t2762r487b2786],

1	.2003	CD	NUMBER	.2003	num	2	SENT_142	[p6l362t2762r487b2786],
2	5133	CD	NUMBER	5133	_	0	SENT_142	[p6l734t2762r783b2784],
3	"	''	O	"	punct	2	SENT_142	[p6l956t2762r1005b2784],
4	ms	VBZ	O	m	rcmod	2	SENT_142	[p6l956t2762r1005b2784],
5	`	``	O	`	_	0	SENT_142	[p6l256t2800r371b2826],
6	*	JJ	O	*	amod	9	SENT_142	[p6l256t2800r371b2826],
7	El	NNP	O	El	dep	6	SENT_142	[p6l378t2802r399b2820],
8	3	CD	NUMBER	3	num	7	SENT_142	[p6l405t2800r440b2824],
9	]	NN	O	]	dobj	4	SENT_142	[p6l405t2800r440b2824],
10	.	.	O	.	_	0	SENT_142	[p6l405t2800r440b2824],

1	,	,	O	,	_	0	SENT_143	[p6l405t2800r440b2824],
2	2003 34/99	CD	NUMBER	2003 34/99	dep	4	SENT_143	[p6l719t2800r783b2820],[p6l448t2800r503b2820],
3	12124	CD	NUMBER	12124	dep	2	SENT_143	[p6l944t2800r1007b2820],
4	Cuchacovich	NNP	O	Cuchacovich	_	0	SENT_143	[p6l258t2835r408b2856],
5	et	FW	O	et	nn	6	SENT_143	[p6l415t2837r436b2856],
6	a1.	FW	O	a1.	dep	4	SENT_143	[p6l443t2835r477b2860],
7	,	,	O	,	_	0	SENT_143	[p6l443t2835r477b2860],
8	2004 7/14	CD	NUMBER	2004 7/14	number	9	SENT_143	[p6l733t2835r784b2856],[p6l484t2836r542b2856],
9	1/2	CD	NUMBER	1/2	num	10	SENT_143	[p6l972t2835r1006b2856],
10	Fonseca	NNP	PERSON	Fonseca	appos	4	SENT_143	[p6l255t2874r350b2894],
11	at	IN	O	at	_	0	SENT_143	[p6l356t2876r378b2894],
12	31.	CD	NUMBER	31.	prep_at	10	SENT_143	[p6l384t2873r419b2898],
13	,	,	O	,	_	0	SENT_143	[p6l384t2873r419b2898],
14	2005	CD	DATE	2005	num	15	SENT_143	[p6l426t2874r483b2894],
15	3	CD	NUMBER	3	appos	4	SENT_143	[p6l733t2873r756b2894],
16	/	:	O	/	punct	18	SENT_143	[p6l733t2873r756b2894],
17	14 4/8	CD	NUMBER	14 4/8	num	18	SENT_143	[p6l967t2874r1003b2894],[p6l758t2874r784b2894],
18	Cuclmwvich	NNP	O	Cuclmwvich	dep	15	SENT_143	[p6l258t2912r408b2934],
19	et	FW	O	et	nn	20	SENT_143	[p6l415t2915r436b2934],
20	a1	FW	O	a1	amod	18	SENT_143	[p6l443t2913r477b2937],
21	.	.	O	.	_	0	SENT_143	[p6l443t2913r477b2937],

1	.	.	O	.	_	0	SENT_144	[p6l443t2913r477b2937],

1	2006 13/58	CD	NUMBER	2006 13/58	number	2	SENT_145	[p6l722t2913r783b2934],[p6l484t2913r543b2934],
2	6/12	CD	NUMBER	6/12	num	3	SENT_145	[p6l956t2912r1006b2934],
3	Seitz	NNP	PERSON	Seitz	_	0	SENT_145	[p6l259t2950r317b2972],
4	et	FW	O	et	nn	5	SENT_145	[p6l322t2953r344b2972],
5	a1.	FW	O	a1.	dep	3	SENT_145	[p6l351t2950r385b2976],
6	,	,	O	,	_	0	SENT_145	[p6l351t2950r385b2976],
7	2007 14/51	CD	NUMBER	2007 14/51	number	8	SENT_145	[p6l724t2950r783b2972],[p6l393t2951r449b2972],
8	3/3	CD	NUMBER	3/3	num	9	SENT_145	[p6l970t2950r1005b2972],
9	Guis	NNP	O	Guis	appos	5	SENT_145	[p6l258t2987r313b3010],
10	et	FW	O	et	nn	11	SENT_145	[p6l320t2989r341b3010],
11	al.	FW	O	al.	dep	9	SENT_145	[p6l348t2987r382b3013],
12	.	.	O	.	_	0	SENT_145	[p6l348t2987r382b3013],

1	2000 10/66	CD	NUMBER	2000 10/66	num	2	SENT_146	[p6l721t2987r783b3010],[p6l390t2988r447b3010],
2	8120	CD	NUMBER	8120	_	0	SENT_146	[p6l954t2987r1004b3010],
3	Malone	NNP	PERSON	Malone	dep	2	SENT_146	[p6l258t3025r349b3046],
4	at	IN	O	at	_	0	SENT_146	[p6l356t3027r377b3046],
5	al.	FW	O	al.	prep_at	3	SENT_146	[p6l384t3025r419b3049],
6	.	.	O	.	_	0	SENT_146	[p6l384t3025r419b3049],

1	2008 32/131	CD	NUMBER	2008 32/131	num	2	SENT_147	[p6l710t3025r787b3046],[p6l426t3025r483b3046],
2	19/67	CD	NUMBER	19/67	_	0	SENT_147	[p6l944t3025r1006b3046],

1	‘	NN	O	‘	nn	2	SENT_148	[p6l258t3122r387b3150],
2	l'ota1	NN	O	l'ota1	dep	9	SENT_148	[p6l258t3122r387b3150],
3	[	CD	PERCENT	[	num	5	SENT_148	[p6l258t3122r387b3150],
4	95	CD	PERCENT	95	num	5	SENT_148	[p6l258t3122r387b3150],
5	%	NN	PERCENT	%	dep	2	SENT_148	[p6l258t3122r387b3150],
6	CI	NN	O	ci	dep	9	SENT_148	[p6l394t3122r431b3151],
7	]	CD	NUMBER	]	num	6	SENT_148	[p6l394t3122r431b3151],
8	118/4	CD	NUMBER	118/4	num	9	SENT_148	[p6l698t3123r786b3144],
9	'71	CD	NUMBER	'71	dep	19	SENT_148	[p6l698t3123r786b3144],
10	60/151	CD	NUMBER	60/151	number	11	SENT_148	[p6l930t3122r1007b3144],
11	*	CD	NUMBER	*	dep	9	SENT_148	[p6l258t3159r345b3181],
12	Eﬂeel	NNP	O	Eﬂeel	dep	11	SENT_148	[p6l351t3159r427b3181],
13	:	:	O	:	_	0	SENT_148	[p6l351t3159r427b3181],
14	E-3	NN	O	e-3	dep	11	SENT_148	[p6l434t3160r521b3181],
15	.51	CD	NUMBER	.51	number	16	SENT_148	[p6l434t3160r521b3181],
16	(	CD	NUMBER	(	num	17	SENT_148	[p6l530t3159r672b3187],
17	p90	NN	O	p90	dep	14	SENT_148	[p6l530t3159r672b3187],
18	.00045	CD	NUMBER	.00045	num	19	SENT_148	[p6l530t3159r672b3187],
19	)	NN	O	)	_	0	SENT_148	[p6l530t3159r672b3187],

1	with	IN	O	with	_	0	SENT_149	[p6l1104t2050r1183b2078],
2	a	DT	O	a	det	4	SENT_149	[p6l1204t2058r1221b2078],
3	poor	JJ	O	poor	amod	4	SENT_149	[p6l1241t2058r1321b2087],
4	response	NN	O	response	prep_with	13	SENT_149	[p6l1341t2058r1490b2087],
5	to	TO	O	to	_	0	SENT_149	[p6l1511t2054r1545b2078],
6	a	DT	O	a	det	9	SENT_149	[p6l1567t2058r1584b2078],
7	speciﬁc	NN	O	speciﬁc	nn	9	SENT_149	[p6l1605t2050r1732b2087],
8	TNF-cx	NN	MISC	tnf-cx	nn	9	SENT_149	[p6l1751t2051r1856b2078],
9	blocker	NN	O	blocker	prep_to	4	SENT_149	[p6l1875t2050r2009b2085],
10	,	,	O	,	_	0	SENT_149	[p6l1875t2050r2009b2085],
11	studies	NNS	O	study	nsubjpass	13	SENT_149	[p6l2032t2050r2149b2078],
12	were	VBD	O	be	auxpass	13	SENT_149	[p6l1104t2105r1184b2125],
13	grouped	VBN	O	group	_	0	SENT_149	[p6l1203t2097r1345b2134],
14	and	CC	O	and	_	0	SENT_149	[p6l1364t2097r1428b2125],
15	data	NNS	O	datum	nsubjpass	17	SENT_149	[p6l1447t2097r1519b2125],
16	were	VBD	O	be	auxpass	17	SENT_149	[p6l1537t2105r1617b2125],
17	analyzed	VBN	O	analyze	conj_and	13	SENT_149	[p6l1636t2097r1788b2134],
18	on	IN	O	on	_	0	SENT_149	[p6l1806t2105r1851b2125],
19	the	DT	O	the	det	20	SENT_149	[p6l1869t2097r1924b2125],
20	basis	NN	O	basis	prep_on	17	SENT_149	[p6l1942t2097r2024b2125],
21	of	IN	O	of	_	0	SENT_149	[p6l2043t2097r2078b2125],
22	the	DT	O	the	det	25	SENT_149	[p6l2094t2097r2149b2125],
23	speciﬁc	NN	O	speciﬁc	nn	25	SENT_149	[p6l1106t2143r1233b2180],
24	TNF-or	NN	O	tnf-or	nn	25	SENT_149	[p6l1243t2144r1347b2171],
25	inhibitor	NN	O	inhibitor	prep_of	20	SENT_149	[p6l1358t2143r1513b2171],
26	used	VBN	O	use	partmod	25	SENT_149	[p6l1523t2143r1610b2171],
27	.	.	O	.	_	0	SENT_149	[p6l1523t2143r1610b2171],

1	In	IN	O	in	_	0	SENT_150	[p6l1624t2144r1659b2171],
2	the	DT	O	the	det	4	SENT_150	[p6l1670t2143r1725b2171],
3	five	CD	NUMBER	five	num	4	SENT_150	[p6l1736t2143r1798b2171],
4	studies	NNS	O	study	pobj	1	SENT_150	[p6l1810t2143r1928b2171],
5	in	IN	O	in	_	0	SENT_150	[p6l1939t2144r1973b2171],
6	which	WDT	O	which	rel	9	SENT_150	[p6l1983t2143r2091b2171],
7	RA	NN	O	ra	nn	8	SENT_150	[p6l2103t2144r2150b2171],
8	patients	NNS	O	patient	nsubj	9	SENT_150	[p6l1105t2190r1243b2226],
9	received	VBD	O	receive	rcmod	4	SENT_150	[p6l1255t2189r1397b2217],
10	inﬂiximab	NN	O	inﬂiximab	iobj	9	SENT_150	[p6l1409t2189r1597b2223],
11	,	,	O	,	_	0	SENT_150	[p6l1409t2189r1597b2223],
12	172/233	CD	PERCENT	172/233	number	13	SENT_150	[p6l1614t2189r1751b2221],
13	(	CD	PERCENT	(	conj_and	10	SENT_150	[p6l1766t2189r1864b2224],
14	74	CD	PERCENT	74	number	15	SENT_150	[p6l1766t2189r1864b2224],
15	%	NN	PERCENT	%	amod	13	SENT_150	[p6l1766t2189r1864b2224],
16	)	CD	NUMBER	)	npadvmod	13	SENT_150	[p6l1766t2189r1864b2224],
17	of	IN	O	of	_	0	SENT_150	[p6l1878t2189r1912b2217],
18	patients	NNS	O	patient	prep_of	13	SENT_150	[p6l1922t2190r2060b2226],
19	with	IN	O	with	_	0	SENT_150	[p6l2071t2189r2150b2217],
20	a	DT	O	a	det	22	SENT_150	[p6l1106t2243r1123b2263],
21	G/G	NN	O	g/g	nn	22	SENT_150	[p6l1139t2235r1210b2267],
22	genotype	NN	O	genotype	prep_with	18	SENT_150	[p6l1225t2239r1384b2272],
23	and	CC	O	and	_	0	SENT_150	[p6l1400t2235r1464b2263],
24	55/88	CD	PERCENT	55/88	number	25	SENT_150	[p6l1481t2235r1577b2267],
25	(	CD	PERCENT	(	conj_and	10	SENT_150	[p6l1595t2235r1693b2270],
26	63	CD	PERCENT	63	num	27	SENT_150	[p6l1595t2235r1693b2270],
27	%	NN	PERCENT	%	dep	25	SENT_150	[p6l1595t2235r1693b2270],
28	)	CD	NUMBER	)	dobj	9	SENT_150	[p6l1595t2235r1693b2270],
29	of	IN	O	of	_	0	SENT_150	[p6l1710t2235r1745b2263],
30	patients	NNS	O	patient	prep_of	28	SENT_150	[p6l1758t2237r1896b2272],
31	carrying	VBG	O	carry	partmod	30	SENT_150	[p6l1912t2237r2054b2272],
32	an	DT	O	a	det	33	SENT_150	[p6l2069t2243r2111b2263],
33	A	NN	O	a	dobj	31	SENT_150	[p6l2125t2236r2150b2263],

1	OI	NN	O	ous	_	0	SENT_151	[p6l1235t2663r1277b2685],
2	!	.	O	!	_	0	SENT_151	[p6l1235t2663r1277b2685],

1	I	PRP	O	I	nsubj	2	SENT_152	[p6l1285t2663r1401b2689],
2	[	VBP	O	[	_	0	SENT_152	[p6l1285t2663r1401b2689],
3	!	.	O	!	_	0	SENT_152	[p6l1285t2663r1401b2689],
4	'	''	O	'	_	0	SENT_152	[p6l1285t2663r1401b2689],

1	l	NN	O	l	nsubj	2	SENT_153	[p6l1285t2663r1401b2689],
2	‘	NN	O	‘	_	0	SENT_153	[p6l1285t2663r1401b2689],
3	.	.	O	.	_	0	SENT_153	[p6l1285t2663r1401b2689],
4	'	''	O	'	_	0	SENT_153	[p6l1285t2663r1401b2689],

1	.	.	O	.	_	0	SENT_154	[p6l1285t2663r1401b2689],

1	I	PRP	O	I	_	0	SENT_155	[p6l1285t2663r1401b2689],
2	!	.	O	!	_	0	SENT_155	[p6l1285t2663r1401b2689],

1	d1	NN	O	d1	_	0	SENT_156	[p6l1285t2663r1401b2689],
2	|	NN	O	|	dep	1	SENT_156	[p6l1285t2663r1401b2689],
3	.	.	O	.	_	0	SENT_156	[p6l1285t2663r1401b2689],

1	lm	NN	O	lm	dep	10	SENT_157	[p6l1285t2663r1401b2689],
2	)	CD	NUMBER	)	num	1	SENT_157	[p6l1285t2663r1401b2689],
3	‘	CD	NUMBER	‘	num	5	SENT_157	[p6l1285t2663r1401b2689],
4	Welgljt	NNP	O	Welgljt	nn	5	SENT_157	[p6l1507t2663r1597b2691],
5	DR	NN	O	dr	dep	1	SENT_157	[p6l1671t2663r1715b2683],
6	(	CD	NUMBER	(	num	7	SENT_157	[p6l1721t2663r1837b2689],
7	i-iililrmi	NN	O	i-iililrmus	dep	10	SENT_157	[p6l1721t2663r1837b2689],
8	)	CD	PERCENT	)	num	10	SENT_157	[p6l1721t2663r1837b2689],
9	95	CD	PERCENT	95	num	10	SENT_157	[p6l1269t2698r1325b2718],
10	%	NN	PERCENT	%	_	0	SENT_157	[p6l1269t2698r1325b2718],
11	CI	CD	PERCENT	ci	num	12	SENT_157	[p6l1335t2698r1365b2718],
12	%	NN	PERCENT	%	dep	10	SENT_157	[p6l1539t2698r1565b2718],
13	95	CD	PERCENT	95	number	14	SENT_157	[p6l1707t2696r1761b2716],
14	%	NN	PERCENT	%	amod	15	SENT_157	[p6l1707t2696r1761b2716],
15	CI	NN	O	ci	dep	12	SENT_157	[p6l1771t2696r1803b2716],

1	3.32	CD	NUMBER	3.32	num	5	SENT_158	[p6l1531t2764r1579b2784],
2	0.17	CD	NUMBER	0.17	num	5	SENT_158	[p6l1659t2764r1709b2784],
3	[	CD	NUMBER	[	num	5	SENT_158	[p6l1729t2762r1859b2790],
4	o.m.	NNP	O	o.m.	nn	5	SENT_158	[p6l1729t2762r1859b2790],
5	im9	NNP	O	im9	dep	32	SENT_158	[p6l1729t2762r1859b2790],
6	]	CD	NUMBER	]	number	7	SENT_158	[p6l1729t2762r1859b2790],
7	20.77	CD	NUMBER	20.77	dep	5	SENT_158	[p6l1517t2800r1579b2820],
8	0.52	CD	NUMBER	0.52	num	9	SENT_158	[p6l1661t2800r1711b2820],
9	[	NN	O	[	dep	7	SENT_158	[p6l1729t2798r1793b2826],
10	0.21	CD	NUMBER	0.21	dep	7	SENT_158	[p6l1729t2798r1793b2826],
11	,	,	O	,	_	0	SENT_158	[p6l1729t2798r1793b2826],
12	1.26	CD	NUMBER	1.26	number	13	SENT_158	[p6l1805t2798r1859b2826],
13	]	CD	NUMBER	]	num	15	SENT_158	[p6l1805t2798r1859b2826],
14	11.92	CD	NUMBER	11.92	number	15	SENT_158	[p6l1533t2836r1579b2856],
15	11.00	CD	NUMBER	11.00	appos	10	SENT_158	[p6l1661t2836r1709b2856],
16	[	CD	NUMBER	[	num	18	SENT_158	[p6l1729t2835r1793b2863],
17	n.	NN	O	n.	nn	18	SENT_158	[p6l1729t2835r1793b2863],
18	r	NN	O	r	dep	15	SENT_158	[p6l1729t2835r1793b2863],
19	:	:	O	:	_	0	SENT_158	[p6l1729t2835r1793b2863],
20	-5	CD	NUMBER	-5	dep	15	SENT_158	[p6l1729t2835r1793b2863],
21	,	,	O	,	_	0	SENT_158	[p6l1729t2835r1793b2863],
22	19.315	CD	NUMBER	19.315	number	23	SENT_158	[p6l1805t2835r1875b2863],
23	]	CD	NUMBER	]	appos	20	SENT_158	[p6l1805t2835r1875b2863],
24	;	:	O	;	_	0	SENT_158	[p6l1805t2835r1875b2863],
25	4.75	CD	NUMBER	4.75	num	27	SENT_158	[p6l1531t2876r1579b2898],
26	0.27	CD	NUMBER	0.27	num	27	SENT_158	[p6l1659t2876r1709b2898],
27	[	NN	O	[	dep	15	SENT_158	[p6l1729t2875r1859b2904],
28	0.04.1.7	CD	NUMBER	0.04.1.7	number	29	SENT_158	[p6l1729t2875r1859b2904],
29	‘	CD	NUMBER	‘	dep	27	SENT_158	[p6l1729t2875r1859b2904],
30	9	CD	NUMBER	9	num	31	SENT_158	[p6l1729t2875r1859b2904],
31	‘	NN	O	‘	dep	32	SENT_158	[p6l1729t2875r1859b2904],
32	]	CD	NUMBER	]	dep	39	SENT_158	[p6l1729t2875r1859b2904],
33	10.16	CD	NUMBER	10.16	number	34	SENT_158	[p6l1519t2913r1581b2934],
34	0.29	CD	NUMBER	0.29	num	35	SENT_158	[p6l1659t2913r1709b2934],
35	‘	NN	O	‘	dep	32	SENT_158	[p6l1659t2913r1709b2934],
36	[	CD	NUMBER	[	number	37	SENT_158	[p6l1729t2912r1859b2940],
37	0.08.1.05	CD	DATE	0.08.1.05	num	38	SENT_158	[p6l1729t2912r1859b2940],
38	]	NN	O	]	dep	35	SENT_158	[p6l1729t2912r1859b2940],
39	1.8	CD	NUMBER	1.8	_	0	SENT_158	[p6l1533t2951r1581b2972],
40	-	:	O	-	_	0	SENT_158	[p6l1533t2951r1581b2972],
41	=	JJ	O	=	amod	42	SENT_158	[p6l1533t2951r1581b2972],
42	1	CD	NUMBER	1	dep	49	SENT_158	[p6l1533t2951r1581b2972],
43	0.06	CD	NUMBER	0.06	num	44	SENT_158	[p6l1659t2951r1709b2972],
44	[	NN	O	[	dep	42	SENT_158	[p6l1729t2950r1859b2978],
45	0.00.1.14	CD	NUMBER	0.00.1.14	number	46	SENT_158	[p6l1729t2950r1859b2978],
46	]	CD	NUMBER	]	dep	44	SENT_158	[p6l1729t2950r1859b2978],
47	1.31.41	CD	NUMBER	1.31.41	dep	49	SENT_158	[p6l1523t2988r1583b3010],
48	0.27	CD	NUMBER	0.27	num	49	SENT_158	[p6l1659t2988r1709b3010],
49	[	NN	O	[	dep	54	SENT_158	[p6l1729t2987r1859b3016],
50	0.09.0.02	CD	NUMBER	0.09.0.02	number	51	SENT_158	[p6l1729t2987r1859b3016],
51	]	CD	NUMBER	]	dep	49	SENT_158	[p6l1729t2987r1859b3016],
52	33.26	CD	NUMBER	33.26	num	53	SENT_158	[p6l1519t3025r1583b3046],
53	0.02	CD	NUMBER	0.02	dep	51	SENT_158	[p6l1659t3025r1709b3046],
54	[	NN	O	[	dep	57	SENT_158	[p6l1729t3024r1859b3052],
55	0.-12	CD	DATE	0.-12	num	54	SENT_158	[p6l1729t3024r1859b3052],
56	.1.59	CD	DATE	.1.59	num	57	SENT_158	[p6l1729t3024r1859b3052],
57	]	NN	O	]	dep	39	SENT_158	[p6l1729t3024r1859b3052],

1	100.00	CD	NUMBER	100.00	number	2	SENT_159	[p6l1511t3123r1585b3144],
2	0.41	CD	NUMBER	0.41	_	0	SENT_159	[p6l1661t3123r1709b3144],
3	[	CD	NUMBER	[	num	4	SENT_159	[p6l1729t3122r1859b3150],
4	n.	NN	O	n.	dep	2	SENT_159	[p6l1729t3122r1859b3150],
5	25	CD	NUMBER	25	dep	2	SENT_159	[p6l1729t3122r1859b3150],
6	,	,	O	,	_	0	SENT_159	[p6l1729t3122r1859b3150],
7	n.	NN	O	n.	nn	8	SENT_159	[p6l1729t3122r1859b3150],
8	5a	NN	O	5a	appos	5	SENT_159	[p6l1729t3122r1859b3150],
9	]	CD	NUMBER	]	dep	8	SENT_159	[p6l1729t3122r1859b3150],

1	0011	CD	DATE	0011	num	2	SENT_160	[p6l1129t3253r1167b3271],
2	um	NN	O	um	_	0	SENT_160	[p6l1233t3253r1271b3271],
3	on	IN	O	on	_	0	SENT_160	[p6l1285t3253r1323b3271],
4	1	CD	NUMBER	1	number	5	SENT_160	[p6l1347t3253r1355b3269],
5	5.1	CD	NUMBER	5.1	prep_on	2	SENT_160	[p6l1387t3253r1425b3271],
6	:	:	O	:	_	0	SENT_160	[p6l1387t3253r1425b3271],
7	‘	CD	NUMBER	‘	number	8	SENT_160	[p6l1387t3253r1425b3271],
8	31.9	CD	NUMBER	31.9	dep	2	SENT_160	[p6l1483t3236r1531b3271],
9	Responder	NN	O	responder	nn	10	SENT_160	[p6l1181t3285r1305b3313],
10	Nun-responder	NN	O	nun-responder	dep	8	SENT_160	[p6l1393t3285r1565b3313],

1	Figure	NN	O	figure	nn	4	SENT_161	[p6l9t3358r103b3391],
2	2	CD	NUMBER	2	num	4	SENT_161	[p6l117t3358r134b3383],
3	Forest	NN	O	forest	nn	4	SENT_161	[p6l168t3359r253b3383],
4	plot	NN	O	plot	_	0	SENT_161	[p6l266t3358r322b3391],
5	of	IN	O	of	_	0	SENT_161	[p6l334t3358r362b3383],
6	a	DT	O	a	det	9	SENT_161	[p6l374t3365r388b3383],
7	fixed	JJ	O	fixed	amod	9	SENT_161	[p6l400t3358r469b3383],
8	effects	NNS	O	effect	nn	9	SENT_161	[p6l483t3358r575b3383],
9	meta-analysis	NN	O	meta-analysis	prep_of	4	SENT_161	[p6l589t3358r782b3391],
10	of	IN	O	of	_	0	SENT_161	[p6l794t3358r822b3383],
11	eight	CD	NUMBER	eight	num	12	SENT_161	[p6l834t3358r908b3391],
12	studies	NNS	O	study	prep_of	9	SENT_161	[p6l920t3358r1018b3383],
13	with	IN	O	with	_	0	SENT_161	[p6l1030t3358r1093b3383],
14	patients	NNS	O	patient	prep_with	4	SENT_161	[p6l1108t3358r1221b3391],
15	of	IN	O	of	_	0	SENT_161	[p6l1234t3358r1262b3383],
16	Caucasian	JJ	MISC	caucasian	amod	17	SENT_161	[p6l1273t3358r1417b3383],
17	descent	NN	O	descent	prep_of	14	SENT_161	[p6l1431t3358r1550b3383],
18	.	.	O	.	_	0	SENT_161	[p6l1431t3358r1550b3383],

1	A	DT	O	a	det	4	SENT_162	[p6l1564t3359r1584b3383],
2	random	JJ	O	random	amod	4	SENT_162	[p6l1597t3358r1708b3383],
3	effects	NNS	O	effect	nn	4	SENT_162	[p6l1722t3358r1814b3383],
4	model	NN	O	model	nsubj	7	SENT_162	[p6l1828t3358r1917b3383],
5	was	VBD	O	be	cop	7	SENT_162	[p6l1930t3365r1984b3383],
6	initially	RB	O	initially	advmod	7	SENT_162	[p6l1997t3358r2099b3391],
7	fit	JJ	O	fit	_	0	SENT_162	[p6l2110t3358r2146b3389],
8	,	,	O	,	_	0	SENT_162	[p6l2110t3358r2146b3389],
9	which	WDT	O	which	nsubj	10	SENT_162	[p6l7t3399r93b3424],
10	collapsed	VBD	O	collapse	ccomp	7	SENT_162	[p6l111t3399r245b3432],
11	to	TO	O	to	_	0	SENT_162	[p6l262t3402r291b3424],
12	the	DT	O	the	det	15	SENT_162	[p6l308t3399r354b3424],
13	fixed	JJ	O	fixed	amod	15	SENT_162	[p6l370t3399r440b3424],
14	effects	NNS	O	effect	nn	15	SENT_162	[p6l458t3399r550b3424],
15	model	NN	O	model	prep_to	10	SENT_162	[p6l568t3399r657b3424],
16	in	IN	O	in	_	0	SENT_162	[p6l676t3400r699b3424],
17	the	DT	O	the	det	18	SENT_162	[p6l717t3399r763b3424],
18	absence	NN	O	absence	prep_in	15	SENT_162	[p6l781t3399r897b3424],
19	of	IN	O	of	_	0	SENT_162	[p6l914t3399r942b3424],
20	significant	JJ	O	significant	amod	23	SENT_162	[p6l958t3399r1106b3432],
21	heterogeneity	NN	O	heterogeneity	nn	23	SENT_162	[p6l1123t3399r1324b3432],
22	(	CD	NUMBER	(	num	23	SENT_162	[p6l1341t3396r1527b3430],
23	I2	NN	O	i2	prep_of	18	SENT_162	[p6l1341t3396r1527b3430],
24	:19.6	CD	PERCENT	:19.6	num	25	SENT_162	[p6l1341t3396r1527b3430],
25	%	NN	PERCENT	%	tmod	10	SENT_162	[p6l1341t3396r1527b3430],
26	)	CD	NUMBER	)	dep	25	SENT_162	[p6l1341t3396r1527b3430],
27	.	.	O	.	_	0	SENT_162	[p6l1341t3396r1527b3430],

1	The	DT	O	the	det	3	SENT_163	[p6l1545t3399r1599b3424],
2	vertical	JJ	O	vertical	amod	3	SENT_163	[p6l1615t3399r1717b3424],
3	line	NN	O	line	nsubj	8	SENT_163	[p6l1737t3399r1786b3424],
4	in	IN	O	in	_	0	SENT_163	[p6l1804t3400r1827b3424],
5	the	DT	O	the	det	7	SENT_163	[p6l1845t3399r1891b3424],
6	OR	NN	O	or	nn	7	SENT_163	[p6l1909t3400r1952b3424],
7	plot	NN	O	plot	prep_in	3	SENT_163	[p6l1970t3399r2026b3432],
8	is	VBZ	O	be	_	0	SENT_163	[p6l2043t3400r2061b3424],
9	at	IN	O	at	_	0	SENT_163	[p6l2078t3402r2105b3424],
10	1	CD	NUMBER	1	prep_at	8	SENT_163	[p6l2123t3400r2146b3429],
11	,	,	O	,	_	0	SENT_163	[p6l2123t3400r2146b3429],
12	corresponding	VBG	O	correspond	prep	8	SENT_163	[p6l8t3440r216b3473],
13	to	TO	O	to	pcomp	12	SENT_163	[p6l231t3443r260b3465],
14	the	DT	O	the	det	16	SENT_163	[p6l273t3440r319b3465],
15	null	JJ	O	null	amod	16	SENT_163	[p6l334t3440r384b3465],
16	hypothesis	NN	O	hypothesis	pobj	13	SENT_163	[p6l400t3440r552b3473],
17	of	IN	O	of	_	0	SENT_163	[p6l566t3440r594b3465],
18	no	DT	O	no	det	20	SENT_163	[p6l607t3447r642b3465],
19	genotype	NN	O	genotype	nn	20	SENT_163	[p6l656t3443r794b3473],
20	effect	NN	O	effect	prep_of	16	SENT_163	[p6l808t3440r894b3465],
21	.	.	O	.	_	0	SENT_163	[p6l808t3440r894b3465],

1	CI	NN	O	ci	_	0	SENT_164	[p6l910t3441r947b3471],
2	,	,	O	,	_	0	SENT_164	[p6l910t3441r947b3471],
3	confidence	NN	O	confidence	nn	4	SENT_164	[p6l962t3440r1121b3465],
4	interval	NN	O	interval	appos	1	SENT_164	[p6l1135t3440r1248b3470],
5	;	:	O	;	_	0	SENT_164	[p6l1135t3440r1248b3470],
6	n	NN	O	n	nn	8	SENT_164	[p6l1264t3447r1310b3465],
7	=	JJ	O	=	amod	8	SENT_164	[p6l1264t3447r1310b3465],
8	number	NN	O	number	dep	1	SENT_164	[p6l1319t3440r1433b3465],
9	of	IN	O	of	_	0	SENT_164	[p6l1446t3440r1474b3465],
10	responders	NNS	O	responder	prep_of	8	SENT_164	[p6l1487t3440r1644b3473],
11	or	CC	O	or	_	0	SENT_164	[p6l1657t3447r1687b3465],
12	non-responders	JJ	O	non-responders	conj_or	10	SENT_164	[p6l1701t3440r1926b3473],
13	carrying	VBG	O	carry	partmod	12	SENT_164	[p6l1940t3441r2055b3473],
14	the	DT	O	the	det	16	SENT_164	[p6l2070t3440r2116b3465],
15	A	NN	O	a	nn	16	SENT_164	[p6l2128t3441r2149b3465],
16	allele	NN	O	allele	dobj	13	SENT_164	[p6l8t3481r88b3511],
17	;	:	O	;	_	0	SENT_164	[p6l8t3481r88b3511],
18	N	NN	O	n	dep	12	SENT_164	[p6l104t3482r133b3512],
19	,	,	O	,	_	0	SENT_164	[p6l104t3482r133b3512],
20	total	JJ	O	total	amod	21	SENT_164	[p6l147t3481r211b3506],
21	number	NN	O	number	appos	18	SENT_164	[p6l226t3481r341b3506],
22	of	IN	O	of	_	0	SENT_164	[p6l352t3481r380b3506],
23	responders	NNS	O	responder	prep_of	21	SENT_164	[p6l393t3481r550b3514],
24	or	CC	O	or	_	0	SENT_164	[p6l563t3488r592b3506],
25	non-responders	NNS	O	non-responder	prep_of	21	SENT_164	[p6l605t3481r838b3514],
26	;	:	O	;	_	0	SENT_164	[p6l605t3481r838b3514],
27	OR	NN	O	or	dep	12	SENT_164	[p6l853t3482r903b3512],
28	,	,	O	,	_	0	SENT_164	[p6l853t3482r903b3512],
29	odds	NNS	O	odds	nn	30	SENT_164	[p6l918t3481r988b3506],
30	ratio	NN	O	ratio	appos	27	SENT_164	[p6l1002t3482r1073b3506],
31	.	.	O	.	_	0	SENT_164	[p6l1002t3482r1073b3506],

1	Table	NNP	O	Table	nn	3	SENT_165	[p6l7t3589r99b3617],
2	2	CD	NUMBER	2	num	3	SENT_165	[p6l117t3590r136b3616],
3	Characteristics	NNS	O	characteristic	_	0	SENT_165	[p6l174t3590r412b3617],
4	of	IN	O	of	_	0	SENT_165	[p6l429t3590r462b3617],
5	pharmacogenetic	JJ	O	pharmacogenetic	amod	6	SENT_165	[p6l479t3590r765b3625],
6	studies	NNS	O	study	prep_of	3	SENT_165	[p6l782t3590r895b3617],
7	using	VBG	O	use	partmod	6	SENT_165	[p6l913t3590r998b3625],
8	the	DT	O	the	det	9	SENT_165	[p6l1015t3590r1068b3617],
9	TNF-oz	NN	O	tnf-oz	nsubj	12	SENT_165	[p6l1084t3591r1181b3617],
10	-308	CD	NUMBER	-308	npadvmod	11	SENT_165	[p6l1199t3590r1283b3617],
11	variant	JJ	O	variant	dep	12	SENT_165	[p6l1299t3590r1413b3617],
12	categorized	VBN	O	categorize	xcomp	7	SENT_165	[p6l1430t3590r1622b3625],
13	on	IN	O	on	_	0	SENT_165	[p6l1640t3598r1680b3617],
14	the	DT	O	the	det	15	SENT_165	[p6l1697t3590r1749b3617],
15	basis	NN	O	basis	prep_on	12	SENT_165	[p6l1768t3590r1845b3617],
16	of	IN	O	of	_	0	SENT_165	[p6l1862t3590r1895b3617],
17	the	DT	O	the	det	19	SENT_165	[p6l1910t3590r1962b3617],
18	anti-TNF-oz	JJ	O	anti-tnf-oz	amod	19	SENT_165	[p6l1980t3590r2152b3617],
19	inhibitor	NN	O	inhibitor	prep_of	15	SENT_165	[p6l9t3631r150b3658],
20	employed	VBN	O	employ	partmod	19	SENT_165	[p6l163t3631r324b3666],
21	in	IN	O	in	_	0	SENT_165	[p6l340t3631r367b3658],
22	each	DT	O	each	det	23	SENT_165	[p6l382t3631r456b3658],
23	study	NN	O	study	prep_in	20	SENT_165	[p6l471t3631r560b3666],

1	Drug	NN	O	drug	_	0	SENT_166	[p7l12t60r167b132],
2	Study	NNP	O	Study	nn	4	SENT_166	[p7l514t57r694b132],
3	Response	NNP	O	Response	nn	4	SENT_166	[p7l1217t60r1506b132],
4	Responder	NNP	O	Responder	dep	1	SENT_166	[p7l1782t57r2112b132],
5	criteria	NNS	O	criterion	dep	1	SENT_166	[p7l1217t149r1432b205],

1	Infliximab	NNP	O	Infliximab	nn	3	SENT_167	[p7l13t431r335b488],
2	Mugnier	NNP	O	Mugnier	nn	3	SENT_167	[p7l515t432r796b506],
3	iDAS28	NN	O	idas28	dep	16	SENT_167	[p7l1225t432r1490b503],
4	>	JJR	O	>	dep	3	SENT_167	[p7l1532t432r1698b495],
5	1.2	CD	NUMBER	1.2	number	6	SENT_167	[p7l1532t432r1698b495],
6	33	CD	NUMBER	33	num	11	SENT_167	[p7l1925t432r2001b488],
7	Cuchacovich2004	NN	O	cuchacovich2004	nn	11	SENT_167	[p7l512t520r1109b577],
8	ACR20	NN	O	acr20	nn	11	SENT_167	[p7l1212t522r1436b577],
9	7	CD	NUMBER	7	num	11	SENT_167	[p7l1969t523r2003b577],
10	Fonseca	NNP	ORGANIZATION	Fonseca	nn	11	SENT_167	[p7l515t614r772b668],
11	iDAS28	NN	O	idas28	dep	4	SENT_167	[p7l1225t613r1490b683],
12	>	JJR	O	>	amod	11	SENT_167	[p7l1532t613r1698b676],
13	1.2	CD	NUMBER	1.2	dep	16	SENT_167	[p7l1532t613r1698b676],
14	11	CD	NUMBER	11	num	16	SENT_167	[p7l1925t613r1989b668],
15	Seitz	NNP	PERSON	Seitz	nn	16	SENT_167	[p7l513t704r664b759],
16	1DAS28	NN	O	1das28	dep	25	SENT_167	[p7l1225t704r1490b774],
17	>	JJR	O	>	dep	16	SENT_167	[p7l1532t704r1698b767],
18	1.2	CD	NUMBER	1.2	number	19	SENT_167	[p7l1532t704r1698b767],
19	22	CD	NUMBER	22	dep	17	SENT_167	[p7l1922t704r2002b759],
20	Marotte	NNP	PERSON	Marotte	nn	23	SENT_167	[p7l515t796r775b851],
21	ACRZO	NNP	O	ACRZO	nn	23	SENT_167	[p7l1212t795r1436b851],
22	99	CD	NUMBER	99	num	23	SENT_167	[p7l1922t795r2002b851],
23	SUBTOTAL	NNP	O	SUBTOTAL	dep	19	SENT_167	[p7l1216t886r1595b942],
24	1	CD	NUMBER	1	num	25	SENT_167	[p7l1883t886r1906b941],
25	72	CD	NUMBER	72	_	0	SENT_167	[p7l1925t886r2005b941],

1	Etanercept	NNP	O	Etanercept	nn	3	SENT_168	[p7l13t1069r364b1141],
2	Padyukov	NNP	O	Padyukov	nn	3	SENT_168	[p7l515t1066r831b1141],
3	iDAS28	NN	O	idas28	dep	11	SENT_168	[p7l1225t1068r1490b1138],
4	>	JJR	O	>	dep	3	SENT_168	[p7l1532t1068r1698b1131],
5	1.2	CD	NUMBER	1.2	number	6	SENT_168	[p7l1532t1068r1698b1131],
6	65	CD	NUMBER	65	num	7	SENT_168	[p7l1923t1068r2000b1124],
7	Kang	NNP	O	Kang	dep	4	SENT_168	[p7l515t1159r676b1231],
8	ACR20	NN	O	acr20	dep	11	SENT_168	[p7l1212t1158r1436b1214],
9	59	CD	NUMBER	59	num	8	SENT_168	[p7l1922t1158r2002b1214],
10	Guis	NNP	O	Guis	nn	11	SENT_168	[p7l512t1248r653b1304],
11	iDAS28	NN	O	idas28	dep	16	SENT_168	[p7l1225t1248r1490b1319],
12	>	JJR	O	>	dep	11	SENT_168	[p7l1532t1249r1698b1312],
13	1.2	CD	NUMBER	1.2	number	14	SENT_168	[p7l1532t1249r1698b1312],
14	56	CD	NUMBER	56	dep	12	SENT_168	[p7l1922t1249r2003b1304],
15	Seitz	NNP	PERSON	Seitz	nn	16	SENT_168	[p7l513t1338r664b1394],
16	1DAS28	NN	O	1das28	dep	20	SENT_168	[p7l1225t1338r1490b1409],
17	>	JJR	O	>	dep	16	SENT_168	[p7l1532t1339r1698b1402],
18	1.2	CD	NUMBER	1.2	number	19	SENT_168	[p7l1532t1339r1698b1402],
19	10	CD	NUMBER	10	dep	17	SENT_168	[p7l1925t1339r2003b1394],
20	SUBTOTAL	NN	O	subtotal	_	0	SENT_168	[p7l1216t1430r1595b1485],
21	190	CD	NUMBER	190	num	20	SENT_168	[p7l1883t1430r2004b1485],

1	Adalimumab	NNP	O	Adalimumab	nn	2	SENT_169	[p7l6t1610r432b1667],
2	Cuchacovich	NNP	O	Cuchacovich	dep	9	SENT_169	[p7l512t1610r934b1667],
3	2006	CD	DATE	2006	num	4	SENT_169	[p7l967t1612r1135b1667],
4	LDASZ8	NN	O	ldasz8	dep	2	SENT_169	[p7l1225t1612r1490b1682],
5	>	JJR	O	>	dep	4	SENT_169	[p7l1532t1612r1698b1675],
6	1.2	CD	NUMBER	1.2	dep	9	SENT_169	[p7l1532t1612r1698b1675],
7	45	CD	NUMBER	45	num	9	SENT_169	[p7l1920t1613r2000b1667],
8	Seitz	NNP	PERSON	Seitz	nn	9	SENT_169	[p7l513t1703r664b1758],
9	iDAS28	NN	O	idas28	dep	13	SENT_169	[p7l1225t1703r1490b1773],
10	>	JJR	O	>	dep	9	SENT_169	[p7l1532t1703r1698b1766],
11	1.2	CD	NUMBER	1.2	number	12	SENT_169	[p7l1532t1703r1698b1766],
12	5	CD	NUMBER	5	dep	10	SENT_169	[p7l1966t1704r2000b1758],
13	SUBTOTAL	NN	ORGANIZATION	subtotal	_	0	SENT_169	[p7l1216t1794r1595b1849],
14	50	CD	NUMBER	50	num	13	SENT_169	[p7l1921t1794r2004b1849],

1	Combined	VBN	O	combine	_	0	SENT_170	[p7l10t1975r356b2032],
2	TOTAL	JJ	O	total	amod	3	SENT_170	[p7l1212t1977r1451b2032],
3	412	CD	NUMBER	412	dep	1	SENT_170	[p7l1877t1977r2005b2031],
4	TNF-oc	NN	O	tnf-oc	nn	7	SENT_170	[p7l37t2063r194b2110],
5	-308	CD	NUMBER	-308	num	7	SENT_170	[p7l224t2063r382b2110],
6	Percentage	NN	O	percentage	nn	7	SENT_170	[p7l653t2063r955b2126],
7	Responder	NN	O	responder	dep	3	SENT_170	[p7l1022t2061r1309b2126],
8	TNF-oc	JJ	O	tnf-oc	amod	7	SENT_170	[p7l1376t2063r1533b2110],
9	-308	CD	NUMBER	-308	tmod	8	SENT_170	[p7l1563t2063r1720b2110],
10	Percentage	NN	O	percentage	nn	12	SENT_170	[p7l1851t2063r2153b2126],
11	G/G	NN	O	g/g	nn	12	SENT_170	[p7l35t2139r146b2195],
12	Non-responder	NN	O	non-responder	dep	7	SENT_170	[p7l174t2139r589b2204],

1	G/A	NN	O	g/a	dep	13	SENT_171	[p7l1374t2139r1477b2195],
2	or	CC	O	or	_	0	SENT_171	[p7l1504t2154r1562b2188],
3	A/A	NN	O	a/a	dep	13	SENT_171	[p7l1579t2139r1678b2195],
4	Non-responder	JJ	O	non-responder	amod	6	SENT_171	[p7l1372t2218r1787b2283],
5	gg	NN	O	gg	nn	6	SENT_171	[p7l1540t2749r1571b2877],
6	_	NN	O	_	dep	1	SENT_171	[p7l1540t2749r1571b2877],
7	\	CD	NUMBER	\	num	8	SENT_171	[p7l1540t2749r1571b2877],
8	O	NN	O	o	dep	1	SENT_171	[p7l1576t3463r1611b3669],
9	\	CD	NUMBER	\	num	10	SENT_171	[p7l1576t3463r1611b3669],
10	OO	NN	O	oo	dep	8	SENT_171	[p7l1576t3463r1611b3669],
11	’	CD	NUMBER	’	num	13	SENT_171	[p7l1576t3463r1611b3669],
12	\	NN	O	\	nn	13	SENT_171	[p7l1576t3463r1611b3669],
13	H	NN	O	h	_	0	SENT_171	[p7l1577t2987r1610b3351],
14	-	:	O	-	_	0	SENT_171	[p7l1577t2987r1610b3351],
15	‘	CD	NUMBER	‘	nsubj	16	SENT_171	[p7l1577t2987r1610b3351],
16	OoOl	NN	O	oool	parataxis	13	SENT_171	[p7l1577t2987r1610b3351],
17	\	CD	NUMBER	\	number	18	SENT_171	[p7l1577t2987r1610b3351],
18	)	CD	NUMBER	)	num	22	SENT_171	[p7l1577t2987r1610b3351],
19	UU	NNP	O	UU	nn	22	SENT_171	[p7l1576t2434r1610b2877],
20	\	CD	NUMBER	\	num	22	SENT_171	[p7l1576t2434r1610b2877],
21	Ol	JJ	O	ol	amod	22	SENT_171	[p7l1576t2434r1610b2877],
22	\	NN	O	\	dep	16	SENT_171	[p7l1576t2434r1610b2877],
23	)	SYM	O	)	dep	16	SENT_171	[p7l1576t2434r1610b2877],
24	-	:	O	-	_	0	SENT_171	[p7l1576t2434r1610b2877],
25	|	NN	O	|	dep	26	SENT_171	[p7l1576t2434r1610b2877],
26	>	JJR	O	>	parataxis	13	SENT_171	[p7l1576t2434r1610b2877],
27	.	.	O	.	_	0	SENT_171	[p7l1576t2434r1610b2877],

1	—	NN	O	—	_	0	SENT_172	[p7l1576t2434r1610b2877],
2	.	.	O	.	_	0	SENT_172	[p7l1576t2434r1610b2877],

1	‘	NN	O	‘	_	0	SENT_173	[p7l1576t2434r1610b2877],
2	\	NN	O	\	dep	1	SENT_173	[p7l1576t2434r1610b2877],
3	l	NN	O	l	tmod	2	SENT_173	[p7l1576t2434r1610b2877],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_174	[p8l7t161r181b184],
2	:	:	O	:	_	0	SENT_174	[p8l7t161r181b184],
3	ACRZO	NNP	LOCATION	ACRZO	nn	6	SENT_174	[p8l192t162r283b189],
4	,	,	O	,	_	0	SENT_174	[p8l192t162r283b189],
5	American	NNP	ORGANIZATION	American	appos	6	SENT_174	[p8l294t162r410b184],
6	College	NNP	ORGANIZATION	College	dep	1	SENT_174	[p8l422t162r514b191],
7	of	IN	ORGANIZATION	of	_	0	SENT_174	[p8l525t162r549b184],
8	Rheumatology	NNP	ORGANIZATION	Rheumatology	prep_of	6	SENT_174	[p8l560t162r738b191],
9	20	CD	PERCENT	20	number	10	SENT_174	[p8l749t162r806b184],
10	%	NN	PERCENT	%	amod	12	SENT_174	[p8l749t162r806b184],
11	improvement	NN	O	improvement	nn	12	SENT_174	[p8l818t162r984b191],
12	criteria	NNS	O	criterion	dep	8	SENT_174	[p8l994t162r1082b189],
13	;	:	O	;	_	0	SENT_174	[p8l994t162r1082b189],
14	DAS28	NN	O	das28	nn	18	SENT_174	[p8l1096t162r1184b189],
15	,	,	O	,	_	0	SENT_174	[p8l1096t162r1184b189],
16	disease	NN	O	disease	dep	18	SENT_174	[p8l1197t162r1283b184],
17	activity	NN	O	activity	nn	18	SENT_174	[p8l1294t162r1380b191],
18	score	NN	NUMBER	score	dep	8	SENT_174	[p8l1390t168r1452b184],
19	using	VBG	O	use	partmod	18	SENT_174	[p8l1464t162r1528b191],
20	28	CD	NUMBER	28	num	22	SENT_174	[p8l1539t162r1570b184],
21	joint	JJ	O	joint	amod	22	SENT_174	[p8l1580t162r1636b191],
22	counts	NNS	O	count	dobj	19	SENT_174	[p8l1646t164r1733b189],
23	;	:	O	;	_	0	SENT_174	[p8l1646t164r1733b189],
24	TNF-a	NN	O	tnf-a	nn	25	SENT_174	[p8l1744t160r1824b189],
25	’	NN	O	’	dep	1	SENT_174	[p8l1744t160r1824b189],
26	,	,	O	,	_	0	SENT_174	[p8l1744t160r1824b189],
27	tumor	NN	O	tumor	nn	29	SENT_174	[p8l1837t164r1913b184],
28	necrosis	NN	O	necrosis	nn	29	SENT_174	[p8l1924t162r2019b184],
29	factor-oi	NN	O	factor-ous	appos	25	SENT_174	[p8l2029t162r2130b184],
30	.	.	O	.	_	0	SENT_174	[p8l2029t162r2130b184],

1	allele	NN	O	allele	nsubj	2	SENT_175	[p8l9t345r191b403],
2	responded	VBD	O	respond	_	0	SENT_175	[p8l238t345r606b421],
3	to	TO	O	to	_	0	SENT_175	[p8l651t352r720b403],
4	the	DT	O	the	det	5	SENT_175	[p8l766t345r878b403],
5	treatment	NN	O	treatment	prep_to	2	SENT_175	[p8l925t352r1276b403],
6	(	CD	NUMBER	(	num	7	SENT_175	[p8l1324t345r1531b417],
7	Table	NNP	O	Table	tmod	2	SENT_175	[p8l1324t345r1531b417],
8	2	CD	NUMBER	2	num	7	SENT_175	[p8l1578t345r1662b417],
9	)	CD	NUMBER	)	dep	7	SENT_175	[p8l1578t345r1662b417],
10	.	.	O	.	_	0	SENT_175	[p8l1578t345r1662b417],

1	Likewise	RB	O	likewise	advmod	35	SENT_176	[p8l1713t345r2028b415],
2	,	,	O	,	_	0	SENT_176	[p8l1713t345r2028b415],
3	in	IN	O	in	_	0	SENT_176	[p8l2078t348r2149b402],
4	studies	NNS	O	study	prep_in	35	SENT_176	[p8l10t440r250b497],
5	in	IN	O	in	_	0	SENT_176	[p8l288t442r358b496],
6	which	WDT	O	which	rel	9	SENT_176	[p8l393t439r614b497],
7	RA	NN	O	ra	nn	8	SENT_176	[p8l651t441r748b496],
8	patients	NNS	O	patient	nsubj	9	SENT_176	[p8l784t442r1066b515],
9	received	VBD	O	receive	rcmod	4	SENT_176	[p8l1103t439r1394b497],
10	etanercept	NN	O	etanercept	dobj	9	SENT_176	[p8l1431t447r1819b515],
11	,	,	O	,	_	0	SENT_176	[p8l1431t447r1819b515],
12	190/224	CD	PERCENT	190/224	num	13	SENT_176	[p8l1866t439r2147b505],
13	(	CD	PERCENT	(	nsubj	35	SENT_176	[p8l12t535r212b607],
14	85	CD	PERCENT	85	number	15	SENT_176	[p8l12t535r212b607],
15	%	NN	PERCENT	%	amod	13	SENT_176	[p8l12t535r212b607],
16	)	CD	NUMBER	)	advmod	13	SENT_176	[p8l12t535r212b607],
17	of	IN	O	of	_	0	SENT_176	[p8l247t534r319b592],
18	patients	NNS	O	patient	prep_of	16	SENT_176	[p8l344t537r627b610],
19	with	IN	O	with	_	0	SENT_176	[p8l656t534r818b592],
20	a	DT	O	a	det	22	SENT_176	[p8l849t551r884b592],
21	G/G	NN	O	g/g	nn	22	SENT_176	[p8l915t534r1061b600],
22	genotype	NN	O	genotype	prep_with	18	SENT_176	[p8l1091t542r1417b610],
23	and	CC	O	and	_	0	SENT_176	[p8l1450t534r1581b592],
24	47/68	CD	PERCENT	47/68	number	25	SENT_176	[p8l1612t534r1811b600],
25	(	CD	PERCENT	(	conj_and	18	SENT_176	[p8l1846t534r2046b607],
26	69	CD	PERCENT	69	num	27	SENT_176	[p8l1846t534r2046b607],
27	%	NN	PERCENT	%	dep	25	SENT_176	[p8l1846t534r2046b607],
28	)	CD	NUMBER	)	dep	13	SENT_176	[p8l1846t534r2046b607],
29	of	IN	O	of	_	0	SENT_176	[p8l2081t534r2153b592],
30	patients	NNS	O	patient	prep_of	28	SENT_176	[p8l8t633r290b706],
31	carrying	VBG	O	carry	partmod	13	SENT_176	[p8l335t633r626b706],
32	an	DT	O	a	det	34	SENT_176	[p8l669t647r753b688],
33	A	NN	O	a	nn	34	SENT_176	[p8l796t632r847b687],
34	allele	NN	O	allele	dobj	31	SENT_176	[p8l890t630r1072b688],
35	responded	VBD	O	respond	_	0	SENT_176	[p8l1117t630r1484b706],
36	to	TO	O	to	_	0	SENT_176	[p8l1528t637r1598b688],
37	the	DT	O	the	det	38	SENT_176	[p8l1641t630r1754b688],
38	treatment	NN	O	treatment	prep_to	35	SENT_176	[p8l1798t637r2149b688],
39	(	CD	NUMBER	(	num	40	SENT_176	[p8l12t724r219b797],
40	Table	NNP	O	Table	tmod	35	SENT_176	[p8l12t724r219b797],
41	2	CD	NUMBER	2	num	40	SENT_176	[p8l252t724r336b797],
42	)	CD	NUMBER	)	dep	40	SENT_176	[p8l252t724r336b797],
43	.	.	O	.	_	0	SENT_176	[p8l252t724r336b797],

1	Similarly	RB	O	similarly	advmod	27	SENT_177	[p8l373t724r697b800],
2	,	,	O	,	_	0	SENT_177	[p8l373t724r697b800],
3	50/56	CD	PERCENT	50/56	nsubj	27	SENT_177	[p8l735t724r933b790],
4	(	CD	PERCENT	(	num	6	SENT_177	[p8l969t725r1169b796],
5	89	CD	PERCENT	89	num	6	SENT_177	[p8l969t725r1169b796],
6	%	NN	PERCENT	%	dep	3	SENT_177	[p8l969t725r1169b796],
7	)	CD	NUMBER	)	dep	3	SENT_177	[p8l969t725r1169b796],
8	of	IN	O	of	_	0	SENT_177	[p8l1204t724r1276b782],
9	RA	NN	O	ra	nn	10	SENT_177	[p8l1303t726r1401b781],
10	patients	NNS	O	patient	prep_of	7	SENT_177	[p8l1430t727r1713b800],
11	with	IN	O	with	_	0	SENT_177	[p8l1743t724r1904b782],
12	a	DT	O	a	det	14	SENT_177	[p8l1937t741r1971b782],
13	G/G	NN	O	g/g	nn	14	SENT_177	[p8l2003t724r2149b790],
14	genotype	NN	O	genotype	prep_with	27	SENT_177	[p8l9t827r335b895],
15	and	CC	O	and	_	0	SENT_177	[p8l371t820r502b877],
16	17/23	CD	PERCENT	17/23	number	17	SENT_177	[p8l543t819r735b885],
17	(	CD	PERCENT	(	prep_with	27	SENT_177	[p8l777t820r977b892],
18	74	CD	PERCENT	74	num	19	SENT_177	[p8l777t820r977b892],
19	%	NN	PERCENT	%	dep	17	SENT_177	[p8l777t820r977b892],
20	)	CD	NUMBER	)	nsubj	27	SENT_177	[p8l777t820r977b892],
21	of	IN	O	of	_	0	SENT_177	[p8l1016t819r1088b877],
22	patients	NNS	O	patient	prep_of	20	SENT_177	[p8l1118t823r1400b895],
23	carrying	VBG	O	carry	partmod	22	SENT_177	[p8l1437t823r1727b895],
24	an	DT	O	a	det	26	SENT_177	[p8l1761t836r1846b877],
25	A	NN	O	a	nn	26	SENT_177	[p8l1880t821r1931b877],
26	allele	NN	O	allele	dobj	23	SENT_177	[p8l1966t820r2148b877],
27	responded	VBD	O	respond	_	0	SENT_177	[p8l9t915r376b991],
28	to	TO	O	to	_	0	SENT_177	[p8l423t922r492b973],
29	adalimumab	JJ	O	adalimumab	amod	30	SENT_177	[p8l542t915r984b973],
30	treatment	NN	O	treatment	prep_to	27	SENT_177	[p8l1032t922r1382b973],
31	(	CD	NUMBER	(	num	32	SENT_177	[p8l1433t915r1639b987],
32	Table	NNP	O	Table	tmod	27	SENT_177	[p8l1433t915r1639b987],
33	2	CD	NUMBER	2	num	32	SENT_177	[p8l1689t915r1773b987],
34	)	CD	NUMBER	)	dep	32	SENT_177	[p8l1689t915r1773b987],
35	.	.	O	.	_	0	SENT_177	[p8l1689t915r1773b987],

1	All	DT	O	all	det	3	SENT_178	[p8l1823t915r1920b972],
2	three	CD	NUMBER	three	num	3	SENT_178	[p8l1967t915r2148b973],
3	biologics	NNS	O	biologic	nsubj	4	SENT_178	[p8l7t1010r321b1085],
4	seem	VBP	O	seem	_	0	SENT_178	[p8l350t1026r524b1067],
5	to	TO	O	to	aux	6	SENT_178	[p8l551t1017r620b1067],
6	have	VB	O	have	xcomp	4	SENT_178	[p8l647t1010r812b1067],
7	similar	JJ	O	similar	amod	9	SENT_178	[p8l841t1010r1080b1067],
8	response	NN	O	response	nn	9	SENT_178	[p8l1106t1026r1411b1085],
9	rates	NNS	O	rate	dobj	6	SENT_178	[p8l1439t1017r1601b1067],
10	to	TO	O	to	_	0	SENT_178	[p8l1627t1017r1697b1067],
11	TNF-or	JJ	O	tnf-or	amod	13	SENT_178	[p8l1722t1012r1937b1067],
12	-308	CD	NUMBER	-308	num	13	SENT_178	[p8l1966t1011r2147b1067],
13	Variants	NNS	O	variant	prep_to	6	SENT_178	[p8l6t1108r306b1163],
14	.	.	O	.	_	0	SENT_178	[p8l6t1108r306b1163],

1	A	DT	O	a	det	3	SENT_179	[p8l354t1107r406b1162],
2	subgroup	NN	O	subgroup	nn	3	SENT_179	[p8l451t1105r777b1181],
3	analysis	NN	O	analysis	nsubj	6	SENT_179	[p8l824t1105r1099b1181],
4	did	VBD	O	do	aux	6	SENT_179	[p8l1145t1105r1257b1163],
5	not	RB	O	not	neg	6	SENT_179	[p8l1302t1112r1423b1163],
6	show	VB	O	show	dep	13	SENT_179	[p8l1469t1105r1653b1163],
7	a	DT	O	a	det	9	SENT_179	[p8l1697t1122r1731b1163],
8	significant	JJ	O	significant	amod	9	SENT_179	[p8l1778t1105r2149b1181],
9	difference	NN	O	difference	dobj	6	SENT_179	[p8l9t1199r359b1257],
10	in	IN	O	in	_	0	SENT_179	[p8l391t1202r461b1256],
11	the	DT	O	the	det	12	SENT_179	[p8l493t1199r606b1257],
12	OR	NN	O	or	prep_in	6	SENT_179	[p8l640t1201r747b1257],
13	estimates	VBZ	O	estimate	_	0	SENT_179	[p8l778t1202r1105b1257],
14	for	IN	O	for	_	0	SENT_179	[p8l1137t1199r1236b1257],
15	each	DT	O	each	det	18	SENT_179	[p8l1267t1199r1428b1257],
16	inhibitor	NN	O	inhibitor	nn	18	SENT_179	[p8l1460t1199r1777b1257],
17	(	NN	O	(	nn	18	SENT_179	[p8l1811t1199r2144b1271],
18	Q	NNP	O	Q	prep_for	13	SENT_179	[p8l1811t1199r2144b1271],
19	=	JJ	O	=	amod	20	SENT_179	[p8l1811t1199r2144b1271],
20	0.98	CD	NUMBER	0.98	nsubj	13	SENT_179	[p8l1811t1199r2144b1271],
21	,	,	O	,	_	0	SENT_179	[p8l1811t1199r2144b1271],
22	df	NN	O	df	appos	20	SENT_179	[p8l9t1295r223b1365],
23	=	JJ	O	=	amod	22	SENT_179	[p8l9t1295r223b1365],
24	2	CD	NUMBER	2	tmod	23	SENT_179	[p8l9t1295r223b1365],
25	,	,	O	,	_	0	SENT_179	[p8l9t1295r223b1365],
26	P	NN	O	p	appos	20	SENT_179	[p8l266t1297r314b1352],
27	=	JJ	O	=	amod	29	SENT_179	[p8l329t1295r593b1367],
28	0.61	CD	NUMBER	0.61	tmod	27	SENT_179	[p8l329t1295r593b1367],
29	)	NN	O	)	dep	26	SENT_179	[p8l329t1295r593b1367],
30	,	,	O	,	_	0	SENT_179	[p8l329t1295r593b1367],
31	although	IN	O	although	mark	40	SENT_179	[p8l641t1295r962b1371],
32	the	DT	O	the	det	33	SENT_179	[p8l1004t1295r1117b1353],
33	number	NN	O	number	nsubj	40	SENT_179	[p8l1160t1295r1439b1353],
34	of	IN	O	of	_	0	SENT_179	[p8l1481t1295r1553b1353],
35	studies	NNS	O	study	prep_of	33	SENT_179	[p8l1592t1295r1832b1353],
36	in	IN	O	in	_	0	SENT_179	[p8l1875t1298r1945b1352],
37	each	DT	O	each	det	38	SENT_179	[p8l1988t1295r2148b1353],
38	group	NN	O	group	prep_in	35	SENT_179	[p8l9t1406r214b1465],
39	is	VBZ	O	be	cop	40	SENT_179	[p8l244t1392r294b1447],
40	low	JJ	O	low	dep	20	SENT_179	[p8l324t1389r462b1460],
41	,	,	O	,	_	0	SENT_179	[p8l324t1389r462b1460],
42	and	CC	O	and	_	0	SENT_179	[p8l498t1389r629b1447],
43	is	VBZ	O	be	auxpass	44	SENT_179	[p8l658t1392r708b1447],
44	hampered	VBN	O	hamper	conj_and	40	SENT_179	[p8l738t1389r1095b1465],
45	by	IN	O	by	_	0	SENT_179	[p8l1122t1389r1210b1465],
46	low	JJ	O	low	amod	49	SENT_179	[p8l1237t1389r1365b1447],
47	overall	JJ	O	overall	amod	49	SENT_179	[p8l1392t1389r1630b1447],
48	sample	NN	O	sample	nn	49	SENT_179	[p8l1662t1389r1906b1465],
49	size	NN	O	size	agent	44	SENT_179	[p8l1938t1392r2080b1447],
50	.	.	O	.	_	0	SENT_179	[p8l1938t1392r2080b1447],

1	The	DT	O	the	det	2	SENT_180	[p8l82t1870r215b1928],
2	decrease	NN	O	decrease	nsubjpass	11	SENT_180	[p8l257t1870r550b1928],
3	in	IN	O	in	_	0	SENT_180	[p8l592t1873r662b1927],
4	DAS28	NN	O	das28	nn	5	SENT_180	[p8l704t1871r936b1928],
5	score	NN	NUMBER	score	prep_in	2	SENT_180	[p8l980t1887r1155b1928],
6	in	IN	O	in	_	0	SENT_180	[p8l1197t1873r1268b1927],
7	RA	NN	O	ra	nn	8	SENT_180	[p8l1309t1871r1407b1927],
8	patients	NNS	O	patient	prep_in	5	SENT_180	[p8l1445t1873r1728b1946],
9	was	VBD	O	be	auxpass	11	SENT_180	[p8l1768t1887r1896b1928],
10	subsequently	RB	O	subsequently	advmod	11	SENT_180	[p8l1939t1870r2151b1928, p8l8t1965r283b2041],
11	quantified	VBN	O	quantify	_	0	SENT_180	[p8l327t1965r694b2041],
12	on	IN	O	on	_	0	SENT_180	[p8l740t1982r832b2023],
13	the	DT	O	the	det	14	SENT_180	[p8l877t1965r990b2023],
14	basis	NN	O	basis	prep_on	11	SENT_180	[p8l1034t1965r1201b2023],
15	of	IN	O	of	_	0	SENT_180	[p8l1249t1965r1321b2023],
16	the	DT	O	the	det	17	SENT_180	[p8l1362t1965r1475b2023],
17	TNF-or	NN	O	tnf-or	prep_of	14	SENT_180	[p8l1520t1968r1734b2023],
18	-308	CD	NUMBER	-308	num	20	SENT_180	[p8l1783t1967r1965b2023],
19	A/G	NN	O	a/g	nn	20	SENT_180	[p8l2011t1965r2151b2030],
20	polymorphism	NN	O	polymorphism	dep	17	SENT_180	[p8l7t2059r552b2135],
21	.	.	O	.	_	0	SENT_180	[p8l7t2059r552b2135],

1	The	DT	O	the	det	4	SENT_181	[p8l599t2059r732b2117],
2	three	CD	NUMBER	three	num	4	SENT_181	[p8l777t2059r958b2117],
3	TNF-or	NN	MISC	tnf-or	nn	4	SENT_181	[p8l1002t2062r1216b2117],
4	inhibitors	NNS	O	inhibitor	nsubjpass	6	SENT_181	[p8l1260t2059r1607b2117],
5	were	VBD	O	be	auxpass	6	SENT_181	[p8l1651t2076r1814b2117],
6	grouped	VBN	O	group	_	0	SENT_181	[p8l1861t2059r2152b2135],
7	together	RB	O	together	advmod	6	SENT_181	[p8l7t2155r306b2231],
8	for	IN	O	for	_	0	SENT_181	[p8l361t2155r459b2213],
9	analysis	NN	O	analysis	nn	10	SENT_181	[p8l516t2155r792b2231],
10	purposes	NNS	O	purpose	prep_for	6	SENT_181	[p8l848t2172r1179b2231],
11	.	.	O	.	_	0	SENT_181	[p8l848t2172r1179b2231],

1	Six	CD	NUMBER	six	nsubj	6	SENT_182	[p8l1240t2157r1343b2213],
2	of	IN	O	of	_	0	SENT_182	[p8l1399t2155r1471b2213],
3	the	DT	O	the	det	5	SENT_182	[p8l1522t2155r1635b2213],
4	nine	CD	NUMBER	nine	num	5	SENT_182	[p8l1693t2158r1851b2213],
5	studies	NNS	O	study	prep_of	1	SENT_182	[p8l1910t2155r2150b2213],
6	quantified	VBD	O	quantify	dep	39	SENT_182	[p8l8t2249r374b2325],
7	the	DT	O	the	det	8	SENT_182	[p8l407t2250r520b2307],
8	decrease	NN	O	decrease	dobj	6	SENT_182	[p8l555t2249r848b2307],
9	in	IN	O	in	_	0	SENT_182	[p8l882t2252r952b2306],
10	DAS28	NN	O	das28	nn	11	SENT_182	[p8l986t2251r1219b2307],
11	score	NN	NUMBER	score	prep_in	8	SENT_182	[p8l1255t2266r1450b2320],
12	,	,	O	,	_	0	SENT_182	[p8l1255t2266r1450b2320],
13	which	WDT	O	which	nsubj	14	SENT_182	[p8l1486t2249r1707b2307],
14	represented	VBD	O	represent	rcmod	11	SENT_182	[p8l1740t2249r2152b2325],
15	124/179	CD	PERCENT	124/179	number	16	SENT_182	[p8l13t2344r294b2410],
16	(	CD	PERCENT	(	nsubj	18	SENT_182	[p8l340t2345r540b2417],
17	69	CD	PERCENT	69	num	18	SENT_182	[p8l340t2345r540b2417],
18	%	NN	PERCENT	%	ccomp	14	SENT_182	[p8l340t2345r540b2417],
19	)	CD	NUMBER	)	dobj	18	SENT_182	[p8l340t2345r540b2417],
20	of	IN	O	of	_	0	SENT_182	[p8l584t2344r656b2402],
21	the	DT	O	the	det	24	SENT_182	[p8l691t2345r803b2402],
22	A	NN	O	a	nn	24	SENT_182	[p8l843t2346r894b2402],
23	allele	NN	O	allele	nn	24	SENT_182	[p8l933t2345r1115b2402],
24	carriers	NNS	O	carrier	prep_of	19	SENT_182	[p8l1156t2348r1410b2402],
25	in	IN	O	in	_	0	SENT_182	[p8l1450t2348r1520b2402],
26	RA	NN	O	ra	nn	27	SENT_182	[p8l1561t2346r1658b2402],
27	patients	NNS	O	patient	prep_in	18	SENT_182	[p8l1697t2348r1980b2420],
28	and	CC	O	and	_	0	SENT_182	[p8l2020t2345r2151b2402],
29	483/692	CD	PERCENT	483/692	number	30	SENT_182	[p8l8t2440r296b2505],
30	(	CD	PERCENT	(	prep_in	18	SENT_182	[p8l335t2440r536b2512],
31	70	CD	PERCENT	70	num	32	SENT_182	[p8l335t2440r536b2512],
32	%	NN	PERCENT	%	dep	30	SENT_182	[p8l335t2440r536b2512],
33	)	CD	NUMBER	)	nsubj	39	SENT_182	[p8l335t2440r536b2512],
34	of	IN	O	of	_	0	SENT_182	[p8l576t2440r648b2498],
35	the	DT	O	the	det	38	SENT_182	[p8l678t2440r791b2498],
36	total	JJ	O	total	amod	38	SENT_182	[p8l827t2440r990b2498],
37	RA	NN	O	ra	nn	38	SENT_182	[p8l1025t2442r1123b2497],
38	population	NN	O	population	prep_of	33	SENT_182	[p8l1157t2440r1551b2516],
39	included	VBD	O	include	_	0	SENT_182	[p8l1587t2440r1897b2498],
40	in	IN	O	in	_	0	SENT_182	[p8l1932t2443r2002b2497],
41	the	DT	O	the	det	42	SENT_182	[p8l2038t2440r2150b2498],
42	meta-analysis	NN	O	meta-analysis	prep_in	39	SENT_182	[p8l7t2535r507b2610],
43	.	.	O	.	_	0	SENT_182	[p8l7t2535r507b2610],

1	There	EX	O	there	expl	2	SENT_183	[p8l562t2535r763b2592],
2	was	VBD	O	be	_	0	SENT_183	[p8l815t2551r943b2592],
3	a	DT	O	a	det	5	SENT_183	[p8l997t2551r1032b2592],
4	significant	JJ	O	significant	amod	5	SENT_183	[p8l1086t2534r1458b2610],
5	difference	NN	O	difference	nn	26	SENT_183	[p8l1511t2534r1861b2592],
6	in	IN	O	in	_	0	SENT_183	[p8l1915t2538r1985b2592],
7	the	DT	O	the	det	8	SENT_183	[p8l2038t2535r2150b2592],
8	decrease	NN	O	decrease	prep_in	5	SENT_183	[p8l8t2629r301b2687],
9	in	IN	O	in	_	0	SENT_183	[p8l343t2632r413b2686],
10	DAS28	NN	O	das28	nn	13	SENT_183	[p8l454t2631r686b2687],
11	score	NN	NUMBER	score	nn	13	SENT_183	[p8l730t2646r905b2687],
12	(	NN	O	(	nn	13	SENT_183	[p8l950t2629r1395b2701],
13	difference	NN	O	difference	prep_in	8	SENT_183	[p8l950t2629r1395b2701],
14	:	:	O	:	_	0	SENT_183	[p8l950t2629r1395b2701],
15	1.09	CD	NUMBER	1.09	dep	5	SENT_183	[p8l1420t2631r1581b2700],
16	,	,	O	,	_	0	SENT_183	[p8l1420t2631r1581b2700],
17	95	CD	PERCENT	95	number	18	SENT_183	[p8l1627t2631r1780b2687],
18	%	NN	PERCENT	%	amod	19	SENT_183	[p8l1627t2631r1780b2687],
19	CI	NN	O	ci	appos	15	SENT_183	[p8l1822t2631r1919b2687],
20	:	:	O	:	_	0	SENT_183	[p8l1822t2631r1919b2687],
21	0.321.85	CD	NUMBER	0.321.85	dep	5	SENT_183	[p8l1963t2631r2153b2687, p8l13t2727r175b2796],
22	,	,	O	,	_	0	SENT_183	[p8l1963t2631r2153b2687, p8l13t2727r175b2796],
23	P	NN	O	p	appos	21	SENT_183	[p8l221t2725r658b2797],
24	=	JJ	O	=	amod	26	SENT_183	[p8l221t2725r658b2797],
25	0.00527	CD	NUMBER	0.00527	tmod	24	SENT_183	[p8l221t2725r658b2797],
26	)	NN	O	)	nsubj	2	SENT_183	[p8l221t2725r658b2797],
27	for	IN	O	for	_	0	SENT_183	[p8l706t2725r804b2783],
28	the	DT	O	the	det	32	SENT_183	[p8l847t2725r960b2783],
29	A	NN	O	a	nn	32	SENT_183	[p8l1004t2727r1055b2782],
30	allele	NN	O	allele	nn	32	SENT_183	[p8l1098t2725r1280b2783],
31	carrier	NN	O	carrier	nn	32	SENT_183	[p8l1326t2728r1550b2783],
32	state	NN	O	state	prep_for	2	SENT_183	[p8l1595t2732r1755b2783],
33	compared	VBN	O	compare	_	0	SENT_183	[p8l1801t2725r2152b2801],
34	with	IN	O	with	prepc_compared_with	32	SENT_183	[p8l6t2820r167b2878],
35	the	DT	O	the	det	41	SENT_183	[p8l204t2820r317b2878],
36	G/G	NN	O	g/g	nn	41	SENT_183	[p8l356t2820r502b2885],
37	genotype	NN	O	genotype	nn	41	SENT_183	[p8l540t2827r866b2896],
38	(	CD	NUMBER	(	num	41	SENT_183	[p8l907t2820r1147b2896],
39	Figure	NNP	O	Figure	dep	40	SENT_183	[p8l907t2820r1147b2896],
40	3	CD	NUMBER	3	amod	41	SENT_183	[p8l1187t2820r1270b2892],
41	)	NN	O	)	pobj	32	SENT_183	[p8l1187t2820r1270b2892],
42	,	,	O	,	_	0	SENT_183	[p8l1187t2820r1270b2892],
43	using	VBG	O	use	partmod	41	SENT_183	[p8l1310t2823r1503b2896],
44	a	DT	O	a	det	47	SENT_183	[p8l1540t2837r1575b2878],
45	random	JJ	O	random	amod	47	SENT_183	[p8l1612t2820r1891b2878],
46	effects	NNS	O	effect	nn	47	SENT_183	[p8l1929t2820r2151b2878],
47	model	NN	O	model	dobj	43	SENT_183	[p8l7t2915r248b2973],
48	.	.	O	.	_	0	SENT_183	[p8l7t2915r248b2973],

1	In	IN	O	in	_	0	SENT_184	[p8l284t2918r357b2972],
2	this	DT	O	this	det	3	SENT_184	[p8l388t2915r518b2973],
3	meta-analysis	NN	O	meta-analysis	pobj	1	SENT_184	[p8l550t2915r1031b2991],
4	of	IN	O	of	_	0	SENT_184	[p8l1063t2915r1135b2973],
5	the	DT	O	the	det	7	SENT_184	[p8l1162t2915r1275b2973],
6	six	CD	NUMBER	six	num	7	SENT_184	[p8l1309t2918r1403b2973],
7	studies	NNS	O	study	prep_of	3	SENT_184	[p8l1435t2915r1675b2973],
8	with	IN	O	with	_	0	SENT_184	[p8l1705t2915r1867b2973],
9	change	NN	O	change	prep_with	7	SENT_184	[p8l1899t2915r2150b2991],

1	TNF-oz	JJ	O	tnf-oz	amod	4	SENT_185	[p8l1104t3073r1168b3094],
2	-308	CD	NUMBER	-308	tmod	1	SENT_185	[p8l1179t3072r1238b3094],
3	G/A	NN	O	g/a	nn	4	SENT_185	[p8l1247t3072r1294b3097],
4	variant	NN	O	variant	dep	14	SENT_185	[p8l1302t3072r1386b3094],
5	and	CC	O	and	_	0	SENT_185	[p8l1395t3072r1438b3094],
6	anti-TNF-or	JJ	O	anti-tnf-or	amod	7	SENT_185	[p8l1447t3072r1567b3094],
7	agents	NNS	O	agent	conj_and	4	SENT_185	[p8l1576t3074r1654b3101],
8	@	IN	O	@	_	0	SENT_185	[p8l2088t3066r2150b3127],
9	D	NN	O	d	nn	10	SENT_185	[p8l1105t3108r1120b3127],
10	D	NN	O	d	prep_@	4	SENT_185	[p8l1130t3108r1144b3127],
11	o’Rie	NN	O	o’rie	dep	14	SENT_185	[p8l1154t3107r1229b3134],
12	|	CD	NUMBER	|	num	11	SENT_185	[p8l1154t3107r1229b3134],
13	|	NN	O	|	nn	14	SENT_185	[p8l1154t3107r1229b3134],
14	y	NN	O	y	_	0	SENT_185	[p8l1154t3107r1229b3134],
15	et	FW	O	et	nn	16	SENT_185	[p8l1239t3109r1256b3128],
16	al	FW	O	al	dep	14	SENT_185	[p8l1264t3107r1282b3128],

1	Stmly	RB	O	stmly	advmod	2	SENT_186	[p9l478t46r548b74],
2	˧	NN	O	˧	_	0	SENT_186	[p9l1010t46r1084b68],
3	+	CC	O	+	_	0	SENT_186	[p9l1010t46r1084b68],
4	̧	NN	O	̧	conj_+	2	SENT_186	[p9l1090t46r1138b68],
5	+	CC	O	+	_	0	SENT_186	[p9l1090t46r1138b68],
6	Weight	NNP	O	Weight	nn	7	SENT_186	[p9l1358t46r1446b74],
7	8V	NN	O	8v	conj_+	2	SENT_186	[p9l1536t44r1608b66],
8	+	CC	O	+	_	0	SENT_186	[p9l1536t44r1608b66],
9	Size	NN	O	size	conj_+	2	SENT_186	[p9l1614t44r1662b66],
10	95	CD	PERCENT	95	num	13	SENT_186	[p9l1027t79r1084b101],
11	%	NN	PERCENT	%	nn	13	SENT_186	[p9l1027t79r1084b101],
12	C1	NN	PERCENT	c1	nn	13	SENT_186	[p9l1090t79r1122b101],
13	%	NN	PERCENT	%	dep	2	SENT_186	[p9l1388t79r1416b101],
14	95	CD	PERCENT	95	number	15	SENT_186	[p9l1552t77r1608b99],
15	%	NN	PERCENT	%	amod	16	SENT_186	[p9l1552t77r1608b99],
16	Ci	NN	O	ci	dep	13	SENT_186	[p9l1616t77r1646b99],

1	Muyjier	JJR	O	muyjier	_	0	SENT_187	[p9l413t141r511b169],
2	:1	NN	O	:1	dep	1	SENT_187	[p9l517t145r538b163],
3	.	.	O	.	_	0	SENT_187	[p9l517t145r538b163],

1	al.	FW	O	al.	_	0	SENT_188	[p9l545t141r578b167],
2	,	,	O	,	_	0	SENT_188	[p9l545t141r578b167],
3	2003	CD	DATE	2003	num	4	SENT_188	[p9l586t141r642b163],
4	1	CD	DATE	1	appos	1	SENT_188	[p9l413t187r506b207],
5	'	''	O	'	_	0	SENT_188	[p9l413t187r506b207],
6	-	:	O	-	_	0	SENT_188	[p9l413t187r506b207],
7	‘	NN	O	‘	dep	8	SENT_188	[p9l413t187r506b207],
8	unseen	JJ	O	unseen	dep	1	SENT_188	[p9l413t187r506b207],
9	at	IN	O	at	_	0	SENT_188	[p9l512t189r533b207],
10	al	NNP	O	al	prep_at	8	SENT_188	[p9l539t185r574b211],
11	_	NNP	O	_	dep	1	SENT_188	[p9l539t185r574b211],
12	,	,	O	,	_	0	SENT_188	[p9l539t185r574b211],
13	2005	CD	DATE	2005	num	16	SENT_188	[p9l581t187r636b207],
14	Cuchacuvich	NNP	O	Cuchacuvich	nn	16	SENT_188	[p9l415t227r564b249],
15	:1	CD	NUMBER	:1	num	16	SENT_188	[p9l570t231r590b249],
16	aL	NNP	O	aL	appos	11	SENT_188	[p9l597t227r632b253],
17	,	,	O	,	_	0	SENT_188	[p9l597t227r632b253],
18	2006	CD	DATE	2006	dep	1	SENT_188	[p9l639t229r696b249],

1	131.79	CD	NUMBER	131.79	number	2	SENT_189	[p9l1376t141r1436b163],
2	‘	CD	NUMBER	‘	num	4	SENT_189	[p9l1376t141r1436b163],
3	l.	NN	O	l.	nn	4	SENT_189	[p9l1518t141r1562b163],
4	IlJS	NN	O	ilj	nsubj	6	SENT_189	[p9l1518t141r1562b163],
5	l	NN	O	l	tmod	4	SENT_189	[p9l1584t141r1658b169],
6	=	JJ	O	=	_	0	SENT_189	[p9l1584t141r1658b169],
7	‘	CD	NUMBER	‘	num	8	SENT_189	[p9l1584t141r1658b169],
8	lJ	NN	O	lj	iobj	6	SENT_189	[p9l1584t141r1658b169],
9	.02	CD	NUMBER	.02	dobj	6	SENT_189	[p9l1584t141r1658b169],
10	.	.	O	.	_	0	SENT_189	[p9l1584t141r1658b169],

1	2.12	CD	NUMBER	2.12	num	2	SENT_190	[p9l1666t141r1724b169],
2	]	CD	NUMBER	]	_	0	SENT_190	[p9l1666t141r1724b169],
3	--	:	O	--	_	0	SENT_190	[p9l1202t183r1286b213],
4	13.19	CD	NUMBER	13.19	number	5	SENT_190	[p9l1376t189r1434b211],
5	2.52	CD	NUMBER	2.52	dep	2	SENT_190	[p9l1514t189r1562b211],
6	l2	NN	O	l2	dep	5	SENT_190	[p9l1584t189r1714b217],
7	,19.2	CD	NUMBER	,19.2	num	6	SENT_190	[p9l1584t189r1714b217],
8	.	.	O	.	_	0	SENT_190	[p9l1584t189r1714b217],

1	s5	NN	O	s5	_	0	SENT_191	[p9l1584t189r1714b217],
2	]	CD	NUMBER	]	number	3	SENT_191	[p9l1584t189r1714b217],
3	16.3	CD	NUMBER	16.3	num	1	SENT_191	[p9l1376t229r1434b249],
4	?	.	O	?	_	0	SENT_191	[p9l1376t229r1434b249],

1	0.10	CD	NUMBER	0.10	num	2	SENT_192	[p9l1514t229r1562b249],
2	l	NN	O	l	_	0	SENT_192	[p9l1584t227r1714b255],
3	|	CD	NUMBER	|	number	4	SENT_192	[p9l1584t227r1714b255],
4	[	CD	NUMBER	[	dep	2	SENT_192	[p9l1584t227r1714b255],
5	D.	NNP	O	D.	nn	6	SENT_192	[p9l1584t227r1714b255],
6	l	NN	O	l	dep	4	SENT_192	[p9l1584t227r1714b255],
7	]	CD	NUMBER	]	num	8	SENT_192	[p9l1584t227r1714b255],
8	2,1.3	CD	NUMBER	2,1.3	dep	2	SENT_192	[p9l1584t227r1714b255],
9	B	NN	O	b	prep	8	SENT_192	[p9l1584t227r1714b255],
10	]	CD	NUMBER	]	dep	9	SENT_192	[p9l1584t227r1714b255],
11	—	SYM	O	—	dep	8	SENT_192	[p9l1068t269r1142b299],
12	-	:	O	-	_	0	SENT_192	[p9l1068t269r1142b299],
13	13.32	CD	NUMBER	13.32	number	14	SENT_192	[p9l1376t273r1434b295],
14	1.34	CD	NUMBER	1.34	num	16	SENT_192	[p9l1520t273r1566b295],
15	»	NN	O	»	nn	16	SENT_192	[p9l1520t273r1566b295],
16	ll1	NN	O	ll1	dep	8	SENT_192	[p9l1584t273r1648b301],
17	.	.	O	.	_	0	SENT_192	[p9l1584t273r1648b301],

1	o4	NN	O	o4	_	0	SENT_193	[p9l1584t273r1648b301],
2	.	.	O	.	_	0	SENT_193	[p9l1584t273r1648b301],

1	1.63	CD	NUMBER	1.63	number	2	SENT_194	[p9l1660t273r1714b301],
2	]	CD	NUMBER	]	num	3	SENT_194	[p9l1660t273r1714b301],
3	115.41	CD	NUMBER	115.41	_	0	SENT_194	[p9l1376t313r1434b335],
4	0.54	CD	NUMBER	0.54	num	5	SENT_194	[p9l1516t313r1566b335],
5	lg-13	NN	O	lg-13	dep	3	SENT_194	[p9l1584t311r1658b341],
6	.13	CD	NUMBER	.13	dep	5	SENT_194	[p9l1584t311r1658b341],
7	.	.	O	.	_	0	SENT_194	[p9l1584t311r1658b341],

1	1.21	CD	NUMBER	1.21	_	0	SENT_195	[p9l1670t311r1724b341],
2	]	CD	NUMBER	]	number	3	SENT_195	[p9l1670t311r1724b341],
3	16.35	CD	NUMBER	16.35	dep	1	SENT_195	[p9l1376t357r1434b379],
4	0.22	CD	NUMBER	0.22	num	5	SENT_195	[p9l1514t359r1562b379],
5	ll	NN	O	ll	dep	3	SENT_195	[p9l1584t357r1724b385],
6	.	.	O	.	_	0	SENT_195	[p9l1584t357r1724b385],

1	—	NN	O	—	_	0	SENT_196	[p9l1584t357r1724b385],
2	.	.	O	.	_	0	SENT_196	[p9l1584t357r1724b385],

1	D.	NNP	O	D.	nn	2	SENT_197	[p9l1584t357r1724b385],
2	3B.	NNP	O	3B.	_	0	SENT_197	[p9l1584t357r1724b385],
3	,	,	O	,	_	0	SENT_197	[p9l1584t357r1724b385],
4	iJ	NNP	O	iJ	appos	2	SENT_197	[p9l1584t357r1724b385],
5	.	.	O	.	_	0	SENT_197	[p9l1584t357r1724b385],

1	S2	NN	O	s2	_	0	SENT_198	[p9l1584t357r1724b385],
2	]	CD	NUMBER	]	num	3	SENT_198	[p9l1584t357r1724b385],
3	l	NN	O	l	dep	1	SENT_198	[p9l1584t357r1724b385],

1	-	:	O	-	_	0	SENT_199	[p9l982t467r1168b531],
2	.	.	O	.	_	0	SENT_199	[p9l982t467r1168b531],

1	100.00	CD	NUMBER	100.00	num	2	SENT_200	[p9l1362t487r1436b509],
2	1.09	CD	NUMBER	1.09	_	0	SENT_200	[p9l1516t487r1562b509],
3	lmsz	NN	O	lmsz	dep	2	SENT_200	[p9l1584t487r1648b515],
4	.	.	O	.	_	0	SENT_200	[p9l1584t487r1648b515],

1	1.113	CD	NUMBER	1.113	num	2	SENT_201	[p9l1660t487r1714b515],
2	]	CD	NUMBER	]	_	0	SENT_201	[p9l1660t487r1714b515],

1	aI	NN	O	aus	nsubj	5	SENT_202	[p9l861t601r1332b617],
2	|	SYM	O	|	dep	5	SENT_202	[p9l861t601r1332b617],
3	.5	CD	NUMBER	.5	num	5	SENT_202	[p9l861t601r1332b617],
4	I.	NN	O	i.	nn	5	SENT_202	[p9l861t601r1332b617],
5	IIlI	NN	O	iili	_	0	SENT_202	[p9l861t601r1332b617],
6	.	.	O	.	_	0	SENT_202	[p9l861t601r1332b617],

1	lI	NN	O	li	_	0	SENT_203	[p9l861t601r1332b617],
2	.	.	O	.	_	0	SENT_203	[p9l861t601r1332b617],

1	I1	NN	O	i1	_	0	SENT_204	[p9l861t601r1332b617],
2	.	.	O	.	_	0	SENT_204	[p9l861t601r1332b617],

1	ﬁ2	NN	O	ﬁ2	_	0	SENT_205	[p9l861t601r1332b617],
2	.	.	O	.	_	0	SENT_205	[p9l861t601r1332b617],

1	II	NNP	O	II	_	0	SENT_206	[p9l861t601r1332b617],
2	‘	CD	NUMBER	‘	num	3	SENT_206	[p9l861t601r1332b617],
3	2.53.0	CD	NUMBER	2.53.0	dep	1	SENT_206	[p9l861t601r1332b617],

1	Sail	VB	O	sail	_	0	SENT_207	[p9l417t273r472b295],
2	:	:	O	:	_	0	SENT_207	[p9l417t273r472b295],
3	at	IN	O	at	advmod	4	SENT_207	[p9l479t277r500b293],
4	al.	FW	O	al.	dep	1	SENT_207	[p9l506t273r540b297],
5	.	.	O	.	_	0	SENT_207	[p9l506t273r540b297],

1	2007	CD	DATE	2007	number	2	SENT_208	[p9l548t273r604b295],
2	G	NN	O	g	_	0	SENT_208	[p9l415t313r469b335],
3	+	CC	O	+	cc	2	SENT_208	[p9l415t313r469b335],
4	at	IN	O	at	_	0	SENT_208	[p9l476t315r497b335],
5	31	CD	NUMBER	31	prep_at	2	SENT_208	[p9l503t313r538b337],
6	-	:	O	-	_	0	SENT_208	[p9l503t313r538b337],
7	.	.	O	.	_	0	SENT_208	[p9l503t313r538b337],

1	2007	CD	DATE	2007	num	2	SENT_209	[p9l545t313r601b335],
2	Mamu	NNP	O	Mamu	_	0	SENT_209	[p9l415t357r506b379],
3	:	:	O	:	_	0	SENT_209	[p9l415t357r506b379],
4	at	IN	O	at	advmod	5	SENT_209	[p9l512t361r534b379],
5	al.	FW	O	al.	dep	2	SENT_209	[p9l539t357r573b383],
6	,	,	O	,	_	0	SENT_209	[p9l539t357r573b383],
7	2003	CD	DATE	2003	appos	5	SENT_209	[p9l581t357r638b379],

1	Total	JJ	O	total	amod	2	SENT_210	[p9l415t487r472b509],
2	[	NN	O	[	_	0	SENT_210	[p9l481t487r542b515],
3	95	CD	PERCENT	95	num	4	SENT_210	[p9l481t487r542b515],
4	%	NN	PERCENT	%	dep	7	SENT_210	[p9l481t487r542b515],
5	Cl	NN	O	cl	dep	4	SENT_210	[p9l547t487r586b515],
6	]	CD	NUMBER	]	dep	7	SENT_210	[p9l547t487r586b515],
7	Difference	NN	O	difference	dep	2	SENT_210	[p9l415t523r536b545],
8	=	JJ	O	=	amod	9	SENT_210	[p9l542t531r559b537],
9	o	NN	O	o	dep	7	SENT_210	[p9l565t525r587b549],
10	;	:	O	;	_	0	SENT_210	[p9l565t525r587b549],
11	2.79	CD	NUMBER	2.79	number	12	SENT_210	[p9l595t525r644b545],
12	(	CD	NUMBER	(	num	13	SENT_210	[p9l651t525r792b551],
13	p	NN	O	p	dep	2	SENT_210	[p9l651t525r792b551],
14	=	JJ	O	=	amod	16	SENT_210	[p9l651t525r792b551],
15	n_oo527	NN	O	n_oo527	nn	16	SENT_210	[p9l651t525r792b551],
16	)	NN	O	)	dep	13	SENT_210	[p9l651t525r792b551],

1	Figure	NNP	O	Figure	_	0	SENT_211	[p9l10t652r104b685],
2	3	CD	NUMBER	3	num	4	SENT_211	[p9l115t652r131b677],
3	Forest	NN	O	forest	nn	4	SENT_211	[p9l167t653r252b677],
4	plot	NN	O	plot	dep	1	SENT_211	[p9l262t652r318b685],
5	of	IN	O	of	_	0	SENT_211	[p9l327t652r355b677],
6	a	DT	O	a	det	9	SENT_211	[p9l364t659r378b677],
7	random	JJ	O	random	amod	9	SENT_211	[p9l391t652r502b677],
8	effects	NNS	O	effect	nn	9	SENT_211	[p9l513t652r605b677],
9	meta-analysis	NN	O	meta-analysis	prep_of	4	SENT_211	[p9l616t652r809b685],
10	of	IN	O	of	_	0	SENT_211	[p9l819t652r847b677],
11	six	CD	NUMBER	six	num	12	SENT_211	[p9l856t652r892b677],
12	studies	NNS	O	study	prep_of	9	SENT_211	[p9l902t652r1001b677],
13	quantifying	VBG	O	quantify	partmod	1	SENT_211	[p9l1011t652r1175b685],
14	the	DT	O	the	det	15	SENT_211	[p9l1186t652r1232b677],
15	decrease	NN	O	decrease	dobj	13	SENT_211	[p9l1243t652r1368b677],
16	in	IN	O	in	_	0	SENT_211	[p9l1379t652r1402b677],
17	DAS28	NN	O	das28	nn	18	SENT_211	[p9l1415t652r1511b677],
18	score	NN	NUMBER	score	prep_in	15	SENT_211	[p9l1522t659r1596b677],
19	after	IN	O	after	_	0	SENT_211	[p9l1606t652r1672b677],
20	treatment	NN	O	treatment	prep_after	13	SENT_211	[p9l1680t655r1825b677],
21	with	IN	O	with	_	0	SENT_211	[p9l1833t652r1895b677],
22	TN	NN	MISC	tn	nn	24	SENT_211	[p9l1906t653r1947b677],
23	F-oc	NN	MISC	f-oc	nn	24	SENT_211	[p9l1953t653r1995b677],
24	inhibitors	NNS	O	inhibitor	prep_with	20	SENT_211	[p9l2005t652r2147b683],
25	,	,	O	,	_	0	SENT_211	[p9l2005t652r2147b683],
26	by	IN	O	by	_	0	SENT_211	[p9l10t693r44b726],
27	genotype	NN	O	genotype	agent	13	SENT_211	[p9l55t696r192b726],
28	at	IN	O	at	_	0	SENT_211	[p9l204t696r231b718],
29	the	DT	O	the	det	32	SENT_211	[p9l242t693r288b718],
30	TNF-or	NN	O	tnf-or	nn	32	SENT_211	[p9l299t694r387b718],
31	-308	CD	NUMBER	-308	num	32	SENT_211	[p9l400t694r479b718],
32	variant	NN	O	variant	prep_at	27	SENT_211	[p9l490t694r597b718],
33	.	.	O	.	_	0	SENT_211	[p9l490t694r597b718],

1	This	DT	O	this	det	2	SENT_212	[p9l609t693r667b718],
2	analysis	NN	O	analysis	nsubj	3	SENT_212	[p9l678t693r787b726],
3	showed	VBD	O	show	_	0	SENT_212	[p9l798t693r909b718],
4	significant	JJ	O	significant	amod	5	SENT_212	[p9l922t693r1069b726],
5	heterogeneity	NN	O	heterogeneity	dep	3	SENT_212	[p9l1081t693r1282b726],
6	(	CD	NUMBER	(	dep	5	SENT_212	[p9l1294t690r1327b725],
7	/	:	O	/	punct	5	SENT_212	[p9l1294t690r1327b725],
8	2	CD	NUMBER	2	dep	5	SENT_212	[p9l1294t690r1327b725],
9	:	:	O	:	_	0	SENT_212	[p9l1335t705r1357b714],
10	92.7	CD	PERCENT	92.7	num	11	SENT_212	[p9l1366t693r1480b725],
11	%	NN	PERCENT	%	dep	8	SENT_212	[p9l1366t693r1480b725],
12	)	CD	NUMBER	)	dep	11	SENT_212	[p9l1366t693r1480b725],
13	.	.	O	.	_	0	SENT_212	[p9l1366t693r1480b725],

1	The	DT	O	the	det	3	SENT_213	[p9l1493t693r1546b718],
2	vertical	JJ	O	vertical	amod	3	SENT_213	[p9l1557t693r1659b718],
3	line	NN	O	line	nsubj	4	SENT_213	[p9l1673t693r1722b718],
4	is	VBZ	O	be	_	0	SENT_213	[p9l1735t694r1753b718],
5	at	IN	O	at	_	0	SENT_213	[p9l1765t696r1792b718],
6	o	NN	O	o	prep_at	4	SENT_213	[p9l1803t694r1828b724],
7	,	,	O	,	_	0	SENT_213	[p9l1803t694r1828b724],
8	corresponding	VBG	O	correspond	partmod	6	SENT_213	[p9l1841t693r2050b726],
9	to	TO	O	to	_	0	SENT_213	[p9l2062t696r2091b718],
10	the	DT	O	the	det	12	SENT_213	[p9l2103t693r2149b718],
11	null	JJ	O	null	amod	12	SENT_213	[p9l10t734r60b759],
12	hypothesis	NN	O	hypothesis	prep_to	8	SENT_213	[p9l72t734r225b767],
13	of	IN	O	of	_	0	SENT_213	[p9l235t734r263b759],
14	no	DT	O	no	det	15	SENT_213	[p9l273t741r308b759],
15	difference	NN	O	difference	prep_of	12	SENT_213	[p9l319t734r461b759],
16	in	IN	O	in	_	0	SENT_213	[p9l472t735r495b759],
17	DAS28	NN	O	das28	nn	18	SENT_213	[p9l508t735r604b759],
18	decrease	NN	O	decrease	prep_in	15	SENT_213	[p9l615t734r740b759],
19	between	IN	O	between	_	0	SENT_213	[p9l751t734r874b759],
20	RA	NN	O	ra	nn	21	SENT_213	[p9l887t735r923b759],
21	patients	NNS	O	patient	prep_between	18	SENT_213	[p9l933t735r1046b767],
22	carrying	VBG	O	carry	xcomp	8	SENT_213	[p9l1056t735r1172b767],
23	the	DT	O	the	det	25	SENT_213	[p9l1183t734r1229b759],
24	A	NN	O	a	nn	25	SENT_213	[p9l1238t735r1258b759],
25	allele	NN	O	allele	dobj	22	SENT_213	[p9l1268t734r1340b759],
26	and	CC	O	and	_	0	SENT_213	[p9l1350t734r1403b759],
27	RA	NN	O	ra	nn	28	SENT_213	[p9l1415t735r1452b759],
28	patients	NNS	O	patient	conj_and	25	SENT_213	[p9l1462t735r1575b767],
29	with	IN	O	with	_	0	SENT_213	[p9l1584t734r1646b759],
30	the	DT	O	the	det	32	SENT_213	[p9l1657t734r1703b759],
31	G/G	NN	O	g/g	nn	32	SENT_213	[p9l1714t734r1772b763],
32	genotype	NN	O	genotype	prep_with	22	SENT_213	[p9l1784t737r1929b767],
33	.	.	O	.	_	0	SENT_213	[p9l1784t737r1929b767],

1	CI	NN	O	ci	_	0	SENT_214	[p9l1942t735r1978b765],
2	,	,	O	,	_	0	SENT_214	[p9l1942t735r1978b765],
3	confidence	NN	O	confidence	nn	4	SENT_214	[p9l1990t734r2149b759],
4	interval	NN	O	interval	appos	1	SENT_214	[p9l13t785r244b846],
5	;	:	O	;	_	0	SENT_214	[p9l13t785r244b846],
6	RA	NN	O	ra	dep	1	SENT_214	[p9l277t787r364b846],
7	,	,	O	,	_	0	SENT_214	[p9l277t787r364b846],
8	rheumatoid	JJ	O	rheumatoid	amod	9	SENT_214	[p9l397t785r738b835],
9	arthritis	NN	O	arthritis	appos	6	SENT_214	[p9l767t785r1005b846],
10	;	:	O	;	_	0	SENT_214	[p9l767t785r1005b846],
11	TNF-oc	NN	O	tnf-oc	dep	1	SENT_214	[p9l1032t787r1229b846],
12	,	,	O	,	_	0	SENT_214	[p9l1032t787r1229b846],
13	tumor	NN	O	tumor	nn	15	SENT_214	[p9l1259t790r1444b835],
14	necrosis	NN	O	necrosis	nn	15	SENT_214	[p9l1470t786r1701b835],
15	factor-oc	NN	O	factor-oc	appos	11	SENT_214	[p9l1725t785r1971b835],
16	.	.	O	.	_	0	SENT_214	[p9l1725t785r1971b835],

1	in	IN	O	in	_	0	SENT_215	[p9l11t1003r81b1057],
2	DAS28	NN	O	das28	nn	3	SENT_215	[p9l108t1001r341b1058],
3	scores	NNS	O	score	prep_in	6	SENT_215	[p9l371t1017r595b1070],
4	,	,	O	,	_	0	SENT_215	[p9l371t1017r595b1070],
5	there	EX	O	there	expl	6	SENT_215	[p9l627t1000r806b1058],
6	was	VBD	O	be	_	0	SENT_215	[p9l833t1017r961b1058],
7	significant	JJ	O	significant	acomp	6	SENT_215	[p9l990t1000r1360b1076],
8	heterogeneity	NN	O	heterogeneity	nsubj	12	SENT_215	[p9l1387t1000r1879b1076],
9	among	IN	O	among	_	0	SENT_215	[p9l1904t1017r2149b1076],
10	the	DT	O	the	det	11	SENT_215	[p9l10t1093r123b1150],
11	studies	NNS	O	study	prep_among	8	SENT_215	[p9l155t1093r395b1150],
12	(	VBP	O	(	ccomp	7	SENT_215	[p9l429t1085r509b1165],
13	I2	NN	O	i2	nsubj	14	SENT_215	[p9l429t1085r509b1165],
14	=	JJ	O	=	ccomp	12	SENT_215	[p9l526t1121r577b1139],
15	92.7	CD	PERCENT	92.7	num	16	SENT_215	[p9l597t1093r860b1164],
16	%	NN	PERCENT	%	iobj	14	SENT_215	[p9l597t1093r860b1164],
17	)	CD	NUMBER	)	dobj	14	SENT_215	[p9l597t1093r860b1164],
18	.	.	O	.	_	0	SENT_215	[p9l597t1093r860b1164],

1	Visual	JJ	MISC	visual	amod	2	SENT_216	[p9l893t1093r1109b1150],
2	inspection	NN	O	inspection	nsubj	19	SENT_216	[p9l1140t1095r1511b1168],
3	of	IN	O	of	_	0	SENT_216	[p9l1542t1092r1613b1150],
4	the	DT	O	the	det	6	SENT_216	[p9l1639t1093r1751b1150],
5	forest	NN	O	forest	nn	6	SENT_216	[p9l1782t1092r1977b1150],
6	plot	NN	O	plot	prep_of	2	SENT_216	[p9l2007t1092r2148b1168],
7	(	CD	NUMBER	(	num	10	SENT_216	[p9l14t1189r253b1265],
8	Figure	NNP	O	Figure	nn	10	SENT_216	[p9l14t1189r253b1265],
9	3	CD	NUMBER	3	num	10	SENT_216	[p9l292t1189r354b1261],
10	)	NN	O	)	nsubj	11	SENT_216	[p9l292t1189r354b1261],
11	revealed	VBD	O	reveal	rcmod	6	SENT_216	[p9l396t1189r688b1247],
12	that	IN	O	that	complm	15	SENT_216	[p9l725t1189r868b1247],
13	the	DT	O	the	det	14	SENT_216	[p9l905t1189r1018b1247],
14	difference	NN	O	difference	nsubj	15	SENT_216	[p9l1057t1189r1406b1247],
15	estimates	VBZ	O	estimate	ccomp	11	SENT_216	[p9l1445t1192r1771b1247],
16	from	IN	O	from	_	0	SENT_216	[p9l1810t1189r1979b1247],
17	two	CD	NUMBER	two	num	18	SENT_216	[p9l2017t1196r2147b1247],
18	studies	NNS	O	study	prep_from	15	SENT_216	[p9l12t1283r252b1341],
19	(	VBP	O	(	_	0	SENT_216	[p9l291t1283r531b1355],
20	11,14	CD	NUMBER	11,14	num	21	SENT_216	[p9l291t1283r531b1355],
21	)	CD	NUMBER	)	nsubj	22	SENT_216	[p9l291t1283r531b1355],
22	had	VBD	O	have	ccomp	19	SENT_216	[p9l570t1283r701b1341],
23	much	RB	O	much	advmod	24	SENT_216	[p9l735t1283r938b1341],
24	smaller	JJR	O	smaller	amod	26	SENT_216	[p9l975t1283r1228b1341],
25	standard	JJ	O	standard	amod	26	SENT_216	[p9l1264t1283r1568b1341],
26	errors	NNS	O	error	dobj	22	SENT_216	[p9l1603t1300r1800b1341],
27	than	IN	O	than	_	0	SENT_216	[p9l1836t1283r2000b1341],
28	the	DT	O	the	det	31	SENT_216	[p9l2034t1283r2147b1341],
29	other	JJ	O	other	amod	31	SENT_216	[p9l11t1378r200b1435],
30	four	CD	NUMBER	four	num	31	SENT_216	[p9l234t1377r380b1435],
31	studies	NNS	O	study	prep_than	22	SENT_216	[p9l416t1378r674b1435],
32	.	.	O	.	_	0	SENT_216	[p9l416t1378r674b1435],

1	We	PRP	O	we	nsubj	2	SENT_217	[p9l714t1380r823b1435],
2	contacted	VBD	O	contact	_	0	SENT_217	[p9l861t1378r1208b1435],
3	the	DT	O	the	det	4	SENT_217	[p9l1243t1378r1355b1435],
4	authors	NNS	O	author	dobj	2	SENT_217	[p9l1393t1378r1658b1435],
5	of	IN	O	of	_	0	SENT_217	[p9l1696t1377r1767b1435],
6	these	DT	O	these	det	8	SENT_217	[p9l1799t1378r1980b1435],
7	two	CD	NUMBER	two	num	8	SENT_217	[p9l2017t1385r2147b1435],
8	studies	NNS	O	study	prep_of	4	SENT_217	[p9l12t1473r270b1543],
9	,	,	O	,	_	0	SENT_217	[p9l12t1473r270b1543],
10	who	WP	O	who	nsubj	11	SENT_217	[p9l307t1473r460b1531],
11	reconfirmed	VBD	O	reconfirm	rcmod	8	SENT_217	[p9l496t1473r929b1531],
12	their	PRP$	O	they	poss	13	SENT_217	[p9l963t1473r1130b1531],
13	data	NNS	O	datum	dobj	11	SENT_217	[p9l1164t1473r1330b1531],
14	.	.	O	.	_	0	SENT_217	[p9l1164t1473r1330b1531],

1	Nevertheless	RB	O	nevertheless	advmod	30	SENT_218	[p9l1367t1473r1832b1543],
2	,	,	O	,	_	0	SENT_218	[p9l1367t1473r1832b1543],
3	analysis	NN	O	analysis	nsubj	30	SENT_218	[p9l1872t1473r2147b1549],
4	of	IN	O	of	_	0	SENT_218	[p9l11t1568r83b1626],
5	the	DT	O	the	det	8	SENT_218	[p9l139t1568r251b1626],
6	four	CD	NUMBER	four	num	8	SENT_218	[p9l312t1568r457b1626],
7	remaining	VBG	O	remain	amod	8	SENT_218	[p9l516t1571r882b1644],
8	studies	NNS	O	study	prep_of	3	SENT_218	[p9l943t1568r1183b1626],
9	(	CD	NUMBER	(	number	10	SENT_218	[p9l1247t1568r1663b1640],
10	8,13,15,16	CD	NUMBER	8,13,15,16	num	11	SENT_218	[p9l1247t1568r1663b1640],
11	)	NN	O	)	nsubj	12	SENT_218	[p9l1247t1568r1663b1640],
12	showed	VBD	O	show	rcmod	8	SENT_218	[p9l1730t1568r1996b1626],
13	no	DT	O	no	det	17	SENT_218	[p9l2056t1585r2147b1626],
14	significant	JJ	O	significant	amod	17	SENT_218	[p9l12t1661r383b1737],
15	heterogeneity	NN	O	heterogeneity	nn	17	SENT_218	[p9l424t1661r916b1737],
16	(	CD	NUMBER	(	num	17	SENT_218	[p9l959t1654r1279b1733],
17	I2	NN	O	i2	iobj	12	SENT_218	[p9l959t1654r1279b1733],
18	=	JJ	O	=	dep	21	SENT_218	[p9l959t1654r1279b1733],
19	0	CD	PERCENT	0	num	20	SENT_218	[p9l959t1654r1279b1733],
20	%	NN	PERCENT	%	dep	18	SENT_218	[p9l959t1654r1279b1733],
21	)	CD	NUMBER	)	dobj	12	SENT_218	[p9l959t1654r1279b1733],
22	,	,	O	,	_	0	SENT_218	[p9l959t1654r1279b1733],
23	and	CC	O	and	_	0	SENT_218	[p9l1327t1661r1458b1719],
24	the	DT	O	the	det	26	SENT_218	[p9l1500t1661r1612b1719],
25	overall	JJ	O	overall	amod	26	SENT_218	[p9l1656t1661r1893b1719],
26	difference	NN	O	difference	conj_and	21	SENT_218	[p9l1937t1661r2147b1719, p9l11t1774r170b1815],
27	in	IN	O	in	_	0	SENT_218	[p9l205t1760r276b1814],
28	DAS28	NN	O	das28	nn	29	SENT_218	[p9l311t1759r543b1815],
29	score	NN	NUMBER	score	prep_in	26	SENT_218	[p9l581t1774r756b1815],
30	decreased	VBD	O	decrease	_	0	SENT_218	[p9l793t1757r1150b1828],
31	,	,	O	,	_	0	SENT_218	[p9l793t1757r1150b1828],
32	but	CC	O	but	_	0	SENT_218	[p9l1188t1757r1307b1815],
33	remained	VBD	O	remain	cop	45	SENT_218	[p9l1341t1757r1675b1815],
34	significantly	RB	O	significantly	advmod	35	SENT_218	[p9l1711t1757r2150b1833],
35	different	JJ	O	different	amod	45	SENT_218	[p9l11t1850r314b1908],
36	from	IN	O	from	_	0	SENT_218	[p9l355t1850r524b1908],
37	zero	CD	NUMBER	zero	num	39	SENT_218	[p9l564t1867r708b1908],
38	(	NN	O	(	nn	39	SENT_218	[p9l753t1850r1383b1922],
39	difference	NN	O	difference	prep_from	35	SENT_218	[p9l753t1850r1383b1922],
40	=	JJ	O	=	amod	39	SENT_218	[p9l753t1850r1383b1922],
41	0.53	CD	NUMBER	0.53	tmod	40	SENT_218	[p9l753t1850r1383b1922],
42	,	,	O	,	_	0	SENT_218	[p9l753t1850r1383b1922],
43	95	CD	PERCENT	95	number	44	SENT_218	[p9l1429t1852r1580b1908],
44	%	NN	PERCENT	%	amod	45	SENT_218	[p9l1429t1852r1580b1908],
45	CI	NN	O	ci	conj_but	30	SENT_218	[p9l1623t1852r1719b1908],
46	:	:	O	:	_	0	SENT_218	[p9l1623t1852r1719b1908],
47	0.18	CD	NUMBER	0.18	attr	45	SENT_218	[p9l1763t1852r1930b1921],
48	,	,	O	,	_	0	SENT_218	[p9l1763t1852r1930b1921],
49	0.88	CD	NUMBER	0.88	appos	47	SENT_218	[p9l1976t1852r2143b1921],
50	,	,	O	,	_	0	SENT_218	[p9l1976t1852r2143b1921],
51	P	NN	O	p	appos	47	SENT_218	[p9l7t1947r421b2019],
52	=	JJ	O	=	amod	54	SENT_218	[p9l7t1947r421b2019],
53	0.0033	CD	NUMBER	0.0033	tmod	52	SENT_218	[p9l7t1947r421b2019],
54	)	NN	O	)	dep	51	SENT_218	[p9l7t1947r421b2019],
55	.	.	O	.	_	0	SENT_218	[p9l7t1947r421b2019],

1	Five	CD	NUMBER	five	nsubj	12	SENT_219	[p9l462t1950r601b2005],
2	of	IN	O	of	_	0	SENT_219	[p9l639t1947r710b2005],
3	the	DT	O	the	det	5	SENT_219	[p9l743t1947r855b2005],
4	six	CD	NUMBER	six	num	5	SENT_219	[p9l894t1950r988b2005],
5	studies	NNS	O	study	prep_of	1	SENT_219	[p9l1025t1947r1283b2017],
6	,	,	O	,	_	0	SENT_219	[p9l1025t1947r1283b2017],
7	which	WDT	O	which	nsubj	8	SENT_219	[p9l1322t1947r1542b2005],
8	reported	VBD	O	report	rcmod	5	SENT_219	[p9l1579t1947r1877b2023],
9	DAS28	NN	O	das28	nn	10	SENT_219	[p9l1914t1949r2146b2005],
10	score	NN	NUMBER	score	dobj	8	SENT_219	[p9l12t2058r187b2099],
11	also	RB	O	also	advmod	8	SENT_219	[p9l229t2042r363b2099],
12	used	VBD	O	use	_	0	SENT_219	[p9l403t2041r563b2099],
13	this	DT	O	this	dobj	12	SENT_219	[p9l602t2041r731b2099],
14	as	IN	O	as	_	0	SENT_219	[p9l773t2058r837b2099],
15	the	DT	O	the	det	16	SENT_219	[p9l878t2041r990b2099],
16	criterion	NN	O	criterion	prep_as	12	SENT_219	[p9l1032t2044r1334b2099],
17	to	TO	O	to	aux	18	SENT_219	[p9l1374t2049r1444b2099],
18	determine	VB	O	determine	xcomp	12	SENT_219	[p9l1485t2041r1844b2099],
19	responsiveness	NN	O	responsiveness	dobj	18	SENT_219	[p9l1886t2058r2147b2117, p9l12t2139r292b2193],
20	to	TO	O	to	_	0	SENT_219	[p9l317t2143r386b2193],
21	the	DT	O	the	det	23	SENT_219	[p9l411t2136r523b2193],
22	TNF-or	NN	O	tnf-or	nn	23	SENT_219	[p9l546t2138r760b2193],
23	inhibitor	NN	O	inhibitor	prep_to	18	SENT_219	[p9l783t2136r1112b2193],
24	.	.	O	.	_	0	SENT_219	[p9l783t2136r1112b2193],

1	The	DT	O	the	det	2	SENT_220	[p9l1139t2136r1271b2193],
2	OR	NN	O	or	nsubj	11	SENT_220	[p9l1297t2138r1404b2193],
3	for	IN	O	for	_	0	SENT_220	[p9l1427t2136r1525b2193],
4	these	DT	O	these	det	5	SENT_220	[p9l1548t2136r1730b2193],
5	studies	NNS	O	study	prep_for	2	SENT_220	[p9l1756t2136r1996b2193],
6	was	VBD	O	be	cop	11	SENT_220	[p9l2019t2153r2147b2193],
7	0.23	CD	PERCENT	0.23	num	11	SENT_220	[p9l11t2232r157b2288],
8	(	CD	PERCENT	(	number	9	SENT_220	[p9l193t2230r369b2302],
9	95	CD	PERCENT	95	dep	10	SENT_220	[p9l193t2230r369b2302],
10	%	NN	PERCENT	%	dep	11	SENT_220	[p9l193t2230r369b2302],
11	CI	NN	O	ci	_	0	SENT_220	[p9l400t2232r497b2288],
12	:	:	O	:	_	0	SENT_220	[p9l400t2232r497b2288],
13	0.12-0	CD	NUMBER	0.12-0	num	15	SENT_220	[p9l531t2230r917b2302],
14	.44	CD	NUMBER	.44	num	15	SENT_220	[p9l531t2230r917b2302],
15	)	NN	O	)	dep	11	SENT_220	[p9l531t2230r917b2302],
16	.	.	O	.	_	0	SENT_220	[p9l531t2230r917b2302],

1	Discussion	NN	O	discussion	_	0	SENT_221	[p9l13t2456r405b2513],

1	TNF-oc	NN	O	tnf-oc	nn	2	SENT_222	[p9l9t2648r222b2702],
2	inhibitors	NNS	O	inhibitor	nsubj	4	SENT_222	[p9l257t2645r604b2702],
3	have	VBP	O	have	aux	4	SENT_222	[p9l640t2645r804b2702],
4	revolutionized	VBN	O	revolutionize	_	0	SENT_222	[p9l841t2645r1356b2702],
5	the	DT	O	the	det	6	SENT_222	[p9l1391t2645r1503b2702],
6	treatment	NN	O	treatment	dobj	4	SENT_222	[p9l1540t2652r1890b2702],
7	of	IN	O	of	_	0	SENT_222	[p9l1926t2645r1997b2702],
8	RA	NN	O	ra	prep_of	6	SENT_222	[p9l2029t2647r2144b2702],
9	.	.	O	.	_	0	SENT_222	[p9l2029t2647r2144b2702],

1	Although	IN	O	although	mark	5	SENT_223	[p9l9t2740r346b2816],
2	they	PRP	O	they	nsubj	5	SENT_223	[p9l388t2740r546b2816],
3	have	VBP	O	have	aux	5	SENT_223	[p9l586t2740r751b2798],
4	convincingly	RB	O	convincingly	advmod	5	SENT_223	[p9l795t2740r1261b2816],
5	proven	VBN	O	prove	advcl	19	SENT_223	[p9l1301t2757r1549b2816],
6	to	TO	O	to	aux	9	SENT_223	[p9l1592t2747r1661b2798],
7	be	VB	O	be	cop	9	SENT_223	[p9l1702t2740r1782b2798],
8	clinically	RB	O	clinically	advmod	9	SENT_223	[p9l1826t2740r2150b2816],
9	efficacious	JJ	O	efficacious	xcomp	5	SENT_223	[p9l11t2835r382b2893],
10	in	IN	O	in	_	0	SENT_223	[p9l413t2838r484b2892],
11	the	DT	O	the	det	12	SENT_223	[p9l514t2835r626b2893],
12	treatment	NN	O	treatment	prep_in	9	SENT_223	[p9l658t2842r1008b2893],
13	of	IN	O	of	_	0	SENT_223	[p9l1039t2835r1110b2893],
14	RA	NN	O	ra	prep_of	12	SENT_223	[p9l1138t2837r1252b2906],
15	,	,	O	,	_	0	SENT_223	[p9l1138t2837r1252b2906],
16	not	RB	O	not	neg	18	SENT_223	[p9l1287t2842r1408b2893],
17	all	DT	O	all	det	18	SENT_223	[p9l1439t2835r1521b2893],
18	patients	NNS	O	patient	nsubj	19	SENT_223	[p9l1551t2838r1833b2911],
19	respond	VBP	O	respond	_	0	SENT_223	[p9l1865t2835r2148b2911],
20	to	TO	O	to	_	0	SENT_223	[p9l10t2937r80b2987],
21	these	DT	O	these	det	22	SENT_223	[p9l125t2929r306b2987],
22	agents	NNS	O	agent	prep_to	19	SENT_223	[p9l352t2937r594b3005],
23	.	.	O	.	_	0	SENT_223	[p9l352t2937r594b3005],

1	This	DT	O	this	det	2	SENT_224	[p9l640t2929r789b2987],
2	meta-analysis	NN	O	meta-analysis	nsubj	3	SENT_224	[p9l834t2930r1313b3005],
3	shows	VBZ	O	show	_	0	SENT_224	[p9l1360t2929r1572b2987],
4	that	IN	O	that	_	0	SENT_224	[p9l1617t2929r1760b2987],
5	the	DT	O	the	det	6	SENT_224	[p9l1803t2929r1916b2987],
6	probability	NN	O	probability	prep_that	3	SENT_224	[p9l1960t2929r2147b3005, p9l11t3025r235b3101],
7	of	IN	O	of	_	0	SENT_224	[p9l282t3025r353b3083],
8	successful	JJ	O	successful	amod	9	SENT_224	[p9l399t3025r743b3083],
9	treatment	NN	O	treatment	prep_of	6	SENT_224	[p9l791t3032r1141b3083],
10	with	IN	O	with	_	0	SENT_224	[p9l1188t3025r1349b3083],
11	anti	JJ	O	anti	prep_with	3	SENT_224	[p9l1398t3027r1776b3083],
12	.	.	O	.	_	0	SENT_224	[p9l1398t3027r1776b3083],

1	—	NN	O	—	_	0	SENT_225	[p9l1398t3027r1776b3083],
2	.	.	O	.	_	0	SENT_225	[p9l1398t3027r1776b3083],

1	TNF	NN	O	tnf	_	0	SENT_226	[p9l1398t3027r1776b3083],
2	.	.	O	.	_	0	SENT_226	[p9l1398t3027r1776b3083],

1	—	NN	O	—	_	0	SENT_227	[p9l1398t3027r1776b3083],
2	.	.	O	.	_	0	SENT_227	[p9l1398t3027r1776b3083],

1	oc	NN	O	oc	nn	2	SENT_228	[p9l1398t3027r1776b3083],
2	agents	NNS	O	agent	nsubjpass	4	SENT_228	[p9l1825t3032r2048b3101],
3	is	VBZ	O	be	auxpass	4	SENT_228	[p9l2097t3028r2147b3083],
4	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_228	[p9l11t3119r405b3190],
5	,	,	O	,	_	0	SENT_228	[p9l11t3119r405b3190],
6	at	IN	O	at	advmod	4	SENT_228	[p9l435t3127r498b3177],
7	least	JJS	O	least	pobj	6	SENT_228	[p9l522t3119r679b3177],
8	in	IN	O	in	_	0	SENT_228	[p9l703t3122r773b3176],
9	part	NN	O	part	prep_in	6	SENT_228	[p9l796t3127r953b3195],
10	,	,	O	,	_	0	SENT_228	[p9l796t3127r953b3195],
11	by	IN	O	by	_	0	SENT_228	[p9l980t3119r1067b3195],
12	the	DT	O	the	det	14	SENT_228	[p9l1088t3120r1200b3177],
13	-308	CD	NUMBER	-308	num	14	SENT_228	[p9l1230t3121r1410b3177],
14	variant	NN	O	variant	agent	4	SENT_228	[p9l1434t3122r1685b3177],
15	of	IN	O	of	_	0	SENT_228	[p9l1709t3119r1781b3177],
16	the	DT	O	the	det	18	SENT_228	[p9l1800t3119r1912b3177],
17	TNF-oc	NN	O	tnf-oc	nn	18	SENT_228	[p9l1935t3122r2149b3177],
18	gene	NN	O	gene	prep_of	14	SENT_228	[p9l11t3231r174b3290],
19	possessed	VBN	O	possess	partmod	18	SENT_228	[p9l228t3215r563b3290],
20	by	IN	O	by	_	0	SENT_228	[p9l615t3214r702b3290],
21	the	DT	O	the	det	23	SENT_228	[p9l753t3214r866b3272],
22	RA	NN	O	ra	nn	23	SENT_228	[p9l921t3216r1019b3271],
23	patient	NN	O	patient	agent	19	SENT_228	[p9l1071t3217r1340b3290],
24	.	.	O	.	_	0	SENT_228	[p9l1071t3217r1340b3290],

1	Specifically	RB	O	specifically	advmod	13	SENT_229	[p9l1399t3214r1807b3290],
2	,	,	O	,	_	0	SENT_229	[p9l1399t3214r1807b3290],
3	patients	NNS	O	patient	nsubj	13	SENT_229	[p9l1865t3217r2147b3290],
4	carrying	VBG	O	carry	partmod	3	SENT_229	[p9l11t3313r302b3386],
5	the	DT	O	the	det	7	SENT_229	[p9l331t3310r444b3368],
6	G/G	NN	O	g/g	nn	7	SENT_229	[p9l478t3310r623b3375],
7	genotype	NN	O	genotype	dobj	4	SENT_229	[p9l655t3317r980b3386],
8	of	IN	O	of	_	0	SENT_229	[p9l1014t3310r1085b3368],
9	-308	CD	NUMBER	-308	num	10	SENT_229	[p9l1116t3312r1297b3368],
10	variant	NN	O	variant	prep_of	7	SENT_229	[p9l1328t3313r1578b3368],
11	are	VBP	O	be	cop	13	SENT_229	[p9l1611t3327r1712b3368],
12	more	RBR	O	more	advmod	13	SENT_229	[p9l1744t3327r1924b3368],
13	likely	JJ	O	likely	_	0	SENT_229	[p9l1957t3310r2150b3386],
14	to	TO	O	to	aux	15	SENT_229	[p9l10t3412r80b3462],
15	respond	VB	O	respond	xcomp	13	SENT_229	[p9l136t3405r419b3480],
16	to	TO	O	to	_	0	SENT_229	[p9l473t3412r542b3462],
17	anti-TNF-oc	JJ	O	anti-tnf-oc	amod	18	SENT_229	[p9l598t3407r977b3462],
18	agents	NNS	O	agent	prep_to	15	SENT_229	[p9l1032t3412r1255b3480],
19	as	IN	O	as	prep	15	SENT_229	[p9l1311t3421r1376b3462],
20	compared	VBN	O	compare	_	0	SENT_229	[p9l1432t3405r1782b3480],
21	with	IN	O	with	prepc_compared_with	15	SENT_229	[p9l1835t3405r1996b3462],
22	RA	NN	O	ra	nn	23	SENT_229	[p9l2051t3406r2149b3462],
23	patients	NNS	O	patient	pobj	15	SENT_229	[p9l10t3503r292b3575],
24	that	WDT	O	that	nsubj	26	SENT_229	[p9l325t3500r469b3557],
25	are	VBP	O	be	cop	26	SENT_229	[p9l501t3516r602b3557],
26	carriers	NNS	O	carrier	rcmod	23	SENT_229	[p9l637t3503r889b3557],
27	of	IN	O	of	_	0	SENT_229	[p9l924t3499r995b3557],
28	at	IN	O	at	quantmod	30	SENT_229	[p9l1024t3507r1088b3557],
29	least	JJS	O	least	mwe	28	SENT_229	[p9l1120t3500r1277b3557],
30	one	CD	NUMBER	one	num	32	SENT_229	[p9l1310t3516r1439b3557],
31	A	DT	O	a	det	32	SENT_229	[p9l1472t3501r1522b3557],
32	allele	NN	O	allele	prep_of	26	SENT_229	[p9l1555t3500r1755b3557],
33	.	.	O	.	_	0	SENT_229	[p9l1555t3500r1755b3557],

1	The	DT	O	the	det	2	SENT_230	[p9l1790t3500r1923b3557],
2	effect	NN	O	effect	nsubj	5	SENT_230	[p9l1957t3499r2148b3557],
3	shown	VBN	O	show	partmod	2	SENT_230	[p9l12t3595r244b3653],
4	here	RB	O	here	advmod	3	SENT_230	[p9l277t3595r429b3653],
5	seems	VBZ	O	seem	_	0	SENT_230	[p9l464t3612r669b3653],
6	to	TO	O	to	aux	9	SENT_230	[p9l703t3602r773b3653],
7	be	VB	O	be	cop	9	SENT_230	[p9l805t3595r885b3653],
8	present	JJ	DATE	present	amod	9	SENT_230	[p9l919t3602r1178b3671],
9	irrespective	JJ	O	irrespective	xcomp	5	SENT_230	[p9l1210t3598r1613b3671],
10	of	IN	O	of	_	0	SENT_230	[p9l1648t3595r1719b3653],
11	the	DT	O	the	det	12	SENT_230	[p9l1748t3595r1860b3653],
12	type	NN	O	type	prep_of	9	SENT_230	[p9l1895t3602r2046b3671],
13	of	IN	O	of	_	0	SENT_230	[p9l2080t3595r2152b3653],
14	anti	JJ	O	anti	prep_of	12	SENT_230	[p9l11t3692r390b3748],
15	.	.	O	.	_	0	SENT_230	[p9l11t3692r390b3748],

1	—	NN	O	—	_	0	SENT_231	[p9l11t3692r390b3748],
2	.	.	O	.	_	0	SENT_231	[p9l11t3692r390b3748],

1	TNF	NN	O	tnf	_	0	SENT_232	[p9l11t3692r390b3748],
2	.	.	O	.	_	0	SENT_232	[p9l11t3692r390b3748],

1	—	NN	O	—	_	0	SENT_233	[p9l11t3692r390b3748],
2	.	.	O	.	_	0	SENT_233	[p9l11t3692r390b3748],

1	oc	NN	O	oc	nn	3	SENT_234	[p9l11t3692r390b3748],
2	inhibitor	NN	O	inhibitor	nn	3	SENT_234	[p9l421t3690r739b3748],
3	(	NN	O	(	_	0	SENT_234	[p9l775t3690r941b3762],
4	that	WDT	O	that	nsubj	10	SENT_234	[p9l775t3690r941b3762],
5	is	VBZ	O	be	cop	8	SENT_234	[p9l974t3693r1042b3760],
6	,	,	O	,	_	0	SENT_234	[p9l974t3693r1042b3760],
7	receptor	NN	O	receptor	nn	8	SENT_234	[p9l1080t3697r1370b3766],
8	antagonist	NN	O	antagonist	rcmod	3	SENT_234	[p9l1403t3693r1776b3766],
9	or	CC	O	or	_	0	SENT_234	[p9l1809t3707r1881b3748],
10	monoclonal	JJ	O	monoclonal	rcmod	3	SENT_234	[p9l1912t3707r2147b3748, p10l11t16r226b74],

1	antibody	NN	O	antibody	_	0	SENT_235	[p10l257t16r617b92],
2	)	NN	O	)	dep	1	SENT_235	[p10l257t16r617b92],
3	.	.	O	.	_	0	SENT_235	[p10l257t16r617b92],

1	The	DT	O	the	det	2	SENT_236	[p10l85t110r217b168],
2	prevalence	NN	O	prevalence	nsubj	13	SENT_236	[p10l248t110r626b186],
3	of	IN	O	of	_	0	SENT_236	[p10l658t110r730b168],
4	the	DT	O	the	det	6	SENT_236	[p10l755t110r868b168],
5	carrier	NN	O	carrier	nn	6	SENT_236	[p10l899t113r1123b168],
6	status	NN	O	status	prep_of	2	SENT_236	[p10l1154t118r1353b168],
7	for	IN	O	for	_	0	SENT_236	[p10l1384t110r1482b168],
8	the	DT	O	the	det	10	SENT_236	[p10l1511t110r1623b168],
9	A	NN	O	a	nn	10	SENT_236	[p10l1653t112r1704b167],
10	allele	NN	O	allele	prep_for	6	SENT_236	[p10l1733t110r1915b168],
11	is	VBZ	O	be	cop	13	SENT_236	[p10l1946t113r1996b168],
12	not	RB	O	not	neg	13	SENT_236	[p10l2027t118r2148b168],
13	infrequent	JJ	O	infrequent	_	0	SENT_236	[p10l11t206r403b282],
14	.	.	O	.	_	0	SENT_236	[p10l11t206r403b282],

1	For	IN	O	for	_	0	SENT_237	[p10l435t208r546b264],
2	the	DT	O	the	det	4	SENT_237	[p10l572t206r684b264],
3	Caucasian	JJ	LOCATION	caucasian	amod	4	SENT_237	[p10l714t207r1071b264],
4	population	NN	O	population	prep_for	36	SENT_237	[p10l1098t206r1508b282],
5	,	,	O	,	_	0	SENT_237	[p10l1098t206r1508b282],
6	among	IN	O	among	_	0	SENT_237	[p10l1541t223r1786b282],
7	the	DT	O	the	det	9	SENT_237	[p10l1811t206r1924b264],
8	seven	CD	NUMBER	seven	num	9	SENT_237	[p10l1953t223r2148b264],
9	studies	NNS	O	study	prep_among	36	SENT_237	[p10l12t300r252b358],
10	in	IN	O	in	_	0	SENT_237	[p10l281t303r351b357],
11	which	WDT	O	which	rel	15	SENT_237	[p10l378t300r598b358],
12	participants	NNS	O	participant	nsubjpass	15	SENT_237	[p10l625t303r1045b376],
13	were	VBD	O	be	auxpass	15	SENT_237	[p10l1072t317r1236b358],
14	not	RB	O	not	neg	15	SENT_237	[p10l1265t308r1386b358],
15	selected	VBN	O	select	rcmod	9	SENT_237	[p10l1416t300r1693b358],
16	on	IN	O	on	_	0	SENT_237	[p10l1721t317r1812b358],
17	the	DT	O	the	det	18	SENT_237	[p10l1840t300r1952b358],
18	basis	NN	O	basis	prep_on	15	SENT_237	[p10l1980t300r2147b358],
19	of	IN	O	of	_	0	SENT_237	[p10l11t393r83b451],
20	genotype	NN	O	genotype	prep_of	18	SENT_237	[p10l117t401r443b469],
21	at	IN	O	at	_	0	SENT_237	[p10l483t401r546b451],
22	the	DT	O	the	det	24	SENT_237	[p10l584t394r697b451],
23	-308	CD	NUMBER	-308	num	24	SENT_237	[p10l741t395r921b451],
24	variant	NN	O	variant	prep_at	15	SENT_237	[p10l960t396r1228b464],
25	,	,	O	,	_	0	SENT_237	[p10l960t396r1228b464],
26	2115	CD	DATE	2115	number	28	SENT_237	[p10l1272t387r1418b450],
27	to	TO	O	to	dep	28	SENT_237	[p10l1459t401r1528b451],
28	37	CD	PERCENT	37	num	29	SENT_237	[p10l1569t387r1752b451],
29	%	NN	PERCENT	%	nsubj	36	SENT_237	[p10l1569t387r1752b451],
30	9	CD	NUMBER	9	amod	29	SENT_237	[p10l1569t387r1752b451],
31	of	IN	O	of	_	0	SENT_237	[p10l1793t393r1865b451],
32	the	DT	O	the	det	34	SENT_237	[p10l1899t394r2011b451],
33	RA	NN	O	ra	nn	34	SENT_237	[p10l2051t395r2149b451],
34	patients	NNS	O	patient	prep_of	29	SENT_237	[p10l10t493r292b566],
35	were	VBD	O	be	cop	36	SENT_237	[p10l320t507r483b548],
36	carriers	NNS	O	carrier	_	0	SENT_237	[p10l514t493r767b548],
37	of	IN	O	of	_	0	SENT_237	[p10l797t490r869b548],
38	at	IN	O	at	quantmod	40	SENT_237	[p10l894t497r958b548],
39	least	JJS	O	least	mwe	38	SENT_237	[p10l987t490r1144b548],
40	one	CD	NUMBER	one	num	42	SENT_237	[p10l1174t507r1302b548],
41	A	DT	O	a	det	42	SENT_237	[p10l1331t492r1382b547],
42	allele	NN	O	allele	prep_of	36	SENT_237	[p10l1411t490r1611b548],
43	.	.	O	.	_	0	SENT_237	[p10l1411t490r1611b548],

1	Therefore	RB	O	therefore	advmod	11	SENT_238	[p10l1642t490r2000b560],
2	,	,	O	,	_	0	SENT_238	[p10l1642t490r2000b560],
3	the	DT	O	the	det	5	SENT_238	[p10l2034t490r2147b548],
4	clinical	JJ	O	clinical	amod	5	SENT_238	[p10l11t585r266b642],
5	impact	NN	O	impact	nsubj	11	SENT_238	[p10l289t588r534b660],
6	of	IN	O	of	_	0	SENT_238	[p10l557t584r629b642],
7	prospective	JJ	O	prospective	amod	8	SENT_238	[p10l646t588r1049b660],
8	genotyping	NN	O	genotyping	prep_of	5	SENT_238	[p10l1073t588r1478b660],
9	may	MD	O	may	aux	11	SENT_238	[p10l1501t601r1653b660],
10	be	VB	O	be	cop	11	SENT_238	[p10l1671t585r1751b642],
11	significant	JJ	O	significant	_	0	SENT_238	[p10l1777t584r2148b660],
12	in	IN	O	in	_	0	SENT_238	[p10l11t683r81b737],
13	the	DT	O	the	det	16	SENT_238	[p10l127t680r239b737],
14	Caucasian	JJ	O	caucasian	amod	16	SENT_238	[p10l288t681r646b737],
15	RA	NN	O	ra	nn	16	SENT_238	[p10l693t681r790b737],
16	patients	NNS	O	patient	prep_in	11	SENT_238	[p10l835t683r1136b755],
17	.	.	O	.	_	0	SENT_238	[p10l835t683r1136b755],

1	However	RB	O	however	advmod	8	SENT_239	[p10l1187t682r1512b750],
2	,	,	O	,	_	0	SENT_239	[p10l1187t682r1512b750],
3	there	EX	O	there	expl	8	SENT_239	[p10l1563t680r1743b737],
4	may	MD	O	may	aux	8	SENT_239	[p10l1791t696r1943b755],
5	be	VB	O	be	cop	8	SENT_239	[p10l1985t680r2065b737],
6	a	DT	O	a	det	8	SENT_239	[p10l2113t696r2148b737],
7	marked	JJ	O	marked	amod	8	SENT_239	[p10l11t775r275b833],
8	decrease	NN	O	decrease	_	0	SENT_239	[p10l301t775r593b833],
9	in	IN	O	in	_	0	SENT_239	[p10l619t778r690b832],
10	prevalence	NN	O	prevalence	prep_in	8	SENT_239	[p10l715t775r1093b851],
11	of	IN	O	of	_	0	SENT_239	[p10l1121t775r1192b833],
12	the	DT	O	the	det	15	SENT_239	[p10l1213t775r1326b833],
13	A	NN	O	a	nn	15	SENT_239	[p10l1352t777r1402b832],
14	carrier	NN	O	carrier	nn	15	SENT_239	[p10l1428t778r1652b833],
15	status	NN	O	status	prep_of	10	SENT_239	[p10l1678t782r1877b833],
16	among	IN	O	among	_	0	SENT_239	[p10l1904t792r2149b851],
17	Asians	NNPS	MISC	Asians	prep_among	15	SENT_239	[p10l7t871r250b940],
18	,	,	O	,	_	0	SENT_239	[p10l7t871r250b940],
19	as	IN	O	as	mark	29	SENT_239	[p10l278t887r343b928],
20	only	RB	O	only	quantmod	21	SENT_239	[p10l367t870r527b946],
21	1.4	CD	PERCENT	1.4	num	22	SENT_239	[p10l552t871r722b927],
22	%	NN	PERCENT	%	nsubj	29	SENT_239	[p10l552t871r722b927],
23	of	IN	O	of	_	0	SENT_239	[p10l745t870r817b928],
24	the	DT	O	the	det	27	SENT_239	[p10l835t870r947b928],
25	Korean	JJ	MISC	korean	amod	27	SENT_239	[p10l971t872r1221b928],
26	RA	NN	O	ra	nn	27	SENT_239	[p10l1244t871r1341b927],
27	cohort	NN	O	cohort	prep_of	22	SENT_239	[p10l1364t870r1596b928],
28	were	VBD	O	be	cop	29	SENT_239	[p10l1616t887r1780b928],
29	carriers	NNS	O	carrier	advcl	8	SENT_239	[p10l1804t873r2057b928],
30	of	IN	O	of	_	0	SENT_239	[p10l2081t870r2153b928],
31	this	DT	O	this	det	32	SENT_239	[p10l8t962r137b1020],
32	allele	NN	O	allele	prep_of	29	SENT_239	[p10l173t955r444b1020],
33	.	.	O	.	_	0	SENT_239	[p10l173t955r444b1020],

1	”	RB	O	”	advmod	3	SENT_240	[p10l173t955r444b1020],
2	It	PRP	O	it	nsubj	3	SENT_240	[p10l479t965r530b1020],
3	is	VBZ	O	be	_	0	SENT_240	[p10l563t965r614b1020],
4	of	IN	O	of	_	0	SENT_240	[p10l649t962r721b1020],
5	interest	NN	O	interest	prep_of	3	SENT_240	[p10l751t966r1016b1020],
6	that	IN	O	that	complm	23	SENT_240	[p10l1050t963r1193b1020],
7	in	IN	O	in	_	0	SENT_240	[p10l1226t965r1296b1020],
8	the	DT	O	the	det	11	SENT_240	[p10l1330t963r1443b1020],
9	Korean	JJ	MISC	korean	amod	11	SENT_240	[p10l1479t965r1728b1020],
10	RA	NN	MISC	ra	nn	11	SENT_240	[p10l1762t964r1860b1019],
11	cohort	NN	O	cohort	prep_in	23	SENT_240	[p10l1894t962r2143b1033],
12	,	,	O	,	_	0	SENT_240	[p10l1894t962r2143b1033],
13	patients	NNS	O	patient	nsubj	23	SENT_240	[p10l8t1062r290b1135],
14	with	IN	O	with	_	0	SENT_240	[p10l315t1059r476b1117],
15	the	DT	O	the	det	17	SENT_240	[p10l502t1059r615b1117],
16	T	NN	O	t	nn	17	SENT_240	[p10l640t1061r687b1116],
17	allele	NN	O	allele	prep_with	13	SENT_240	[p10l707t1059r889b1117],
18	of	IN	O	of	_	0	SENT_240	[p10l917t1059r988b1117],
19	TNF-oc	NN	O	tnf-oc	nn	22	SENT_240	[p10l1008t1061r1222b1117],
20	-857	CD	NUMBER	-857	num	22	SENT_240	[p10l1252t1061r1432b1117],
21	C/T	NNP	O	C/T	nn	22	SENT_240	[p10l1462t1059r1591b1124],
22	SNP	NN	ORGANIZATION	snp	prep_of	17	SENT_240	[p10l1617t1061r1755b1117],
23	responded	VBD	O	respond	ccomp	3	SENT_240	[p10l1781t1059r2149b1135],
24	better	JJR	O	better	dobj	23	SENT_240	[p10l6t1154r213b1212],
25	to	TO	O	to	aux	26	SENT_240	[p10l252t1161r321b1212],
26	etancercept	VB	O	etancercept	xcomp	23	SENT_240	[p10l362t1161r770b1230],
27	therapy	NN	O	therapy	dobj	26	SENT_240	[p10l809t1154r1082b1230],
28	than	IN	O	than	_	0	SENT_240	[p10l1119t1154r1283b1212],
29	homozygotes	NNS	O	homozygote	prep_than	26	SENT_240	[p10l1323t1154r1795b1230],
30	of	IN	O	of	_	0	SENT_240	[p10l1836t1154r1907b1212],
31	the	DT	O	the	det	33	SENT_240	[p10l1943t1154r2055b1212],
32	C	NN	O	c	nn	33	SENT_240	[p10l2097t1156r2148b1212],
33	allele	NN	O	allele	prep_of	29	SENT_240	[p10l9t1240r280b1304],
34	.	.	O	.	_	0	SENT_240	[p10l9t1240r280b1304],

1	”	NN	O	”	nsubjpass	19	SENT_241	[p10l9t1240r280b1304],
2	This	DT	O	this	det	3	SENT_241	[p10l347t1247r497b1304],
3	finding	NN	O	finding	dep	1	SENT_241	[p10l566t1246r826b1322],
4	has	VBZ	O	have	aux	7	SENT_241	[p10l894t1247r1010b1304],
5	not	RB	O	not	neg	7	SENT_241	[p10l1080t1254r1201b1304],
6	been	VBN	O	be	auxpass	7	SENT_241	[p10l1267t1247r1437b1304],
7	replicated	VBN	O	replicate	_	0	SENT_241	[p10l1506t1247r1854b1322],
8	in	IN	O	in	_	0	SENT_241	[p10l1923t1250r1994b1304],
9	an	DT	O	a	det	12	SENT_241	[p10l2064t1264r2148b1304],
10	independent	JJ	O	independent	amod	12	SENT_241	[p10l8t1343r462b1419],
11	Asian	JJ	MISC	asian	amod	12	SENT_241	[p10l515t1345r709b1401],
12	cohort	NN	O	cohort	prep_in	7	SENT_241	[p10l765t1343r1014b1414],
13	,	,	O	,	_	0	SENT_241	[p10l765t1343r1014b1414],
14	nor	CC	O	nor	_	0	SENT_241	[p10l1075t1360r1197b1401],
15	has	VBZ	O	have	aux	19	SENT_241	[p10l1251t1343r1366b1401],
16	it	PRP	O	it	dobj	19	SENT_241	[p10l1422t1346r1471b1401],
17	been	VBN	O	be	auxpass	19	SENT_241	[p10l1524t1343r1693b1401],
18	thoroughly	RB	O	thoroughly	advmod	19	SENT_241	[p10l1748t1343r2151b1419],
19	investigated	VBN	O	investigate	conj_nor	7	SENT_241	[p10l8t1438r437b1514],
20	in	IN	O	in	_	0	SENT_241	[p10l496t1441r567b1495],
21	a	DT	O	a	det	24	SENT_241	[p10l627t1455r662b1496],
22	Caucasian	JJ	MISC	caucasian	amod	24	SENT_241	[p10l723t1440r1081b1496],
23	RA	NN	O	ra	nn	24	SENT_241	[p10l1142t1440r1239b1495],
24	cohort	NN	O	cohort	prep_in	19	SENT_241	[p10l1299t1438r1550b1496],
25	.	.	O	.	_	0	SENT_241	[p10l1299t1438r1550b1496],

1	Therefore	RB	O	therefore	advmod	11	SENT_242	[p10l1612t1438r1970b1509],
2	,	,	O	,	_	0	SENT_242	[p10l1612t1438r1970b1509],
3	the	DT	O	the	det	4	SENT_242	[p10l2035t1438r2147b1496],
4	conclusions	NNS	O	conclusion	nsubjpass	21	SENT_242	[p10l9t1533r427b1591],
5	of	IN	O	of	_	0	SENT_242	[p10l464t1533r536b1591],
6	this	DT	O	this	det	9	SENT_242	[p10l567t1533r696b1591],
7	meta	NN	O	meta	nn	9	SENT_242	[p10l732t1533r1212b1609],
8	—	NN	O	—	nn	9	SENT_242	[p10l732t1533r1212b1609],
9	analysis	NN	O	analysis	prep_of	4	SENT_242	[p10l732t1533r1212b1609],
10	only	RB	O	only	advmod	11	SENT_242	[p10l1250t1533r1410b1609],
11	pertain	VBP	O	pertain	_	0	SENT_242	[p10l1442t1536r1695b1609],
12	to	TO	O	to	_	0	SENT_242	[p10l1731t1540r1800b1591],
13	a	DT	O	a	det	16	SENT_242	[p10l1837t1550r1872b1591],
14	Caucasian	JJ	MISC	caucasian	amod	16	SENT_242	[p10l1909t1534r2148b1591, p10l10t1631r149b1686],
15	RA	NN	MISC	ra	nn	16	SENT_242	[p10l183t1630r281b1685],
16	population	NN	O	population	prep_to	11	SENT_242	[p10l313t1628r706b1704],
17	and	CC	O	and	_	0	SENT_242	[p10l740t1628r871b1686],
18	can	MD	O	can	aux	21	SENT_242	[p10l905t1635r1152b1686],
19	not	RB	O	not	neg	21	SENT_242	[p10l905t1635r1152b1686],
20	be	VB	O	be	auxpass	21	SENT_242	[p10l1183t1628r1263b1686],
21	generalized	VBN	O	generalize	conj_and	11	SENT_242	[p10l1298t1628r1699b1704],
22	to	TO	O	to	_	0	SENT_242	[p10l1732t1635r1802b1686],
23	an	DT	O	a	det	26	SENT_242	[p10l1837t1645r1922b1686],
24	Asian	JJ	MISC	asian	amod	26	SENT_242	[p10l1954t1630r2148b1686],
25	RA	NN	O	ra	nn	26	SENT_242	[p10l9t1723r107b1778],
26	cohort	NN	O	cohort	prep_to	21	SENT_242	[p10l136t1721r386b1778],
27	.	.	O	.	_	0	SENT_242	[p10l136t1721r386b1778],

1	There	EX	O	there	expl	2	SENT_243	[p10l83t1817r283b1875],
2	are	VBP	O	be	_	0	SENT_243	[p10l311t1834r412b1875],
3	limitations	NNS	O	limitation	nsubj	2	SENT_243	[p10l439t1817r825b1875],
4	in	IN	O	in	_	0	SENT_243	[p10l851t1820r922b1874],
5	this	DT	O	this	det	8	SENT_243	[p10l948t1817r1077b1875],
6	meta	NN	O	meta	nn	8	SENT_243	[p10l1103t1817r1602b1893],
7	—	NN	O	—	nn	8	SENT_243	[p10l1103t1817r1602b1893],
8	analysis	NN	O	analysis	prep_in	3	SENT_243	[p10l1103t1817r1602b1893],
9	.	.	O	.	_	0	SENT_243	[p10l1103t1817r1602b1893],

1	First	RB	ORDINAL	first	advmod	4	SENT_244	[p10l1633t1819r1799b1887],
2	,	,	O	,	_	0	SENT_244	[p10l1633t1819r1799b1887],
3	there	EX	O	there	expl	4	SENT_244	[p10l1830t1817r2010b1875],
4	is	VBZ	O	be	_	0	SENT_244	[p10l2036t1820r2087b1875],
5	a	DT	O	a	det	6	SENT_244	[p10l2114t1834r2149b1875],
6	scarcity	NN	O	scarcity	nsubj	4	SENT_244	[p10l10t1914r276b1987],
7	of	IN	O	of	_	0	SENT_244	[p10l301t1911r373b1969],
8	studies	NNS	O	study	prep_of	6	SENT_244	[p10l397t1911r655b1982],
9	,	,	O	,	_	0	SENT_244	[p10l397t1911r655b1982],
10	which	WDT	O	which	nsubj	12	SENT_244	[p10l685t1911r906b1969],
11	have	VBP	O	have	aux	12	SENT_244	[p10l932t1911r1098b1969],
12	investigated	VBN	O	investigate	rcmod	8	SENT_244	[p10l1126t1911r1554b1987],
13	the	DT	O	the	det	14	SENT_244	[p10l1581t1911r1693b1969],
14	relationship	NN	O	relationship	dobj	12	SENT_244	[p10l1722t1911r2148b1987],
15	between	IN	O	between	_	0	SENT_244	[p10l6t2007r303b2065],
16	the	DT	O	the	det	20	SENT_244	[p10l343t2007r455b2065],
17	TNF-oc	NN	O	tnf-oc	nn	20	SENT_244	[p10l494t2009r707b2065],
18	-308	CD	NUMBER	-308	num	20	SENT_244	[p10l751t2009r931b2065],
19	G/A	NN	O	g/a	nn	20	SENT_244	[p10l973t2007r1112b2072],
20	polymorphism	NN	O	polymorphism	prep_between	14	SENT_244	[p10l1149t2007r1675b2083],
21	and	CC	O	and	_	0	SENT_244	[p10l1716t2007r1847b2065],
22	responsiveness	NN	O	responsiveness	prep_between	14	SENT_244	[p10l1886t2024r2147b2083, p10l10t2105r290b2160],
23	to	TO	O	to	_	0	SENT_244	[p10l326t2109r396b2160],
24	TNF-oc	NN	O	tnf-oc	nn	26	SENT_244	[p10l430t2104r644b2160],
25	blockade	NN	O	blockade	nn	26	SENT_244	[p10l677t2102r991b2160],
26	therapy	NN	O	therapy	prep_to	12	SENT_244	[p10l1028t2102r1301b2178],
27	in	IN	O	in	_	0	SENT_244	[p10l1334t2105r1404b2159],
28	moderate-to	JJ	O	moderate-to	amod	29	SENT_244	[p10l1439t2102r1872b2160],
29	severeRA	NN	O	severera	prep_in	26	SENT_244	[p10l1911t2119r2148b2160, p10l9t2198r124b2254],
30	.	.	O	.	_	0	SENT_244	[p10l1911t2119r2148b2160, p10l9t2198r124b2254],

1	Second	RB	ORDINAL	second	advmod	6	SENT_245	[p10l171t2197r440b2267],
2	,	,	O	,	_	0	SENT_245	[p10l171t2197r440b2267],
3	those	DT	O	those	det	5	SENT_245	[p10l486t2197r675b2254],
4	aforementioned	JJ	O	aforementioned	amod	5	SENT_245	[p10l719t2196r1287b2254],
5	studies	NNS	O	study	nsubj	6	SENT_245	[p10l1331t2197r1571b2254],
6	have	VBP	O	have	_	0	SENT_245	[p10l1614t2197r1779b2254],
7	relatively	RB	O	relatively	advmod	8	SENT_245	[p10l1822t2197r2151b2272],
8	small	JJ	O	small	amod	10	SENT_245	[p10l10t2292r195b2350],
9	sample	NN	O	sample	nn	10	SENT_245	[p10l228t2292r473b2368],
10	sizes	NNS	O	size	dobj	6	SENT_245	[p10l507t2295r661b2350],
11	limiting	VBG	O	limit	partmod	10	SENT_245	[p10l693t2292r979b2368],
12	statistical	JJ	O	statistical	amod	13	SENT_245	[p10l1011t2292r1341b2350],
13	power	NN	O	power	dobj	11	SENT_245	[p10l1372t2309r1602b2368],
14	.	.	O	.	_	0	SENT_245	[p10l1372t2309r1602b2368],

1	Third	NNP	ORDINAL	Third	nsubj	4	SENT_246	[p10l1635t2292r1848b2362],
2	,	,	O	,	_	0	SENT_246	[p10l1635t2292r1848b2362],
3	there	EX	O	there	expl	4	SENT_246	[p10l1884t2292r2064b2350],
4	is	VBZ	O	be	_	0	SENT_246	[p10l2097t2295r2148b2350],
5	likely	JJ	O	likely	amod	6	SENT_246	[p10l8t2387r201b2463],
6	heterogeneity	NN	O	heterogeneity	nsubj	4	SENT_246	[p10l237t2387r730b2463],
7	among	IN	O	among	_	0	SENT_246	[p10l766t2404r1011b2463],
8	the	DT	O	the	det	10	SENT_246	[p10l1048t2387r1161b2445],
9	clinical	JJ	O	clinical	amod	10	SENT_246	[p10l1201t2387r1455b2445],
10	profiles	NNS	O	profile	prep_among	6	SENT_246	[p10l1494t2387r1754b2463],
11	of	IN	O	of	_	0	SENT_246	[p10l1794t2387r1865b2445],
12	the	DT	O	the	det	14	SENT_246	[p10l1899t2387r2012b2445],
13	RA	NN	O	ra	nn	14	SENT_246	[p10l2051t2389r2149b2444],
14	patients	NNS	O	patient	prep_of	10	SENT_246	[p10l8t2485r290b2558],
15	in	IN	O	in	_	0	SENT_246	[p10l345t2485r415b2539],
16	the	DT	O	the	det	18	SENT_246	[p10l469t2482r581b2540],
17	various	JJ	O	various	amod	18	SENT_246	[p10l634t2485r890b2540],
18	studies	NNS	O	study	prep_in	14	SENT_246	[p10l946t2482r1205b2540],
19	.	.	O	.	_	0	SENT_246	[p10l946t2482r1205b2540],

1	The	DT	O	the	det	2	SENT_247	[p10l1261t2482r1394b2540],
2	differences	NNS	O	difference	nsubj	3	SENT_247	[p10l1450t2482r1830b2540],
3	include	VBP	O	include	_	0	SENT_247	[p10l1885t2482r2148b2540],
4	clinical	JJ	O	clinical	amod	5	SENT_247	[p10l9t2577r264b2635],
5	parameters	NNS	O	parameter	dobj	3	SENT_247	[p10l291t2584r679b2653],
6	such	JJ	O	such	_	0	SENT_247	[p10l708t2577r868b2635],
7	as	IN	O	as	_	0	SENT_247	[p10l896t2594r961b2635],
8	disease	NN	O	disease	nn	9	SENT_247	[p10l990t2577r1232b2635],
9	duration	NN	O	duration	prep_such_as	5	SENT_247	[p10l1260t2577r1583b2648],
10	,	,	O	,	_	0	SENT_247	[p10l1260t2577r1583b2648],
11	disease	NN	O	disease	nn	12	SENT_247	[p10l1616t2577r1858b2635],
12	activity	NN	O	activity	conj_and	5	SENT_247	[p10l1887t2580r2151b2653],
13	at	IN	O	at	_	0	SENT_247	[p10l9t2678r73b2728],
14	baseline	NN	O	baseline	prep_at	12	SENT_247	[p10l102t2670r408b2741],
15	,	,	O	,	_	0	SENT_247	[p10l102t2670r408b2741],
16	baseline	NN	O	baseline	conj_and	5	SENT_247	[p10l443t2670r730b2728],
17	functional	JJ	O	functional	amod	18	SENT_247	[p10l763t2670r1130b2728],
18	scores	NNS	O	score	dep	16	SENT_247	[p10l1165t2687r1372b2728],
19	and	CC	O	and	_	0	SENT_247	[p10l1406t2670r1537b2728],
20	use	NN	O	use	dobj	3	SENT_247	[p10l1568t2687r1681b2728],
21	of	IN	O	of	_	0	SENT_247	[p10l1714t2670r1786b2728],
22	concomitant	JJ	O	concomitant	amod	23	SENT_247	[p10l1815t2673r2147b2728, p10l8t2774r152b2825],
23	medication	NN	O	medication	prep_of	20	SENT_247	[p10l192t2767r612b2825],
24	.	.	O	.	_	0	SENT_247	[p10l192t2767r612b2825],

1	Finally	RB	O	finally	advmod	7	SENT_248	[p10l659t2767r909b2843],
2	,	,	O	,	_	0	SENT_248	[p10l659t2767r909b2843],
3	two	CD	NUMBER	two	num	6	SENT_248	[p10l955t2774r1085b2825],
4	different	JJ	O	different	amod	6	SENT_248	[p10l1128t2767r1432b2825],
5	outcome	NN	O	outcome	nn	6	SENT_248	[p10l1473t2774r1783b2825],
6	measures	NNS	O	measure	nsubj	7	SENT_248	[p10l1825t2784r2148b2825],
7	(	VBP	O	(	_	0	SENT_248	[p10l12t2861r268b2933],
8	DAS28	NN	O	das28	nn	11	SENT_248	[p10l12t2861r268b2933],
9	and	CC	O	and	_	0	SENT_248	[p10l300t2860r431b2918],
10	ACRZO	NN	O	acrzo	nn	11	SENT_248	[p10l459t2861r725b2932],
11	)	NN	O	)	nsubjpass	13	SENT_248	[p10l459t2861r725b2932],
12	were	VBD	O	be	auxpass	13	SENT_248	[p10l756t2877r920b2918],
13	used	VBN	O	use	ccomp	7	SENT_248	[p10l949t2861r1109b2918],
14	to	TO	O	to	aux	15	SENT_248	[p10l1138t2868r1207b2918],
15	assess	VB	O	assess	xcomp	13	SENT_248	[p10l1238t2877r1435b2918],
16	the	DT	O	the	det	17	SENT_248	[p10l1464t2861r1577b2918],
17	outcomes	NNS	O	outcome	dobj	15	SENT_248	[p10l1608t2868r1948b2918],
18	from	IN	O	from	_	0	SENT_248	[p10l1978t2860r2148b2918],
19	anti-TNF	JJ	O	anti-tnf	amod	20	SENT_248	[p10l9t2959r319b3014],
20	therapy	NN	O	therapy	prep_from	15	SENT_248	[p10l360t2957r644b3032],
21	.	.	O	.	_	0	SENT_248	[p10l360t2957r644b3032],

1	As	IN	O	as	mark	7	SENT_249	[p10l688t2958r769b3014],
2	six	CD	NUMBER	six	nsubj	7	SENT_249	[p10l812t2960r907b3014],
3	of	IN	O	of	_	0	SENT_249	[p10l948t2956r1019b3014],
4	the	DT	O	the	det	6	SENT_249	[p10l1056t2957r1169b3014],
5	nine	CD	NUMBER	nine	num	6	SENT_249	[p10l1211t2960r1369b3014],
6	studies	NNS	O	study	prep_of	2	SENT_249	[p10l1413t2957r1653b3014],
7	reported	VBD	O	report	advcl	17	SENT_249	[p10l1695t2957r1994b3032],
8	the	DT	O	the	det	10	SENT_249	[p10l2035t2957r2147b3014],
9	DAS28	NN	O	das28	nn	10	SENT_249	[p10l9t3054r241b3110],
10	score	NN	NUMBER	score	dobj	7	SENT_249	[p10l276t3069r469b3122],
11	,	,	O	,	_	0	SENT_249	[p10l276t3069r469b3122],
12	this	DT	O	this	nsubj	17	SENT_249	[p10l506t3052r635b3110],
13	was	VBD	O	be	cop	17	SENT_249	[p10l666t3069r793b3110],
14	the	DT	O	the	det	17	SENT_249	[p10l826t3052r938b3110],
15	preferred	JJ	O	preferred	amod	17	SENT_249	[p10l969t3052r1289b3128],
16	response	NN	O	response	nn	17	SENT_249	[p10l1320t3069r1625b3128],
17	index	NN	O	index	_	0	SENT_249	[p10l1658t3052r1858b3110],
18	used	VBN	O	use	partmod	17	SENT_249	[p10l1886t3052r2047b3110],
19	in	IN	O	in	_	0	SENT_249	[p10l2078t3055r2148b3109],
20	this	DT	O	this	det	23	SENT_249	[p10l8t3147r137b3204],
21	meta	NN	O	meta	nn	23	SENT_249	[p10l168t3147r666b3222],
22	—	NN	O	—	nn	23	SENT_249	[p10l168t3147r666b3222],
23	analysis	NN	O	analysis	prep_in	18	SENT_249	[p10l168t3147r666b3222],
24	.	.	O	.	_	0	SENT_249	[p10l168t3147r666b3222],

1	In	IN	O	in	_	0	SENT_250	[p10l86t3245r158b3299],
2	using	VBG	O	use	prepc_in	11	SENT_250	[p10l188t3245r380b3318],
3	the	DT	O	the	det	5	SENT_250	[p10l410t3242r522b3300],
4	DAS28	NN	O	das28	nn	5	SENT_250	[p10l555t3244r787b3300],
5	score	NN	NUMBER	score	dobj	2	SENT_250	[p10l822t3259r1016b3312],
6	,	,	O	,	_	0	SENT_250	[p10l822t3259r1016b3312],
7	it	PRP	O	it	nsubj	11	SENT_250	[p10l1051t3245r1101b3300],
8	would	MD	O	would	aux	11	SENT_250	[p10l1130t3242r1351b3300],
9	have	VB	O	have	aux	11	SENT_250	[p10l1382t3242r1547b3300],
10	been	VBN	O	be	cop	11	SENT_250	[p10l1577t3242r1746b3300],
11	ideal	JJ	O	ideal	_	0	SENT_250	[p10l1778t3242r1945b3300],
12	if	IN	O	if	mark	16	SENT_250	[p10l1976t3242r2026b3299],
13	we	PRP	O	we	nsubj	16	SENT_250	[p10l2051t3259r2147b3300],
14	could	MD	O	could	aux	16	SENT_250	[p10l9t3337r205b3395],
15	also	RB	O	also	advmod	16	SENT_250	[p10l239t3337r373b3395],
16	report	VB	O	report	advcl	11	SENT_250	[p10l407t3344r621b3413],
17	the	DT	O	the	det	19	SENT_250	[p10l655t3337r767b3395],
18	percentage	NN	O	percentage	nn	19	SENT_250	[p10l801t3344r1184b3413],
19	change	NN	O	change	dobj	16	SENT_250	[p10l1219t3337r1470b3413],
20	in	IN	O	in	_	0	SENT_250	[p10l1504t3340r1575b3394],
21	disease	NN	O	disease	nn	22	SENT_250	[p10l1609t3337r1851b3395],
22	activity	NN	O	activity	prep_in	16	SENT_250	[p10l1887t3340r2151b3413],
23	for	IN	O	for	_	0	SENT_250	[p10l8t3432r107b3490],
24	all	DT	O	all	det	25	SENT_250	[p10l133t3432r215b3490],
25	studies	NNS	O	study	prep_for	22	SENT_250	[p10l244t3432r502b3490],
26	.	.	O	.	_	0	SENT_250	[p10l244t3432r502b3490],

1	However	RB	O	however	advmod	7	SENT_251	[p10l535t3434r861b3502],
2	,	,	O	,	_	0	SENT_251	[p10l535t3434r861b3502],
3	these	DT	O	these	det	4	SENT_251	[p10l892t3432r1074b3490],
4	data	NNS	O	datum	nsubj	7	SENT_251	[p10l1102t3432r1251b3490],
5	were	VBD	O	be	cop	7	SENT_251	[p10l1276t3449r1439b3490],
6	only	RB	O	only	advmod	7	SENT_251	[p10l1468t3432r1627b3508],
7	available	JJ	O	available	_	0	SENT_251	[p10l1653t3432r1961b3490],
8	for	IN	O	for	_	0	SENT_251	[p10l1989t3432r2088b3490],
9	a	DT	O	a	det	10	SENT_251	[p10l2114t3449r2149b3490],
10	handful	NN	O	handful	prep_for	7	SENT_251	[p10l8t3527r287b3585],
11	of	IN	O	of	_	0	SENT_251	[p10l316t3527r388b3585],
12	studies	NNS	O	study	prep_of	10	SENT_251	[p10l414t3527r672b3585],
13	.	.	O	.	_	0	SENT_251	[p10l414t3527r672b3585],

1	It	PRP	O	it	nsubj	3	SENT_252	[p10l706t3530r757b3585],
2	is	VBZ	O	be	cop	3	SENT_252	[p10l785t3530r836b3585],
3	possible	JJ	O	possible	_	0	SENT_252	[p10l864t3527r1145b3603],
4	that	IN	O	that	complm	12	SENT_252	[p10l1174t3527r1317b3585],
5	even	RB	O	even	advmod	6	SENT_252	[p10l1345t3544r1510b3585],
6	more	JJR	O	more	amod	8	SENT_252	[p10l1539t3544r1719b3585],
7	discriminatory	JJ	O	discriminatory	amod	8	SENT_252	[p10l1749t3527r2147b3585, p10l8t3629r154b3697],
8	results	NNS	O	result	nsubjpass	12	SENT_252	[p10l186t3621r411b3679],
9	would	MD	O	would	aux	12	SENT_252	[p10l445t3621r667b3679],
10	have	VB	O	have	aux	12	SENT_252	[p10l702t3621r867b3679],
11	been	VBN	O	be	auxpass	12	SENT_252	[p10l901t3621r1071b3679],
12	obtained	VBN	O	obtain	ccomp	3	SENT_252	[p10l1107t3621r1419b3679],
13	between	IN	O	between	_	0	SENT_252	[p10l1452t3621r1749b3679],
14	the	DT	O	the	det	15	SENT_252	[p10l1784t3621r1896b3679],
15	A	NN	O	a	prep_between	12	SENT_252	[p10l1932t3623r1982b3678],
16	and	CC	O	and	_	0	SENT_252	[p10l2018t3621r2149b3679],
17	non	JJ	O	non	conj_and	15	SENT_252	[p10l8t3718r230b3775],
18	.	.	O	.	_	0	SENT_252	[p10l8t3718r230b3775],

1	—	NN	O	—	_	0	SENT_253	[p10l8t3718r230b3775],
2	.	.	O	.	_	0	SENT_253	[p10l8t3718r230b3775],

1	A	DT	O	a	det	3	SENT_254	[p10l8t3718r230b3775],
2	carrier	NN	O	carrier	nn	3	SENT_254	[p10l256t3720r480b3775],
3	status	NN	O	status	_	0	SENT_254	[p10l508t3724r725b3787],
4	,	,	O	,	_	0	SENT_254	[p10l508t3724r725b3787],
5	if	IN	O	if	mark	11	SENT_254	[p10l757t3717r808b3774],
6	the	DT	O	the	det	9	SENT_254	[p10l831t3717r943b3775],
7	disease	NN	O	disease	nn	9	SENT_254	[p10l972t3717r1214b3775],
8	activity	NN	O	activity	nn	9	SENT_254	[p10l1244t3720r1508b3793],
9	score	NN	NUMBER	score	nsubjpass	11	SENT_254	[p10l1534t3734r1709b3775],
10	was	VBD	O	be	auxpass	11	SENT_254	[p10l1736t3734r1863b3775],
11	used	VBN	O	use	dep	3	SENT_254	[p10l1890t3717r2050b3775],
12	or	CC	O	or	_	0	SENT_254	[p10l2078t3734r2150b3775],
13	if	IN	O	if	mark	18	SENT_254	[p11l8t16r59b73],
14	the	DT	O	the	det	16	SENT_254	[p11l91t16r204b74],
15	response	NN	O	response	nn	16	SENT_254	[p11l242t33r547b92],
16	criteria	NNS	O	criterion	nsubjpass	18	SENT_254	[p11l586t19r831b74],
17	were	VBD	O	be	auxpass	18	SENT_254	[p11l866t33r1030b74],
18	set	VBN	O	set	dep	3	SENT_254	[p11l1070t24r1163b74],
19	at	IN	O	at	_	0	SENT_254	[p11l1200t24r1263b74],
20	a	DT	O	a	det	22	SENT_254	[p11l1300t33r1335b74],
21	higher	JJR	O	higher	amod	22	SENT_254	[p11l1372t16r1603b92],
22	threshold	NN	O	threshold	prep_at	18	SENT_254	[p11l1638t16r1996b74],
23	.	.	O	.	_	0	SENT_254	[p11l1638t16r1996b74],

1	For	IN	O	for	_	0	SENT_255	[p11l2038t19r2149b74],
2	instance	NN	O	instance	prep_for	21	SENT_255	[p11l8t113r321b180],
3	,	,	O	,	_	0	SENT_255	[p11l8t113r321b180],
4	in	IN	O	in	_	0	SENT_255	[p11l368t113r438b167],
5	the	DT	O	the	det	6	SENT_255	[p11l479t110r592b167],
6	study	NN	O	study	prep_in	2	SENT_255	[p11l637t110r829b185],
7	by	IN	O	by	_	0	SENT_255	[p11l867t110r954b185],
8	Seitz	NNP	PERSON	Seitz	prep_by	6	SENT_255	[p11l995t111r1155b167],
9	et	FW	O	et	nn	10	SENT_255	[p11l1197t115r1257b167],
10	al.	FW	O	al.	dep	8	SENT_255	[p11l1293t103r1463b180],
11	,	,	O	,	_	0	SENT_255	[p11l1293t103r1463b180],
12	”	CD	NUMBER	”	number	13	SENT_255	[p11l1293t103r1463b180],
13	14	CD	TIME	14	appos	8	SENT_255	[p11l1511t111r1587b167],
14	of	IN	TIME	of	_	0	SENT_255	[p11l1631t109r1703b167],
15	17	CD	TIME	17	num	16	SENT_255	[p11l1746t112r1822b167],
16	patients	NNS	O	patient	prep_of	13	SENT_255	[p11l1865t113r2148b185],
17	carrying	VBG	O	carry	partmod	16	SENT_255	[p11l9t209r300b282],
18	the	DT	O	the	det	20	SENT_255	[p11l351t206r464b264],
19	A	NN	O	a	nn	20	SENT_255	[p11l516t208r568b263],
20	allele	NN	O	allele	dobj	17	SENT_255	[p11l620t206r802b264],
21	achieved	VBD	O	achieve	_	0	SENT_255	[p11l856t206r1168b264],
22	a	DT	O	a	det	25	SENT_255	[p11l1221t223r1256b264],
23	moderate	JJ	O	moderate	amod	25	SENT_255	[p11l1308t206r1642b264],
24	response	NN	O	response	nn	25	SENT_255	[p11l1696t223r2001b282],
25	(	NN	O	(	dobj	21	SENT_255	[p11l2058t206r2147b278],
26	as	IN	O	as	prep	21	SENT_255	[p11l2058t206r2147b278],
27	defined	VBN	O	define	dep	26	SENT_255	[p11l9t300r274b358],
28	by	IN	O	by	_	0	SENT_255	[p11l294t301r382b376],
29	DAS28	NN	O	das28	nn	30	SENT_255	[p11l402t302r634b358],
30	improvement	NN	O	improvement	prep_by	27	SENT_255	[p11l659t304r1143b376],
31	of	IN	O	of	_	0	SENT_255	[p11l1166t300r1237b358],
32	2	CD	NUMBER	2	number	33	SENT_255	[p11l1266t310r1315b366],
33	1.2	CD	NUMBER	1.2	prep_of	30	SENT_255	[p11l1336t302r1436b358],
34	and	CC	O	and	_	0	SENT_255	[p11l1459t301r1590b358],
35	<	JJR	O	<	dep	26	SENT_255	[p11l1624t317r1672b358],
36	2.2	CD	NUMBER	2.2	num	37	SENT_255	[p11l1689t301r1838b373],
37	)	NN	O	)	nsubj	21	SENT_255	[p11l1689t301r1838b373],
38	,	,	O	,	_	0	SENT_255	[p11l1689t301r1838b373],
39	whereas	IN	O	whereas	mark	41	SENT_255	[p11l1863t301r2147b358],
40	none	NN	O	none	nsubj	41	SENT_255	[p11l8t414r188b455],
41	had	VBD	O	have	dep	37	SENT_255	[p11l227t397r359b455],
42	a	DT	O	a	det	44	SENT_255	[p11l398t414r432b455],
43	good	JJ	O	good	amod	44	SENT_255	[p11l470t397r645b473],
44	response	NN	O	response	nsubj	46	SENT_255	[p11l684t414r989b473],
45	(	RB	O	(	advmod	46	SENT_255	[p11l1031t397r1230b473],
46	good	JJ	O	good	xcomp	41	SENT_255	[p11l1031t397r1230b473],
47	response	NN	O	response	nsubjpass	49	SENT_255	[p11l1268t414r1573b473],
48	was	VBD	O	be	auxpass	49	SENT_255	[p11l1611t414r1739b455],
49	defined	VBN	O	define	ccomp	46	SENT_255	[p11l1779t397r2044b455],
50	as	IN	O	as	_	0	SENT_255	[p11l2083t414r2147b455],
51	DAS28	NN	O	das28	nn	52	SENT_255	[p11l9t494r241b550],
52	improvement	NN	O	improvement	prep_as	49	SENT_255	[p11l268t495r752b568],
53	>	JJR	O	>	tmod	41	SENT_255	[p11l789t508r837b550],
54	2.2	CD	NUMBER	2.2	num	55	SENT_255	[p11l854t492r1004b564],
55	)	NN	O	)	dep	53	SENT_255	[p11l854t492r1004b564],
56	.	.	O	.	_	0	SENT_255	[p11l854t492r1004b564],

1	In	IN	O	in	_	0	SENT_256	[p11l1034t495r1107b549],
2	contrast	NN	O	contrast	prep_in	11	SENT_256	[p11l1132t499r1435b562],
3	,	,	O	,	_	0	SENT_256	[p11l1132t499r1435b562],
4	all	DT	O	all	det	6	SENT_256	[p11l1466t492r1548b550],
5	37	CD	NUMBER	37	num	6	SENT_256	[p11l1575t494r1655b550],
6	patients	NNS	O	patient	nsubj	11	SENT_256	[p11l1681t495r1963b568],
7	with	IN	O	with	_	0	SENT_256	[p11l1987t492r2149b550],
8	the	DT	O	the	det	10	SENT_256	[p11l8t587r121b645],
9	G/G	NN	O	g/g	nn	10	SENT_256	[p11l156t587r301b652],
10	genotype	NN	O	genotype	prep_with	6	SENT_256	[p11l334t594r660b663],
11	had	VBD	O	have	_	0	SENT_256	[p11l694t587r826b645],
12	a	DT	O	a	det	14	SENT_256	[p11l860t604r895b645],
13	good	JJ	O	good	amod	14	SENT_256	[p11l927t587r1102b663],
14	response	NN	O	response	dobj	11	SENT_256	[p11l1134t604r1459b663],
15	.	.	O	.	_	0	SENT_256	[p11l1134t604r1459b663],

1	Therefore	RB	O	therefore	advmod	38	SENT_257	[p11l1494t587r1853b657],
2	,	,	O	,	_	0	SENT_257	[p11l1494t587r1853b657],
3	using	VBG	O	use	dep	38	SENT_257	[p11l1889t590r2081b663],
4	a	DT	O	a	det	6	SENT_257	[p11l2114t604r2149b645],
5	higher	JJR	O	higher	amod	6	SENT_257	[p11l8t681r239b757],
6	threshold	NN	O	threshold	dobj	3	SENT_257	[p11l266t681r606b739],
7	for	IN	O	for	_	0	SENT_257	[p11l633t681r732b739],
8	DAS28	NN	O	das28	prep_for	6	SENT_257	[p11l759t683r1011b752],
9	,	,	O	,	_	0	SENT_257	[p11l759t683r1011b752],
10	instead	RB	O	instead	_	0	SENT_257	[p11l1043t681r1298b739],
11	of	IN	O	of	_	0	SENT_257	[p11l1325t681r1397b739],
12	DAS28	NN	O	das28	conj_negcc	6	SENT_257	[p11l1421t683r1654b739],
13	2	CD	NUMBER	2	number	14	SENT_257	[p11l1694t691r1743b747],
14	1.2	CD	NUMBER	1.2	dep	12	SENT_257	[p11l1763t683r1864b739],
15	used	VBN	O	use	partmod	12	SENT_257	[p11l1890t682r2051b739],
16	in	IN	O	in	_	0	SENT_257	[p11l2078t684r2148b738],
17	mg	NN	O	mg	nn	18	SENT_257	[p11l10t1161r137b1284],
18	TNF-oz	NN	O	tnf-oz	prep_in	15	SENT_257	[p11l1017t1175r1149b1218],
19	-308	CD	NUMBER	-308	num	21	SENT_257	[p11l1169t1174r1290b1217],
20	G/A	NN	O	g/a	nn	21	SENT_257	[p11l1308t1173r1404b1223],
21	variant	NN	O	variant	dep	18	SENT_257	[p11l1420t1172r1592b1217],
22	and	CC	O	and	_	0	SENT_257	[p11l1610t1173r1697b1217],
23	anti-TNF-oz	JJ	O	anti-tnf-oz	amod	24	SENT_257	[p11l1717t1173r1961b1218],
24	agents	NNS	O	agent	prep_in	15	SENT_257	[p11l1979t1178r2138b1231],
25	D	NN	O	d	nn	30	SENT_257	[p11l1782t1245r1811b1284],
26	D	NN	O	d	nn	30	SENT_257	[p11l1832t1245r1861b1284],
27	O’Rie	NN	O	o’rie	nn	30	SENT_257	[p11l1881t1243r2035b1298],
28	|	CD	NUMBER	|	num	30	SENT_257	[p11l1881t1243r2035b1298],
29	|	NN	O	|	nn	30	SENT_257	[p11l1881t1243r2035b1298],
30	y	NN	O	y	dep	24	SENT_257	[p11l1881t1243r2035b1298],
31	et	FW	O	et	nn	32	SENT_257	[p11l2054t1248r2090b1285],
32	al	FW	O	al	tmod	15	SENT_257	[p11l2106t1243r2142b1285],
33	this	DT	O	this	det	34	SENT_257	[p11l10t1530r139b1587],
34	study	NN	O	study	dep	32	SENT_257	[p11l172t1530r373b1605],
35	,	,	O	,	_	0	SENT_257	[p11l172t1530r373b1605],
36	would	MD	O	would	aux	38	SENT_257	[p11l406t1530r626b1587],
37	have	VB	O	have	aux	38	SENT_257	[p11l656t1530r820b1587],
38	produced	VBN	O	produce	_	0	SENT_257	[p11l851t1530r1182b1605],
39	a	DT	O	a	det	41	SENT_257	[p11l1214t1547r1248b1587],
40	greater	JJR	O	greater	amod	41	SENT_257	[p11l1278t1537r1518b1605],
41	difference	NN	O	difference	dobj	38	SENT_257	[p11l1548t1530r1895b1587],
42	of	IN	O	of	_	0	SENT_257	[p11l1927t1530r1998b1587],
43	the	DT	O	the	det	45	SENT_257	[p11l2025t1530r2136b1587],
44	response	NN	O	response	nn	45	SENT_257	[p11l11t1639r314b1698],
45	rate	NN	O	rate	prep_of	41	SENT_257	[p11l344t1630r474b1680],
46	among	IN	O	among	_	0	SENT_257	[p11l505t1639r749b1698],
47	the	DT	O	the	det	48	SENT_257	[p11l777t1623r888b1680],
48	genotypes	NNS	O	genotype	prep_among	38	SENT_257	[p11l919t1630r1292b1698],
49	.	.	O	.	_	0	SENT_257	[p11l919t1630r1292b1698],

1	It	PRP	O	it	nsubj	3	SENT_258	[p11l87t1720r139b1774],
2	is	VBZ	O	be	cop	3	SENT_258	[p11l186t1720r236b1774],
3	possible	JJ	O	possible	_	0	SENT_258	[p11l284t1717r562b1792],
4	that	IN	O	that	complm	23	SENT_258	[p11l611t1717r754b1774],
5	a	DT	O	a	det	8	SENT_258	[p11l801t1734r836b1774],
6	poor	JJ	O	poor	amod	8	SENT_258	[p11l883t1734r1046b1792],
7	therapeutic	JJ	O	therapeutic	amod	8	SENT_258	[p11l1093t1717r1495b1792],
8	response	NN	O	response	nsubj	23	SENT_258	[p11l1542t1734r1845b1792],
9	among	IN	O	among	_	0	SENT_258	[p11l1895t1734r2139b1792],
10	carriers	NNS	O	carrier	prep_among	8	SENT_258	[p11l11t1813r263b1867],
11	of	IN	O	of	_	0	SENT_258	[p11l290t1810r361b1867],
12	the	DT	O	the	det	14	SENT_258	[p11l382t1810r494b1867],
13	A	NN	O	a	nn	14	SENT_258	[p11l519t1812r569b1867],
14	allele	NN	O	allele	prep_of	10	SENT_258	[p11l595t1810r775b1867],
15	of	IN	O	of	_	0	SENT_258	[p11l802t1810r874b1867],
16	the	DT	O	the	det	20	SENT_258	[p11l895t1810r1006b1867],
17	-308	CD	NUMBER	-308	num	20	SENT_258	[p11l1038t1812r1217b1867],
18	TNF-oc	NN	O	tnf-oc	nn	20	SENT_258	[p11l1242t1813r1455b1867],
19	gene	NN	O	gene	nn	20	SENT_258	[p11l1480t1827r1642b1885],
20	variant	NN	O	variant	prep_of	14	SENT_258	[p11l1666t1813r1916b1867],
21	is	VBZ	O	be	cop	23	SENT_258	[p11l1942t1813r1991b1867],
22	not	RB	O	not	neg	23	SENT_258	[p11l2017t1818r2138b1867],
23	specific	JJ	O	specific	ccomp	3	SENT_258	[p11l12t1904r270b1979],
24	to	TO	O	to	_	0	SENT_258	[p11l326t1911r395b1961],
25	anti	JJ	O	anti	prep_to	23	SENT_258	[p11l452t1906r829b1961],
26	.	.	O	.	_	0	SENT_258	[p11l452t1906r829b1961],

1	—	NN	O	—	_	0	SENT_259	[p11l452t1906r829b1961],
2	.	.	O	.	_	0	SENT_259	[p11l452t1906r829b1961],

1	TNF-oc	JJ	O	tnf-oc	amod	2	SENT_260	[p11l452t1906r829b1961],
2	agents	NNS	O	agent	nsubj	6	SENT_260	[p11l885t1911r1125b1979],
3	,	,	O	,	_	0	SENT_260	[p11l885t1911r1125b1979],
4	but	CC	O	but	advmod	2	SENT_260	[p11l1183t1904r1302b1961],
5	merely	RB	O	merely	advmod	6	SENT_260	[p11l1357t1904r1599b1979],
6	reflects	VBZ	O	reflect	_	0	SENT_260	[p11l1653t1904r1900b1961],
7	more	RBR	O	more	advmod	8	SENT_260	[p11l1956t1921r2136b1961],
8	aggressive	JJ	O	aggressive	amod	10	SENT_260	[p11l11t2002r360b2073],
9	disease	NN	O	disease	nn	10	SENT_260	[p11l386t1999r626b2056],
10	and/or	NN	O	and/or	dobj	6	SENT_260	[p11l653t1998r887b2063],
11	poorer	JJR	O	poorer	amod	12	SENT_260	[p11l909t2015r1140b2073],
12	response	NN	O	response	dep	10	SENT_260	[p11l1163t2015r1467b2073],
13	to	TO	O	to	_	0	SENT_260	[p11l1492t2006r1561b2056],
14	any	DT	O	any	det	16	SENT_260	[p11l1586t2015r1715b2073],
15	therapeutic	JJ	O	therapeutic	amod	16	SENT_260	[p11l1736t1999r2138b2073],
16	regime	NN	O	regime	prep_to	12	SENT_260	[p11l11t2095r267b2167],
17	.	.	O	.	_	0	SENT_260	[p11l11t2095r267b2167],

1	The	DT	O	the	det	6	SENT_261	[p11l304t2092r436b2149],
2	minor	JJ	O	minor	amod	6	SENT_261	[p11l473t2095r691b2149],
3	allele	NN	O	allele	nn	6	SENT_261	[p11l726t2092r906b2149],
4	‘	NN	O	‘	nn	6	SENT_261	[p11l945t2092r1027b2148],
5	A	NN	O	a	nn	6	SENT_261	[p11l945t2092r1027b2148],
6	’	NN	O	’	nsubjpass	14	SENT_261	[p11l945t2092r1027b2148],
7	of	IN	O	of	_	0	SENT_261	[p11l1066t2092r1137b2149],
8	the	DT	O	the	det	10	SENT_261	[p11l1168t2092r1279b2149],
9	-308	CD	NUMBER	-308	num	10	SENT_261	[p11l1320t2094r1499b2149],
10	variant	NN	O	variant	prep_of	6	SENT_261	[p11l1535t2095r1784b2149],
11	has	VBZ	O	have	aux	14	SENT_261	[p11l1820t2092r1935b2149],
12	been	VBN	O	be	auxpass	14	SENT_261	[p11l1969t2092r2138b2149],
13	earlier	JJR	O	earlier	advmod	14	SENT_261	[p11l11t2185r229b2242],
14	associated	VBN	O	associate	_	0	SENT_261	[p11l274t2185r628b2242],
15	with	IN	O	with	_	0	SENT_261	[p11l671t2185r832b2242],
16	disease	NN	O	disease	nn	17	SENT_261	[p11l878t2185r1119b2242],
17	susceptibility	NN	O	susceptibility	prep_with	14	SENT_261	[p11l1167t2185r1633b2260],
18	and	CC	O	and	_	0	SENT_261	[p11l1676t2185r1807b2242],
19	severity	NN	O	severity	conj_and	17	SENT_261	[p11l1854t2188r2133b2260],
20	.	.	O	.	_	0	SENT_261	[p11l1854t2188r2133b2260],

1	However	RB	O	however	advmod	5	SENT_262	[p11l11t2280r334b2347],
2	,	,	O	,	_	0	SENT_262	[p11l11t2280r334b2347],
3	there	EX	O	there	expl	5	SENT_262	[p11l385t2278r564b2335],
4	are	VBP	O	be	aux	5	SENT_262	[p11l612t2294r713b2335],
5	conﬂicting	VBG	O	conﬂicting	_	0	SENT_262	[p11l760t2277r1143b2352],
6	reports	NNS	O	report	dobj	5	SENT_262	[p11l1187t2285r1430b2352],
7	of	IN	O	of	_	0	SENT_262	[p11l1478t2277r1548b2335],
8	the	DT	O	the	det	9	SENT_262	[p11l1590t2278r1701b2335],
9	association	NN	O	association	prep_of	6	SENT_262	[p11l1749t2281r2137b2335],
10	between	IN	O	between	_	0	SENT_262	[p11l9t2371r304b2428],
11	the	DT	O	the	det	13	SENT_262	[p11l339t2371r451b2428],
12	A	NN	O	a	nn	13	SENT_262	[p11l486t2373r537b2427],
13	allele	NN	O	allele	prep_between	9	SENT_262	[p11l573t2371r753b2428],
14	of	IN	O	of	_	0	SENT_262	[p11l790t2371r861b2428],
15	TNF-oc	NN	O	tnf-oc	nn	17	SENT_262	[p11l891t2374r1104b2428],
16	-308	CD	NUMBER	-308	num	17	SENT_262	[p11l1143t2373r1323b2428],
17	gene	NN	O	gene	prep_of	13	SENT_262	[p11l1360t2388r1522b2446],
18	and	CC	O	and	_	0	SENT_262	[p11l1559t2371r1690b2428],
19	RA	NN	O	ra	nn	20	SENT_262	[p11l1726t2373r1823b2427],
20	susceptibility	NN	O	susceptibility	prep_of	13	SENT_262	[p11l1859t2378r2136b2446, p11l11t2464r219b2539],
21	as	RB	O	as	_	0	SENT_262	[p11l245t2481r309b2521],
22	well	RB	O	well	_	0	SENT_262	[p11l335t2464r479b2521],
23	as	IN	O	as	_	0	SENT_262	[p11l507t2481r571b2521],
24	radiographic	JJ	O	radiographic	amod	25	SENT_262	[p11l599t2464r1045b2539],
25	damage	NN	O	damage	prep_of	6	SENT_262	[p11l1073t2464r1342b2539],
26	as	IN	O	as	mark	27	SENT_262	[p11l1371t2481r1435b2521],
27	summarized	VBN	O	summarize	dep	25	SENT_262	[p11l1465t2464r1893b2521],
28	earlier	RB	O	earlier	advmod	27	SENT_262	[p11l1921t2464r2139b2521],
29	by	IN	O	by	_	0	SENT_262	[p11l9t2557r96b2632],
30	Kooloos	NNP	PERSON	Kooloos	prep_by	28	SENT_262	[p11l124t2557r404b2614],
31	et	FW	O	et	nn	32	SENT_262	[p11l437t2563r496b2614],
32	611.19	FW	NUMBER	611.19	dobj	27	SENT_262	[p11l521t2550r666b2614],
33	This	DT	O	this	det	34	SENT_262	[p11l696t2557r844b2614],
34	possibility	NN	O	possibility	nsubj	36	SENT_262	[p11l875t2557r1237b2632],
35	will	MD	O	will	aux	36	SENT_262	[p11l1264t2557r1393b2613],
36	need	VB	O	need	rcmod	32	SENT_262	[p11l1424t2557r1592b2614],
37	to	TO	O	to	aux	39	SENT_262	[p11l1622t2564r1691b2614],
38	be	VB	O	be	auxpass	39	SENT_262	[p11l1720t2557r1800b2614],
39	explored	VBN	O	explore	xcomp	36	SENT_262	[p11l1832t2557r2138b2632],
40	further	RB	O	further	advmod	39	SENT_262	[p11l11t2649r256b2706],
41	by	IN	O	by	_	0	SENT_262	[p11l297t2650r384b2724],
42	examining	VBG	O	examine	agent	39	SENT_262	[p11l427t2652r805b2724],
43	the	DT	O	the	det	44	SENT_262	[p11l848t2649r960b2706],
44	association	NN	O	association	dobj	42	SENT_262	[p11l1006t2652r1395b2706],
45	of	IN	O	of	_	0	SENT_262	[p11l1440t2649r1511b2706],
46	-308	CD	NUMBER	-308	num	47	SENT_262	[p11l1556t2651r1736b2706],
47	genotypes	NNS	O	genotype	prep_of	44	SENT_262	[p11l1781t2657r2137b2724],
48	with	IN	O	with	_	0	SENT_262	[p11l9t2742r169b2799],
49	other	JJ	O	other	amod	51	SENT_262	[p11l199t2742r387b2799],
50	therapeutic	JJ	O	therapeutic	amod	51	SENT_262	[p11l415t2742r816b2817],
51	modalities	NNS	O	modality	prep_with	42	SENT_262	[p11l845t2742r1211b2799],
52	in	IN	O	in	_	0	SENT_262	[p11l1241t2745r1311b2799],
53	RA	NN	O	ra	prep_in	51	SENT_262	[p11l1341t2744r1455b2799],
54	.	.	O	.	_	0	SENT_262	[p11l1341t2744r1455b2799],

1	However	RB	O	however	advmod	15	SENT_263	[p11l1490t2745r1813b2812],
2	,	,	O	,	_	0	SENT_263	[p11l1490t2745r1813b2812],
3	whether	IN	O	whether	dep	8	SENT_263	[p11l1845t2742r2139b2799],
4	-308	CD	NUMBER	-308	num	6	SENT_263	[p11l15t2838r195b2893],
5	TNF-oc	NN	O	tnf-oc	nn	6	SENT_263	[p11l239t2838r452b2893],
6	genotypes	NNS	O	genotype	nsubj	8	SENT_263	[p11l497t2843r852b2911],
7	are	VBP	O	be	cop	8	SENT_263	[p11l899t2853r999b2893],
8	specific	JJ	O	specific	csubj	15	SENT_263	[p11l1047t2836r1305b2911],
9	for	IN	O	for	_	0	SENT_263	[p11l1350t2836r1447b2893],
10	anti-TNF-on	JJ	O	anti-tnf-on	amod	11	SENT_263	[p11l1493t2838r1869b2893],
11	agents	NNS	O	agent	prep_for	8	SENT_263	[p11l1915t2843r2137b2911],
12	does	VBZ	O	do	aux	15	SENT_263	[p11l11t2929r166b2986],
13	not	RB	O	not	neg	15	SENT_263	[p11l199t2936r319b2986],
14	necessarily	RB	O	necessarily	advmod	15	SENT_263	[p11l351t2929r733b3003],
15	diminish	VB	O	diminish	_	0	SENT_263	[p11l763t2929r1079b2986],
16	the	DT	O	the	det	19	SENT_263	[p11l1111t2929r1223b2986],
17	potential	JJ	O	potential	amod	19	SENT_263	[p11l1256t2929r1575b3003],
18	clinical	JJ	O	clinical	amod	19	SENT_263	[p11l1608t2929r1862b2986],
19	impact	NN	O	impact	dobj	15	SENT_263	[p11l1895t2932r2138b3003],
20	of	IN	O	of	_	0	SENT_263	[p11l11t3022r82b3079],
21	this	DT	O	this	det	22	SENT_263	[p11l113t3022r241b3079],
22	knowledge	NN	O	knowledge	prep_of	19	SENT_263	[p11l277t3022r675b3097],
23	.	.	O	.	_	0	SENT_263	[p11l277t3022r675b3097],

1	Such	JJ	O	such	amod	4	SENT_264	[p11l715t3022r883b3079],
2	crucial	JJ	O	crucial	amod	4	SENT_264	[p11l918t3022r1150b3079],
3	pharmacogenetic	JJ	O	pharmacogenetic	amod	4	SENT_264	[p11l1184t3022r1796b3097],
4	information	NN	O	information	nsubj	6	SENT_264	[p11l1830t3022r2136b3079, p11l10t3118r154b3172],
5	may	MD	O	may	aux	6	SENT_264	[p11l224t3132r376b3190],
6	provide	VB	O	provide	_	0	SENT_264	[p11l443t3115r708b3190],
7	a	DT	O	a	det	10	SENT_264	[p11l780t3132r815b3172],
8	superior	JJ	O	superior	amod	10	SENT_264	[p11l886t3118r1171b3190],
9	therapeutic	JJ	O	therapeutic	amod	10	SENT_264	[p11l1240t3115r1642b3190],
10	strategy	NN	O	strategy	dobj	6	SENT_264	[p11l1713t3122r1996b3190],
11	,	,	O	,	_	0	SENT_264	[p11l1713t3122r1996b3190],
12	as	IN	O	as	mark	16	SENT_264	[p11l2072t3132r2137b3172],
13	therapies	NNS	O	therapy	nsubjpass	16	SENT_264	[p11l10t3208r329b3282],
14	can	MD	O	can	aux	16	SENT_264	[p11l365t3224r487b3265],
15	be	VB	O	be	auxpass	16	SENT_264	[p11l519t3208r599b3265],
16	guided	VBN	O	guide	advcl	6	SENT_264	[p11l634t3208r872b3282],
17	by	IN	O	by	_	0	SENT_264	[p11l905t3208r992b3282],
18	the	DT	O	the	det	19	SENT_264	[p11l1024t3208r1136b3265],
19	presence	NN	O	presence	agent	16	SENT_264	[p11l1171t3224r1474b3282],
20	or	CC	O	or	_	0	SENT_264	[p11l1510t3224r1581b3265],
21	absence	NN	O	absence	conj_or	19	SENT_264	[p11l1616t3208r1887b3265],
22	of	IN	O	of	_	0	SENT_264	[p11l1924t3207r1994b3265],
23	the	DT	O	the	det	24	SENT_264	[p11l2025t3208r2136b3265],
24	-308	CD	NUMBER	-308	prep_of	19	SENT_264	[p11l15t3304r195b3359],
25	A	DT	O	a	det	26	SENT_264	[p11l224t3304r275b3358],
26	allele	NN	O	allele	dep	24	SENT_264	[p11l303t3302r503b3359],
27	.	.	O	.	_	0	SENT_264	[p11l303t3302r503b3359],

1	On	IN	O	on	_	0	SENT_265	[p11l88t3396r195b3451],
2	the	DT	O	the	det	3	SENT_265	[p11l221t3395r333b3451],
3	basis	NN	O	basis	prep_on	34	SENT_265	[p11l359t3394r525b3451],
4	of	IN	O	of	_	0	SENT_265	[p11l554t3394r625b3451],
5	the	DT	O	the	det	7	SENT_265	[p11l647t3394r759b3451],
6	high	JJ	O	high	amod	7	SENT_265	[p11l787t3394r948b3469],
7	prevalence	NN	O	prevalence	prep_of	3	SENT_265	[p11l974t3394r1351b3469],
8	of	IN	O	of	_	0	SENT_265	[p11l1379t3394r1450b3451],
9	the	DT	O	the	det	12	SENT_265	[p11l1473t3395r1585b3451],
10	A	NN	O	a	nn	12	SENT_265	[p11l1611t3396r1662b3451],
11	carrier	NN	O	carrier	nn	12	SENT_265	[p11l1689t3397r1911b3451],
12	status	NN	O	status	prep_of	7	SENT_265	[p11l1938t3402r2137b3451],
13	for	IN	O	for	_	0	SENT_265	[p11l11t3489r108b3546],
14	the	DT	O	the	det	17	SENT_265	[p11l135t3489r247b3546],
15	-308	CD	NUMBER	-308	num	17	SENT_265	[p11l281t3490r460b3546],
16	TNF-oc	NN	O	tnf-oc	nn	17	SENT_265	[p11l488t3491r701b3546],
17	variant	NN	O	variant	prep_for	12	SENT_265	[p11l726t3492r976b3546],
18	and	CC	O	and	_	0	SENT_265	[p11l1005t3489r1135b3546],
19	the	DT	O	the	det	21	SENT_265	[p11l1162t3489r1274b3546],
20	consistent	JJ	O	consistent	amod	21	SENT_265	[p11l1304t3492r1663b3546],
21	difference	NN	O	difference	conj_and	12	SENT_265	[p11l1691t3489r2038b3546],
22	in	IN	O	in	_	0	SENT_265	[p11l2068t3492r2138b3545],
23	response	NN	O	response	prep_in	21	SENT_265	[p12l11t41r314b99],
24	among	IN	O	among	_	0	SENT_265	[p12l343t41r587b99],
25	carriers	NNS	O	carrier	prep_among	23	SENT_265	[p12l613t27r865b81],
26	and	CC	O	and	_	0	SENT_265	[p12l893t24r1024b81],
27	non-carriers	NNS	O	non-carrier	conj_and	25	SENT_265	[p12l1051t27r1473b81],
28	of	IN	O	of	_	0	SENT_265	[p12l1502t24r1573b81],
29	the	DT	O	the	det	31	SENT_265	[p12l1596t24r1708b81],
30	A	NN	O	a	nn	31	SENT_265	[p12l1734t26r1785b81],
31	allele	NN	O	allele	prep_of	25	SENT_265	[p12l1812t24r2011b94],
32	,	,	O	,	_	0	SENT_265	[p12l1812t24r2011b94],
33	we	PRP	O	we	nsubj	34	SENT_265	[p12l2041t41r2137b81],
34	feel	VBP	O	feel	_	0	SENT_265	[p12l11t117r132b174],
35	that	IN	O	that	complm	52	SENT_265	[p12l155t117r298b174],
36	the	DT	O	the	det	37	SENT_265	[p12l321t117r432b174],
37	utility	NN	O	utility	nsubjpass	52	SENT_265	[p12l454t117r671b192],
38	of	IN	O	of	_	0	SENT_265	[p12l693t117r764b174],
39	prospectively	RB	O	prospectively	advmod	40	SENT_265	[p12l782t117r1252b192],
40	genotyping	VBG	O	genotype	prepc_of	37	SENT_265	[p12l1272t120r1675b192],
41	for	IN	O	for	_	0	SENT_265	[p12l1697t117r1795b174],
42	the	DT	O	the	det	44	SENT_265	[p12l1816t118r1928b174],
43	-308	CD	NUMBER	-308	num	44	SENT_265	[p12l1956t119r2136b174],
44	variant	NN	O	variant	prep_for	40	SENT_265	[p12l8t214r258b268],
45	before	IN	O	before	_	0	SENT_265	[p12l299t211r517b268],
46	initiation	NN	O	initiation	prep_before	40	SENT_265	[p12l561t214r893b268],
47	of	IN	O	of	_	0	SENT_265	[p12l937t211r1007b268],
48	anti-TNF-oz	JJ	O	anti-tnf-oz	amod	49	SENT_265	[p12l1047t213r1424b268],
49	therapy	NN	O	therapy	prep_of	46	SENT_265	[p12l1466t211r1737b286],
50	should	MD	O	should	aux	52	SENT_265	[p12l1779t211r2017b268],
51	be	VB	O	be	auxpass	52	SENT_265	[p12l2057t211r2137b268],
52	evaluated	VBN	O	evaluate	ccomp	34	SENT_265	[p12l11t304r366b361],
53	.	.	O	.	_	0	SENT_265	[p12l11t304r366b361],

1	The	DT	O	the	det	2	SENT_266	[p12l418t304r550b361],
2	value	NN	O	value	nsubj	8	SENT_266	[p12l598t304r785b361],
3	of	IN	O	of	_	0	SENT_266	[p12l837t303r908b361],
4	this	DT	O	this	det	6	SENT_266	[p12l954t304r1082b361],
5	genotypic	JJ	O	genotypic	amod	6	SENT_266	[p12l1133t307r1481b378],
6	information	NN	O	information	prep_of	2	SENT_266	[p12l1531t303r1959b361],
7	will	MD	O	will	aux	8	SENT_266	[p12l2008t304r2137b360],
8	increase	VB	O	increase	_	0	SENT_266	[p12l11t400r292b454],
9	if	IN	O	if	mark	11	SENT_266	[p12l324t396r375b453],
10	there	EX	O	there	expl	11	SENT_266	[p12l402t397r581b454],
11	is	VBZ	O	be	advcl	8	SENT_266	[p12l614t400r664b454],
12	further	JJ	O	further	amod	13	SENT_266	[p12l697t396r942b454],
13	improvement	NN	O	improvement	nsubj	11	SENT_266	[p12l972t400r1454b471],
14	in	IN	O	in	_	0	SENT_266	[p12l1486t400r1555b453],
15	the	DT	O	the	det	16	SENT_266	[p12l1587t397r1699b454],
16	response	NN	O	response	prep_in	13	SENT_266	[p12l1731t413r2035b471],
17	to	TO	O	to	_	0	SENT_266	[p12l2067t404r2137b454],
18	anti-TNF-oc	JJ	O	anti-tnf-oc	amod	19	SENT_266	[p12l11t493r388b547],
19	agents	NNS	O	agent	prep_to	16	SENT_266	[p12l431t497r653b565],
20	based	VBN	O	base	partmod	19	SENT_266	[p12l695t490r892b547],
21	on	IN	O	on	_	0	SENT_266	[p12l935t507r1026b547],
22	the	DT	O	the	det	23	SENT_266	[p12l1069t490r1181b547],
23	knowledge	NN	O	knowledge	prep_on	20	SENT_266	[p12l1225t490r1604b565],
24	of	IN	O	of	_	0	SENT_266	[p12l1650t490r1721b547],
25	the	DT	O	the	det	27	SENT_266	[p12l1760t490r1871b547],
26	carrier	NN	O	carrier	nn	27	SENT_266	[p12l1916t493r2139b547],
27	status	NN	O	status	prep_of	23	SENT_266	[p12l12t591r211b641],
28	of	IN	O	of	_	0	SENT_266	[p12l239t583r310b641],
29	the	DT	O	the	det	31	SENT_266	[p12l333t584r445b641],
30	A	NN	O	a	nn	31	SENT_266	[p12l471t585r522b640],
31	allele	NN	O	allele	prep_of	27	SENT_266	[p12l549t584r749b641],
32	.	.	O	.	_	0	SENT_266	[p12l549t584r749b641],

1	It	PRP	O	it	nsubj	3	SENT_267	[p12l781t586r832b641],
2	is	VBZ	O	be	cop	3	SENT_267	[p12l859t587r909b641],
3	conceivable	JJ	O	conceivable	_	0	SENT_267	[p12l938t584r1350b641],
4	that	IN	O	that	complm	13	SENT_267	[p12l1379t584r1521b641],
5	those	DT	O	those	nsubj	22	SENT_267	[p12l1547t584r1735b641],
6	with	IN	O	with	_	0	SENT_267	[p12l1762t584r1922b641],
7	the	DT	O	the	det	9	SENT_267	[p12l1949t584r2061b641],
8	A	NN	O	a	nn	9	SENT_267	[p12l2088t585r2138b640],
9	allele	NN	O	allele	prep_with	5	SENT_267	[p12l11t677r192b734],
10	could	MD	O	could	aux	13	SENT_267	[p12l261t677r455b734],
11	either	RB	O	either	advmod	13	SENT_267	[p12l522t677r726b734],
12	be	VB	O	be	auxpass	13	SENT_267	[p12l790t677r870b734],
13	treated	VBN	O	treat	ccomp	3	SENT_267	[p12l938t677r1182b734],
14	more	RBR	O	more	advmod	15	SENT_267	[p12l1248t694r1428b734],
15	aggressively	RB	O	aggressively	advmod	13	SENT_267	[p12l1496t677r1914b752],
16	with	IN	O	with	_	0	SENT_267	[p12l1977t677r2137b734],
17	concomitant	JJ	O	concomitant	amod	20	SENT_267	[p12l11t772r463b826],
18	disease-modifying	JJ	O	disease-modifying	amod	20	SENT_267	[p12l512t769r1151b844],
19	anti-rheumatoid	JJ	O	anti-rheumatoid	amod	20	SENT_267	[p12l1199t769r1779b826],
20	drugs	NNS	O	drug	prep_with	13	SENT_267	[p12l1829t769r2018b844],
21	or	CC	O	or	_	0	SENT_267	[p12l2067t786r2138b826],
22	implement	VB	O	implement	ccomp	3	SENT_267	[p12l11t863r399b938],
23	these	DT	O	these	det	24	SENT_267	[p12l440t863r621b920],
24	biologics	NNS	O	biologic	dobj	22	SENT_267	[p12l662t863r974b938],
25	earlier	RBR	O	earlier	advmod	22	SENT_267	[p12l1017t863r1235b920],
26	in	IN	O	in	_	0	SENT_267	[p12l1276t866r1346b919],
27	the	DT	O	the	det	29	SENT_267	[p12l1387t863r1498b920],
28	therapeutic	JJ	O	therapeutic	amod	29	SENT_267	[p12l1541t863r1942b938],
29	regimen	NN	O	regimen	prep_in	25	SENT_267	[p12l1984t866r2136b938, p12l11t972r185b1012],
30	.	.	O	.	_	0	SENT_267	[p12l1984t866r2136b938, p12l11t972r185b1012],

1	Another	DT	O	another	det	3	SENT_268	[p12l230t956r522b1012],
2	potential	JJ	O	potential	amod	3	SENT_268	[p12l562t955r881b1030],
3	option	NN	O	option	nsubj	5	SENT_268	[p12l924t958r1158b1030],
4	may	MD	O	may	aux	5	SENT_268	[p12l1201t972r1352b1030],
5	include	VB	O	include	_	0	SENT_268	[p12l1392t955r1652b1012],
6	initiation	NN	O	initiation	dobj	5	SENT_268	[p12l1696t958r2028b1012],
7	of	IN	O	of	_	0	SENT_268	[p12l2071t955r2142b1012],
8	biologics	NNS	O	biologic	prep_of	6	SENT_268	[p12l9t1048r321b1123],
9	that	WDT	O	that	nsubj	13	SENT_268	[p12l373t1049r515b1105],
10	do	VBP	O	do	aux	13	SENT_268	[p12l567t1049r652b1105],
11	not	RB	O	not	neg	13	SENT_268	[p12l704t1056r824b1105],
12	specifically	RB	O	specifically	advmod	13	SENT_268	[p12l877t1048r1265b1123],
13	target	VB	O	target	rcmod	8	SENT_268	[p12l1313t1056r1514b1123],
14	TNF-or	JJ	O	tnf-or	amod	15	SENT_268	[p12l1563t1051r1776b1105],
15	blockade	NN	O	blockade	nsubj	20	SENT_268	[p12l1824t1048r2136b1105],
16	such	JJ	O	such	_	0	SENT_268	[p12l12t1142r172b1199],
17	as	IN	O	as	_	0	SENT_268	[p12l202t1159r266b1199],
18	co-stimulatory	JJ	O	co-stimulatory	amod	19	SENT_268	[p12l298t1142r814b1217],
19	antagonists	NNS	O	antagonist	prep_such_as	15	SENT_268	[p12l841t1145r1243b1217],
20	(	VBP	O	(	ccomp	13	SENT_268	[p12l1277t1142r1398b1213],
21	for	IN	O	for	_	0	SENT_268	[p12l1277t1142r1398b1213],
22	example	NN	O	example	prep_for	20	SENT_268	[p12l1428t1142r1741b1217],
23	,	,	O	,	_	0	SENT_268	[p12l1428t1142r1741b1217],
24	abatacept	JJ	O	abatacept	amod	25	SENT_268	[p12l1776t1142r2134b1217],
25	)	NN	O	)	conj_or	22	SENT_268	[p12l1776t1142r2134b1217],
26	or	CC	O	or	_	0	SENT_268	[p12l11t1251r83b1292],
27	anti-B	JJ	O	anti-b	amod	30	SENT_268	[p12l112t1237r319b1292],
28	cell	NN	O	cell	nn	30	SENT_268	[p12l350t1235r468b1292],
29	therapy	NN	O	therapy	nn	30	SENT_268	[p12l498t1235r769b1309],
30	(	NN	O	(	prep_for	20	SENT_268	[p12l800t1234r921b1306],
31	for	IN	O	for	_	0	SENT_268	[p12l800t1234r921b1306],
32	example	NN	O	example	prep_for	20	SENT_268	[p12l950t1235r1263b1309],
33	,	,	O	,	_	0	SENT_268	[p12l950t1235r1263b1309],
34	rituximab	NN	O	rituximab	nn	35	SENT_268	[p12l1298t1235r1690b1306],
35	)	NN	O	)	appos	32	SENT_268	[p12l1298t1235r1690b1306],
36	.	.	O	.	_	0	SENT_268	[p12l1298t1235r1690b1306],

1	Meanwhile	RB	O	meanwhile	advmod	12	SENT_269	[p12l1723t1235r2132b1304],
2	,	,	O	,	_	0	SENT_269	[p12l1723t1235r2132b1304],
3	for	IN	O	for	_	0	SENT_269	[p12l11t1327r108b1385],
4	those	DT	O	those	prep_for	12	SENT_269	[p12l154t1328r342b1385],
5	with	IN	O	with	_	0	SENT_269	[p12l388t1328r548b1385],
6	the	DT	O	the	det	8	SENT_269	[p12l596t1328r707b1385],
7	G/G	NN	O	g/g	nn	8	SENT_269	[p12l757t1327r901b1392],
8	genotype	NN	O	genotype	prep_with	4	SENT_269	[p12l948t1335r1291b1402],
9	,	,	O	,	_	0	SENT_269	[p12l948t1335r1291b1402],
10	it	PRP	O	it	nsubj	12	SENT_269	[p12l1343t1331r1391b1385],
11	may	MD	O	may	aux	12	SENT_269	[p12l1438t1344r1590b1402],
12	be	VB	O	be	_	0	SENT_269	[p12l1632t1328r1712b1385],
13	of	IN	O	of	_	0	SENT_269	[p12l1761t1327r1831b1385],
14	interest	NN	O	interest	prep_of	12	SENT_269	[p12l1874t1331r2138b1385],
15	to	TO	O	to	aux	16	SENT_269	[p12l10t1428r80b1478],
16	monitor	VB	O	monitor	xcomp	12	SENT_269	[p12l176t1424r467b1478],
17	therapeutic	JJ	O	therapeutic	amod	18	SENT_269	[p12l561t1421r963b1496],
18	endpoints	NNS	O	endpoint	dobj	16	SENT_269	[p12l1058t1421r1411b1496],
19	with	IN	O	with	_	0	SENT_269	[p12l1505t1421r1666b1478],
20	anti-TNF-oc	JJ	O	anti-tnf-oc	amod	21	SENT_269	[p12l1762t1424r2139b1478],
21	monotherapy	NN	O	monotherapy	prep_with	16	SENT_269	[p12l11t1514r494b1588],
22	(	CD	NUMBER	(	num	21	SENT_269	[p12l538t1513r612b1585],
23	if	IN	O	if	mark	24	SENT_269	[p12l538t1513r612b1585],
24	deemed	VBN	O	deem	dep	21	SENT_269	[p12l651t1514r925b1571],
25	appropriate	JJ	O	appropriate	acomp	24	SENT_269	[p12l968t1517r1373b1588],
26	on	IN	O	on	_	0	SENT_269	[p12l1417t1530r1508b1571],
27	the	DT	O	the	det	28	SENT_269	[p12l1551t1514r1662b1571],
28	basis	NN	O	basis	prep_on	25	SENT_269	[p12l1704t1514r1870b1571],
29	of	IN	O	of	_	0	SENT_269	[p12l1915t1513r1986b1571],
30	the	DT	O	the	det	31	SENT_269	[p12l2025t1514r2137b1571],
31	type	NN	O	type	prep_of	28	SENT_269	[p12l10t1614r160b1682],
32	of	IN	O	of	_	0	SENT_269	[p12l206t1607r277b1664],
33	anti-TNF	JJ	O	anti-tnf	amod	35	SENT_269	[p12l318t1610r626b1664],
34	therapy	NN	O	therapy	nn	35	SENT_269	[p12l670t1607r962b1682],
35	)	NN	O	)	prep_of	31	SENT_269	[p12l670t1607r962b1682],
36	rather	RB	O	rather	advmod	24	SENT_269	[p12l1010t1607r1221b1664],
37	than	IN	O	than	_	0	SENT_269	[p12l1265t1607r1428b1664],
38	the	DT	O	the	det	44	SENT_269	[p12l1472t1607r1584b1664],
39	more	JJR	O	more	amod	44	SENT_269	[p12l1629t1624r1808b1664],
40	conventional	JJ	O	conventional	amod	44	SENT_269	[p12l1854t1624r2136b1664, p12l10t1699r216b1756],
41	combination	NN	O	combination	nn	44	SENT_269	[p12l254t1699r708b1756],
42	therapy	NN	O	therapy	nn	44	SENT_269	[p12l746t1699r1017b1774],
43	(	CD	NUMBER	(	num	44	SENT_269	[p12l1055t1700r1190b1770],
44	use	NN	O	use	prep_than	24	SENT_269	[p12l1055t1700r1190b1770],
45	of	IN	O	of	_	0	SENT_269	[p12l1228t1699r1300b1756],
46	anti-TNF-or	JJ	O	anti-tnf-or	amod	47	SENT_269	[p12l1333t1702r1710b1756],
47	agents	NNS	O	agent	prep_of	44	SENT_269	[p12l1747t1707r1969b1774],
48	and	CC	O	and	_	0	SENT_269	[p12l2007t1699r2138b1756],
49	concomitant	JJ	O	concomitant	amod	52	SENT_269	[p12l11t1796r463b1850],
50	disease-modifying	JJ	O	disease-modifying	amod	52	SENT_269	[p12l536t1793r1174b1868],
51	anti-rheumatoid	JJ	O	anti-rheumatoid	amod	52	SENT_269	[p12l1245t1793r1826b1850],
52	drugs	NNS	O	drug	prep_of	44	SENT_269	[p12l1898t1793r2132b1868],
53	)	RB	O	)	tmod	44	SENT_269	[p12l1898t1793r2132b1868],
54	,	,	O	,	_	0	SENT_269	[p12l1898t1793r2132b1868],
55	which	WDT	O	which	nsubjpass	58	SENT_269	[p12l9t1885r228b1942],
56	is	VBZ	O	be	auxpass	58	SENT_269	[p12l267t1888r317b1942],
57	routinely	RB	O	routinely	advmod	58	SENT_269	[p12l357t1885r683b1960],
58	prescribed	VBN	O	prescribe	dep	53	SENT_269	[p12l720t1885r1080b1960],
59	for	IN	O	for	_	0	SENT_269	[p12l1119t1885r1217b1942],
60	the	DT	O	the	det	61	SENT_269	[p12l1255t1885r1367b1942],
61	treatment	NN	O	treatment	prep_for	58	SENT_269	[p12l1407t1893r1756b1942],
62	of	IN	O	of	_	0	SENT_269	[p12l1795t1885r1867b1942],
63	RA	NN	O	ra	prep_of	61	SENT_269	[p12l1903t1887r2017b1942],
64	.	.	O	.	_	0	SENT_269	[p12l1903t1887r2017b1942],

1	At	IN	O	at	_	0	SENT_270	[p12l2059t1887r2138b1942],
2	present	JJ	DATE	present	prep_at	9	SENT_270	[p12l10t1986r285b2053],
3	,	,	O	,	_	0	SENT_270	[p12l10t1986r285b2053],
4	these	DT	O	these	det	6	SENT_270	[p12l323t1979r503b2035],
5	therapeutic	JJ	O	therapeutic	amod	6	SENT_270	[p12l538t1979r939b2053],
6	options	NNS	O	option	nsubj	9	SENT_270	[p12l973t1981r1237b2053],
7	are	VBP	O	be	cop	9	SENT_270	[p12l1272t1995r1373b2035],
8	just	RB	O	just	advmod	9	SENT_270	[p12l1408t1981r1533b2053],
9	hypotheses	NNS	O	hypothesis	_	0	SENT_270	[p12l1567t1978r1962b2053],
10	that	WDT	O	that	nsubj	12	SENT_270	[p12l1995t1978r2138b2035],
11	will	MD	O	will	aux	12	SENT_270	[p12l9t2072r138b2128],
12	require	VB	O	require	rcmod	9	SENT_270	[p12l177t2075r423b2147],
13	testing	NN	O	testing	dobj	12	SENT_270	[p12l463t2075r702b2147],
14	in	IN	O	in	_	0	SENT_270	[p12l738t2075r809b2128],
15	the	DT	O	the	det	17	SENT_270	[p12l847t2072r959b2129],
16	clinical	JJ	O	clinical	amod	17	SENT_270	[p12l999t2072r1253b2129],
17	setting	NN	O	setting	prep_in	12	SENT_270	[p12l1294t2075r1547b2147],
18	.	.	O	.	_	0	SENT_270	[p12l1294t2075r1547b2147],

1	However	RB	O	however	advmod	4	SENT_271	[p12l1591t2074r1914b2141],
2	,	,	O	,	_	0	SENT_271	[p12l1591t2074r1914b2141],
3	there	EX	O	there	expl	4	SENT_271	[p12l1957t2072r2136b2129],
4	seems	VBZ	O	seem	_	0	SENT_271	[p12l12t2181r216b2222],
5	to	TO	O	to	aux	8	SENT_271	[p12l266t2172r335b2222],
6	be	VB	O	be	cop	8	SENT_271	[p12l384t2165r463b2222],
7	mounting	VBG	O	mount	amod	8	SENT_271	[p12l514t2168r869b2239],
8	evidence	NN	O	evidence	xcomp	4	SENT_271	[p12l918t2165r1225b2222],
9	to	TO	O	to	aux	10	SENT_271	[p12l1275t2172r1345b2222],
10	proceed	VB	O	proceed	infmod	8	SENT_271	[p12l1394t2165r1671b2239],
11	in	IN	O	in	_	0	SENT_271	[p12l1721t2168r1791b2221],
12	formally	RB	O	formally	advmod	13	SENT_271	[p12l1840t2164r2140b2239],
13	evaluating	VBG	O	evaluate	prepc_in	10	SENT_271	[p12l11t2258r380b2332],
14	these	DT	O	these	det	16	SENT_271	[p12l400t2258r581b2315],
15	therapeutic	JJ	O	therapeutic	amod	16	SENT_271	[p12l604t2258r1005b2332],
16	approaches	NNS	O	approach	dobj	13	SENT_271	[p12l1028t2258r1440b2332],
17	,	,	O	,	_	0	SENT_271	[p12l1028t2258r1440b2332],
18	as	IN	O	as	mark	21	SENT_271	[p12l1468t2274r1533b2315],
19	they	PRP	O	they	nsubj	21	SENT_271	[p12l1555t2258r1712b2332],
20	may	MD	O	may	aux	21	SENT_271	[p12l1732t2274r1883b2332],
21	lead	VB	O	lead	advcl	4	SENT_271	[p12l1903t2258r2046b2315],
22	to	TO	O	to	_	0	SENT_271	[p12l2067t2265r2137b2315],
23	improved	VBN	O	improve	amod	24	SENT_271	[p12l11t2351r349b2426],
24	effectiveness	NN	O	effectiveness	prep_to	21	SENT_271	[p12l379t2351r821b2408],
25	of	IN	O	of	_	0	SENT_271	[p12l852t2351r923b2408],
26	these	DT	O	these	det	28	SENT_271	[p12l948t2351r1128b2408],
27	expensive	JJ	O	expensive	amod	28	SENT_271	[p12l1159t2354r1504b2426],
28	drugs	NNS	O	drug	prep_of	24	SENT_271	[p12l1535t2351r1743b2426],
29	.	.	O	.	_	0	SENT_271	[p12l1535t2351r1743b2426],

1	Materials	NNPS	O	Materials	_	0	SENT_272	[p12l13t2579r368b2637],
2	and	CC	O	and	_	0	SENT_272	[p12l398t2579r538b2637],
3	Methods	NNS	O	method	conj_and	1	SENT_272	[p12l572t2579r902b2637],

1	Data	NNS	O	datum	nn	2	SENT_273	[p12l14t2768r170b2822],
2	extraction	NN	O	extraction	_	0	SENT_273	[p12l200t2767r534b2822],
3	:	:	O	:	_	0	SENT_273	[p12l200t2767r534b2822],
4	selection	NN	O	selection	dep	2	SENT_273	[p12l563t2765r833b2822],
5	of	IN	O	of	_	0	SENT_273	[p12l863t2765r930b2822],
6	association	NN	O	association	nn	7	SENT_273	[p12l950t2767r1300b2822],
7	studies	NNS	O	study	prep_of	4	SENT_273	[p12l1329t2765r1545b2822],
8	for	IN	O	for	_	0	SENT_273	[p12l1575t2765r1663b2822],
9	analysis	NN	O	analysis	prep_for	4	SENT_273	[p12l1686t2765r1935b2840],
10	We	PRP	O	we	nsubj	11	SENT_273	[p12l9t2861r118b2915],
11	searched	VBD	O	search	rcmod	4	SENT_273	[p12l162t2858r465b2915],
12	MEDLINE	NN	ORGANIZATION	medline	nn	14	SENT_273	[p12l503t2861r852b2915],
13	citation	NN	O	citation	nn	14	SENT_273	[p12l892t2861r1164b2915],
14	index	NN	O	index	dobj	11	SENT_273	[p12l1205t2858r1403b2915],
15	(	CD	NUMBER	(	dobj	40	SENT_273	[p12l1447t2858r1639b2929],
16	from	IN	O	from	_	0	SENT_273	[p12l1447t2858r1639b2929],
17	1950	CD	DATE	1950	prep_from	15	SENT_273	[p12l1686t2860r1850b2915],
18	to	TO	DATE	to	_	0	SENT_273	[p12l1891t2866r1960b2915],
19	July	NNP	DATE	July	prep_to	17	SENT_273	[p12l1993t2858r2140b2933],
20	2008	CD	DATE	2008	num	19	SENT_273	[p12l12t2952r225b3023],
21	)	NNP	O	)	nn	23	SENT_273	[p12l12t2952r225b3023],
22	,	,	O	,	_	0	SENT_273	[p12l12t2952r225b3023],
23	EMBASE	NNP	O	EMBASE	nsubj	40	SENT_273	[p12l255t2954r549b3009],
24	(	CD	NUMBER	(	num	23	SENT_273	[p12l576t2952r768b3023],
25	from	IN	O	from	_	0	SENT_273	[p12l576t2952r768b3023],
26	1980	CD	DATE	1980	prep_from	23	SENT_273	[p12l799t2954r963b3009],
27	to	TO	DATE	to	_	0	SENT_273	[p12l988t2959r1057b3009],
28	July	NNP	DATE	July	prep_to	26	SENT_273	[p12l1074t2952r1220b3027],
29	2008	CD	DATE	2008	num	28	SENT_273	[p12l1243t2952r1457b3023],
30	)	CD	NUMBER	)	dep	28	SENT_273	[p12l1243t2952r1457b3023],
31	,	,	O	,	_	0	SENT_273	[p12l1243t2952r1457b3023],
32	as	RB	O	as	_	0	SENT_273	[p12l1487t2969r1551b3009],
33	well	RB	O	well	_	0	SENT_273	[p12l1575t2952r1718b3009],
34	as	IN	O	as	_	0	SENT_273	[p12l1744t2969r1809b3009],
35	abstracts	NNS	O	abstract	conj_and	28	SENT_273	[p12l1835t2952r2137b3009],
36	in	IN	O	in	_	0	SENT_273	[p12l11t3048r81b3101],
37	major	JJ	O	major	amod	39	SENT_273	[p12l148t3048r354b3119],
38	rheumatology	NN	O	rheumatology	nn	39	SENT_273	[p12l421t3045r921b3119],
39	journals	NNS	O	journal	prep_in	35	SENT_273	[p12l987t3045r1269b3119],
40	(	VBP	O	(	rcmod	14	SENT_273	[p12l1341t3045r1636b3116],
41	Arthritis	NNP	MISC	Arthritis	nn	44	SENT_273	[p12l1341t3045r1636b3116],
42	Rheumatism	NNP	MISC	Rheumatism	nn	44	SENT_273	[p12l1701t3044r2133b3114],
43	,	,	O	,	_	0	SENT_273	[p12l1701t3044r2133b3114],
44	Annals	NNP	O	Annals	dobj	40	SENT_273	[p12l6t3138r240b3195],
45	of	IN	O	of	_	0	SENT_273	[p12l290t3137r366b3212],
46	Rheumatic	NNP	O	Rheumatic	nn	47	SENT_273	[p12l395t3138r748b3195],
47	Disease	NNP	O	Disease	prep_of	44	SENT_273	[p12l790t3138r1056b3207],
48	,	,	O	,	_	0	SENT_273	[p12l790t3138r1056b3207],
49	Rheumatology	NNP	O	Rheumatology	prep_of	44	SENT_273	[p12l1107t3138r1576b3213],
50	and	CC	O	and	_	0	SENT_273	[p12l1622t3138r1747b3195],
51	Ioamal	NNP	O	Ioamal	prep_of	44	SENT_273	[p12l1788t3138r2031b3208],
52	of	IN	O	of	_	0	SENT_273	[p12l2078t3137r2154b3212],
53	Rheumatology	NNP	O	Rheumatology	prep_of	44	SENT_273	[p12l7t3231r517b3306],
54	)	CD	NUMBER	)	num	53	SENT_273	[p12l7t3231r517b3306],
55	.	.	O	.	_	0	SENT_273	[p12l7t3231r517b3306],

1	In	IN	O	in	_	0	SENT_274	[p12l566t3234r638b3287],
2	searching	VBG	O	search	prepc_in	17	SENT_274	[p12l683t3231r1017b3306],
3	the	DT	O	the	det	4	SENT_274	[p12l1059t3231r1171b3288],
4	databases	NNS	O	database	dobj	2	SENT_274	[p12l1216t3231r1564b3301],
5	,	,	O	,	_	0	SENT_274	[p12l1216t3231r1564b3301],
6	the	DT	O	the	det	8	SENT_274	[p12l1612t3231r1724b3288],
7	key	JJ	O	key	amod	8	SENT_274	[p12l1768t3231r1889b3306],
8	words	NNS	O	word	nsubj	17	SENT_274	[p12l1928t3231r2137b3288],
9	used	VBN	O	use	partmod	8	SENT_274	[p13l7t83r168b141],
10	in	IN	O	in	_	0	SENT_274	[p13l193t86r264b140],
11	the	DT	O	the	det	12	SENT_274	[p13l290t83r403b141],
12	search	NN	O	search	prep_in	9	SENT_274	[p13l431t83r651b141],
13	were	VBD	O	be	cop	17	SENT_274	[p13l675t100r838b141],
14	‘	CD	NUMBER	‘	num	17	SENT_274	[p13l868t83r1108b141],
15	tumor	NN	O	tumor	nn	17	SENT_274	[p13l868t83r1108b141],
16	necrosis	NN	O	necrosis	nn	17	SENT_274	[p13l1133t86r1415b141],
17	factor	NN	O	factor	_	0	SENT_274	[p13l1442t83r1684b153],
18	’	CD	NUMBER	’	dep	17	SENT_274	[p13l1442t83r1684b153],
19	,	,	O	,	_	0	SENT_274	[p13l1442t83r1684b153],
20	’	CD	NUMBER	’	num	22	SENT_274	[p13l1717t83r2144b159],
21	TNF-alpha	NN	O	tnf-alpha	nn	22	SENT_274	[p13l1717t83r2144b159],
22	’	NN	O	’	appos	17	SENT_274	[p13l1717t83r2144b159],
23	,	,	O	,	_	0	SENT_274	[p13l1717t83r2144b159],
24	‘	CD	NUMBER	‘	num	26	SENT_274	[p13l10t178r398b254],
25	TNF-alpha	NN	O	tnf-alpha	nn	26	SENT_274	[p13l10t178r398b254],
26	blockade	NN	O	blockade	appos	17	SENT_274	[p13l456t178r811b248],
27	’	CD	NUMBER	’	dep	26	SENT_274	[p13l456t178r811b248],
28	,	,	O	,	_	0	SENT_274	[p13l456t178r811b248],
29	‘	CD	NUMBER	‘	npadvmod	30	SENT_274	[p13l880t178r1279b236],
30	anti	JJ	O	anti	amod	17	SENT_274	[p13l880t178r1279b236],
31	.	.	O	.	_	0	SENT_274	[p13l880t178r1279b236],

1	—	NN	O	—	_	0	SENT_275	[p13l880t178r1279b236],
2	.	.	O	.	_	0	SENT_275	[p13l880t178r1279b236],

1	TNF-oc	JJ	O	tnf-oc	amod	3	SENT_276	[p13l880t178r1279b236],
2	therapy	NN	O	therapy	nn	3	SENT_276	[p13l1339t178r1648b254],
3	’	NN	O	’	_	0	SENT_276	[p13l1339t178r1648b254],
4	,	,	O	,	_	0	SENT_276	[p13l1339t178r1648b254],
5	‘	NN	O	‘	nn	7	SENT_276	[p13l1716t178r2143b248],
6	inﬂiximab	NN	O	inﬂiximab	nn	7	SENT_276	[p13l1716t178r2143b248],
7	’	NN	O	’	appos	3	SENT_276	[p13l1716t178r2143b248],
8	,	,	O	,	_	0	SENT_276	[p13l1716t178r2143b248],
9	’	NN	O	’	nn	10	SENT_276	[p13l10t273r439b349],
10	etanercept	NN	O	etanercept	appos	3	SENT_276	[p13l10t273r439b349],
11	’	CD	NUMBER	’	dep	10	SENT_276	[p13l10t273r439b349],
12	,	,	O	,	_	0	SENT_276	[p13l10t273r439b349],
13	‘	CD	NUMBER	‘	num	15	SENT_276	[p13l496t273r998b344],
14	adalimumab	JJ	O	adalimumab	amod	15	SENT_276	[p13l496t273r998b344],
15	’	NN	O	’	appos	3	SENT_276	[p13l496t273r998b344],
16	,	,	O	,	_	0	SENT_276	[p13l496t273r998b344],
17	‘	CD	NUMBER	‘	num	20	SENT_276	[p13l1055t273r1491b331],
18	rheumatoid	JJ	O	rheumatoid	amod	20	SENT_276	[p13l1055t273r1491b331],
19	arthritis	NN	O	arthritis	nn	20	SENT_276	[p13l1542t273r1861b344],
20	’	NN	O	’	appos	3	SENT_276	[p13l1542t273r1861b344],
21	,	,	O	,	_	0	SENT_276	[p13l1542t273r1861b344],
22	’	CD	NUMBER	’	num	25	SENT_276	[p13l1917t274r2149b331],
23	TNF-oz	NN	O	tnf-oz	nn	25	SENT_276	[p13l1917t274r2149b331],
24	promoter	NN	O	promoter	nn	25	SENT_276	[p13l8t375r341b443],
25	SNPs	NNS	O	snp	appos	3	SENT_276	[p13l380t368r568b425],
26	’	CD	NUMBER	’	num	29	SENT_276	[p13l380t368r568b425],
27	and	CC	O	and	_	0	SENT_276	[p13l611t367r742b425],
28	‘	CD	NUMBER	‘	num	29	SENT_276	[p13l783t368r1014b425],
29	TNF-oc	NN	O	tnf-oc	npadvmod	30	SENT_276	[p13l783t368r1014b425],
30	variant	JJ	O	variant	amod	25	SENT_276	[p13l1050t370r1302b425],
31	-308	CD	NUMBER	-308	num	32	SENT_276	[p13l1345t367r1567b425],
32	’	NN	O	’	dep	25	SENT_276	[p13l1345t367r1567b425],
33	.	.	O	.	_	0	SENT_276	[p13l1345t367r1567b425],

1	The	DT	O	the	det	3	SENT_277	[p13l1609t367r1741b425],
2	key	JJ	O	key	amod	3	SENT_277	[p13l1781t368r1903b443],
3	words	NNS	O	word	nsubjpass	5	SENT_277	[p13l1938t367r2148b425],
4	were	VBD	O	be	auxpass	5	SENT_277	[p13l7t480r170b521],
5	entered	VBN	O	enter	_	0	SENT_277	[p13l208t463r473b521],
6	as	IN	O	as	_	0	SENT_277	[p13l510t480r575b521],
7	both	DT	O	both	det	9	SENT_277	[p13l609t463r776b521],
8	medical	JJ	O	medical	amod	9	SENT_277	[p13l812t463r1090b521],
9	subject	NN	O	subject	prep_as	5	SENT_277	[p13l1128t463r1374b539],
10	and	CC	O	and	_	0	SENT_277	[p13l1411t463r1542b521],
11	text	NN	O	text	nn	12	SENT_277	[p13l1577t470r1713b521],
12	words	NNS	O	word	conj_and	9	SENT_277	[p13l1747t463r1976b521],
13	.	.	O	.	_	0	SENT_277	[p13l1747t463r1976b521],

1	The	DT	O	the	det	2	SENT_278	[p13l2015t463r2147b521],
2	language	NN	O	language	nsubjpass	7	SENT_278	[p13l8t558r324b633],
3	of	IN	O	of	_	0	SENT_278	[p13l353t557r424b615],
4	origin	NN	O	origin	prep_of	2	SENT_278	[p13l448t560r657b633],
5	was	VBD	O	be	auxpass	7	SENT_278	[p13l683t574r811b615],
6	not	RB	O	not	neg	7	SENT_278	[p13l839t565r959b615],
7	limited	VBN	O	limit	_	0	SENT_278	[p13l986t557r1258b615],
8	.	.	O	.	_	0	SENT_278	[p13l986t557r1258b615],

1	Once	RB	DATE	once	advmod	5	SENT_279	[p13l1291t559r1473b615],
2	these	DT	O	these	det	3	SENT_279	[p13l1500t557r1682b615],
3	articles	NNS	O	article	nsubjpass	5	SENT_279	[p13l1711t558r1958b615],
4	were	VBD	O	be	auxpass	5	SENT_279	[p13l1984t574r2147b615],
5	identified	VBN	O	identify	dep	14	SENT_279	[p13l8t653r368b723],
6	,	,	O	,	_	0	SENT_279	[p13l8t653r368b723],
7	the	DT	O	the	det	8	SENT_279	[p13l399t653r511b711],
8	references	NNS	O	reference	nsubjpass	14	SENT_279	[p13l539t653r891b711],
9	of	IN	O	of	_	0	SENT_279	[p13l918t653r990b711],
10	these	DT	O	these	det	11	SENT_279	[p13l1011t653r1193b711],
11	articles	NNS	O	article	prep_of	8	SENT_279	[p13l1221t653r1468b711],
12	were	VBD	O	be	auxpass	14	SENT_279	[p13l1493t670r1656b711],
13	subsequently	RB	O	subsequently	advmod	14	SENT_279	[p13l1685t653r2151b729],
14	searched	VBN	O	search	_	0	SENT_279	[p13l10t747r332b804],
15	.	.	O	.	_	0	SENT_279	[p13l10t747r332b804],

1	Genetic	JJ	O	genetic	amod	3	SENT_280	[p13l86t843r359b899],
2	association	NN	O	association	nn	3	SENT_280	[p13l391t845r781b899],
3	studies	NNS	O	study	nsubjpass	51	SENT_280	[p13l814t842r1054b899],
4	that	WDT	O	that	nsubj	5	SENT_280	[p13l1086t842r1229b899],
5	assessed	VBD	O	assess	rcmod	3	SENT_280	[p13l1261t842r1543b899],
6	T	NN	O	t	iobj	5	SENT_280	[p13l1572t844r1619b899],
7	NF-oc	NN	MISC	nf-oc	nn	8	SENT_280	[p13l1620t844r1786b899],
8	promoter	NN	O	promoter	dobj	5	SENT_280	[p13l1816t849r2150b917],
9	variant	JJ	O	variant	amod	10	SENT_280	[p13l6t940r257b995],
10	-308	CD	NUMBER	-308	nsubj	14	SENT_280	[p13l303t939r484b995],
11	in	IN	O	in	_	0	SENT_280	[p13l527t940r598b994],
12	RA	NN	O	ra	prep_in	10	SENT_280	[p13l640t939r738b994],
13	were	VBD	O	be	cop	14	SENT_280	[p13l775t954r939b995],
14	eligible	JJ	O	eligible	rcmod	8	SENT_280	[p13l983t937r1235b1013],
15	for	IN	O	for	_	0	SENT_280	[p13l1278t937r1376b995],
16	inclusion	NN	O	inclusion	prep_for	14	SENT_280	[p13l1417t937r1746b995],
17	if	IN	O	if	advmod	14	SENT_280	[p13l1788t937r1853b995],
18	:	:	O	:	_	0	SENT_280	[p13l1788t937r1853b995],
19	(	NN	O	(	conj_and	8	SENT_280	[p13l1903t937r1989b1009],
20	1	CD	NUMBER	1	number	21	SENT_280	[p13l1903t937r1989b1009],
21	)	CD	NUMBER	)	num	23	SENT_280	[p13l1903t937r1989b1009],
22	the	DT	O	the	det	23	SENT_280	[p13l2035t937r2147b995],
23	study	NN	O	study	nsubjpass	25	SENT_280	[p13l10t1032r202b1108],
24	was	VBD	O	be	auxpass	25	SENT_280	[p13l224t1049r352b1090],
25	published	VBN	O	publish	rcmod	19	SENT_280	[p13l378t1032r727b1108],
26	by	IN	O	by	_	0	SENT_280	[p13l751t1032r838b1108],
27	July	NNP	DATE	July	agent	25	SENT_280	[p13l853t1032r1001b1108],
28	2008	CD	DATE	2008	num	27	SENT_280	[p13l1026t1034r1214b1102],
29	;	:	O	;	_	0	SENT_280	[p13l1026t1034r1214b1102],
30	(	CD	NUMBER	(	number	31	SENT_280	[p13l1248t1032r1335b1104],
31	2	CD	NUMBER	2	conj_and	8	SENT_280	[p13l1248t1032r1335b1104],
32	)	IN	O	)	_	0	SENT_280	[p13l1248t1032r1335b1104],
33	the	DT	O	the	det	34	SENT_280	[p13l1365t1032r1477b1090],
34	study	NN	O	study	prep_)	31	SENT_280	[p13l1506t1032r1698b1108],
35	was	VBD	O	be	cop	37	SENT_280	[p13l1720t1049r1848b1090],
36	original	JJ	O	original	amod	37	SENT_280	[p13l1875t1032r2148b1108],
37	data	NNS	O	datum	rcmod	34	SENT_280	[p13l9t1127r158b1185],
38	that	WDT	O	that	nsubjpass	42	SENT_280	[p13l184t1127r327b1185],
39	was	VBD	O	be	auxpass	42	SENT_280	[p13l352t1144r480b1185],
40	not	RB	O	not	neg	42	SENT_280	[p13l507t1134r628b1185],
41	earlier	JJR	O	earlier	advmod	42	SENT_280	[p13l654t1127r873b1185],
42	published	VBN	O	publish	rcmod	37	SENT_280	[p13l898t1127r1246b1203],
43	and	CC	O	and	_	0	SENT_280	[p13l1274t1127r1405b1185],
44	(	NN	O	(	nn	46	SENT_280	[p13l1435t1127r1522b1199],
45	3	CD	NUMBER	3	num	46	SENT_280	[p13l1435t1127r1522b1199],
46	)	NN	O	)	conj_and	8	SENT_280	[p13l1435t1127r1522b1199],
47	enough	RB	O	enough	advmod	48	SENT_280	[p13l1553t1127r1821b1203],
48	raw	JJ	O	raw	amod	49	SENT_280	[p13l1848t1144r1975b1185],
49	data	NNS	O	datum	dep	46	SENT_280	[p13l2000t1127r2149b1185],
50	was	VBD	O	be	auxpass	51	SENT_280	[p13l7t1239r134b1280],
51	provided	VBN	O	provide	_	0	SENT_280	[p13l165t1222r480b1298],
52	in	IN	O	in	_	0	SENT_280	[p13l510t1225r580b1279],
53	the	DT	O	the	det	54	SENT_280	[p13l610t1222r723b1280],
54	paper	NN	O	paper	prep_in	51	SENT_280	[p13l754t1239r951b1298],
55	to	TO	O	to	aux	56	SENT_280	[p13l980t1229r1049b1280],
56	calculate	VB	O	calculate	xcomp	51	SENT_280	[p13l1081t1222r1391b1280],
57	the	DT	O	the	det	58	SENT_280	[p13l1422t1222r1534b1280],
58	OR	NN	O	or	dobj	56	SENT_280	[p13l1567t1224r1691b1280],
59	.	.	O	.	_	0	SENT_280	[p13l1567t1224r1691b1280],

1	Studies	NNS	O	study	_	0	SENT_281	[p13l1726t1222r1975b1280],
2	that	WDT	O	that	nsubj	3	SENT_281	[p13l2005t1222r2149b1280],
3	had	VBD	O	have	rcmod	1	SENT_281	[p13l8t1316r140b1374],
4	overlapping	VBG	O	overlap	amod	5	SENT_281	[p13l169t1316r592b1392],
5	data	NNS	O	datum	dobj	3	SENT_281	[p13l621t1316r769b1374],
6	and/or	NN	O	and/or	nn	8	SENT_281	[p13l798t1316r1035b1382],
7	insufficient	JJ	O	insufficient	amod	8	SENT_281	[p13l1062t1316r1465b1374],
8	data	NNS	O	datum	dep	1	SENT_281	[p13l1495t1316r1644b1374],
9	on	IN	O	on	_	0	SENT_281	[p13l1672t1333r1764b1374],
10	the	DT	O	the	det	11	SENT_281	[p13l1792t1316r1904b1374],
11	alleles	NNS	O	allele	prep_on	8	SENT_281	[p13l1935t1316r2148b1374],
12	that	WDT	O	that	nsubj	13	SENT_281	[p13l8t1412r152b1470],
13	predicted	VBD	O	predict	rcmod	8	SENT_281	[p13l214t1412r545b1488],
14	response	NN	O	response	nsubjpass	16	SENT_281	[p13l608t1429r913b1488],
15	were	VBD	O	be	auxpass	16	SENT_281	[p13l976t1429r1139b1470],
16	excluded	VBN	O	exclude	ccomp	13	SENT_281	[p13l1204t1412r1521b1470],
17	from	IN	O	from	_	0	SENT_281	[p13l1584t1412r1753b1470],
18	statistical	JJ	O	statistical	amod	19	SENT_281	[p13l1818t1412r2148b1470],
19	analysis	NN	O	analysis	prep_from	16	SENT_281	[p13l9t1506r303b1582],
20	.	.	O	.	_	0	SENT_281	[p13l9t1506r303b1582],

1	The	DT	O	the	det	2	SENT_282	[p13l83t1602r215b1660],
2	information	NN	O	information	nsubjpass	4	SENT_282	[p13l255t1602r687b1660],
3	was	VBD	O	be	auxpass	4	SENT_282	[p13l724t1619r852b1660],
4	extracted	VBN	O	extract	_	0	SENT_282	[p13l892t1602r1218b1660],
5	from	IN	O	from	_	0	SENT_282	[p13l1256t1602r1426b1660],
6	each	DT	O	each	det	7	SENT_282	[p13l1466t1602r1626b1660],
7	study	NN	O	study	prep_from	4	SENT_282	[p13l1667t1602r1859b1678],
8	by	IN	O	by	_	0	SENT_282	[p13l1893t1602r1981b1678],
9	two	CD	NUMBER	two	num	11	SENT_282	[p13l2018t1609r2148b1660],
10	independent	JJ	O	independent	amod	11	SENT_282	[p13l8t1697r462b1773],
11	investigators	NNS	O	investigator	agent	4	SENT_282	[p13l502t1700r951b1773],
12	(	VBP	O	(	dep	11	SENT_282	[p13l996t1697r1137b1769],
13	DO	NN	O	do	nn	16	SENT_282	[p13l996t1697r1137b1769],
14	and	CC	O	and	_	0	SENT_282	[p13l1179t1697r1311b1755],
15	NR	NN	MISC	nr	nn	16	SENT_282	[p13l1350t1697r1502b1769],
16	)	NN	O	)	dobj	12	SENT_282	[p13l1350t1697r1502b1769],
17	.	.	O	.	_	0	SENT_282	[p13l1350t1697r1502b1769],

1	The	DT	O	the	det	2	SENT_283	[p13l1544t1697r1677b1755],
2	results	NNS	O	result	nsubjpass	5	SENT_283	[p13l1719t1697r1944b1755],
3	were	VBD	O	be	auxpass	5	SENT_283	[p13l1984t1714r2147b1755],
4	subsequently	RB	O	subsequently	advmod	5	SENT_283	[p13l10t1792r476b1867],
5	reassessed	VBN	O	reassess	_	0	SENT_283	[p13l522t1792r872b1849],
6	by	IN	O	by	_	0	SENT_283	[p13l919t1792r1006b1867],
7	a	DT	O	a	det	9	SENT_283	[p13l1054t1808r1088b1849],
8	third	JJ	ORDINAL	third	amod	9	SENT_283	[p13l1137t1792r1312b1849],
9	investigator	NN	O	investigator	agent	5	SENT_283	[p13l1361t1795r1780b1867],
10	after	IN	O	after	mark	15	SENT_283	[p13l1829t1791r1987b1849],
11	the	DT	O	the	det	13	SENT_283	[p13l2035t1792r2147b1849],
12	relevant	JJ	O	relevant	amod	13	SENT_283	[p13l8t1886r295b1944],
13	data	NNS	O	datum	nsubjpass	15	SENT_283	[p13l350t1886r499b1944],
14	was	VBD	O	be	auxpass	15	SENT_283	[p13l551t1903r679b1944],
15	extracted	VBN	O	extract	advcl	5	SENT_283	[p13l734t1886r1060b1944],
16	(	JJ	O	(	amod	18	SENT_283	[p13l1118t1886r1274b1958],
17	PR	NN	O	pr	nn	18	SENT_283	[p13l1118t1886r1274b1958],
18	)	NN	O	)	dobj	15	SENT_283	[p13l1118t1886r1274b1958],
19	,	,	O	,	_	0	SENT_283	[p13l1118t1886r1274b1958],
20	and	CC	O	and	_	0	SENT_283	[p13l1334t1886r1465b1944],
21	a	DT	O	a	det	22	SENT_283	[p13l1521t1903r1555b1944],
22	consensus	NN	O	consensus	nsubjpass	24	SENT_283	[p13l1610t1903r1966b1944],
23	was	VBD	O	be	auxpass	24	SENT_283	[p13l2020t1903r2148b1944],
24	reached	VBN	O	reach	conj_and	5	SENT_283	[p13l8t1981r284b2038],
25	for	IN	O	for	_	0	SENT_283	[p13l315t1981r414b2038],
26	all	DT	O	all	det	27	SENT_283	[p13l445t1981r527b2038],
27	studies	NNS	O	study	prep_for	24	SENT_283	[p13l560t1981r819b2038],
28	.	.	O	.	_	0	SENT_283	[p13l560t1981r819b2038],

1	The	DT	O	the	det	2	SENT_284	[p13l853t1981r986b2038],
2	information	NN	O	information	nsubj	4	SENT_284	[p13l1018t1981r1450b2038],
3	extracted	VBN	O	extract	partmod	2	SENT_284	[p13l1482t1981r1808b2038],
4	included	VBD	O	include	_	0	SENT_284	[p13l1839t1981r2149b2038],
5	the	DT	O	the	det	12	SENT_284	[p13l8t2076r121b2134],
6	authors	NNS	O	author	nn	12	SENT_284	[p13l152t2076r436b2146],
7	,	,	O	,	_	0	SENT_284	[p13l152t2076r436b2146],
8	population	NN	O	population	dep	12	SENT_284	[p13l470t2076r880b2152],
9	,	,	O	,	_	0	SENT_284	[p13l470t2076r880b2152],
10	ethnicity	NN	O	ethnicity	dep	12	SENT_284	[p13l916t2076r1247b2152],
11	,	,	O	,	_	0	SENT_284	[p13l916t2076r1247b2152],
12	variant	NN	O	variant	dobj	4	SENT_284	[p13l1280t2079r1531b2134],
13	of	IN	O	of	_	0	SENT_284	[p13l1561t2076r1633b2134],
14	T	NN	O	t	nn	15	SENT_284	[p13l1656t2078r1703b2133],
15	NF-oc	NN	O	nf-oc	prep_of	12	SENT_284	[p13l1704t2078r1870b2134],
16	variant	JJ	O	variant	amod	15	SENT_284	[p13l1898t2079r2149b2134],
17	typed	VBN	O	type	partmod	15	SENT_284	[p13l8t2171r223b2247],
18	,	,	O	,	_	0	SENT_284	[p13l8t2171r223b2247],
19	year	NN	DURATION	year	appos	15	SENT_284	[p13l275t2188r423b2247],
20	of	IN	O	of	_	0	SENT_284	[p13l471t2171r543b2229],
21	publication	NN	O	publication	prep_of	19	SENT_284	[p13l586t2171r1011b2247],
22	,	,	O	,	_	0	SENT_284	[p13l586t2171r1011b2247],
23	diagnosis	NN	O	diagnosis	appos	15	SENT_284	[p13l1065t2171r1392b2247],
24	of	IN	O	of	_	0	SENT_284	[p13l1442t2171r1514b2229],
25	RA	NN	O	ra	prep_of	23	SENT_284	[p13l1558t2173r1672b2242],
26	,	,	O	,	_	0	SENT_284	[p13l1558t2173r1672b2242],
27	duration	NN	O	duration	appos	15	SENT_284	[p13l1726t2171r2032b2229],
28	of	IN	O	of	_	0	SENT_284	[p13l2081t2171r2152b2229],
29	follow-up	NN	O	follow-up	nn	32	SENT_284	[p13l8t2265r348b2341],
30	and	CC	O	and	_	0	SENT_284	[p13l394t2266r526b2323],
31	response	NN	O	response	nn	32	SENT_284	[p13l571t2282r875b2341],
32	criteria	NNS	O	criterion	prep_of	27	SENT_284	[p13l923t2268r1168b2323],
33	(	CD	NUMBER	(	nsubjpass	40	SENT_284	[p13l1217t2265r1406b2337],
34	both	CC	O	both	prep	33	SENT_284	[p13l1217t2265r1406b2337],
35	DAS28	NN	O	das28	nn	38	SENT_284	[p13l1452t2267r1684b2323],
36	and	CC	O	and	_	0	SENT_284	[p13l1731t2265r1862b2323],
37	ACR20	NN	O	acr20	nn	38	SENT_284	[p13l1906t2267r2148b2323],
38	responses	NNS	O	response	dep	34	SENT_284	[p13l8t2378r345b2437],
39	were	VBD	O	be	auxpass	40	SENT_284	[p13l397t2378r560b2419],
40	recorded	VBN	O	record	rcmod	27	SENT_284	[p13l615t2361r966b2433],
41	)	RB	O	)	advmod	40	SENT_284	[p13l615t2361r966b2433],
42	.	.	O	.	_	0	SENT_284	[p13l615t2361r966b2433],

1	Quality	JJ	O	quality	amod	2	SENT_285	[p13l1025t2361r1290b2437],
2	assessments	NNS	O	assessment	nsubjpass	5	SENT_285	[p13l1341t2368r1758b2419],
3	were	VBD	O	be	auxpass	5	SENT_285	[p13l1811t2378r1974b2419],
4	not	RB	O	not	neg	5	SENT_285	[p13l2028t2368r2149b2419],
5	done	VBN	O	do	_	0	SENT_285	[p13l9t2455r183b2513],
6	before	IN	O	before	_	0	SENT_285	[p13l218t2455r437b2513],
7	data	NN	O	datum	nn	8	SENT_285	[p13l475t2455r623b2513],
8	analysis	NN	O	analysis	prep_before	5	SENT_285	[p13l660t2455r953b2531],
9	,	,	O	,	_	0	SENT_285	[p13l660t2455r953b2531],
10	as	IN	O	as	_	0	SENT_285	[p13l995t2472r1059b2513],
11	relevant	JJ	O	relevant	amod	15	SENT_285	[p13l1095t2455r1382b2513],
12	and	CC	O	and	_	0	SENT_285	[p13l1418t2455r1549b2513],
13	well-established	JJ	O	well-established	conj_and	11	SENT_285	[p13l1583t2455r2149b2513],
14	quality	NN	O	quality	nn	15	SENT_285	[p13l9t2551r258b2626],
15	assessments	NNS	O	assessment	prep_as	5	SENT_285	[p13l345t2558r763b2608],
16	tools	NNS	O	tool	nsubj	18	SENT_285	[p13l852t2551r1022b2608],
17	were	VBD	O	be	aux	18	SENT_285	[p13l1110t2567r1274b2608],
18	lacking	VBG	O	lack	rcmod	15	SENT_285	[p13l1364t2551r1619b2626],
19	for	IN	O	for	_	0	SENT_285	[p13l1708t2550r1806b2608],
20	genetic	JJ	O	genetic	amod	22	SENT_285	[p13l1894t2554r2149b2626],
21	association	NN	O	association	nn	22	SENT_285	[p13l9t2648r400b2702],
22	studies	NNS	O	study	prep_for	18	SENT_285	[p13l431t2645r690b2702],
23	.	.	O	.	_	0	SENT_285	[p13l431t2645r690b2702],

1	Statistical	JJ	O	statistical	amod	2	SENT_286	[p13l11t2836r323b2893],
2	evaluation	NN	O	evaluation	_	0	SENT_286	[p13l349t2836r681b2893],

1	As	IN	O	as	mark	7	SENT_287	[p13l7t2933r87b2989],
2	the	DT	O	the	det	5	SENT_287	[p13l128t2931r240b2989],
3	homozygous	JJ	O	homozygous	amod	5	SENT_287	[p13l281t2931r733b3007],
4	A/A	NN	O	a/a	nn	5	SENT_287	[p13l772t2931r906b2996],
5	genotype	NN	O	genotype	nsubj	7	SENT_287	[p13l945t2938r1271b3007],
6	was	VBD	O	be	cop	7	SENT_287	[p13l1310t2948r1438b2989],
7	rare	JJ	O	rare	advcl	17	SENT_287	[p13l1478t2948r1609b2989],
8	in	IN	O	in	_	0	SENT_287	[p13l1651t2934r1721b2988],
9	all	DT	O	all	det	10	SENT_287	[p13l1761t2931r1843b2989],
10	studies	NNS	O	study	prep_in	7	SENT_287	[p13l1885t2931r2143b3001],
11	,	,	O	,	_	0	SENT_287	[p13l1885t2931r2143b3001],
12	patients	NNS	O	patient	nsubjpass	17	SENT_287	[p13l8t3029r290b3102],
13	with	IN	O	with	_	0	SENT_287	[p13l318t3026r480b3084],
14	this	DT	O	this	det	15	SENT_287	[p13l509t3026r638b3084],
15	genotype	NN	O	genotype	prep_with	12	SENT_287	[p13l668t3033r994b3102],
16	were	VBD	O	be	auxpass	17	SENT_287	[p13l1023t3043r1187b3084],
17	pooled	VBN	O	pool	_	0	SENT_287	[p13l1217t3026r1459b3102],
18	with	IN	O	with	_	0	SENT_287	[p13l1486t3026r1648b3084],
19	patients	NNS	O	patient	prep_with	17	SENT_287	[p13l1676t3029r1959b3102],
20	with	IN	O	with	_	0	SENT_287	[p13l1987t3026r2148b3084],
21	the	DT	O	the	det	23	SENT_287	[p13l8t3121r121b3179],
22	G/A	NNP	O	G/A	nn	23	SENT_287	[p13l150t3121r289b3186],
23	genotype	NN	O	genotype	prep_with	19	SENT_287	[p13l316t3128r661b3197],
24	,	,	O	,	_	0	SENT_287	[p13l316t3128r661b3197],
25	and	CC	O	and	_	0	SENT_287	[p13l694t3121r826b3179],
26	the	DT	O	the	det	27	SENT_287	[p13l852t3121r965b3179],
27	response	NN	O	response	prep_with	17	SENT_287	[p13l994t3138r1299b3197],
28	of	IN	O	of	_	0	SENT_287	[p13l1329t3121r1400b3179],
29	patients	NNS	O	patient	prep_of	27	SENT_287	[p13l1423t3124r1705b3197],
30	with	IN	O	with	_	0	SENT_287	[p13l1732t3121r1894b3179],
31	the	DT	O	the	det	32	SENT_287	[p13l1921t3121r2033b3179],
32	G	NN	O	g	prep_with	17	SENT_287	[p13l2064t3121r2148b3186],
33	/	:	O	/	punct	32	SENT_287	[p13l2064t3121r2148b3186],
34	G	NN	O	g	nn	35	SENT_287	[p13l10t3217r65b3273],
35	genotype	NN	O	genotype	nsubjpass	32	SENT_287	[p13l108t3223r435b3291],
36	was	VBD	O	be	auxpass	32	SENT_287	[p13l477t3232r606b3273],
37	compared	VBN	O	compare	_	0	SENT_287	[p13l650t3215r1001b3291],
38	with	IN	O	with	_	0	SENT_287	[p13l1043t3215r1204b3273],
39	the	DT	O	the	det	40	SENT_287	[p13l1248t3215r1360b3273],
40	response	NN	O	response	prep_compared_with	32	SENT_287	[p13l1405t3232r1710b3291],
41	of	IN	O	of	_	0	SENT_287	[p13l1755t3215r1827b3273],
42	patients	NNS	O	patient	prep_of	40	SENT_287	[p13l1865t3218r2148b3291],
43	carrying	VBG	O	carry	partmod	32	SENT_287	[p13l9t3314r300b3387],
44	an	DT	O	a	det	46	SENT_287	[p13l328t3328r412b3369],
45	A	NN	O	a	nn	46	SENT_287	[p13l439t3312r490b3368],
46	allele	NN	O	allele	dobj	43	SENT_287	[p13l518t3311r719b3369],
47	.	.	O	.	_	0	SENT_287	[p13l518t3311r719b3369],

1	The	DT	O	the	det	2	SENT_288	[p13l750t3311r882b3369],
2	OR	NN	O	or	nsubjpass	4	SENT_288	[p13l913t3312r1020b3369],
3	was	VBD	O	be	auxpass	4	SENT_288	[p13l1045t3328r1173b3369],
4	used	VBN	O	use	_	0	SENT_288	[p13l1200t3311r1361b3369],
5	to	TO	O	to	aux	6	SENT_288	[p13l1388t3318r1458b3369],
6	quantify	VB	O	quantify	xcomp	4	SENT_288	[p13l1488t3311r1790b3387],
7	the	DT	O	the	det	8	SENT_288	[p13l1815t3311r1928b3369],
8	effect	NN	O	effect	dobj	6	SENT_288	[p13l1958t3311r2149b3369],
9	of	IN	O	of	_	0	SENT_288	[p13l9t3405r81b3463],
10	the	DT	O	the	det	11	SENT_288	[p13l105t3406r218b3463],
11	polymorphism	NN	O	polymorphism	prep_of	8	SENT_288	[p13l247t3405r773b3481],
12	on	IN	O	on	_	0	SENT_288	[p13l803t3422r895b3463],
13	response	NN	O	response	prep_on	11	SENT_288	[p13l924t3422r1248b3481],
14	.	.	O	.	_	0	SENT_288	[p13l924t3422r1248b3481],

1	We	PRP	O	we	nsubj	2	SENT_289	[p13l1281t3408r1390b3463],
2	applied	VBD	O	apply	_	0	SENT_289	[p13l1421t3405r1681b3481],
3	a	DT	O	a	det	5	SENT_289	[p13l1710t3422r1745b3463],
4	continuity	NN	O	continuity	nn	5	SENT_289	[p13l1775t3408r2151b3481],
5	correction	NN	O	correction	dobj	2	SENT_289	[p13l9t3504r370b3558],
6	of	IN	O	of	_	0	SENT_289	[p13l402t3500r474b3558],
7	0.5	CD	NUMBER	0.5	prep_of	5	SENT_289	[p13l501t3502r603b3558],
8	to	TO	O	to	_	0	SENT_289	[p13l637t3508r707b3558],
9	all	DT	O	all	det	11	SENT_289	[p13l740t3501r822b3558],
10	four	CD	NUMBER	four	num	11	SENT_289	[p13l854t3500r999b3558],
11	cells	NNS	O	cell	prep_to	2	SENT_289	[p13l1029t3501r1178b3558],
12	of	IN	O	of	_	0	SENT_289	[p13l1211t3500r1282b3558],
13	the	DT	O	the	det	18	SENT_289	[p13l1309t3501r1422b3558],
14	2	CD	NUMBER	2	number	15	SENT_289	[p13l1455t3501r1675b3576],
15	—	CD	NUMBER	—	num	18	SENT_289	[p13l1455t3501r1675b3576],
16	by-2	NN	O	by-2	nn	18	SENT_289	[p13l1455t3501r1675b3576],
17	contingency	NN	O	contingency	nn	18	SENT_289	[p13l1707t3504r2151b3576],
18	table	NN	O	table	prep_of	11	SENT_289	[p13l8t3596r178b3654],
19	for	IN	O	for	_	0	SENT_289	[p13l208t3596r306b3654],
20	studies	NNS	O	study	prep_for	18	SENT_289	[p13l336t3596r576b3654],
21	in	IN	O	in	_	0	SENT_289	[p13l606t3599r676b3653],
22	which	WDT	O	which	rel	29	SENT_289	[p13l703t3596r924b3654],
23	at	IN	O	at	quantmod	25	SENT_289	[p13l954t3603r1017b3654],
24	least	JJS	O	least	mwe	23	SENT_289	[p13l1046t3596r1203b3654],
25	one	CD	NUMBER	one	nsubj	29	SENT_289	[p13l1233t3613r1361b3654],
26	of	IN	O	of	_	0	SENT_289	[p13l1392t3596r1463b3654],
27	the	DT	O	the	det	28	SENT_289	[p13l1488t3596r1600b3654],
28	groups	NNS	O	group	prep_of	25	SENT_289	[p13l1630t3613r1866b3672],
29	had	VBD	O	have	rcmod	20	SENT_289	[p13l1896t3596r2028b3654],
30	no	DT	O	no	det	31	SENT_289	[p13l2057t3613r2148b3654],
31	events	NNS	O	event	dobj	29	SENT_289	[p13l9t3698r251b3761],
32	,	,	O	,	_	0	SENT_289	[p13l9t3698r251b3761],
33	so	RB	O	so	advmod	44	SENT_289	[p13l284t3707r354b3748],
34	that	IN	O	that	dep	44	SENT_289	[p13l382t3691r525b3748],
35	estimates	NNS	O	estimate	nsubjpass	44	SENT_289	[p13l552t3694r878b3748],
36	of	IN	O	of	_	0	SENT_289	[p13l907t3690r979b3748],
37	OR	NN	O	or	prep_of	35	SENT_289	[p13l1003t3692r1110b3748],
38	and	CC	O	and	_	0	SENT_289	[p13l1136t3691r1267b3748],
39	accompanying	VBG	O	accompany	amod	41	SENT_289	[p13l1294t3694r1817b3766],
40	standard	JJ	O	standard	amod	41	SENT_289	[p13l1844t3691r2149b3748],
41	errors	NNS	O	error	prep_of	35	SENT_289	[p14l9t34r207b75],
42	can	MD	O	can	aux	44	SENT_289	[p14l238t34r360b75],
43	be	VB	O	be	auxpass	44	SENT_289	[p14l387t17r467b75],
44	computed	VBN	O	compute	advcl	29	SENT_289	[p14l499t17r874b93],
45	.	.	O	.	_	0	SENT_289	[p14l499t17r874b93],

1	As	IN	O	as	mark	3	SENT_290	[p14l84t114r164b170],
2	we	PRP	O	we	nsubj	3	SENT_290	[p14l230t129r326b170],
3	anticipated	VBD	O	anticipate	advcl	13	SENT_290	[p14l396t112r793b188],
4	heterogeneity	NN	O	heterogeneity	dobj	3	SENT_290	[p14l860t112r1353b188],
5	between	IN	O	between	_	0	SENT_290	[p14l1416t112r1713b170],
6	studies	NNS	O	study	prep_between	4	SENT_290	[p14l1783t112r2040b183],
7	,	,	O	,	_	0	SENT_290	[p14l1783t112r2040b183],
8	a	DT	O	a	det	11	SENT_290	[p14l2114t129r2149b170],
9	random	JJ	O	random	amod	11	SENT_290	[p14l8t206r287b263],
10	effect	NN	O	effect	nn	11	SENT_290	[p14l324t206r515b263],
11	model	NN	O	model	nsubjpass	13	SENT_290	[p14l550t206r773b263],
12	was	VBD	O	be	auxpass	13	SENT_290	[p14l807t222r935b263],
13	used	VBN	O	use	_	0	SENT_290	[p14l970t206r1130b263],
14	to	TO	O	to	aux	15	SENT_290	[p14l1165t213r1235b263],
15	combine	VB	O	combine	xcomp	13	SENT_290	[p14l1272t206r1579b263],
16	the	DT	O	the	det	17	SENT_290	[p14l1616t206r1728b263],
17	ORs	NNS	O	or	dobj	15	SENT_290	[p14l1766t207r1902b263],
18	across	IN	O	across	_	0	SENT_290	[p14l1940t222r2148b263],
19	studies	NNS	O	study	prep_across	15	SENT_290	[p14l10t291r339b356],
20	.	.	O	.	_	0	SENT_290	[p14l10t291r339b356],

1	”	NN	O	”	nsubj	11	SENT_291	[p14l10t291r339b356],
2	This	DT	O	this	det	3	SENT_291	[p14l395t298r544b356],
3	model	NN	O	model	nsubj	5	SENT_291	[p14l603t298r826b356],
4	can	MD	O	can	aux	5	SENT_291	[p14l884t315r1006b356],
5	incorporate	VB	O	incorporate	rcmod	1	SENT_291	[p14l1065t301r1474b374],
6	heterogeneity	NN	O	heterogeneity	dobj	5	SENT_291	[p14l1533t298r2025b374],
7	of	IN	O	of	_	0	SENT_291	[p14l2081t298r2153b356],
8	effects	NNS	O	effect	prep_of	6	SENT_291	[p14l9t394r230b452],
9	between	IN	O	between	_	0	SENT_291	[p14l278t395r576b452],
10	study	NN	O	study	prep_between	8	SENT_291	[p14l626t395r819b470],
11	results	VBZ	O	result	_	0	SENT_291	[p14l865t395r1109b465],
12	,	,	O	,	_	0	SENT_291	[p14l865t395r1109b465],
13	when	WRB	O	when	advmod	15	SENT_291	[p14l1161t395r1359b452],
14	it	PRP	O	it	nsubj	15	SENT_291	[p14l1408t398r1456b452],
15	exists	VBZ	O	exist	advcl	11	SENT_291	[p14l1506t398r1717b452],
16	.	.	O	.	_	0	SENT_291	[p14l1506t398r1717b452],

1	When	WRB	O	when	advmod	7	SENT_292	[p14l1769t395r1986b452],
2	the	DT	O	the	det	5	SENT_292	[p14l2035t395r2147b452],
3	random	JJ	O	random	amod	5	SENT_292	[p14l8t490r287b548],
4	variance	NN	O	variance	nn	5	SENT_292	[p14l327t493r624b548],
5	component	NN	O	component	nsubjpass	7	SENT_292	[p14l666t497r1077b566],
6	is	VBZ	O	be	auxpass	7	SENT_292	[p14l1118t493r1168b548],
7	estimated	VBN	O	estimate	advcl	14	SENT_292	[p14l1211t490r1554b548],
8	to	TO	O	to	aux	10	SENT_292	[p14l1594t497r1664b548],
9	be	VB	O	be	cop	10	SENT_292	[p14l1704t490r1784b548],
10	zero	CD	NUMBER	zero	xcomp	7	SENT_292	[p14l1826t507r1989b560],
11	,	,	O	,	_	0	SENT_292	[p14l1826t507r1989b560],
12	the	DT	O	the	det	13	SENT_292	[p14l2035t490r2147b548],
13	model	NN	O	model	nsubj	14	SENT_292	[p14l8t584r231b641],
14	reduces	VBZ	O	reduce	_	0	SENT_292	[p14l276t584r540b641],
15	to	TO	O	to	_	0	SENT_292	[p14l586t591r656b641],
16	a	DT	O	a	det	19	SENT_292	[p14l703t600r738b641],
17	fixed	JJ	O	fixed	amod	19	SENT_292	[p14l783t583r958b641],
18	effects	NNS	O	effect	nn	19	SENT_292	[p14l1004t583r1226b641],
19	model	NN	O	model	prep_to	14	SENT_292	[p14l1272t584r1513b641],
20	.	.	O	.	_	0	SENT_292	[p14l1272t584r1513b641],

1	Consistent	JJ	O	consistent	ccomp	9	SENT_293	[p14l1564t585r1943b641],
2	with	IN	O	with	_	0	SENT_293	[p14l1987t584r2149b641],
3	common	JJ	O	common	amod	4	SENT_293	[p14l9t695r328b736],
4	practice	NN	O	practice	prep_with	1	SENT_293	[p14l358t682r653b754],
5	,	,	O	,	_	0	SENT_293	[p14l358t682r653b754],
6	we	PRP	O	we	nsubj	23	SENT_293	[p14l687t695r783b736],
7	have	VBP	O	have	aux	9	SENT_293	[p14l814t679r979b736],
8	also	RB	O	also	advmod	9	SENT_293	[p14l1012t679r1146b736],
9	carried	VBN	O	carry	_	0	SENT_293	[p14l1179t679r1418b736],
10	out	RP	O	out	prt	9	SENT_293	[p14l1449t686r1566b736],
11	a	DT	O	a	det	13	SENT_293	[p14l1598t695r1632b736],
12	statistical	JJ	O	statistical	amod	13	SENT_293	[p14l1664t679r1994b736],
13	test	NN	O	test	dobj	9	SENT_293	[p14l2025t686r2149b736],
14	for	IN	O	for	_	0	SENT_293	[p14l8t772r107b830],
15	heterogeneity	NN	O	heterogeneity	prep_for	13	SENT_293	[p14l131t772r623b848],
16	using	VBG	O	use	xcomp	9	SENT_293	[p14l644t775r836b848],
17	the	DT	O	the	det	21	SENT_293	[p14l860t772r973b830],
18	Cochran	NNP	O	Cochran	nn	21	SENT_293	[p14l1000t772r1304b830],
19	Q	NNP	O	Q	nn	21	SENT_293	[p14l1330t774r1394b842],
20	test	NN	O	test	nn	21	SENT_293	[p14l1412t765r1597b830],
21	“	NN	O	“	dobj	16	SENT_293	[p14l1412t765r1597b830],
22	and	CC	O	and	_	0	SENT_293	[p14l1626t772r1758b830],
23	quantified	VBD	O	quantify	conj_and	9	SENT_293	[p14l1783t772r2149b848],
24	the	DT	O	the	det	25	SENT_293	[p14l8t866r121b924],
25	degree	NN	O	degree	dobj	23	SENT_293	[p14l171t866r397b942],
26	of	IN	O	of	_	0	SENT_293	[p14l448t866r519b924],
27	heterogeneity	NN	O	heterogeneity	prep_of	25	SENT_293	[p14l563t866r1055b942],
28	with	IN	O	with	_	0	SENT_293	[p14l1099t866r1261b924],
29	the	DT	O	the	det	31	SENT_293	[p14l1309t866r1422b924],
30	12	CD	NUMBER	12	num	31	SENT_293	[p14l1468t858r1527b923],
31	statistic	NN	O	statistic	prep_with	23	SENT_293	[p14l1576t869r1861b924],
32	.	.	O	.	_	0	SENT_293	[p14l1576t869r1861b924],

1	The	DT	O	the	det	3	SENT_294	[p14l1912t866r2045b924],
2	I2	NN	O	i2	nn	3	SENT_294	[p14l2090t858r2150b923],
3	statistic	NN	O	statistic	nsubj	11	SENT_294	[p14l10t965r277b1020],
4	ranges	VBZ	O	range	_	0	SENT_294	[p14l307t979r533b1038],
5	from	IN	O	from	_	0	SENT_294	[p14l563t962r733b1020],
6	o	NN	O	o	prep_from	4	SENT_294	[p14l764t964r804b1020],
7	to	TO	O	to	_	0	SENT_294	[p14l834t969r904b1020],
8	100	CD	PERCENT	100	num	9	SENT_294	[p14l941t964r1132b1020],
9	%	NN	PERCENT	%	prep_to	4	SENT_294	[p14l941t964r1132b1020],
10	and	CC	O	and	_	0	SENT_294	[p14l1163t962r1295b1020],
11	measures	VBZ	O	measure	conj_and	4	SENT_294	[p14l1325t979r1647b1020],
12	the	DT	O	the	det	13	SENT_294	[p14l1678t962r1790b1020],
13	degree	NN	O	degree	dobj	11	SENT_294	[p14l1823t962r2049b1038],
14	of	IN	O	of	_	0	SENT_294	[p14l2081t962r2152b1020],
15	inconsistency	NN	O	inconsistency	prep_of	13	SENT_294	[p14l8t1057r497b1130],
16	across	IN	O	across	_	0	SENT_294	[p14l538t1071r746b1112],
17	studies	NNS	O	study	prep_across	11	SENT_294	[p14l792t1055r1032b1112],
18	in	IN	O	in	_	0	SENT_294	[p14l1076t1057r1146b1111],
19	a	DT	O	a	det	20	SENT_294	[p14l1190t1071r1224b1112],
20	meta-analysis	NN	O	meta-analysis	prep_in	17	SENT_294	[p14l1267t1047r1836b1130],
21	.	.	O	.	_	0	SENT_294	[p14l1267t1047r1836b1130],

1	”	NNP	O	”	nn	2	SENT_295	[p14l1267t1047r1836b1130],
2	Higgins	NNP	PERSON	Higgins	nsubj	6	SENT_295	[p14l1879t1057r2147b1130],
3	et	FW	O	et	nn	4	SENT_295	[p14l9t1155r69b1207],
4	al.	FW	O	al.	dep	2	SENT_295	[p14l115t1141r263b1207],
5	22	CD	NUMBER	22	dep	2	SENT_295	[p14l115t1141r263b1207],
6	assign	VBP	O	assign	_	0	SENT_295	[p14l316t1152r528b1225],
7	as	RB	O	as	advmod	8	SENT_295	[p14l582t1166r646b1207],
8	low	JJ	O	low	acomp	6	SENT_295	[p14l699t1149r837b1219],
9	,	,	O	,	_	0	SENT_295	[p14l699t1149r837b1219],
10	moderate	JJ	O	moderate	acomp	6	SENT_295	[p14l894t1149r1246b1219],
11	,	,	O	,	_	0	SENT_295	[p14l894t1149r1246b1219],
12	and	CC	O	and	_	0	SENT_295	[p14l1304t1149r1435b1207],
13	high	JJ	O	high	acomp	6	SENT_295	[p14l1487t1149r1649b1225],
14	to	TO	O	to	_	0	SENT_295	[p14l1701t1156r1771b1207],
15	12	CD	NUMBER	12	num	16	SENT_295	[p14l1820t1141r1880b1206],
16	values	NNS	O	value	prep_to	13	SENT_295	[p14l1928t1149r2147b1207],
17	of	IN	O	of	_	0	SENT_295	[p14l9t1244r80b1302],
18	25	CD	PERCENT	25	num	19	SENT_295	[p14l105t1246r275b1315],
19	%	NN	PERCENT	%	prep_of	16	SENT_295	[p14l105t1246r275b1315],
20	,	,	O	,	_	0	SENT_295	[p14l105t1246r275b1315],
21	50	CD	PERCENT	50	num	22	SENT_295	[p14l309t1246r478b1315],
22	%	NN	PERCENT	%	conj_and	19	SENT_295	[p14l309t1246r478b1315],
23	,	,	O	,	_	0	SENT_295	[p14l309t1246r478b1315],
24	and	CC	O	and	_	0	SENT_295	[p14l512t1244r643b1302],
25	75	CD	PERCENT	75	num	26	SENT_295	[p14l676t1246r841b1315],
26	%	NN	PERCENT	%	conj_and	19	SENT_295	[p14l676t1246r841b1315],
27	,	,	O	,	_	0	SENT_295	[p14l676t1246r841b1315],
28	respectively	RB	O	respectively	advmod	6	SENT_295	[p14l874t1244r1303b1320],
29	.	.	O	.	_	0	SENT_295	[p14l874t1244r1303b1320],

1	Meta-analyzed	JJ	O	meta-analyzed	amod	2	SENT_296	[p14l1334t1244r1852b1320],
2	ORs	NNS	O	or	nsubjpass	4	SENT_296	[p14l1881t1246r2017b1302],
3	are	VBP	O	be	auxpass	4	SENT_296	[p14l2046t1261r2148b1302],
4	reported	VBN	O	report	_	0	SENT_296	[p14l8t1340r307b1415],
5	with	IN	O	with	_	0	SENT_296	[p14l366t1340r528b1397],
6	95	CD	PERCENT	95	num	8	SENT_296	[p14l589t1341r741b1397],
7	%	NN	PERCENT	%	nn	8	SENT_296	[p14l589t1341r741b1397],
8	CI	NN	O	ci	prep_with	4	SENT_296	[p14l804t1341r881b1397],
9	as	RB	O	as	_	0	SENT_296	[p14l945t1356r1010b1397],
10	well	RB	O	well	_	0	SENT_296	[p14l1070t1340r1214b1397],
11	as	IN	O	as	_	0	SENT_296	[p14l1276t1356r1341b1397],
12	P-values	NNS	O	p-value	prep_with	4	SENT_296	[p14l1399t1340r1689b1397],
13	for	IN	O	for	_	0	SENT_296	[p14l1751t1339r1850b1397],
14	overall	JJ	O	overall	amod	15	SENT_296	[p14l1910t1340r2148b1397],
15	association	NN	O	association	prep_for	12	SENT_296	[p14l9t1437r418b1491],
16	.	.	O	.	_	0	SENT_296	[p14l9t1437r418b1491],

1	Publication	NN	O	publication	nn	2	SENT_297	[p14l86t1528r489b1586],
2	bias	NN	O	bias	nsubjpass	19	SENT_297	[p14l535t1528r689b1598],
3	,	,	O	,	_	0	SENT_297	[p14l535t1528r689b1598],
4	which	WDT	O	which	nsubj	5	SENT_297	[p14l740t1528r960b1586],
5	occurs	VBZ	O	occur	rcmod	2	SENT_297	[p14l1008t1544r1231b1586],
6	when	WRB	O	when	advmod	10	SENT_297	[p14l1277t1528r1474b1586],
7	small	JJ	O	small	amod	8	SENT_297	[p14l1523t1528r1707b1585],
8	studies	NNS	O	study	nsubjpass	10	SENT_297	[p14l1757t1528r1997b1586],
9	are	VBP	O	be	auxpass	10	SENT_297	[p14l2046t1544r2148b1586],
10	published	VBN	O	publish	advcl	5	SENT_297	[p14l8t1624r356b1699],
11	only	RB	O	only	advmod	16	SENT_297	[p14l403t1624r563b1699],
12	if	IN	O	if	dep	16	SENT_297	[p14l607t1623r658b1681],
13	the	DT	O	the	det	14	SENT_297	[p14l700t1624r813b1681],
14	results	NNS	O	result	nsubj	16	SENT_297	[p14l860t1624r1085b1681],
15	are	VBP	O	be	cop	16	SENT_297	[p14l1133t1640r1234b1681],
16	positive	JJ	O	positive	ccomp	10	SENT_297	[p14l1281t1627r1575b1699],
17	,	,	O	,	_	0	SENT_297	[p14l1281t1627r1575b1699],
18	was	VBD	O	be	auxpass	19	SENT_297	[p14l1624t1640r1752b1681],
19	examined	VBN	O	examine	_	0	SENT_297	[p14l1800t1624r2148b1681],
20	using	VBG	O	use	xcomp	19	SENT_297	[p14l7t1722r199b1795],
21	a	DT	O	a	nsubj	22	SENT_297	[p14l228t1736r263b1777],
22	funnel	VB	O	funnel	ccomp	20	SENT_297	[p14l292t1719r524b1777],
23	plot	NN	O	plot	dobj	22	SENT_297	[p14l553t1719r712b1795],
24	.	.	O	.	_	0	SENT_297	[p14l553t1719r712b1795],

1	This	DT	O	this	det	2	SENT_298	[p14l744t1719r893b1777],
2	plot	NN	O	plot	nsubj	5	SENT_298	[p14l923t1719r1065b1795],
3	is	VBZ	O	be	cop	5	SENT_298	[p14l1093t1722r1144b1777],
4	a	DT	O	a	det	5	SENT_298	[p14l1175t1736r1210b1777],
5	graph	NN	O	graph	_	0	SENT_298	[p14l1239t1719r1441b1795],
6	with	IN	O	with	_	0	SENT_298	[p14l1468t1719r1630b1777],
7	the	DT	O	the	det	12	SENT_298	[p14l1660t1719r1772b1777],
8	effect	NN	O	effect	nn	12	SENT_298	[p14l1803t1719r1994b1777],
9	size	NN	O	size	nn	12	SENT_298	[p14l2025t1722r2148b1777],
10	(	CD	NUMBER	(	num	12	SENT_298	[p14l18t1814r172b1886],
11	OR	NN	O	or	nn	12	SENT_298	[p14l18t1814r172b1886],
12	)	NN	O	)	prep_with	5	SENT_298	[p14l18t1814r172b1886],
13	on	IN	O	on	_	0	SENT_298	[p14l227t1831r318b1872],
14	the	DT	O	the	det	16	SENT_298	[p14l369t1814r481b1872],
15	x	NN	O	x	nn	16	SENT_298	[p14l531t1831r568b1872],
16	axis	NN	O	axis	prep_on	12	SENT_298	[p14l621t1817r753b1872],
17	and	CC	O	and	_	0	SENT_298	[p14l806t1814r937b1872],
18	the	DT	O	the	det	19	SENT_298	[p14l987t1814r1100b1872],
19	inverse	NN	O	inverse	conj_and	12	SENT_298	[p14l1151t1817r1400b1872],
20	of	IN	O	of	_	0	SENT_298	[p14l1453t1814r1524b1872],
21	variance	NN	O	variance	prep_of	19	SENT_298	[p14l1568t1817r1865b1872],
22	of	IN	O	of	_	0	SENT_298	[p14l1918t1814r1989b1872],
23	the	DT	O	the	det	24	SENT_298	[p14l2035t1814r2148b1872],
24	effect	NN	O	effect	prep_of	21	SENT_298	[p14l15t1911r206b1969],
25	on	IN	O	on	_	0	SENT_298	[p14l255t1928r346b1969],
26	the	DT	O	the	det	28	SENT_298	[p14l394t1911r507b1969],
27	y	JJ	O	y	amod	28	SENT_298	[p14l554t1928r593b1987],
28	axis	NN	O	axis	prep_on	24	SENT_298	[p14l639t1914r789b1969],
29	.	.	O	.	_	0	SENT_298	[p14l639t1914r789b1969],

1	Asymmetry	NN	O	asymmetry	nsubj	9	SENT_299	[p14l842t1912r1251b1987],
2	without	IN	O	without	_	0	SENT_299	[p14l1296t1911r1578b1969],
3	studies	NNS	O	study	prep_without	1	SENT_299	[p14l1628t1911r1867b1969],
4	in	IN	O	in	_	0	SENT_299	[p14l1917t1914r1987b1968],
5	the	DT	O	the	det	8	SENT_299	[p14l2035t1911r2148b1969],
6	bottom	JJ	O	bottom	amod	8	SENT_299	[p14l13t2005r275b2062],
7	left	JJ	O	left	amod	8	SENT_299	[p14l317t2004r430b2062],
8	corner	NN	O	corner	prep_in	3	SENT_299	[p14l472t2021r699b2062],
9	suggests	VBZ	O	suggest	_	0	SENT_299	[p14l740t2012r1023b2080],
10	publication	NN	O	publication	nn	11	SENT_299	[p14l1065t2004r1471b2080],
11	bias	NN	O	bias	dobj	9	SENT_299	[p14l1511t1997r1733b2062],
12	.	.	O	.	_	0	SENT_299	[p14l1511t1997r1733b2062],

1	”	NN	O	”	nsubjpass	5	SENT_300	[p14l1511t1997r1733b2062],
2	The	DT	O	the	det	3	SENT_300	[p14l1775t2005r1907b2062],
3	metaanalysis	NN	O	metaanalysis	dep	1	SENT_300	[p14l1949t2012r2148b2062, p14l15t2101r290b2177],
4	was	VBD	O	be	auxpass	5	SENT_300	[p14l315t2118r443b2159],
5	implemented	VBN	O	implement	_	0	SENT_300	[p14l471t2101r945b2177],
6	using	VBG	O	use	xcomp	5	SENT_300	[p14l971t2104r1163b2177],
7	the	DT	O	the	det	13	SENT_300	[p14l1188t2101r1300b2159],
8	rmeta	NN	O	rmeta	nn	13	SENT_300	[p14l1328t2109r1532b2159],
9	package	NN	O	package	nn	13	SENT_300	[p14l1558t2101r1837b2177],
10	(	CD	NUMBER	(	num	13	SENT_300	[p14l1869t2102r2148b2174],
11	version	NN	O	version	nn	13	SENT_300	[p14l1869t2102r2148b2174],
12	1.4	CD	NUMBER	1.4	num	13	SENT_300	[p14l20t2198r144b2270],
13	)	NN	O	)	dobj	6	SENT_300	[p14l20t2198r144b2270],
14	of	IN	O	of	_	0	SENT_300	[p14l181t2198r252b2256],
15	the	DT	O	the	det	20	SENT_300	[p14l280t2198r392b2256],
16	statistical	JJ	O	statistical	amod	20	SENT_300	[p14l427t2198r756b2256],
17	package	NN	O	package	nn	20	SENT_300	[p14l789t2198r1067b2274],
18	R	NN	O	r	nn	20	SENT_300	[p14l1101t2200r1147b2255],
19	(	CD	NUMBER	(	num	20	SENT_300	[p14l1181t2198r1461b2270],
20	version	NN	O	version	prep_of	6	SENT_300	[p14l1181t2198r1461b2270],
21	2.7.0	CD	NUMBER	2.7.0	tmod	6	SENT_300	[p14l1495t2200r1682b2268],
22	,	,	O	,	_	0	SENT_300	[p14l1495t2200r1682b2268],
23	http://www	NN	O	http://www	appos	21	SENT_300	[p14l1720t2198r2144b2274],
24	.	.	O	.	_	0	SENT_300	[p14l1720t2198r2144b2274],

1	r-project	NN	O	r-project	_	0	SENT_301	[p14l15t2293r527b2369],
2	.	.	O	.	_	0	SENT_301	[p14l15t2293r527b2369],

1	org	NN	O	org	_	0	SENT_302	[p14l15t2293r527b2369],
2	/	:	O	/	punct	1	SENT_302	[p14l15t2293r527b2369],
3	)	CD	NUMBER	)	dep	1	SENT_302	[p14l15t2293r527b2369],
4	.	.	O	.	_	0	SENT_302	[p14l15t2293r527b2369],

1	Conflict	NN	O	conflict	_	0	SENT_303	[p14l16t2522r318b2579],
2	of	IN	O	of	_	0	SENT_303	[p14l347t2522r428b2579],
3	interest	NN	O	interest	prep_of	1	SENT_303	[p14l455t2522r753b2579],

1	The	DT	O	the	det	2	SENT_304	[p14l13t2710r145b2767],
2	authors	NNS	O	author	nsubj	3	SENT_304	[p14l176t2710r441b2767],
3	declare	VBP	O	declare	_	0	SENT_304	[p14l472t2710r718b2767],
4	no	DT	O	no	det	5	SENT_304	[p14l749t2727r839b2767],
5	conﬂict	NN	O	conﬂict	dobj	3	SENT_304	[p14l870t2710r1138b2767],
6	of	IN	O	of	_	0	SENT_304	[p14l1168t2710r1240b2767],
7	interest	NN	O	interest	prep_of	5	SENT_304	[p14l1265t2713r1547b2767],
8	.	.	O	.	_	0	SENT_304	[p14l1265t2713r1547b2767],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_305	[p14l13t2899r732b2975],

1	JB	NN	O	jb	nsubj	3	SENT_306	[p14l7t3086r76b3146],
2	would	MD	O	would	aux	3	SENT_306	[p14l101t3084r297b3134],
3	like	VB	O	like	_	0	SENT_306	[p14l323t3084r432b3134],
4	to	TO	O	to	aux	5	SENT_306	[p14l459t3090r520b3134],
5	acknowledge	VB	O	acknowledge	xcomp	3	SENT_306	[p14l548t3084r952b3150],
6	funding	NN	O	funding	dobj	5	SENT_306	[p14l979t3083r1230b3150],
7	from	IN	O	from	_	0	SENT_306	[p14l1254t3083r1404b3134],
8	the	DT	O	the	det	10	SENT_306	[p14l1430t3084r1530b3134],
9	Canadian	NNP	ORGANIZATION	Canadian	nn	10	SENT_306	[p14l1558t3084r1859b3134],
10	Institute	NNP	ORGANIZATION	Institute	prep_from	5	SENT_306	[p14l1885t3086r2149b3134],
11	of	IN	ORGANIZATION	of	_	0	SENT_306	[p14l15t3167r79b3217],
12	Health	NNP	ORGANIZATION	Health	nn	13	SENT_306	[p14l100t3167r310b3217],
13	Research	NNP	ORGANIZATION	Research	prep_of	10	SENT_306	[p14l334t3167r621b3228],
14	,	,	O	,	_	0	SENT_306	[p14l334t3167r621b3228],
15	CIHR	NNP	O	CIHR	appos	13	SENT_306	[p14l651t3168r820b3217],
16	(	CD	NUMBER	(	num	15	SENT_306	[p14l845t3167r1063b3230],
17	Grant	NNP	PERSON	Grant	dep	15	SENT_306	[p14l845t3167r1063b3230],
18	.	.	O	.	_	0	SENT_306	[p14l845t3167r1063b3230],

1	no.	RB	O	no.	advmod	7	SENT_307	[p14l1091t3181r1188b3217],
2	84392	CD	NUMBER	84392	num	3	SENT_307	[p14l1218t3167r1428b3230],
3	)	NN	O	)	nsubjpass	7	SENT_307	[p14l1218t3167r1428b3230],
4	and	CC	O	and	_	0	SENT_307	[p14l1455t3167r1572b3217],
5	PR	NN	O	pr	conj_and	3	SENT_307	[p14l1596t3169r1676b3217],
6	was	VBD	O	be	auxpass	7	SENT_307	[p14l1697t3181r1810b3217],
7	supported	VBN	O	support	_	0	SENT_307	[p14l1836t3167r2149b3233],
8	by	IN	O	by	_	0	SENT_307	[p14l12t3250r90b3317],
9	grants	NNS	O	grant	agent	7	SENT_307	[p14l114t3256r305b3316],
10	from	IN	O	from	_	0	SENT_307	[p14l331t3250r482b3301],
11	CIHR	NN	ORGANIZATION	cihr	prep_from	9	SENT_307	[p14l509t3251r677b3301],
12	and	CC	O	and	_	0	SENT_307	[p14l702t3250r818b3301],
13	the	DT	O	the	det	15	SENT_307	[p14l844t3250r943b3301],
14	Arthritis	NNP	O	Arthritis	nn	15	SENT_307	[p14l969t3250r1230b3301],
15	Society	NNP	O	Society	agent	7	SENT_307	[p14l1257t3251r1481b3317],
16	of	IN	O	of	_	0	SENT_307	[p14l1505t3250r1568b3301],
17	Canada	NNP	LOCATION	Canada	prep_of	15	SENT_307	[p14l1591t3250r1842b3301],
18	.	.	O	.	_	0	SENT_307	[p14l1591t3250r1842b3301],

1	References	NNS	O	reference	_	0	SENT_308	[p14l17t3432r429b3489],

1	1	CD	NUMBER	1	num	3	SENT_309	[p14l50t3612r67b3658],
2	Lee	NNP	ORGANIZATION	Lee	nn	3	SENT_309	[p14l150t3613r238b3659],
3	DM	NN	ORGANIZATION	dm	_	0	SENT_309	[p14l291t3613r405b3669],
4	,	,	O	,	_	0	SENT_309	[p14l291t3613r405b3669],
5	Weinblatt	NNP	PERSON	Weinblatt	nn	6	SENT_309	[p14l455t3611r728b3659],
6	ME	NNP	O	ME	appos	3	SENT_309	[p14l779t3613r878b3659],
7	.	.	O	.	_	0	SENT_309	[p14l779t3613r878b3659],

1	Rheumatoid	JJ	O	rheumatoid	amod	2	SENT_310	[p14l934t3611r1266b3659],
2	arthritis	NN	O	arthritis	_	0	SENT_310	[p14l1318t3611r1540b3659],
3	.	.	O	.	_	0	SENT_310	[p14l1318t3611r1540b3659],

1	Lancet	NNP	O	Lancet	_	0	SENT_311	[p14l1596t3613r1770b3659],
2	2001	CD	DATE	2001	num	1	SENT_311	[p14l1815t3612r1971b3669],
3	;	:	O	;	_	0	SENT_311	[p14l1815t3612r1971b3669],
4	358	CD	NUMBER	358	dep	1	SENT_311	[p14l2026t3612r2146b3659],
5	:	:	O	:	_	0	SENT_311	[p14l2026t3612r2146b3659],

1	TNF-oi	JJ	O	tnf-oi	amod	4	SENT_312	[p15l7t2080r139b2123],
2	-308	CD	NUMBER	-308	tmod	1	SENT_312	[p15l160t2079r282b2123],
3	G/A	NN	O	g/a	nn	4	SENT_312	[p15l300t2078r396b2129],
4	variant	NN	O	variant	_	0	SENT_312	[p15l412t2078r585b2123],
5	and	CC	O	and	_	0	SENT_312	[p15l603t2078r691b2123],
6	anti-TNF-oi	JJ	O	anti-tnf-oi	amod	7	SENT_312	[p15l711t2078r956b2123],
7	agents	NNS	O	agent	conj_and	4	SENT_312	[p15l974t2083r1135b2137],
8	DD	NN	O	dd	prep	7	SENT_312	[p15l10t2151r74b2190],
9	O’Rie	NN	O	o’rie	nn	12	SENT_312	[p15l93t2149r249b2204],
10	|	CD	NUMBER	|	num	12	SENT_312	[p15l93t2149r249b2204],
11	|	NN	O	|	nn	12	SENT_312	[p15l93t2149r249b2204],
12	y	NN	O	y	dep	8	SENT_312	[p15l93t2149r249b2204],
13	et	FW	O	et	nn	14	SENT_312	[p15l268t2154r304b2191],
14	al	FW	O	al	dep	4	SENT_312	[p15l320t2149r357b2191],

1	Feldmann	NNP	PERSON	Feldmann	nn	2	SENT_313	[p15l150t20r419b68],
2	M	NNP	O	M	_	0	SENT_313	[p15l452t22r519b78],
3	,	,	O	,	_	0	SENT_313	[p15l452t22r519b78],
4	Brennan	NNP	PERSON	Brennan	nn	5	SENT_313	[p15l552t22r777b68],
5	FM	NNP	O	FM	appos	2	SENT_313	[p15l809t22r907b78],
6	,	,	O	,	_	0	SENT_313	[p15l809t22r907b78],
7	Maini	NNP	PERSON	Maini	nn	8	SENT_313	[p15l940t21r1090b68],
8	RN	NNP	O	RN	appos	5	SENT_313	[p15l1122t22r1215b68],
9	.	.	O	.	_	0	SENT_313	[p15l1122t22r1215b68],

1	Role	NN	O	role	_	0	SENT_314	[p15l1248t20r1360b68],
2	of	IN	O	of	_	0	SENT_314	[p15l1387t20r1441b68],
3	cytokines	NNS	O	cytokine	prep_of	1	SENT_314	[p15l1465t20r1722b83],
4	in	IN	O	in	_	0	SENT_314	[p15l1750t21r1795b67],
5	rheumatoid	JJ	O	rheumatoid	amod	6	SENT_314	[p15l1827t20r2146b68],
6	arthritis	NN	O	arthritis	prep_in	1	SENT_314	[p15l147t95r370b143],
7	.	.	O	.	_	0	SENT_314	[p15l147t95r370b143],

1	Annu	NNP	PERSON	Annu	nn	3	SENT_315	[p15l397t97r538b143],
2	Rev	NN	PERSON	rev	nn	3	SENT_315	[p15l564t97r656b143],
3	Immunol	NNP	O	Immunol	_	0	SENT_315	[p15l677t95r915b143],
4	1996	CD	DATE	1996	dep	3	SENT_315	[p15l939t96r1092b153],
5	;	:	O	;	_	0	SENT_315	[p15l939t96r1092b153],
6	14	CD	NUMBER	14	num	8	SENT_315	[p15l1125t96r1206b143],
7	:	:	O	:	_	0	SENT_315	[p15l1125t96r1206b143],
8	397-440	CD	NUMBER	397-440	dep	3	SENT_315	[p15l1237t96r1496b143],
9	.	.	O	.	_	0	SENT_315	[p15l1237t96r1496b143],

1	Feldmann	NNP	PERSON	Feldmann	nn	2	SENT_316	[p15l150t169r419b217],
2	M	NNP	O	M	_	0	SENT_316	[p15l444t172r511b227],
3	,	,	O	,	_	0	SENT_316	[p15l444t172r511b227],
4	Brennan	NNP	PERSON	Brennan	nn	5	SENT_316	[p15l537t172r762b217],
5	FM	NNP	O	FM	appos	2	SENT_316	[p15l786t172r884b227],
6	,	,	O	,	_	0	SENT_316	[p15l786t172r884b227],
7	Foxwell	NNP	ORGANIZATION	Foxwell	nn	8	SENT_316	[p15l909t169r1113b217],
8	BM	NN	ORGANIZATION	bm	appos	2	SENT_316	[p15l1138t172r1242b227],
9	,	,	O	,	_	0	SENT_316	[p15l1138t172r1242b227],
10	Maini	NNP	PERSON	Maini	nn	11	SENT_316	[p15l1267t171r1417b217],
11	RN	NNP	O	RN	appos	2	SENT_316	[p15l1441t172r1534b217],
12	.	.	O	.	_	0	SENT_316	[p15l1441t172r1534b217],

1	The	DT	O	the	det	2	SENT_317	[p15l1554t169r1657b217],
2	role	NN	O	role	_	0	SENT_317	[p15l1679t169r1778b217],
3	of	IN	O	of	_	0	SENT_317	[p15l1798t169r1852b217],
4	TNF	NN	MISC	tnf	nn	5	SENT_317	[p15l1866t172r1979b217],
5	alpha	NN	O	alpha	prep_of	2	SENT_317	[p15l1999t169r2147b232],
6	and	CC	O	and	_	0	SENT_317	[p15l147t244r247b292],
7	IL-1	NN	O	il-1	conj_and	5	SENT_317	[p15l275t246r360b292],
8	in	IN	O	in	_	0	SENT_317	[p15l397t246r441b292],
9	rheumatoid	JJ	O	rheumatoid	amod	10	SENT_317	[p15l468t244r787b292],
10	arthritis	NN	O	arthritis	prep_in	2	SENT_317	[p15l812t244r1035b292],
11	.	.	O	.	_	0	SENT_317	[p15l812t244r1035b292],

1	Curr	NNP	O	Curr	nn	3	SENT_318	[p15l1065t246r1180b292],
2	Dir	NNP	O	Dir	nn	3	SENT_318	[p15l1198t246r1279b292],
3	Autoimmun	NNP	O	Autoimmun	_	0	SENT_318	[p15l1293t246r1606b292],
4	2001	CD	DATE	2001	num	3	SENT_318	[p15l1627t246r1784b302],
5	;	:	O	;	_	0	SENT_318	[p15l1627t246r1784b302],
6	3	CD	NUMBER	3	num	8	SENT_318	[p15l1811t246r1858b292],
7	:	:	O	:	_	0	SENT_318	[p15l1811t246r1858b292],
8	188-199	CD	NUMBER	188-199	dep	3	SENT_318	[p15l1886t246r2146b292],
9	.	.	O	.	_	0	SENT_318	[p15l1886t246r2146b292],

1	Furst	NNP	ORGANIZATION	Furst	nn	2	SENT_319	[p15l150t322r280b368],
2	DE	NN	ORGANIZATION	de	_	0	SENT_319	[p15l303t322r390b378],
3	,	,	O	,	_	0	SENT_319	[p15l303t322r390b378],
4	Breedveld	NNP	ORGANIZATION	Breedveld	nn	5	SENT_319	[p15l419t320r687b368],
5	FC	NNP	ORGANIZATION	FC	appos	2	SENT_319	[p15l715t322r797b378],
6	,	,	O	,	_	0	SENT_319	[p15l715t322r797b378],
7	Kalden	NNP	ORGANIZATION	Kalden	nn	8	SENT_319	[p15l826t320r1010b368],
8	JR	NNP	ORGANIZATION	JR	appos	2	SENT_319	[p15l1033t322r1097b379],
9	,	,	O	,	_	0	SENT_319	[p15l1033t322r1097b379],
10	Smolen	NNP	PERSON	Smolen	nn	11	SENT_319	[p15l1124t320r1328b368],
11	JS	NNP	O	JS	appos	2	SENT_319	[p15l1352t322r1414b379],
12	,	,	O	,	_	0	SENT_319	[p15l1352t322r1414b379],
13	Burmester	NNP	PERSON	Burmester	nn	14	SENT_319	[p15l1443t322r1723b368],
14	GR	NN	O	gr	appos	2	SENT_319	[p15l1744t322r1836b378],
15	,	,	O	,	_	0	SENT_319	[p15l1744t322r1836b378],
16	Bijlsma	NNP	O	Bijlsma	nn	17	SENT_319	[p15l1865t320r2053b383],
17	JW	NNP	O	JW	appos	2	SENT_319	[p15l2075t322r2150b379],
18	et	FW	O	et	nn	19	SENT_319	[p15l149t400r197b443],
19	al.	FW	O	al.	dep	17	SENT_319	[p15l228t395r285b443],
20	.	.	O	.	_	0	SENT_319	[p15l228t395r285b443],

1	Updated	VBN	O	update	_	0	SENT_320	[p15l324t395r559b458],
2	consensus	NN	O	consensus	nn	3	SENT_320	[p15l594t409r874b443],
3	statement	NN	O	statement	dobj	1	SENT_320	[p15l906t400r1186b443],
4	on	IN	O	on	_	0	SENT_320	[p15l1217t409r1284b443],
5	biological	JJ	O	biological	amod	6	SENT_320	[p15l1321t395r1584b457],
6	agents	NNS	O	agent	prep_on	3	SENT_320	[p15l1620t400r1816b457],
7	,	,	O	,	_	0	SENT_320	[p15l1620t400r1816b457],
8	specifically	RB	O	specifically	advmod	6	SENT_320	[p15l1853t395r2149b458],
9	tumour	NN	O	tumour	nn	13	SENT_320	[p15l146t475r355b517],
10	necrosis	NN	O	necrosis	nn	13	SENT_320	[p15l405t471r622b517],
11	factor	NN	O	factor	nn	13	SENT_320	[p15l669t469r831b517],
12	{	NN	O	{	nn	13	SENT_320	[p15l880t469r1070b532],
13	alpha	NN	O	alpha	dep	6	SENT_320	[p15l880t469r1070b532],
14	}	CD	NUMBER	}	number	15	SENT_320	[p15l880t469r1070b532],
15	(	CD	NUMBER	(	num	17	SENT_320	[p15l1124t469r1477b532],
16	TNF	NN	O	tnf	nn	17	SENT_320	[p15l1124t469r1477b532],
17	{	NN	O	{	dep	13	SENT_320	[p15l1124t469r1477b532],
18	a	DT	O	a	det	20	SENT_320	[p15l1124t469r1477b532],
19	|	NN	O	|	nn	20	SENT_320	[p15l1124t469r1477b532],
20	pha	NN	O	pha	dep	13	SENT_320	[p15l1124t469r1477b532],
21	}	CD	NUMBER	}	number	22	SENT_320	[p15l1124t469r1477b532],
22	)	CD	NUMBER	)	dep	20	SENT_320	[p15l1124t469r1477b532],
23	blocking	VBG	O	block	partmod	3	SENT_320	[p15l1530t469r1762b532],
24	agents	NNS	O	agent	dobj	23	SENT_320	[p15l1814t475r1996b532],
25	and	CC	O	and	_	0	SENT_320	[p15l2046t469r2146b517],
26	interleukin-1	NN	O	interleukin-1	nn	32	SENT_320	[p15l148t545r484b593],
27	receptor	NN	O	receptor	nn	32	SENT_320	[p15l534t551r765b608],
28	antagonist	NN	O	antagonist	nn	32	SENT_320	[p15l798t546r1091b608],
29	(	CD	NUMBER	(	num	32	SENT_320	[p15l1125t545r1235b605],
30	IL-1	NN	O	il-1	nn	32	SENT_320	[p15l1125t545r1235b605],
31	ra	NN	O	ra	nn	32	SENT_320	[p15l1254t545r1339b605],
32	)	NN	O	)	dobj	23	SENT_320	[p15l1254t545r1339b605],
33	,	,	O	,	_	0	SENT_320	[p15l1254t545r1339b605],
34	for	IN	O	for	_	0	SENT_320	[p15l1375t545r1453b593],
35	the	DT	O	the	det	36	SENT_320	[p15l1484t545r1572b593],
36	treatment	NN	O	treatment	prep_for	1	SENT_320	[p15l1607t550r1884b593],
37	of	IN	O	of	_	0	SENT_320	[p15l1918t545r1971b593],
38	rheumatic	JJ	O	rheumatic	amod	39	SENT_320	[p15l2006t545r2148b593, p15l149t621r300b667],
39	diseases	NNS	O	disease	prep_of	36	SENT_320	[p15l325t620r559b677],
40	,	,	O	,	_	0	SENT_320	[p15l325t620r559b677],
41	2005	CD	DATE	2005	dobj	1	SENT_320	[p15l588t621r745b667],
42	.	.	O	.	_	0	SENT_320	[p15l588t621r745b667],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_321	[p15l772t622r878b667],
2	Rheum	NNP	PERSON	Rheum	nn	3	SENT_321	[p15l904t620r1085b667],
3	Dis	NNP	O	Dis	_	0	SENT_321	[p15l1111t621r1191b667],
4	2005	CD	DATE	2005	num	3	SENT_321	[p15l1214t621r1370b677],
5	;	:	O	;	_	0	SENT_321	[p15l1214t621r1370b677],
6	64	CD	NUMBER	64	num	8	SENT_321	[p15l1398t621r1484b667],
7	:	:	O	:	_	0	SENT_321	[p15l1398t621r1484b667],
8	iv2	CD	NUMBER	iv2	dep	3	SENT_321	[p15l1514t621r1757b667],
9	—	CD	NUMBER	—	num	10	SENT_321	[p15l1514t621r1757b667],
10	iv14	NN	O	iv14	dep	8	SENT_321	[p15l1514t621r1757b667],
11	.	.	O	.	_	0	SENT_321	[p15l1514t621r1757b667],

1	Keystone	NN	ORGANIZATION	keystone	nsubj	2	SENT_322	[p15l150t696r397b757],
2	EC	NN	ORGANIZATION	ec	_	0	SENT_322	[p15l420t696r504b742],
3	.	.	O	.	_	0	SENT_322	[p15l420t696r504b742],

1	Safety	NN	O	safety	nsubj	5	SENT_323	[p15l529t694r695b757],
2	of	IN	O	of	_	0	SENT_323	[p15l714t694r768b742],
3	biologic	JJ	O	biologic	amod	4	SENT_323	[p15l788t694r1006b757],
4	therapies	NNS	O	therapy	prep_of	1	SENT_323	[p15l1026t694r1408b757],
5	—	VBP	O	—	_	0	SENT_323	[p15l1026t694r1408b757],
6	an	DT	O	a	nsubj	7	SENT_323	[p15l1026t694r1408b757],
7	update	VBP	O	update	ccomp	5	SENT_323	[p15l1433t694r1640b757],
8	.	.	O	.	_	0	SENT_323	[p15l1433t694r1640b757],

1	/	:	O	/	punct	3	SENT_324	[p15l1660t697r1681b753],
2	Rheumatol	NNP	O	Rheumatol	nn	3	SENT_324	[p15l1700t694r1988b742],
3	Suppl	NNP	O	Suppl	_	0	SENT_324	[p15l2005t694r2153b757],
4	2005	CD	DATE	2005	dep	3	SENT_324	[p15l147t771r304b827],
5	;	:	O	;	_	0	SENT_324	[p15l147t771r304b827],
6	74	CD	NUMBER	74	dep	3	SENT_324	[p15l335t772r417b817],
7	:	:	O	:	_	0	SENT_324	[p15l335t772r417b817],
8	8-12	CD	NUMBER	8-12	dep	6	SENT_324	[p15l446t771r598b817],
9	.	.	O	.	_	0	SENT_324	[p15l446t771r598b817],

1	Louis	NNP	PERSON	Louis	nn	2	SENT_325	[p15l150t846r286b893],
2	E	NNP	PERSON	E	_	0	SENT_325	[p15l308t847r348b903],
3	,	,	O	,	_	0	SENT_325	[p15l308t847r348b903],
4	Franchimont	JJ	O	franchimont	amod	5	SENT_325	[p15l375t845r726b893],
5	D	NN	O	d	appos	2	SENT_325	[p15l747t847r802b903],
6	,	,	O	,	_	0	SENT_325	[p15l747t847r802b903],
7	Piron	NNP	PERSON	Piron	nn	8	SENT_325	[p15l828t846r964b893],
8	A	NNP	O	A	appos	2	SENT_325	[p15l983t847r1036b903],
9	,	,	O	,	_	0	SENT_325	[p15l983t847r1036b903],
10	Gevaert	NNP	ORGANIZATION	Gevaert	nn	11	SENT_325	[p15l1060t846r1276b893],
11	Y	NN	ORGANIZATION	y	appos	2	SENT_325	[p15l1291t847r1339b903],
12	,	,	O	,	_	0	SENT_325	[p15l1291t847r1339b903],
13	Schaaf-Lafontaine	NN	O	schaaf-lafontaine	nn	14	SENT_325	[p15l1363t845r1855b893],
14	N	NN	O	n	appos	2	SENT_325	[p15l1878t847r1935b903],
15	,	,	O	,	_	0	SENT_325	[p15l1878t847r1935b903],
16	Roland	NNP	PERSON	Roland	nn	17	SENT_325	[p15l1962t845r2146b893],
17	S	NNP	O	S	appos	2	SENT_325	[p15l148t921r175b968],
18	et	FW	O	et	nn	19	SENT_325	[p15l210t925r259b968],
19	al.	FW	O	al.	dep	17	SENT_325	[p15l289t920r347b968],
20	.	.	O	.	_	0	SENT_325	[p15l289t920r347b968],

1	Tumour	NN	O	tumour	nn	6	SENT_326	[p15l381t922r606b968],
2	necrosis	NN	O	necrosis	nn	6	SENT_326	[p15l638t921r854b968],
3	factor	NN	O	factor	nn	6	SENT_326	[p15l885t920r1047b968],
4	(	CD	NUMBER	(	num	6	SENT_326	[p15l1078t920r1233b980],
5	TNF	NN	O	tnf	nn	6	SENT_326	[p15l1078t920r1233b980],
6	)	NN	O	)	_	0	SENT_326	[p15l1078t920r1233b980],
7	gene	NN	O	gene	nn	8	SENT_326	[p15l1267t934r1402b982],
8	polymorphism	NN	O	polymorphism	nsubj	9	SENT_326	[p15l1437t920r1837b983],
9	influences	VBZ	O	influence	rcmod	6	SENT_326	[p15l1874t920r2148b968],
10	TNF-alpha	NN	O	tnf-alpha	nn	11	SENT_326	[p15l145t994r431b1057],
11	production	NN	O	production	dobj	9	SENT_326	[p15l480t994r783b1057],
12	in	IN	O	in	_	0	SENT_326	[p15l831t996r875b1042],
13	lipopolysaccharide	NN	O	lipopolysaccharide	nn	15	SENT_326	[p15l924t994r1438b1057],
14	(	CD	NUMBER	(	num	15	SENT_326	[p15l1483t994r1935b1054],
15	LPS	NN	O	lp	prep_in	11	SENT_326	[p15l1483t994r1935b1054],
16	)	SYM	O	)	dep	18	SENT_326	[p15l1483t994r1935b1054],
17	-	:	O	-	_	0	SENT_326	[p15l1483t994r1935b1054],
18	stimulated	VBN	O	stimulate	dep	6	SENT_326	[p15l1483t994r1935b1054],
19	whole	JJ	O	whole	amod	22	SENT_326	[p15l1979t994r2148b1042],
20	blood	NN	O	blood	nn	22	SENT_326	[p15l149t1070r304b1118],
21	cell	NN	O	cell	nn	22	SENT_326	[p15l343t1070r429b1118],
22	culture	NN	O	culture	dobj	18	SENT_326	[p15l469t1070r659b1118],
23	in	IN	O	in	_	0	SENT_326	[p15l698t1071r742b1117],
24	healthy	JJ	O	healthy	amod	25	SENT_326	[p15l783t1070r985b1133],
25	humans	NNS	O	human	prep_in	22	SENT_326	[p15l1023t1070r1256b1118],
26	.	.	O	.	_	0	SENT_326	[p15l1023t1070r1256b1118],

1	Clin	NNP	O	Clin	nn	3	SENT_327	[p15l1299t1070r1396b1118],
2	Exp	NNP	O	Exp	nn	3	SENT_327	[p15l1433t1072r1522b1133],
3	Immunol	NNP	O	Immunol	_	0	SENT_327	[p15l1559t1070r1797b1118],
4	1998	CD	DATE	1998	num	3	SENT_327	[p15l1831t1071r1985b1128],
5	;	:	O	;	_	0	SENT_327	[p15l1831t1071r1985b1128],
6	113	CD	NUMBER	113	num	8	SENT_327	[p15l2028t1071r2146b1118],
7	:	:	O	:	_	0	SENT_327	[p15l2028t1071r2146b1118],
8	401-406	CD	NUMBER	401-406	dep	3	SENT_327	[p15l146t1149r409b1195],
9	.	.	O	.	_	0	SENT_327	[p15l146t1149r409b1195],

1	Nemec	NNP	PERSON	Nemec	nn	2	SENT_328	[p15l150t1223r345b1269],
2	P	NN	O	p	nsubjpass	27	SENT_328	[p15l371t1223r414b1279],
3	,	,	O	,	_	0	SENT_328	[p15l371t1223r414b1279],
4	Pavkova-Goldbergova	NN	O	pavkova-goldbergova	nn	5	SENT_328	[p15l443t1221r1049b1283],
5	M	NN	O	m	appos	2	SENT_328	[p15l1078t1223r1145b1279],
6	,	,	O	,	_	0	SENT_328	[p15l1078t1223r1145b1279],
7	Stouracova	NNP	O	Stouracova	nn	8	SENT_328	[p15l1173t1222r1478b1269],
8	M	NNP	O	M	appos	2	SENT_328	[p15l1505t1223r1572b1279],
9	,	,	O	,	_	0	SENT_328	[p15l1505t1223r1572b1279],
10	Vasku	NNP	O	Vasku	nn	11	SENT_328	[p15l1596t1221r1753b1269],
11	A	NNP	O	A	appos	2	SENT_328	[p15l1777t1223r1829b1279],
12	,	,	O	,	_	0	SENT_328	[p15l1777t1223r1829b1279],
13	Soucek	NNP	PERSON	Soucek	nn	14	SENT_328	[p15l1857t1221r2053b1269],
14	M	NNP	O	M	appos	2	SENT_328	[p15l2078t1223r2145b1279],
15	,	,	O	,	_	0	SENT_328	[p15l2078t1223r2145b1279],
16	Gatterova	NNP	O	Gatterova	nn	18	SENT_328	[p15l147t1298r418b1344],
17	J.	NNP	O	J.	nn	18	SENT_328	[p15l456t1299r485b1355],
18	Polymorphism	NN	O	polymorphism	appos	2	SENT_328	[p15l530t1296r925b1359],
19	in	IN	O	in	_	0	SENT_328	[p15l968t1298r1012b1344],
20	the	DT	O	the	det	25	SENT_328	[p15l1051t1296r1139b1344],
21	tumor	NN	O	tumor	nn	25	SENT_328	[p15l1177t1302r1350b1344],
22	necrosis	NN	O	necrosis	nn	25	SENT_328	[p15l1388t1298r1605b1344],
23	factor-alpha	NN	O	factor-alpha	nn	25	SENT_328	[p15l1640t1296r1973b1359],
24	gene	NN	O	gene	nn	25	SENT_328	[p15l2013t1310r2148b1359],
25	promoter	NN	O	promoter	prep_in	18	SENT_328	[p15l149t1377r412b1434],
26	is	VBZ	O	be	auxpass	27	SENT_328	[p15l431t1372r465b1419],
27	associated	VBN	O	associate	_	0	SENT_328	[p15l486t1371r767b1419],
28	with	IN	O	with	_	0	SENT_328	[p15l788t1371r907b1419],
29	severity	NN	O	severity	prep_with	27	SENT_328	[p15l930t1372r1138b1434],
30	of	IN	O	of	_	0	SENT_328	[p15l1158t1371r1212b1419],
31	rheumatoid	JJ	O	rheumatoid	amod	32	SENT_328	[p15l1232t1371r1551b1419],
32	arthritis	NN	O	arthritis	prep_of	29	SENT_328	[p15l1575t1371r1782b1419],
33	in	IN	O	in	_	0	SENT_328	[p15l1804t1372r1849b1418],
34	the	DT	O	the	det	36	SENT_328	[p15l1871t1371r1959b1419],
35	Czech	JJ	MISC	czech	amod	36	SENT_328	[p15l1981t1371r2146b1419],
36	population	NN	O	population	prep_in	32	SENT_328	[p15l149t1446r465b1509],
37	.	.	O	.	_	0	SENT_328	[p15l149t1446r465b1509],

1	Clin	NNP	O	Clin	nn	2	SENT_329	[p15l496t1446r594b1494],
2	Rheumatol	NNP	O	Rheumatol	_	0	SENT_329	[p15l620t1446r908b1494],
3	2008	CD	DATE	2008	num	2	SENT_329	[p15l929t1447r1085b1504],
4	;	:	O	;	_	0	SENT_329	[p15l929t1447r1085b1504],
5	27	CD	NUMBER	27	num	7	SENT_329	[p15l1115t1447r1199b1494],
6	:	:	O	:	_	0	SENT_329	[p15l1115t1447r1199b1494],
7	59-65	CD	NUMBER	59-65	dep	2	SENT_329	[p15l1227t1447r1416b1494],
8	.	.	O	.	_	0	SENT_329	[p15l1227t1447r1416b1494],

1	Mugnier	NN	O	mugnier	nn	2	SENT_330	[p15l150t1522r385b1583],
2	B	NN	O	b	nsubj	29	SENT_330	[p15l413t1523r457b1578],
3	,	,	O	,	_	0	SENT_330	[p15l413t1523r457b1578],
4	Balandraud	NN	ORGANIZATION	balandraud	nn	5	SENT_330	[p15l491t1520r800b1568],
5	N	NN	ORGANIZATION	n	appos	2	SENT_330	[p15l833t1523r890b1578],
6	,	,	O	,	_	0	SENT_330	[p15l833t1523r890b1578],
7	Darque	NNP	O	Darque	nn	8	SENT_330	[p15l924t1523r1124b1583],
8	A	NNP	O	A	appos	2	SENT_330	[p15l1150t1523r1202b1578],
9	,	,	O	,	_	0	SENT_330	[p15l1150t1523r1202b1578],
10	Roudier	NNP	O	Roudier	nn	11	SENT_330	[p15l1235t1520r1447b1568],
11	C	NNP	O	C	appos	2	SENT_330	[p15l1472t1522r1526b1578],
12	,	,	O	,	_	0	SENT_330	[p15l1472t1522r1526b1578],
13	Roudier	NNP	O	Roudier	nn	14	SENT_330	[p15l1560t1520r1771b1568],
14	J	NNP	O	J	appos	2	SENT_330	[p15l1794t1523r1824b1579],
15	,	,	O	,	_	0	SENT_330	[p15l1794t1523r1824b1579],
16	Reviron	NNP	O	Reviron	nn	18	SENT_330	[p15l1857t1522r2057b1568],
17	D.	NNP	O	D.	nn	18	SENT_330	[p15l2090t1523r2146b1568],
18	Polymorphism	NN	O	polymorphism	appos	2	SENT_330	[p15l150t1596r545b1659],
19	at	IN	O	at	_	0	SENT_330	[p15l569t1602r620b1644],
20	position	NN	O	position	prep_at	18	SENT_330	[p15l641t1597r856b1659],
21	-308	CD	NUMBER	-308	num	20	SENT_330	[p15l883t1597r1034b1644],
22	of	IN	O	of	_	0	SENT_330	[p15l1055t1596r1109b1644],
23	the	DT	O	the	det	28	SENT_330	[p15l1126t1596r1214b1644],
24	tumor	NN	O	tumor	nn	28	SENT_330	[p15l1234t1602r1407b1644],
25	necrosis	NN	O	necrosis	nn	28	SENT_330	[p15l1427t1597r1644b1644],
26	factor	NN	O	factor	nn	28	SENT_330	[p15l1662t1596r1824b1644],
27	alpha	NN	O	alpha	nn	28	SENT_330	[p15l1842t1596r1991b1659],
28	gene	NN	O	gene	prep_of	20	SENT_330	[p15l2013t1610r2148b1659],
29	influences	VBZ	O	influence	_	0	SENT_330	[p15l148t1671r422b1718],
30	outcome	NN	O	outcome	dobj	29	SENT_330	[p15l472t1676r719b1718],
31	of	IN	O	of	_	0	SENT_330	[p15l769t1671r823b1718],
32	infliximab	NN	O	infliximab	nn	33	SENT_330	[p15l870t1671r1141b1718],
33	therapy	NN	O	therapy	prep_of	30	SENT_330	[p15l1190t1671r1403b1733],
34	in	IN	O	in	_	0	SENT_330	[p15l1453t1672r1497b1718],
35	rheumatoid	JJ	O	rheumatoid	amod	36	SENT_330	[p15l1551t1671r1871b1718],
36	arthritis	NN	O	arthritis	prep_in	33	SENT_330	[p15l1923t1671r2145b1718],
37	.	.	O	.	_	0	SENT_330	[p15l1923t1671r2145b1718],

1	Arthritis	NNP	O	Arthritis	nn	2	SENT_331	[p15l145t1746r355b1794],
2	Rheum	NNP	O	Rheum	_	0	SENT_331	[p15l381t1746r561b1794],
3	2003	CD	DATE	2003	num	2	SENT_331	[p15l585t1747r742b1804],
4	;	:	O	;	_	0	SENT_331	[p15l585t1747r742b1804],
5	48	CD	NUMBER	48	num	7	SENT_331	[p15l770t1747r855b1794],
6	:	:	O	:	_	0	SENT_331	[p15l770t1747r855b1794],
7	1849-1852	CD	DATE	1849-1852	dep	2	SENT_331	[p15l887t1747r1218b1794],
8	.	.	O	.	_	0	SENT_331	[p15l887t1747r1218b1794],

1	Padyukov	NNP	PERSON	Padyukov	nn	2	SENT_332	[p15l150t1820r415b1883],
2	L	NNP	PERSON	L	_	0	SENT_332	[p15l461t1823r500b1878],
3	,	,	O	,	_	0	SENT_332	[p15l461t1823r500b1878],
4	Lampa	NNP	PERSON	Lampa	nn	5	SENT_332	[p15l551t1823r732b1883],
5	J	NNP	PERSON	J	appos	2	SENT_332	[p15l776t1823r806b1879],
6	,	,	O	,	_	0	SENT_332	[p15l776t1823r806b1879],
7	Heimburger	NNP	PERSON	Heimburger	nn	8	SENT_332	[p15l857t1820r1191b1883],
8	M	NNP	O	M	appos	2	SENT_332	[p15l1236t1823r1303b1878],
9	,	,	O	,	_	0	SENT_332	[p15l1236t1823r1303b1878],
10	Ernestam	NNP	O	Ernestam	nn	11	SENT_332	[p15l1355t1823r1603b1868],
11	S	NNP	O	S	appos	2	SENT_332	[p15l1652t1822r1695b1878],
12	,	,	O	,	_	0	SENT_332	[p15l1652t1822r1695b1878],
13	Cederholm	NNP	ORGANIZATION	Cederholm	nn	14	SENT_332	[p15l1744t1820r2051b1868],
14	T	NN	ORGANIZATION	t	appos	2	SENT_332	[p15l2097t1823r2145b1878],
15	,	,	O	,	_	0	SENT_332	[p15l2097t1823r2145b1878],
16	Lundkvist	NNP	PERSON	Lundkvist	nn	17	SENT_332	[p15l150t1896r410b1944],
17	I	NNP	O	I	appos	2	SENT_332	[p15l443t1898r450b1943],
18	et	FW	O	et	nn	19	SENT_332	[p15l485t1902r534b1944],
19	al.	FW	O	al.	dep	17	SENT_332	[p15l564t1896r621b1944],
20	.	.	O	.	_	0	SENT_332	[p15l564t1896r621b1944],

1	Genetic	JJ	O	genetic	amod	2	SENT_333	[p15l657t1897r870b1944],
2	markers	NNS	O	marker	_	0	SENT_333	[p15l903t1896r1117b1944],
3	for	IN	O	for	_	0	SENT_333	[p15l1146t1896r1224b1944],
4	the	DT	O	the	det	5	SENT_333	[p15l1252t1896r1340b1944],
5	efficacy	NN	O	efficacy	prep_for	2	SENT_333	[p15l1372t1896r1579b1959],
6	of	IN	O	of	_	0	SENT_333	[p15l1609t1896r1663b1944],
7	tumour	NN	O	tumour	nn	9	SENT_333	[p15l1691t1902r1901b1944],
8	necrosis	NN	O	necrosis	nn	9	SENT_333	[p15l1932t1897r2149b1944],
9	factor	NN	O	factor	prep_of	5	SENT_333	[p15l138t2437r301b2486],
10	blocking	VBG	O	block	partmod	2	SENT_333	[p15l331t2437r564b2501],
11	therapy	NN	O	therapy	dobj	10	SENT_333	[p15l596t2437r810b2501],
12	in	IN	O	in	_	0	SENT_333	[p15l840t2439r885b2485],
13	rheumatoid	JJ	O	rheumatoid	amod	14	SENT_333	[p15l920t2437r1241b2486],
14	arthritis	NN	O	arthritis	prep_in	11	SENT_333	[p15l1274t2437r1497b2486],
15	.	.	O	.	_	0	SENT_333	[p15l1274t2437r1497b2486],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_334	[p15l1530t2440r1636b2485],
2	Rheum	NNP	PERSON	Rheum	nn	3	SENT_334	[p15l1667t2437r1849b2486],
3	Dis	NNP	O	Dis	_	0	SENT_334	[p15l1880t2439r1959b2486],
4	2003	CD	DATE	2003	num	3	SENT_334	[p15l1988t2439r2145b2496],
5	;	:	O	;	_	0	SENT_334	[p15l1988t2439r2145b2496],
6	62	CD	NUMBER	62	num	8	SENT_334	[p15l140t2515r226b2562],
7	:	:	O	:	_	0	SENT_334	[p15l140t2515r226b2562],
8	526-529	CD	NUMBER	526-529	dep	3	SENT_334	[p15l254t2515r516b2562],
9	.	.	O	.	_	0	SENT_334	[p15l254t2515r516b2562],

1	10	CD	NUMBER	10	num	3	SENT_335	[p15l12t2590r77b2636],
2	Cuchacovich	NN	O	cuchacovich	nn	3	SENT_335	[p15l146t2589r501b2636],
3	M	NN	O	m	_	0	SENT_335	[p15l534t2591r601b2646],
4	,	,	O	,	_	0	SENT_335	[p15l534t2591r601b2646],
5	Ferreira	NNP	PERSON	Ferreira	nn	6	SENT_335	[p15l636t2590r836b2636],
6	L	NNP	PERSON	L	appos	3	SENT_335	[p15l869t2591r908b2646],
7	,	,	O	,	_	0	SENT_335	[p15l869t2591r908b2646],
8	Aliste	NNP	O	Aliste	nn	9	SENT_335	[p15l937t2589r1084b2636],
9	M	NNP	O	M	appos	3	SENT_335	[p15l1116t2591r1183b2646],
10	,	,	O	,	_	0	SENT_335	[p15l1116t2591r1183b2646],
11	Soto	NNP	PERSON	Soto	nn	12	SENT_335	[p15l1216t2590r1339b2636],
12	L	NNP	PERSON	L	appos	3	SENT_335	[p15l1370t2591r1409b2646],
13	,	,	O	,	_	0	SENT_335	[p15l1370t2591r1409b2646],
14	Cuenca	NNP	PERSON	Cuenca	nn	15	SENT_335	[p15l1442t2590r1648b2636],
15	J	NNP	PERSON	J	appos	3	SENT_335	[p15l1676t2591r1706b2647],
16	,	,	O	,	_	0	SENT_335	[p15l1676t2591r1706b2647],
17	Cruzat	NNP	PERSON	Cruzat	nn	18	SENT_335	[p15l1739t2590r1920b2636],
18	A	NNP	O	A	appos	3	SENT_335	[p15l1945t2591r1984b2636],
19	et	FW	O	et	nn	20	SENT_335	[p15l2012t2594r2061b2636],
20	al.	FW	O	al.	dep	18	SENT_335	[p15l2087t2589r2144b2636],
21	.	.	O	.	_	0	SENT_335	[p15l2087t2589r2144b2636],

1	Tumour	NN	O	tumour	nn	8	SENT_336	[p15l143t2667r368b2714],
2	necrosis	NN	O	necrosis	nn	8	SENT_336	[p15l391t2666r609b2714],
3	factor	NN	O	factor	nn	8	SENT_336	[p15l630t2665r963b2729],
4	—	NN	O	—	nn	8	SENT_336	[p15l630t2665r963b2729],
5	alpha	NN	O	alpha	nn	8	SENT_336	[p15l630t2665r963b2729],
6	(	CD	NUMBER	(	num	8	SENT_336	[p15l990t2665r1320b2729],
7	TNF	NN	O	tnf	nn	8	SENT_336	[p15l990t2665r1320b2729],
8	—	NN	O	—	_	0	SENT_336	[p15l990t2665r1320b2729],
9	a	DT	O	a	det	13	SENT_336	[p15l990t2665r1320b2729],
10	|	NN	O	|	nn	13	SENT_336	[p15l990t2665r1320b2729],
11	pha	NN	O	pha	nn	13	SENT_336	[p15l990t2665r1320b2729],
12	)	NN	O	)	nn	13	SENT_336	[p15l990t2665r1320b2729],
13	levels	NNS	O	level	dep	8	SENT_336	[p15l1347t2665r1493b2714],
14	and	CC	O	and	_	0	SENT_336	[p15l1516t2665r1617b2714],
15	influence	NN	O	influence	dep	8	SENT_336	[p15l1645t2665r1894b2714],
16	of	IN	O	of	_	0	SENT_336	[p15l1919t2665r1973b2714],
17	-308	CD	NUMBER	-308	num	19	SENT_336	[p15l1997t2667r2148b2714],
18	TNF	NN	O	tnf	nn	19	SENT_336	[p15l143t2741r431b2805],
19	—	NN	O	—	prep_of	13	SENT_336	[p15l143t2741r431b2805],
20	alpha	NN	O	alpha	nn	22	SENT_336	[p15l143t2741r431b2805],
21	promoter	NN	O	promoter	nn	22	SENT_336	[p15l457t2747r720b2805],
22	polymorphism	NN	O	polymorphism	dep	8	SENT_336	[p15l741t2741r1142b2805],
23	on	IN	O	on	_	0	SENT_336	[p15l1167t2756r1234b2790],
24	the	DT	O	the	det	25	SENT_336	[p15l1257t2741r1345b2790],
25	responsiveness	NN	O	responsiveness	prep_on	22	SENT_336	[p15l1370t2743r1776b2805],
26	to	TO	O	to	_	0	SENT_336	[p15l1798t2747r1853b2790],
27	infliximab	NN	O	infliximab	prep_to	25	SENT_336	[p15l1876t2741r2147b2790],
28	in	IN	O	in	_	0	SENT_336	[p15l147t2818r192b2865],
29	patients	NNS	O	patient	prep_in	27	SENT_336	[p15l236t2818r453b2881],
30	with	IN	O	with	_	0	SENT_336	[p15l490t2817r611b2866],
31	rheumatoid	JJ	O	rheumatoid	amod	32	SENT_336	[p15l654t2817r975b2866],
32	arthritis	NN	O	arthritis	prep_with	29	SENT_336	[p15l1017t2817r1240b2866],
33	.	.	O	.	_	0	SENT_336	[p15l1017t2817r1240b2866],

1	Scand	NNP	LOCATION	Scand	_	0	SENT_337	[p15l1285t2817r1448b2866],
2	/	:	O	/	punct	1	SENT_337	[p15l1478t2819r1499b2877],
3	Rheumatol	NNP	O	Rheumatol	dep	1	SENT_337	[p15l1538t2817r1826b2866],
4	2004	CD	DATE	2004	dep	3	SENT_337	[p15l1861t2818r2018b2876],
5	;	:	O	;	_	0	SENT_337	[p15l1861t2818r2018b2876],
6	33	CD	NUMBER	33	dep	3	SENT_337	[p15l2062t2818r2145b2866],
7	:	:	O	:	_	0	SENT_337	[p15l2062t2818r2145b2866],
8	228-232	CD	NUMBER	228-232	dep	6	SENT_337	[p15l146t2894r409b2940],
9	.	.	O	.	_	0	SENT_337	[p15l146t2894r409b2940],

1	Fonseca	NNP	PERSON	Fonseca	nn	2	SENT_338	[p15l148t2970r364b3015],
2	JE	NNP	O	JE	_	0	SENT_338	[p15l395t2970r456b3026],
3	,	,	O	,	_	0	SENT_338	[p15l395t2970r456b3026],
4	Carvalho	NNP	PERSON	Carvalho	nn	5	SENT_338	[p15l491t2967r736b3015],
5	T	NN	PERSON	t	appos	2	SENT_338	[p15l764t2970r813b3025],
6	,	,	O	,	_	0	SENT_338	[p15l764t2970r813b3025],
7	Cruz	NNP	PERSON	Cruz	nn	8	SENT_338	[p15l848t2969r975b3015],
8	M	NNP	O	M	appos	2	SENT_338	[p15l1007t2970r1074b3025],
9	,	,	O	,	_	0	SENT_338	[p15l1007t2970r1074b3025],
10	Nero	NNP	PERSON	Nero	nn	11	SENT_338	[p15l1111t2970r1245b3015],
11	P	NN	PERSON	p	appos	2	SENT_338	[p15l1279t2970r1321b3025],
12	,	,	O	,	_	0	SENT_338	[p15l1279t2970r1321b3025],
13	Sobral	NNP	O	Sobral	nn	14	SENT_338	[p15l1357t2967r1525b3015],
14	M	NNP	O	M	appos	2	SENT_338	[p15l1561t2970r1629b3025],
15	,	,	O	,	_	0	SENT_338	[p15l1561t2970r1629b3025],
16	Mourao	NNP	PERSON	Mourao	nn	17	SENT_338	[p15l1666t2968r1882b3015],
17	AF	NNP	O	AF	appos	2	SENT_338	[p15l1910t2970r1977b3015],
18	et	FW	O	et	nn	19	SENT_338	[p15l2010t2973r2059b3015],
19	al.	FW	O	al.	dep	17	SENT_338	[p15l2087t2967r2145b3015],
20	.	.	O	.	_	0	SENT_338	[p15l2087t2967r2145b3015],

1	Polymorphism	NN	O	polymorphism	_	0	SENT_339	[p15l148t3044r545b3108],
2	at	IN	O	at	_	0	SENT_339	[p15l581t3049r633b3093],
3	position	NN	O	position	prep_at	1	SENT_339	[p15l667t3045r883b3108],
4	-308	CD	NUMBER	-308	num	3	SENT_339	[p15l922t3045r1073b3093],
5	of	IN	O	of	_	0	SENT_339	[p15l1108t3044r1162b3093],
6	the	DT	O	the	det	11	SENT_339	[p15l1192t3044r1280b3093],
7	tumour	NN	O	tumour	nn	11	SENT_339	[p15l1313t3050r1523b3093],
8	necrosis	NN	O	necrosis	nn	11	SENT_339	[p15l1556t3045r1774b3093],
9	factor	NN	O	factor	nn	11	SENT_339	[p15l1804t3044r1967b3093],
10	alpha	NN	O	alpha	nn	11	SENT_339	[p15l1998t3044r2147b3108],
11	gene	NN	O	gene	prep_of	1	SENT_339	[p15l145t3134r281b3183],
12	and	CC	O	and	_	0	SENT_339	[p15l303t3120r404b3168],
13	rheumatoid	JJ	O	rheumatoid	amod	15	SENT_339	[p15l430t3120r750b3168],
14	arthritis	NN	O	arthritis	nn	15	SENT_339	[p15l774t3120r982b3168],
15	pharmacogenetics	NNS	O	pharmacogenetic	conj_and	11	SENT_339	[p15l1006t3120r1533b3183],
16	.	.	O	.	_	0	SENT_339	[p15l1006t3120r1533b3183],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_340	[p15l1557t3122r1663b3168],
2	Rheum	NNP	PERSON	Rheum	nn	3	SENT_340	[p15l1685t3120r1866b3168],
3	Dis	NNP	O	Dis	_	0	SENT_340	[p15l1889t3121r1969b3168],
4	2005	CD	DATE	2005	num	3	SENT_340	[p15l1988t3121r2145b3178],
5	;	:	O	;	_	0	SENT_340	[p15l1988t3121r2145b3178],
6	64	CD	NUMBER	64	num	8	SENT_340	[p15l144t3197r230b3244],
7	:	:	O	:	_	0	SENT_340	[p15l144t3197r230b3244],
8	793-794	CD	NUMBER	793-794	dep	3	SENT_340	[p15l262t3197r521b3244],
9	.	.	O	.	_	0	SENT_340	[p15l262t3197r521b3244],

1	Kang	NNP	PERSON	Kang	nn	2	SENT_341	[p16l148t22r284b84],
2	CP	NNP	O	CP	_	0	SENT_341	[p16l328t22r417b79],
3	,	,	O	,	_	0	SENT_341	[p16l328t22r417b79],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_341	[p16l465t23r553b69],
5	KW	NNP	O	KW	appos	2	SENT_341	[p16l598t22r703b79],
6	,	,	O	,	_	0	SENT_341	[p16l598t22r703b79],
7	Yoo	NNP	O	Yoo	nn	8	SENT_341	[p16l745t22r851b69],
8	DH	NNP	O	DH	appos	2	SENT_341	[p16l895t23r995b79],
9	,	,	O	,	_	0	SENT_341	[p16l895t23r995b79],
10	Kang	NNP	PERSON	Kang	nn	11	SENT_341	[p16l1043t22r1179b84],
11	C	NNP	O	C	appos	2	SENT_341	[p16l1223t22r1277b79],
12	,	,	O	,	_	0	SENT_341	[p16l1223t22r1277b79],
13	Bae	NNP	ORGANIZATION	Bae	nn	14	SENT_341	[p16l1325t23r1418b69],
14	SC	NNP	ORGANIZATION	SC	appos	2	SENT_341	[p16l1461t22r1548b69],
15	.	.	O	.	_	0	SENT_341	[p16l1461t22r1548b69],

1	The	DT	O	the	det	2	SENT_342	[p16l1591t20r1694b69],
2	influence	NN	O	influence	_	0	SENT_342	[p16l1737t20r1986b69],
3	of	IN	O	of	_	0	SENT_342	[p16l2029t20r2082b69],
4	a	DT	O	a	det	5	SENT_342	[p16l2121t35r2147b69],
5	polymorphism	NN	O	polymorphism	prep_of	2	SENT_342	[p16l148t97r549b161],
6	at	IN	O	at	_	0	SENT_342	[p16l585t102r636b146],
7	position	NN	O	position	prep_at	5	SENT_342	[p16l670t98r886b161],
8	-857	CD	NUMBER	-857	num	7	SENT_342	[p16l925t98r1076b146],
9	of	IN	O	of	_	0	SENT_342	[p16l1110t97r1164b146],
10	the	DT	O	the	det	15	SENT_342	[p16l1194t97r1281b146],
11	tumour	NN	O	tumour	nn	15	SENT_342	[p16l1314t103r1524b146],
12	necrosis	NN	O	necrosis	nn	15	SENT_342	[p16l1557t98r1774b146],
13	factor	NN	O	factor	nn	15	SENT_342	[p16l1805t97r1968b146],
14	alpha	NN	O	alpha	nn	15	SENT_342	[p16l1998t97r2147b161],
15	gene	NN	O	gene	prep_of	2	SENT_342	[p16l145t187r281b236],
16	on	IN	O	on	_	0	SENT_342	[p16l304t187r372b221],
17	clinical	JJ	O	clinical	amod	18	SENT_342	[p16l396t173r581b221],
18	response	NN	O	response	prep_on	15	SENT_342	[p16l609t187r850b236],
19	to	TO	O	to	_	0	SENT_342	[p16l872t178r927b221],
20	etanercept	NN	O	etanercept	nn	21	SENT_342	[p16l950t178r1248b236],
21	therapy	NN	O	therapy	prep_to	18	SENT_342	[p16l1268t173r1481b236],
22	in	IN	O	in	_	0	SENT_342	[p16l1504t174r1549b221],
23	rheumatoid	JJ	O	rheumatoid	amod	24	SENT_342	[p16l1576t173r1897b221],
24	arthritis	NN	O	arthritis	prep_in	2	SENT_342	[p16l1921t173r2145b221],
25	.	.	O	.	_	0	SENT_342	[p16l1921t173r2145b221],

1	Rheumatology	NNP	O	Rheumatology	nn	3	SENT_343	[p16l148t248r534b312],
2	(	NNP	O	(	nn	3	SENT_343	[p16l557t248r780b309],
3	Oxford	NNP	LOCATION	Oxford	_	0	SENT_343	[p16l557t248r780b309],
4	)	CD	NUMBER	)	num	5	SENT_343	[p16l557t248r780b309],
5	2005	CD	DATE	2005	dep	3	SENT_343	[p16l804t250r961b307],
6	;	:	O	;	_	0	SENT_343	[p16l804t250r961b307],
7	44	CD	NUMBER	44	num	9	SENT_343	[p16l989t251r1075b297],
8	:	:	O	:	_	0	SENT_343	[p16l989t251r1075b297],
9	547-552	CD	NUMBER	547-552	dep	3	SENT_343	[p16l1104t250r1366b297],
10	.	.	O	.	_	0	SENT_343	[p16l1104t250r1366b297],

1	Cuchacovich	NN	MISC	cuchacovich	nn	2	SENT_344	[p16l146t324r501b372],
2	M	NN	O	m	_	0	SENT_344	[p16l527t326r594b382],
3	,	,	O	,	_	0	SENT_344	[p16l527t326r594b382],
4	Soto	NNP	PERSON	Soto	nn	5	SENT_344	[p16l620t325r743b372],
5	L	NNP	PERSON	L	appos	2	SENT_344	[p16l767t326r806b382],
6	,	,	O	,	_	0	SENT_344	[p16l767t326r806b382],
7	Edwardes	NNP	ORGANIZATION	Edwardes	nn	8	SENT_344	[p16l833t324r1095b372],
8	M	NNP	ORGANIZATION	M	appos	2	SENT_344	[p16l1119t326r1186b382],
9	,	,	O	,	_	0	SENT_344	[p16l1119t326r1186b382],
10	Gutierrez	NNP	PERSON	Gutierrez	nn	11	SENT_344	[p16l1212t325r1466b372],
11	M	NNP	O	M	appos	2	SENT_344	[p16l1490t326r1557b382],
12	,	,	O	,	_	0	SENT_344	[p16l1490t326r1557b382],
13	Llanos	NNP	ORGANIZATION	Llanos	nn	14	SENT_344	[p16l1584t324r1754b372],
14	C	NNP	ORGANIZATION	C	appos	2	SENT_344	[p16l1775t325r1829b382],
15	,	,	O	,	_	0	SENT_344	[p16l1775t325r1829b382],
16	Pacheco	NNP	PERSON	Pacheco	nn	17	SENT_344	[p16l1857t324r2083b372],
17	D	NNP	O	D	appos	2	SENT_344	[p16l2108t326r2147b371],
18	et	FW	O	et	nn	19	SENT_344	[p16l147t405r196b448],
19	al.	FW	O	al.	dep	17	SENT_344	[p16l250t400r308b448],
20	.	.	O	.	_	0	SENT_344	[p16l250t400r308b448],

1	Tumour	NN	O	tumour	nn	7	SENT_345	[p16l366t402r590b448],
2	necrosis	NN	O	necrosis	nn	7	SENT_345	[p16l647t401r864b448],
3	factor	NN	O	factor	nn	7	SENT_345	[p16l918t400r1080b448],
4	(	CD	NUMBER	(	num	7	SENT_345	[p16l1135t400r1445b463],
5	TNF	NN	O	tnf	nn	7	SENT_345	[p16l1135t400r1445b463],
6	)	NN	O	)	nn	7	SENT_345	[p16l1135t400r1445b463],
7	alpha	NN	O	alpha	nsubj	17	SENT_345	[p16l1135t400r1445b463],
8	-308	CD	NUMBER	-308	num	11	SENT_345	[p16l1505t401r1656b448],
9	G/G	NN	O	g/g	nn	11	SENT_345	[p16l1715t400r1827b454],
10	promoter	NN	O	promoter	nn	11	SENT_345	[p16l1888t405r2150b463],
11	polymorphism	NN	O	polymorphism	dep	7	SENT_345	[p16l148t476r549b540],
12	and	CC	O	and	_	0	SENT_345	[p16l587t476r687b524],
13	TNFa	NN	O	tnfa	nsubj	17	SENT_345	[p16l722t476r990b540],
14	|	CD	NUMBER	|	num	16	SENT_345	[p16l722t476r990b540],
15	pha	NN	O	pha	nn	16	SENT_345	[p16l722t476r990b540],
16	levels	NNS	O	level	dep	13	SENT_345	[p16l1029t476r1173b524],
17	correlate	VBP	O	correlate	_	0	SENT_345	[p16l1209t476r1450b524],
18	with	IN	O	with	_	0	SENT_345	[p16l1484t476r1603b524],
19	a	DT	O	a	det	21	SENT_345	[p16l1641t490r1667b524],
20	better	JJR	O	better	amod	21	SENT_345	[p16l1706t476r1871b524],
21	response	NN	O	response	prep_with	17	SENT_345	[p16l1907t490r2148b540],
22	to	TO	O	to	_	0	SENT_345	[p16l144t557r200b600],
23	adalimumab	NN	O	adalimumab	prep_to	21	SENT_345	[p16l222t551r571b600],
24	in	IN	O	in	_	0	SENT_345	[p16l595t553r640b599],
25	patients	NNS	O	patient	prep_in	17	SENT_345	[p16l667t553r884b615],
26	with	IN	O	with	_	0	SENT_345	[p16l904t551r1024b600],
27	rheumatoid	JJ	O	rheumatoid	amod	28	SENT_345	[p16l1050t551r1371b600],
28	arthritis	NN	O	arthritis	prep_with	25	SENT_345	[p16l1396t551r1620b600],
29	.	.	O	.	_	0	SENT_345	[p16l1396t551r1620b600],

1	Scand	NNP	LOCATION	Scand	_	0	SENT_346	[p16l1647t551r1810b600],
2	/	:	O	/	punct	1	SENT_346	[p16l1823t554r1844b611],
3	Rheumatol	NNP	O	Rheumatol	dep	1	SENT_346	[p16l1865t551r2153b600],
4	2006	CD	DATE	2006	dep	3	SENT_346	[p16l146t628r303b685],
5	;	:	O	;	_	0	SENT_346	[p16l146t628r303b685],
6	35	CD	NUMBER	35	dep	3	SENT_346	[p16l333t628r416b675],
7	:	:	O	:	_	0	SENT_346	[p16l333t628r416b675],
8	435-440	CD	NUMBER	435-440	dep	6	SENT_346	[p16l443t628r708b675],
9	.	.	O	.	_	0	SENT_346	[p16l443t628r708b675],

1	Seitz	NNP	PERSON	Seitz	nn	2	SENT_347	[p16l147t704r274b751],
2	M	NNP	O	M	_	0	SENT_347	[p16l319t705r386b761],
3	,	,	O	,	_	0	SENT_347	[p16l319t705r386b761],
4	Wirthmijller	NNP	PERSON	Wirthmijller	nn	5	SENT_347	[p16l430t703r765b751],
5	U	NNP	PERSON	U	appos	2	SENT_347	[p16l808t705r860b761],
6	,	,	O	,	_	0	SENT_347	[p16l808t705r860b761],
7	Moller	NNP	PERSON	Moller	nn	8	SENT_347	[p16l909t703r1085b751],
8	B	NNP	O	B	appos	2	SENT_347	[p16l1129t705r1173b761],
9	,	,	O	,	_	0	SENT_347	[p16l1129t705r1173b761],
10	Villiger	NNP	PERSON	Villiger	nn	11	SENT_347	[p16l1217t703r1409b766],
11	PM	NNP	O	PM	appos	2	SENT_347	[p16l1452t705r1554b751],
12	.	.	O	.	_	0	SENT_347	[p16l1452t705r1554b751],

1	The	DT	O	the	det	4	SENT_348	[p16l1598t703r1701b751],
2	-308	CD	NUMBER	-308	num	4	SENT_348	[p16l1747t704r1898b751],
3	tumour	NN	O	tumour	nn	4	SENT_348	[p16l1941t708r2151b751],
4	necrosis	NN	O	necrosis	nsubj	10	SENT_348	[p16l148t780r365b828],
5	factor	NN	O	factor	nn	9	SENT_348	[p16l384t779r718b843],
6	—	NN	O	—	nn	9	SENT_348	[p16l384t779r718b843],
7	alpha	NN	O	alpha	nn	9	SENT_348	[p16l384t779r718b843],
8	gene	NN	O	gene	nn	9	SENT_348	[p16l741t793r877b843],
9	polymorphism	NN	O	polymorphism	dep	4	SENT_348	[p16l901t779r1301b843],
10	predicts	VBZ	O	predict	_	0	SENT_348	[p16l1328t779r1545b843],
11	therapeutic	JJ	O	therapeutic	amod	12	SENT_348	[p16l1566t779r1883b843],
12	response	NN	O	response	dobj	10	SENT_348	[p16l1907t793r2148b843],
13	to	TO	O	to	_	0	SENT_348	[p16l144t861r200b904],
14	TNFa	FW	O	tnfa	nn	16	SENT_348	[p16l245t855r764b919],
15	|	FW	O	|	nn	16	SENT_348	[p16l245t855r764b919],
16	pha-blockers	NNS	O	pha-blocker	prep_to	10	SENT_348	[p16l245t855r764b919],
17	in	IN	O	in	_	0	SENT_348	[p16l812t856r857b903],
18	rheumatoid	JJ	O	rheumatoid	amod	19	SENT_348	[p16l908t855r1229b904],
19	arthritis	NN	O	arthritis	prep_in	16	SENT_348	[p16l1278t855r1485b904],
20	and	CC	O	and	_	0	SENT_348	[p16l1533t855r1633b904],
21	spondyloarthritis	NN	O	spondyloarthritis	nn	22	SENT_348	[p16l1682t855r2148b919],
22	patients	NNS	O	patient	conj_and	19	SENT_348	[p16l148t932r380b995],
23	.	.	O	.	_	0	SENT_348	[p16l148t932r380b995],

1	Rheumatology	NNP	O	Rheumatology	nn	3	SENT_349	[p16l411t931r799b995],
2	(	NNP	O	(	nn	3	SENT_349	[p16l820t931r1043b992],
3	Oxford	NNP	LOCATION	Oxford	_	0	SENT_349	[p16l820t931r1043b992],
4	)	CD	NUMBER	)	num	5	SENT_349	[p16l820t931r1043b992],
5	2007	CD	DATE	2007	dep	3	SENT_349	[p16l1068t932r1225b990],
6	;	:	O	;	_	0	SENT_349	[p16l1068t932r1225b990],
7	46	CD	NUMBER	46	num	9	SENT_349	[p16l1253t933r1338b980],
8	:	:	O	:	_	0	SENT_349	[p16l1253t933r1338b980],
9	93-96	CD	DATE	93-96	dep	3	SENT_349	[p16l1368t932r1556b980],
10	.	.	O	.	_	0	SENT_349	[p16l1368t932r1556b980],

1	Guis	NNP	O	Guis	nn	2	SENT_350	[p16l146t1008r265b1055],
2	S	NNP	O	S	_	0	SENT_350	[p16l292t1008r335b1065],
3	,	,	O	,	_	0	SENT_350	[p16l292t1008r335b1065],
4	Balandraud	NNP	PERSON	Balandraud	nn	5	SENT_350	[p16l367t1007r678b1055],
5	N	NNP	PERSON	N	appos	2	SENT_350	[p16l709t1009r766b1065],
6	,	,	O	,	_	0	SENT_350	[p16l709t1009r766b1065],
7	Bouvenot	NNP	PERSON	Bouvenot	nn	8	SENT_350	[p16l799t1009r1063b1055],
8	J	NNP	PERSON	J	appos	2	SENT_350	[p16l1085t1009r1115b1066],
9	,	,	O	,	_	0	SENT_350	[p16l1085t1009r1115b1066],
10	Auger	NNP	O	Auger	nn	11	SENT_350	[p16l1142t1009r1311b1070],
11	I	NNP	O	I	appos	2	SENT_350	[p16l1337t1009r1362b1065],
12	,	,	O	,	_	0	SENT_350	[p16l1337t1009r1362b1065],
13	Toussirot	NNP	O	Toussirot	nn	14	SENT_350	[p16l1389t1008r1642b1055],
14	E	NNP	O	E	appos	2	SENT_350	[p16l1669t1009r1709b1065],
15	,	,	O	,	_	0	SENT_350	[p16l1669t1009r1709b1065],
16	Wendling	NNP	PERSON	Wendling	nn	17	SENT_350	[p16l1736t1007r2005b1070],
17	D	NNP	O	D	appos	2	SENT_350	[p16l2036t1009r2075b1055],
18	et	FW	O	et	nn	19	SENT_350	[p16l2104t1012r2153b1055],
19	al.	FW	O	al.	dep	17	SENT_350	[p16l147t1082r205b1131],
20	.	.	O	.	_	0	SENT_350	[p16l147t1082r205b1131],

1	Influence	NN	O	influence	_	0	SENT_351	[p16l240t1082r490b1131],
2	of	IN	O	of	_	0	SENT_351	[p16l519t1082r573b1131],
3	-308	CD	NUMBER	-308	num	5	SENT_351	[p16l601t1084r752b1131],
4	A/G	NN	O	a/g	nn	5	SENT_351	[p16l780t1082r886b1137],
5	polymorphism	NN	O	polymorphism	prep_of	1	SENT_351	[p16l919t1082r1320b1146],
6	in	IN	O	in	_	0	SENT_351	[p16l1353t1084r1397b1130],
7	the	DT	O	the	det	12	SENT_351	[p16l1427t1082r1515b1131],
8	tumor	NN	O	tumor	nn	12	SENT_351	[p16l1543t1088r1717b1131],
9	necrosis	NN	O	necrosis	nn	12	SENT_351	[p16l1745t1084r1963b1131],
10	factor	NN	O	factor	nn	12	SENT_351	[p16l1988t1082r2150b1131],
11	alpha	NN	O	alpha	nn	12	SENT_351	[p16l145t1159r294b1223],
12	gene	NN	O	gene	prep_in	5	SENT_351	[p16l329t1173r465b1223],
13	on	IN	O	on	_	0	SENT_351	[p16l499t1173r566b1208],
14	etanercept	NN	O	etanercept	nn	15	SENT_351	[p16l602t1165r901b1223],
15	treatment	NN	O	treatment	prep_on	1	SENT_351	[p16l931t1165r1209b1208],
16	in	IN	O	in	_	0	SENT_351	[p16l1243t1160r1287b1207],
17	rheumatoid	JJ	O	rheumatoid	amod	18	SENT_351	[p16l1325t1159r1645b1208],
18	arthritis	NN	O	arthritis	prep_in	1	SENT_351	[p16l1681t1159r1905b1208],
19	.	.	O	.	_	0	SENT_351	[p16l1681t1159r1905b1208],

1	Arthritis	NNP	O	Arthritis	nn	2	SENT_352	[p16l1940t1159r2151b1208],
2	Rheum	NNP	O	Rheum	_	0	SENT_352	[p16l148t1234r329b1281],
3	2007	CD	DATE	2007	num	2	SENT_352	[p16l353t1235r510b1291],
4	;	:	O	;	_	0	SENT_352	[p16l353t1235r510b1291],
5	57	CD	NUMBER	57	num	7	SENT_352	[p16l540t1236r624b1281],
6	:	:	O	:	_	0	SENT_352	[p16l540t1236r624b1281],
7	1426-1430	CD	DATE	1426-1430	dep	2	SENT_352	[p16l655t1235r989b1281],
8	.	.	O	.	_	0	SENT_352	[p16l655t1235r989b1281],

1	Marotte	NNP	PERSON	Marotte	nn	2	SENT_353	[p16l148t1312r367b1359],
2	H	NNP	O	H	_	0	SENT_353	[p16l406t1312r459b1369],
3	,	,	O	,	_	0	SENT_353	[p16l406t1312r459b1369],
4	Arnaud	NNP	PERSON	Arnaud	nn	5	SENT_353	[p16l497t1310r697b1359],
5	B	NNP	PERSON	B	appos	2	SENT_353	[p16l738t1312r783b1369],
6	,	,	O	,	_	0	SENT_353	[p16l738t1312r783b1369],
7	Diasparra	NNP	PERSON	Diasparra	nn	8	SENT_353	[p16l825t1311r1081b1374],
8	J	NNP	PERSON	J	appos	2	SENT_353	[p16l1117t1312r1147b1370],
9	,	,	O	,	_	0	SENT_353	[p16l1117t1312r1147b1370],
10	Zrioual	NNP	O	Zrioual	nn	11	SENT_353	[p16l1186t1310r1376b1359],
11	S	NNP	O	S	appos	8	SENT_353	[p16l1416t1312r1459b1369],
12	,	,	O	,	_	0	SENT_353	[p16l1416t1312r1459b1369],
13	Miossec	NNP	O	Miossec	nn	15	SENT_353	[p16l1501t1311r1718b1359],
14	P.	NNP	O	P.	nn	15	SENT_353	[p16l1756t1312r1799b1359],
15	Association	NNP	O	Association	appos	8	SENT_353	[p16l1836t1311r2145b1359],
16	between	IN	O	between	_	0	SENT_353	[p16l147t1385r383b1434],
17	the	DT	O	the	det	18	SENT_353	[p16l415t1385r503b1434],
18	level	NN	O	level	prep_between	15	SENT_353	[p16l535t1385r652b1434],
19	of	IN	O	of	_	0	SENT_353	[p16l684t1385r738b1434],
20	circulating	VBG	O	circulate	prepc_of	18	SENT_353	[p16l765t1385r1053b1449],
21	bioactive	JJ	O	bioactive	amod	24	SENT_353	[p16l1087t1385r1333b1434],
22	tumor	NN	O	tumor	nn	24	SENT_353	[p16l1362t1391r1535b1434],
23	necrosis	NN	O	necrosis	nn	24	SENT_353	[p16l1565t1387r1782b1434],
24	factor	NN	O	factor	dep	25	SENT_353	[p16l1809t1385r1971b1434],
25	alpha	NN	O	alpha	dep	20	SENT_353	[p16l1998t1385r2146b1449],
26	and	CC	O	and	_	0	SENT_353	[p16l145t1462r246b1511],
27	the	DT	O	the	det	30	SENT_353	[p16l280t1462r368b1511],
28	tumor	NN	O	tumor	nn	30	SENT_353	[p16l399t1468r573b1511],
29	necrosis	NN	O	necrosis	nn	30	SENT_353	[p16l604t1463r822b1511],
30	factor	NN	O	factor	dep	31	SENT_353	[p16l851t1462r1014b1511],
31	alpha	NN	O	alpha	dep	20	SENT_353	[p16l1043t1462r1192b1526],
32	gene	NN	O	gene	nn	33	SENT_353	[p16l1225t1476r1361b1526],
33	polymorphism	NN	O	polymorphism	tmod	20	SENT_353	[p16l1396t1462r1796b1526],
34	at	IN	O	at	advmod	33	SENT_353	[p16l1831t1468r1883b1511],
35	-308	CD	NUMBER	-308	pobj	34	SENT_353	[p16l1916t1463r2067b1511],
36	in	IN	O	in	_	0	SENT_353	[p16l2102t1463r2146b1510],
37	patients	NNS	O	patient	prep_in	34	SENT_353	[p16l147t1539r365b1601],
38	with	IN	O	with	_	0	SENT_353	[p16l389t1538r509b1586],
39	rheumatoid	JJ	O	rheumatoid	amod	40	SENT_353	[p16l541t1538r861b1586],
40	arthritis	NN	O	arthritis	prep_with	37	SENT_353	[p16l889t1538r1097b1586],
41	treated	VBN	O	treat	partmod	2	SENT_353	[p16l1124t1538r1319b1586],
42	with	IN	O	with	_	0	SENT_353	[p16l1346t1538r1465b1586],
43	a	DT	O	a	det	48	SENT_353	[p16l1495t1552r1521b1586],
44	tumor	NN	O	tumor	nn	48	SENT_353	[p16l1547t1543r1721b1586],
45	necrosis	NN	O	necrosis	nn	48	SENT_353	[p16l1747t1539r1964b1586],
46	factor	NN	O	factor	nn	48	SENT_353	[p16l1988t1538r2150b1586],
47	alpha	NN	O	alpha	nn	48	SENT_353	[p16l145t1613r294b1677],
48	inhibitor	NN	O	inhibitor	prep_with	41	SENT_353	[p16l323t1613r571b1662],
49	.	.	O	.	_	0	SENT_353	[p16l323t1613r571b1662],

1	Arthritis	NNP	O	Arthritis	nn	2	SENT_354	[p16l599t1613r809b1662],
2	Rheum	NNP	O	Rheum	_	0	SENT_354	[p16l834t1613r1016b1662],
3	2008	CD	DATE	2008	num	2	SENT_354	[p16l1040t1615r1197b1672],
4	;	:	O	;	_	0	SENT_354	[p16l1040t1615r1197b1672],
5	58	CD	NUMBER	58	num	7	SENT_354	[p16l1226t1615r1311b1662],
6	:	:	O	:	_	0	SENT_354	[p16l1226t1615r1311b1662],
7	1258-1263	CD	DATE	1258-1263	dep	2	SENT_354	[p16l1342t1615r1675b1662],
8	.	.	O	.	_	0	SENT_354	[p16l1342t1615r1675b1662],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_355	[p16l148t1692r237b1739],
2	YH	NNP	O	YH	_	0	SENT_355	[p16l255t1692r348b1749],
3	,	,	O	,	_	0	SENT_355	[p16l255t1692r348b1749],
4	Rho	NN	O	rho	nn	5	SENT_355	[p16l375t1690r477b1739],
5	YH	NN	O	yh	appos	2	SENT_355	[p16l495t1692r587b1749],
6	,	,	O	,	_	0	SENT_355	[p16l495t1692r587b1749],
7	Choi	NNP	PERSON	Choi	nn	8	SENT_355	[p16l612t1690r739b1739],
8	SJ	NNP	O	SJ	appos	2	SENT_355	[p16l762t1692r822b1750],
9	,	,	O	,	_	0	SENT_355	[p16l762t1692r822b1750],
10	Ji	NNP	O	Ji	nn	11	SENT_355	[p16l845t1691r872b1750],
11	JD	NNP	O	JD	appos	2	SENT_355	[p16l894t1692r970b1750],
12	,	,	O	,	_	0	SENT_355	[p16l894t1692r970b1750],
13	Song	NN	O	song	nn	14	SENT_355	[p16l996t1692r1133b1754],
14	CG	NN	O	cg	appos	2	SENT_355	[p16l1156t1691r1261b1739],
15	.	.	O	.	_	0	SENT_355	[p16l1156t1691r1261b1739],

1	Association	NNP	O	Association	_	0	SENT_356	[p16l1282t1691r1592b1739],
2	of	IN	O	of	_	0	SENT_356	[p16l1615t1690r1668b1739],
3	TNF-alpha	NN	O	tnf-alpha	nn	6	SENT_356	[p16l1684t1690r1972b1754],
4	-308	CD	NUMBER	-308	num	6	SENT_356	[p16l1996t1691r2147b1739],
5	G/A	NN	O	g/a	nn	6	SENT_356	[p16l146t1766r254b1820],
6	polymorphism	NN	O	polymorphism	prep_of	1	SENT_356	[p16l308t1766r708b1829],
7	with	IN	O	with	_	0	SENT_356	[p16l762t1766r882b1814],
8	responsiveness	NN	O	responsiveness	prep_with	1	SENT_356	[p16l940t1767r1347b1829],
9	to	TO	O	to	_	0	SENT_356	[p16l1399t1771r1454b1814],
10	TNF-alpha-blockers	NNS	O	tnf-alpha-blocker	prep_to	8	SENT_356	[p16l1506t1766r2047b1829],
11	in	IN	O	in	_	0	SENT_356	[p16l2101t1767r2146b1814],
12	rheumatoid	JJ	O	rheumatoid	amod	13	SENT_356	[p16l148t1842r468b1891],
13	arthritis	NN	O	arthritis	prep_in	10	SENT_356	[p16l491t1842r714b1891],
14	:	:	O	:	_	0	SENT_356	[p16l491t1842r714b1891],
15	a	DT	O	a	det	16	SENT_356	[p16l738t1856r764b1891],
16	meta-analysis	NN	O	meta-analysis	dep	1	SENT_356	[p16l788t1842r1175b1906],
17	.	.	O	.	_	0	SENT_356	[p16l788t1842r1175b1906],

1	Rheumatol	NNP	O	Rheumatol	nn	2	SENT_357	[p16l1201t1842r1489b1891],
2	Int	NNP	O	Int	_	0	SENT_357	[p16l1506t1844r1578b1891],
3	2006	CD	DATE	2006	num	2	SENT_357	[p16l1594t1844r1751b1901],
4	;	:	O	;	_	0	SENT_357	[p16l1594t1844r1751b1901],
5	27	CD	NUMBER	27	num	7	SENT_357	[p16l1775t1844r1859b1891],
6	:	:	O	:	_	0	SENT_357	[p16l1775t1844r1859b1891],
7	157-161	CD	NUMBER	157-161	dep	2	SENT_357	[p16l1885t1844r2145b1891],
8	.	.	O	.	_	0	SENT_357	[p16l1885t1844r2145b1891],

1	Balog	NNP	PERSON	Balog	nn	2	SENT_358	[p16l148t1916r297b1980],
2	A	NNP	O	A	_	0	SENT_358	[p16l343t1919r396b1975],
3	,	,	O	,	_	0	SENT_358	[p16l343t1919r396b1975],
4	Klausz	NNP	PERSON	Klausz	nn	5	SENT_358	[p16l448t1916r617b1965],
5	G	NNP	PERSON	G	appos	2	SENT_358	[p16l662t1918r719b1975],
6	,	,	O	,	_	0	SENT_358	[p16l662t1918r719b1975],
7	Gal	NNP	O	Gal	nn	8	SENT_358	[p16l769t1912r856b1965],
8	J	NNP	O	J	appos	2	SENT_358	[p16l903t1919r932b1976],
9	,	,	O	,	_	0	SENT_358	[p16l903t1919r932b1976],
10	Molnar	NNP	PERSON	Molnar	nn	11	SENT_358	[p16l984t1912r1182b1965],
11	T	NN	O	t	appos	2	SENT_358	[p16l1223t1919r1271b1975],
12	,	,	O	,	_	0	SENT_358	[p16l1223t1919r1271b1975],
13	Nagy	NNP	PERSON	Nagy	nn	14	SENT_358	[p16l1324t1919r1469b1980],
14	F	NN	O	f	appos	2	SENT_358	[p16l1516t1919r1555b1975],
15	,	,	O	,	_	0	SENT_358	[p16l1516t1919r1555b1975],
16	Ocsovszky	NNP	O	Ocsovszky	nn	17	SENT_358	[p16l1605t1916r1890b1980],
17	I	NNP	O	I	appos	2	SENT_358	[p16l1938t1919r1945b1964],
18	et	FW	O	et	nn	19	SENT_358	[p16l1995t1922r2044b1965],
19	al.	FW	O	al.	dep	17	SENT_358	[p16l2087t1916r2144b1965],
20	.	.	O	.	_	0	SENT_358	[p16l2087t1916r2144b1965],

1	Investigation	NN	O	investigation	nsubj	12	SENT_359	[p16l148t1995r499b2058],
2	of	IN	O	of	_	0	SENT_359	[p16l525t1994r579b2043],
3	the	DT	O	the	det	5	SENT_359	[p16l598t1994r687b2043],
4	prognostic	JJ	O	prognostic	amod	5	SENT_359	[p16l713t1995r1007b2058],
5	value	NN	O	value	prep_of	1	SENT_359	[p16l1029t1994r1174b2043],
6	of	IN	O	of	_	0	SENT_359	[p16l1198t1994r1252b2043],
7	TNF-alpha	NN	MISC	tnf-alpha	nn	9	SENT_359	[p16l1270t1994r1558b2058],
8	gene	NN	O	gene	nn	9	SENT_359	[p16l1583t2008r1719b2058],
9	polymorphism	NN	O	polymorphism	prep_of	5	SENT_359	[p16l1745t1994r2145b2058],
10	among	IN	O	among	_	0	SENT_359	[p16l145t2084r340b2133],
11	patients	NNS	O	patient	prep_among	9	SENT_359	[p16l376t2071r593b2133],
12	treated	VBN	O	treat	_	0	SENT_359	[p16l625t2070r820b2118],
13	with	IN	O	with	_	0	SENT_359	[p16l852t2070r972b2118],
14	infliximab	NN	O	infliximab	prep_with	12	SENT_359	[p16l1008t2070r1294b2128],
15	,	,	O	,	_	0	SENT_359	[p16l1008t2070r1294b2128],
16	and	CC	O	and	_	0	SENT_359	[p16l1330t2070r1431b2118],
17	the	DT	O	the	det	18	SENT_359	[p16l1464t2070r1553b2118],
18	effects	NNS	O	effect	dep	28	SENT_359	[p16l1584t2070r1760b2118],
19	of	IN	O	of	_	0	SENT_359	[p16l1792t2070r1846b2118],
20	infliximab	NN	O	infliximab	nn	21	SENT_359	[p16l1876t2070r2147b2118],
21	therapy	NN	O	therapy	prep_of	18	SENT_359	[p16l144t2146r358b2210],
22	on	IN	O	on	_	0	SENT_359	[p16l390t2160r457b2195],
23	TNF	NN	O	tnf	nn	24	SENT_359	[p16l490t2146r778b2210],
24	—	NN	O	—	prep_on	21	SENT_359	[p16l490t2146r778b2210],
25	a	DT	O	a	det	28	SENT_359	[p16l490t2146r778b2210],
26	|	NN	O	|	nn	28	SENT_359	[p16l490t2146r778b2210],
27	pha	NN	O	pha	nn	28	SENT_359	[p16l490t2146r778b2210],
28	production	NN	O	production	conj_and	12	SENT_359	[p16l815t2146r1119b2210],
29	and	CC	O	and	_	0	SENT_359	[p16l1155t2146r1255b2195],
30	apoptosis	NN	O	apoptosis	conj_and	12	SENT_359	[p16l1291t2147r1569b2210],
31	.	.	O	.	_	0	SENT_359	[p16l1291t2147r1569b2210],

1	Pathobiology	NNP	O	Pathobiology	_	0	SENT_360	[p16l1608t2146r1961b2210],
2	2004	CD	DATE	2004	num	1	SENT_360	[p16l1988t2148r2145b2205],
3	;	:	O	;	_	0	SENT_360	[p16l1988t2148r2145b2205],
4	71	CD	NUMBER	71	num	6	SENT_360	[p16l148t2223r230b2270],
5	:	:	O	:	_	0	SENT_360	[p16l148t2223r230b2270],
6	274-280	CD	NUMBER	274-280	dep	1	SENT_360	[p16l259t2223r521b2270],
7	.	.	O	.	_	0	SENT_360	[p16l259t2223r521b2270],

1	Kooloos	NNP	O	Kooloos	nn	2	SENT_361	[p16l148t2298r365b2346],
2	WM	NNP	O	WM	_	0	SENT_361	[p16l388t2299r520b2356],
3	,	,	O	,	_	0	SENT_361	[p16l388t2299r520b2356],
4	de	FW	PERSON	de	nn	5	SENT_361	[p16l548t2298r614b2346],
5	Jong	FW	PERSON	jong	dep	6	SENT_361	[p16l637t2300r761b2361],
6	DJ	NNP	PERSON	DJ	dep	2	SENT_361	[p16l791t2300r864b2357],
7	,	,	O	,	_	0	SENT_361	[p16l791t2300r864b2357],
8	Huizinga	NNP	PERSON	Huizinga	nn	9	SENT_361	[p16l895t2299r1135b2361],
9	TW	NNP	O	TW	appos	6	SENT_361	[p16l1159t2299r1267b2356],
10	,	,	O	,	_	0	SENT_361	[p16l1159t2299r1267b2356],
11	Guchelaar	NNP	O	Guchelaar	nn	12	SENT_361	[p16l1295t2298r1578b2346],
12	HJ	NNP	O	HJ	appos	6	SENT_361	[p16l1603t2300r1674b2358],
13	.	.	O	.	_	0	SENT_361	[p16l1603t2300r1674b2358],

1	Potential	JJ	O	potential	amod	2	SENT_362	[p16l1705t2298r1942b2346],
2	role	NN	O	role	_	0	SENT_362	[p16l1972t2298r2072b2346],
3	of	IN	O	of	_	0	SENT_362	[p16l2097t2298r2151b2346],
4	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	2	SENT_362	[p16l147t2374r659b2437],
5	in	IN	O	in	_	0	SENT_362	[p16l695t2375r740b2422],
6	anti-TNF	JJ	O	anti-tnf	amod	7	SENT_362	[p16l776t2375r1015b2422],
7	treatment	NN	O	treatment	prep_in	4	SENT_362	[p16l1048t2379r1326b2422],
8	of	IN	O	of	_	0	SENT_362	[p16l1359t2374r1412b2422],
9	rheumatoid	JJ	O	rheumatoid	amod	10	SENT_362	[p16l1446t2374r1766b2422],
10	arthritis	NN	O	arthritis	prep_of	2	SENT_362	[p16l1803t2374r2011b2422],
11	and	CC	O	and	_	0	SENT_362	[p16l2045t2374r2146b2422],
12	Crohn	NN	PERSON	crohn	poss	14	SENT_362	[p16l146t2448r360b2498],
13	’s	POS	O	’s	_	0	SENT_362	[p16l146t2448r360b2498],
14	disease	NN	O	disease	conj_and	10	SENT_362	[p16l385t2449r595b2498],
15	.	.	O	.	_	0	SENT_362	[p16l385t2449r595b2498],

1	Drug	NN	O	drug	nn	3	SENT_363	[p16l627t2452r757b2513],
2	Discov	NNP	O	Discov	nn	3	SENT_363	[p16l783t2451r956b2498],
3	Today	NNP	DATE	Today	_	0	SENT_363	[p16l981t2449r1144b2513],
4	2007	CD	DATE	2007	num	3	SENT_363	[p16l1164t2451r1321b2508],
5	;	:	O	;	_	0	SENT_363	[p16l1164t2451r1321b2508],
6	12	CD	NUMBER	12	num	8	SENT_363	[p16l1353t2451r1434b2498],
7	:	:	O	:	_	0	SENT_363	[p16l1353t2451r1434b2498],
8	125-131	CD	NUMBER	125-131	dep	3	SENT_363	[p16l1465t2451r1726b2498],
9	.	.	O	.	_	0	SENT_363	[p16l1465t2451r1726b2498],

1	DerSimonian	JJ	MISC	dersimonian	amod	2	SENT_364	[p16l148t2527r504b2575],
2	R	NN	O	r	_	0	SENT_364	[p16l530t2528r574b2585],
3	,	,	O	,	_	0	SENT_364	[p16l530t2528r574b2585],
4	Laird	NNP	PERSON	Laird	nn	10	SENT_364	[p16l600t2526r729b2575],
5	N.	NNP	PERSON	N.	nn	10	SENT_364	[p16l754t2528r812b2575],
6	Meta	NNP	PERSON	Meta	nn	10	SENT_364	[p16l839t2526r1211b2590],
7	—	NNP	O	—	nn	10	SENT_364	[p16l839t2526r1211b2590],
8	ana	NN	O	ana	nn	10	SENT_364	[p16l839t2526r1211b2590],
9	|	NN	O	|	nn	10	SENT_364	[p16l839t2526r1211b2590],
10	ysis	NN	O	ysis	appos	2	SENT_364	[p16l839t2526r1211b2590],
11	in	IN	O	in	_	0	SENT_364	[p16l1233t2527r1278b2574],
12	clinical	JJ	O	clinical	amod	13	SENT_364	[p16l1301t2526r1485b2575],
13	trials	NNS	O	trial	prep_in	10	SENT_364	[p16l1507t2526r1650b2575],
14	.	.	O	.	_	0	SENT_364	[p16l1507t2526r1650b2575],

1	Control	NNP	O	Control	nn	3	SENT_365	[p16l1678t2526r1873b2575],
2	Clin	NNP	O	Clin	nn	3	SENT_365	[p16l1892t2526r1990b2575],
3	Trials	NNPS	O	Trials	_	0	SENT_365	[p16l2014t2526r2150b2575],
4	1986	CD	DATE	1986	dep	3	SENT_365	[p16l148t2602r303b2659],
5	;	:	O	;	_	0	SENT_365	[p16l148t2602r303b2659],
6	7	CD	NUMBER	7	num	8	SENT_365	[p16l335t2603r379b2649],
7	:	:	O	:	_	0	SENT_365	[p16l335t2603r379b2649],
8	177-188	CD	NUMBER	177-188	dep	3	SENT_365	[p16l412t2602r670b2649],
9	.	.	O	.	_	0	SENT_365	[p16l412t2602r670b2649],

1	Hardy	NNP	PERSON	Hardy	nn	2	SENT_366	[p16l148t2676r311b2740],
2	RJ	NN	PERSON	rj	_	0	SENT_366	[p16l348t2679r408b2736],
3	,	,	O	,	_	0	SENT_366	[p16l348t2679r408b2736],
4	Thompson	NNP	PERSON	Thompson	nn	5	SENT_366	[p16l444t2676r742b2740],
5	SC	NNP	O	SC	appos	2	SENT_366	[p16l781t2678r871b2725],
6	.	.	O	.	_	0	SENT_366	[p16l781t2678r871b2725],

1	Detecting	VBG	O	detect	_	0	SENT_367	[p16l912t2678r1180b2740],
2	and	CC	O	and	_	0	SENT_367	[p16l1217t2676r1318b2725],
3	describing	VBG	O	describe	conj_and	1	SENT_367	[p16l1355t2676r1640b2740],
4	heterogeneity	NN	O	heterogeneity	dobj	1	SENT_367	[p16l1679t2676r2066b2740],
5	in	IN	O	in	_	0	SENT_367	[p16l2102t2678r2146b2724],
6	meta-analysis	NN	O	meta-analysis	prep_in	1	SENT_367	[p16l148t2753r535b2817],
7	.	.	O	.	_	0	SENT_367	[p16l148t2753r535b2817],

1	Stat	NN	O	stat	nsubj	2	SENT_368	[p16l565t2754r672b2802],
2	Med	VBD	O	med	_	0	SENT_368	[p16l696t2753r815b2802],
3	1998	CD	DATE	1998	dobj	2	SENT_368	[p16l838t2754r992b2812],
4	;	:	O	;	_	0	SENT_368	[p16l838t2754r992b2812],
5	17	CD	NUMBER	17	num	7	SENT_368	[p16l1025t2754r1106b2802],
6	:	:	O	:	_	0	SENT_368	[p16l1025t2754r1106b2802],
7	841-856	CD	NUMBER	841-856	dep	3	SENT_368	[p16l1135t2754r1396b2802],
8	.	.	O	.	_	0	SENT_368	[p16l1135t2754r1396b2802],

1	Higgins	NNP	PERSON	Higgins	nn	2	SENT_369	[p16l148t2830r355b2892],
2	JP	NNP	O	JP	_	0	SENT_369	[p16l392t2831r456b2888],
3	,	,	O	,	_	0	SENT_369	[p16l392t2831r456b2888],
4	Thompson	NNP	PERSON	Thompson	nn	5	SENT_369	[p16l496t2829r794b2892],
5	SG	NNP	O	SG	appos	2	SENT_369	[p16l836t2830r926b2887],
6	,	,	O	,	_	0	SENT_369	[p16l836t2830r926b2887],
7	Deeks	NNP	PERSON	Deeks	nn	8	SENT_369	[p16l971t2829r1132b2877],
8	JJ	NN	PERSON	jj	appos	2	SENT_369	[p16l1169t2831r1216b2888],
9	,	,	O	,	_	0	SENT_369	[p16l1169t2831r1216b2888],
10	Altman	NNP	PERSON	Altman	nn	11	SENT_369	[p16l1256t2829r1454b2877],
11	DG	NNS	O	dg	appos	2	SENT_369	[p16l1498t2830r1601b2877],
12	.	.	O	.	_	0	SENT_369	[p16l1498t2830r1601b2877],

1	Measuring	VBG	O	measure	amod	2	SENT_370	[p16l1645t2830r1933b2892],
2	inconsistency	NN	O	inconsistency	_	0	SENT_370	[p16l1976t2830r2148b2877, p16l145t2906r361b2969],
3	in	IN	O	in	_	0	SENT_370	[p16l387t2906r432b2953],
4	meta-analyses	NNS	O	meta-analysis	prep_in	2	SENT_370	[p16l462t2905r866b2969],
5	.	.	O	.	_	0	SENT_370	[p16l462t2905r866b2969],

1	BM	NN	O	bm	_	0	SENT_371	[p16l897t2907r1000b2965],
2	]	CD	NUMBER	]	num	3	SENT_371	[p16l897t2907r1000b2965],
3	2003	CD	DATE	2003	dep	1	SENT_371	[p16l1023t2906r1180b2964],
4	;	:	O	;	_	0	SENT_371	[p16l1023t2906r1180b2964],
5	327	CD	NUMBER	327	num	7	SENT_371	[p16l1210t2906r1330b2953],
6	:	:	O	:	_	0	SENT_371	[p16l1210t2906r1330b2953],
7	557-560	CD	NUMBER	557-560	dep	1	SENT_371	[p16l1359t2906r1621b2953],
8	.	.	O	.	_	0	SENT_371	[p16l1359t2906r1621b2953],

1	Sutton	NNP	PERSON	Sutton	nn	2	SENT_372	[p16l147t2982r326b3029],
2	AJ	NNP	PERSON	AJ	_	0	SENT_372	[p16l367t2983r436b3040],
3	,	,	O	,	_	0	SENT_372	[p16l367t2983r436b3040],
4	Duval	NNP	PERSON	Duval	nn	5	SENT_372	[p16l482t2980r635b3029],
5	SJ	NNP	O	SJ	appos	2	SENT_372	[p16l679t2982r739b3040],
6	,	,	O	,	_	0	SENT_372	[p16l679t2982r739b3040],
7	Tweedie	NNP	PERSON	Tweedie	nn	8	SENT_372	[p16l781t2980r1014b3029],
8	RL	NNP	O	RL	appos	5	SENT_372	[p16l1057t2983r1132b3029],
9	.	.	O	.	_	0	SENT_372	[p16l1057t2983r1132b3029],

1	Empirical	JJ	MISC	empirical	amod	2	SENT_373	[p16l1178t2980r1425b3044],
2	assessment	NN	O	assessment	_	0	SENT_373	[p16l1468t2986r1778b3029],
3	of	IN	O	of	_	0	SENT_373	[p16l1816t2980r1869b3029],
4	effect	NN	O	effect	prep_of	2	SENT_373	[p16l1906t2980r2059b3029],
5	of	IN	O	of	_	0	SENT_373	[p16l2097t2980r2151b3029],
6	publication	NN	O	publication	nn	7	SENT_373	[p16l148t3057r455b3121],
7	bias	NN	O	bias	prep_of	2	SENT_373	[p16l485t3057r589b3106],
8	on	IN	O	on	_	0	SENT_373	[p16l615t3071r682b3106],
9	meta-analyses	NNS	O	meta-analysis	prep_on	2	SENT_373	[p16l712t3057r1116b3121],
10	.	.	O	.	_	0	SENT_373	[p16l712t3057r1116b3121],

1	BM	NN	O	bm	_	0	SENT_374	[p16l1147t3059r1250b3117],
2	]	CD	NUMBER	]	num	3	SENT_374	[p16l1147t3059r1250b3117],
3	2000	CD	DATE	2000	dep	1	SENT_374	[p16l1273t3058r1430b3116],
4	;	:	O	;	_	0	SENT_374	[p16l1273t3058r1430b3116],
5	320	CD	NUMBER	320	num	7	SENT_374	[p16l1460t3058r1580b3106],
6	:	:	O	:	_	0	SENT_374	[p16l1460t3058r1580b3106],
7	1574-1577	CD	DATE	1574-1577	dep	1	SENT_374	[p16l1612t3058r1944b3106],
8	.	.	O	.	_	0	SENT_374	[p16l1612t3058r1944b3106],

